Unnamed: 0,title,date,stock,sentiment
706794.0,Moderna On Track To Start Phase 3 Coronavirus Vaccine Trial In July,2020-06-11 10:37:00-04:00,JNJ,neutral
706795.0,"Shares of several healthcare companies are trading lower in sympathy with the overall market following an increase in coronavirus cases in some US states that have reopened, leading to concerns of a second wave of the virus.",2020-06-11 10:22:00-04:00,JNJ,positive
706796.0,"It's Not All COVID-19 And The Fed: Lululemon Reports After Close, And Airline Stocks Dive",2020-06-11 09:38:00-04:00,JNJ,neutral
706797.0,A Peek Into The Markets: US Stock Futures Tumble Ahead Of Jobless Claims Report,2020-06-11 05:56:00-04:00,JNJ,neutral
706798.0,Johnson & Johnson To Start Coronavirus Vaccine Human Trials Ahead Of Schedule In July,2020-06-11 00:16:00-04:00,JNJ,neutral
706799.0,"J&J Moves Up Human Clinical Trails Of its COVID-19 Vaccine To Start In July, Ahead Of Planned September Start",2020-06-10 13:05:00-04:00,JNJ,neutral
706800.0,"J&J Is In Talks To Begin Phase 3 Coronavirus Vaccine Trial Ahead Of Schedule, Pending Phase 1 Studies Outcome, Regulatory Approval",2020-06-10 09:30:00-04:00,JNJ,positive
706801.0,"NIH Official Says U.S. Plans 3 Large Studies of Experimental Coronavirus Vaccines  From Moderna, AstraZeneca Johnson & Johnson Starting in July, August, September",2020-06-10 05:34:00-04:00,JNJ,neutral
706802.0,"Revlon, Chanel, L'Oréal Are Quietly Removing Talc From Their Products As Cancer Lawsuits Mount: Report",2020-06-09 10:15:00-04:00,JNJ,negative
706803.0,Travel Stocks Lose Momentum In Pre-Market After Leading Yesterday's Sharp Rally,2020-06-09 09:49:00-04:00,JNJ,negative
706804.0,"Navarro: China Is 'Trying To Steal Our Vaccines, As We Speak'",2020-06-08 10:28:00-04:00,JNJ,negative
706805.0,Halozyme Announces J&J's Janssen Receives European Marketing Authorization For Subcutaneous DARZALEX Utilizing Halozyme's ENHANZE Technology For The Treatment Of Patients With Multiple Myeloma,2020-06-04 12:38:00-04:00,JNJ,neutral
706806.0,Ex-FDA Chief On White House's Coronavirus Vaccine Shortlist: 'They Chose Very Novel Platforms',2020-06-04 11:02:00-04:00,JNJ,positive
706807.0,Genmab Reports European Marketing Authorization For Subcutaneous Formulation Of DARZALEX For Treatment Of Patients With Multiple Myeloma,2020-06-04 09:44:00-04:00,JNJ,neutral
706808.0,Revisiting The Coronavirus Vaccine Race: Updates On The 10 Candidates In Clinics,2020-06-03 17:53:00-04:00,JNJ,neutral
706809.0,"UPDATE: Five Companies Chosen For 'Vaccine Finalist' Are Moderna, Johnson & Johnson, Merck, Pfizer And AstraZeneca",2020-06-03 13:09:00-04:00,JNJ,neutral
706810.0,Pharma Large And Mid-Caps Race Against COVID-19,2020-06-02 14:50:00-04:00,JNJ,neutral
706811.0,4 Blue Chips That Lived Up To Their Title During the Pandemic,2020-06-02 14:17:00-04:00,JNJ,neutral
706812.0,"U.S. Army Planning To Test Vaccines From Moderna, Astrazeneca, Johnson & Johnson And Sanofi; Army Will Test Its Own Vaccine Candidate In Human Trials Later This Summer",2020-06-02 12:03:00-04:00,JNJ,neutral
706813.0,4 Sector ETFs To Buy And Sell In June,2020-06-01 13:35:00-04:00,JNJ,neutral
706814.0,Novavax Begins Phase 1 Clinical Trial Of Its Coronavirus Vaccine,2020-05-26 02:48:00-04:00,JNJ,neutral
706815.0,"US Health Official Says Vaccines From J&J, Sanofi, Merck May Be Added This Summer As They Complete Phase 1 Safety Studies",2020-05-22 13:50:00-04:00,JNJ,positive
706816.0,"US Says Will Test Experimental Coronavirus Vaccines In 100,000+ People, Health Official Says Oxford Vaccine May Be Tested ""Side By Side"" With Moderna's Starting In July",2020-05-22 13:50:00-04:00,JNJ,neutral
706817.0,"Johnson & Johnson Pulls Talc-Based Baby Powder From US, Canada As Cancer Claims Kill Demand",2020-05-20 01:09:00-04:00,JNJ,negative
706818.0,Johnson & Johnson Consumer Health Will Wind Down Commercialization Of Talc-based Johnson's Baby Powder In The U.S. And Canada In Coming Months,2020-05-19 16:39:00-04:00,JNJ,neutral
706819.0,"In The Midst Of Pandemic, Traders Pin Their Hopes On These Healthcare ETFs",2020-05-19 09:38:00-04:00,JNJ,positive
706820.0,Moncef Slaoui To Divest Moderna Stake As He Joins White House Vaccine Accelerator,2020-05-19 09:00:00-04:00,JNJ,neutral
706821.0,"These 6 Coronavirus Vaccine Candidates Are The Likeliest To Succeed, Says Morgan Stanley",2020-05-18 12:07:00-04:00,JNJ,positive
706822.0,Janssen Gives an Update on its Phase 1 Study on Teclistamab in patients with Multiple Myeloma,2020-05-18 07:10:00-04:00,JNJ,neutral
706823.0,"Barron's Picks And Pans: Cisco, Gilead, Netflix, Wayfair And More",2020-05-17 11:00:00-04:00,JNJ,neutral
706824.0,"Avicanna Combines Sustainable Cultivation Methods, R&D, and Pharmaceutical Standards to Offer API's with the Aureus Brand",2020-05-15 12:15:00-04:00,JNJ,neutral
706825.0,Novavax Analysts Say CEPI Funding 'Speaks Volumes' About Coronavirus Vaccine Development,2020-05-12 14:08:00-04:00,JNJ,neutral
706826.0,Cruise Line Earnings Later This Week Could Provide Insight On Brutal Quarter For Industry,2020-05-11 11:27:00-04:00,JNJ,negative
706827.0,Provention Bio's CEO On Identifying Autoimmune Diseases 'Before It's Too Late',2020-05-05 11:28:00-04:00,JNJ,neutral
706828.0,What You Should Know About Alexion's $1.4B Proposed Buyout Of Portola Pharma,2020-05-05 09:10:00-04:00,JNJ,neutral
706829.0,"The Daily Biotech Pulse: Bio-Rad's Coronavirus Test Gets EUA, Beat-And-Raise Quarter From GenMark, Adverum's Positive Gene Therapy Readout",2020-05-05 08:00:00-04:00,JNJ,positive
706830.0,Attention Biotech Investors: Mark Your Calendar For These May PDUFA Dates,2020-05-03 09:25:00-04:00,JNJ,neutral
706831.0,"Moderna, Lonza Strike Deal To Manufacture Up To 1 Billion Doses Of Coronavirus Vaccine Candidate Annually",2020-05-01 09:11:00-04:00,JNJ,negative
706832.0,"The Daily Biotech Pulse: Gilead Slips Despite Forecast-Beating Q1, Moderna Partners With Lonza For Coronavirus Vaccine Production, Lyra Therapeutics IPO",2020-05-01 07:54:00-04:00,JNJ,neutral
706833.0,Halozyme Highlights Janssen's Receipt Of CHMP Positive Opinion For DARZALEX Subcutaneous Formulation Utilizing Halozyme's ENHANZE Technology For Patients With Multiple Myeloma,2020-04-30 16:56:00-04:00,JNJ,positive
706834.0,Johnson & Johnson Announces Committee For Medicinal Products For Human Use Of Ema Has Issued A Positive Opinion Recommending Approval For Darzalex,2020-04-30 15:39:00-04:00,JNJ,positive
706835.0,"Barclays Maintains Overweight on Johnson & Johnson, Raises Price Target to $182",2020-04-29 11:14:00-04:00,JNJ,negative
706836.0,"Morgan Stanley Maintains Overweight on Johnson & Johnson, Raises Price Target to $170",2020-04-29 09:02:00-04:00,JNJ,negative
706837.0,Catalent Signs Agreement With Johnson & Johnson To Be US Manufacturing Partner For Lead Coronavirus Vaccine Candidate,2020-04-29 08:04:00-04:00,JNJ,positive
706838.0,"Pfizer Says Coronavirus Vaccine Could Be Available By Fall, US Clinical Trials To Begin Next Week",2020-04-29 00:09:00-04:00,JNJ,neutral
706839.0,"UBS Downgrades Johnson & Johnson to Neutral, Lowers Price Target to $160",2020-04-28 06:05:00-04:00,JNJ,negative
706840.0,"J&J Says Federal Judge Excludes Certain Plaintiff Expert Testimony from Talc Ovarian Cancer Trials, Deeming Them Not Scientifically Sound",2020-04-28 05:39:00-04:00,JNJ,negative
706841.0,U.S. Judge Rules J&J Must Defend Federal Talc Lawsuits,2020-04-27 13:35:00-04:00,JNJ,negative
706842.0,Halozyme Announces Janssen Submits NDA In Japan For Daratumumab Subcutaneous Formulation Utilizing Halozyme's ENHANZE® Technology For Patients With Multiple Myeloma,2020-04-27 05:45:00-04:00,JNJ,neutral
706843.0,"Barron's Picks And Pans: Albertsons, Carnival, Harley-Davidson And More",2020-04-25 15:32:00-04:00,JNJ,neutral
706844.0,J&J's Janssen Pharma Reports Submission Of 2 Applicats Seeking Approval Of SIMPONI ARIA For Treatment Of Polyarticular Juvenile Idiopathic Arthritis and Juvenile Psoriatic Arthritis,2020-04-24 09:19:00-04:00,JNJ,positive
706845.0,"The Daily Biotech Pulse: FDA Approves Sanofi's Meningococcal Vaccine, Pluristem Secures $54M In Funding For COVID-19 Treatment, Oric Pharma Prices IPO",2020-04-24 08:38:00-04:00,JNJ,positive
706846.0,"UPDATE: TRACON Says Is Seeking A Licensing Partner To Develop, Commercialize TRC253 In China",2020-04-24 08:16:00-04:00,JNJ,neutral
706847.0,TRACON Pharma Reports Retained Global Rights To TRC253 Following Completion Of Phase 1/2 Trial,2020-04-24 08:15:00-04:00,JNJ,neutral
706848.0,"Six Coronavirus Vaccines Under Clinical Trials, WHO Says",2020-04-24 05:52:00-04:00,JNJ,neutral
706849.0,Inovio CEO Says 'It's Possible' For Coronavirus Vaccine To Be Ready In 12 To 18 Months,2020-04-23 22:19:00-04:00,JNJ,positive
706850.0,Stocks That Hit 52-Week Highs On Thursday,2020-04-23 10:41:00-04:00,JNJ,neutral
706851.0,"The Daily Biotech Pulse: FDA Nod For Immunomedics, Lilly's Solid Q1 Beat, Predictive Oncology Restructures Debt",2020-04-23 07:53:00-04:00,JNJ,negative
706852.0,Why Johnson & Johnson's Stock Is Trading Higher Today,2020-04-22 12:06:00-04:00,JNJ,neutral
706853.0,"Benzinga's Top Upgrades, Downgrades For April 22, 2020",2020-04-22 09:40:00-04:00,JNJ,positive
706854.0,Johnson & Johnson shares are higher after Bank of America upgraded the stock from Neutral to Buy.,2020-04-22 09:13:00-04:00,JNJ,positive
706855.0,B of A Securities Upgrades Johnson & Johnson to Buy,2020-04-22 07:24:00-04:00,JNJ,positive
706856.0,Oxford University Coronavirus Vaccine Clinical Trial To Start Thursday With $24.6M Government Funding,2020-04-22 05:46:00-04:00,JNJ,neutral
706857.0,FDA Says Expanded The Indication Of Ibrutinib (Imbruvica),2020-04-21 14:55:00-04:00,JNJ,neutral
706858.0,How The COVID-19 Pandemic Could End,2020-04-20 16:33:00-04:00,JNJ,neutral
706859.0,"The Week Ahead In Biotech (April 19-25): Eli Lilly, Biogen Earnings On Tap, Sanofi Awaits FDA Decision",2020-04-19 17:22:00-04:00,JNJ,positive
706860.0,"Barron's Picks And Pans: Dropbox, Ford, Johnson & Johnson, Teladoc And More",2020-04-19 14:44:00-04:00,JNJ,neutral
706861.0,"Big Earnings Day As Honeywell, Procter & Gamble, Schlumberger Among Those Reporting",2020-04-17 09:46:00-04:00,JNJ,neutral
706862.0,Moderna Gets $483M Federal Funding For Its Coronavirus Vaccine,2020-04-17 02:09:00-04:00,JNJ,neutral
706863.0,S&P 500 Futures Up 3.2% After Hours; Many Other Stocks Moving Higher With Futures; Investors Reacting Favorably To White Phase Guidelines On Reopening Economy,2020-04-16 18:11:00-04:00,JNJ,positive
706864.0,"Alibaba, Tesla Among Cramer's Stay-At-Home Stock Ideas",2020-04-16 11:48:00-04:00,JNJ,neutral
706865.0,"Why Johnson & Johnson Inspires Cramer's Bullishness On Disney, Visa, Mastercard",2020-04-16 10:19:00-04:00,JNJ,positive
706866.0,Every Member Of Trump's 'Great American Economic Revival' Industry Groups,2020-04-15 13:09:00-04:00,JNJ,positive
706867.0,"Stifel Maintains Hold on Johnson & Johnson, Raises Price Target to $155",2020-04-15 10:14:00-04:00,JNJ,neutral
706868.0,"Wells Fargo Maintains Overweight on Johnson & Johnson, Raises Price Target to $162",2020-04-15 09:17:00-04:00,JNJ,negative
706869.0,10 Biggest Price Target Changes For Wednesday,2020-04-15 08:35:00-04:00,JNJ,neutral
706870.0,"Credit Suisse Reiterates Outperform on Johnson & Johnson, Raises Price Target to $161",2020-04-15 08:27:00-04:00,JNJ,positive
706871.0,"Citigroup Maintains Buy on Johnson & Johnson, Raises Price Target to $165",2020-04-15 08:21:00-04:00,JNJ,neutral
706872.0,"Raymond James Reiterates Outperform on Johnson & Johnson, Raises Price Target to $157",2020-04-15 07:20:00-04:00,JNJ,neutral
706873.0,"J&J Expects Procedure Volumes In Areas Such As Oncology, General Surgery To Rebound Sooner",2020-04-14 10:08:00-04:00,JNJ,neutral
706874.0,"JPMorgan, Wells Fargo Earnings Lower Than Expected, But Positive Tone Helps Shares",2020-04-14 09:56:00-04:00,JNJ,positive
706875.0,J&J CEO Says China Business Starting To Return To Normalcy,2020-04-14 09:53:00-04:00,JNJ,neutral
706876.0,Tuesday's Market Minute: Earnings Season Begins Again,2020-04-14 09:33:00-04:00,JNJ,neutral
706877.0,"The Daily Biotech Pulse: Amarin Reports Strong Q1 Vascepa Sales, BeiGene Aces Late-Stage Lung Cancer Study, Glaxo, Sanofi Strike COVID-19 Vaccine Partnership",2020-04-14 07:59:00-04:00,JNJ,negative
706878.0,Johnson & Johnson shares are trading higher after the company reported better-than-expected Q1 EPS and sales results.,2020-04-14 07:40:00-04:00,JNJ,positive
706879.0,Mike Khouw Saw Unusual Options Activity In Johnson & Johnson Ahead Of Earnings,2020-04-14 07:30:00-04:00,JNJ,neutral
706880.0,Johnson & Johnson: Q1 Earnings Insights,2020-04-14 07:18:00-04:00,JNJ,neutral
706881.0,ImmunoPrecise Announces Research License Agreement With Janssen,2020-04-14 07:07:00-04:00,JNJ,positive
706882.0,Genmab Highlights Q1 Net Sales Of DARZALEX By Johnson And Johnson Were $937M; Genmab Will Receive Royalties On Sales Under Exclusive Worldwide License,2020-04-14 06:37:00-04:00,JNJ,positive
706883.0,"Johnson & Johnson Cuts FY20 Adj. EPS Guidance From $8.95-$9.10 To $7.50-$7.90, Cuts Operational Sales Guidance From $85.8B-$86.6B To $77.5B-$80.5B; Guidance Includes Impact Of Coronavirus And Related Investments",2020-04-14 06:35:00-04:00,JNJ,negative
706884.0,"Johnson & Johnson Q1 Adj. EPS $2.300 Beats $1.990 Estimate, Sales $20.691B Beat $19.440B Estimate",2020-04-14 06:32:00-04:00,JNJ,neutral
706885.0,Johnson & Johnson Raises Quarterly Dividend From $0.95 To $1.01/Share,2020-04-14 06:30:00-04:00,JNJ,neutral
706886.0,"5 Stocks To Watch For April 14, 2020",2020-04-14 05:07:00-04:00,JNJ,neutral
706887.0,"Earnings Scheduled For April 14, 2020",2020-04-14 04:55:00-04:00,JNJ,neutral
706888.0,"Financials, Healthcare In Eye Of Earnings Hurricane Ahead, With Bank CEOs In Spotlight",2020-04-13 10:01:00-04:00,JNJ,neutral
706889.0,Monday's Market Minute: OPEC Production Cut To Avoid A Glut,2020-04-13 09:32:00-04:00,JNJ,negative
706890.0,"The Week Ahead In Biotech: Urogen FDA Decision, Amarin, J&J Earnings And More COVID-19 Updates",2020-04-12 10:05:00-04:00,JNJ,neutral
706891.0,FTC Closes Investigation of Johnson & Johnson's Proposed Acquisition of TachoSil from Takeda Pharmaceutical; FTC Says JNJ Abandoned Proposed Acquisition,2020-04-10 10:55:00-04:00,JNJ,negative
706892.0,"Coronavirus Vaccine Developed In Short Time Unlikely To Be Safe, International Vaccine Institute Says",2020-04-09 06:50:00-04:00,JNJ,positive
706893.0,"SVB Leerink Maintains Outperform on Johnson & Johnson, Lowers Price Target to $160",2020-04-08 11:29:00-04:00,JNJ,negative
706894.0,Materials Stocks See More Interest Amid Hopes for Federal Infrastructure Spending,2020-04-08 10:05:00-04:00,JNJ,positive
706895.0,Inovio Pharmaceuticals Begins Phase 1 Human Testing Of Its COVID-19 Vaccine,2020-04-07 04:02:00-04:00,JNJ,neutral
706896.0,Shares of several healthcare companies are trading higher as markets gain amid optimism that coronavirus cases in several US hotspots may be peaking. A sooner peak could mean a sooner return to economic activity.,2020-04-06 09:42:00-04:00,JNJ,positive
706897.0,"Cramer Gives His Opinion Alteryx, Johnson & Johnson And More",2020-04-06 07:28:00-04:00,JNJ,neutral
706898.0,"Barron's Picks And Pans: Post-Pandemic Ideas, Safe Dividends And More",2020-04-04 14:25:00-04:00,JNJ,positive
706899.0,"The Daily Biotech Pulse: Fate Therapeutics Inks Cell Therapy Deal With J&J, Zentalis IPO",2020-04-03 07:36:00-04:00,JNJ,neutral
706900.0,"Global Coronavirus Cases Surge Past 1M, Medical Equipment Remains In Shortage",2020-04-03 06:40:00-04:00,JNJ,negative
706901.0,"Moderna Coronavirus Vaccine Phase 2 Trials Could Start In Spring, Chairman Says",2020-04-03 03:29:00-04:00,JNJ,neutral
706902.0,Fate Therapeutics Announces Worldwide Collaboration With Janssen For Novel IPSC-derived Cell-Based Cancer Immunotherapies; Co. To Receive $50M Upfront And $50M Equity Investment And Eligible To Receive Up To $1.8B,2020-04-02 16:47:00-04:00,JNJ,negative
706903.0,"Wells Fargo Maintains Overweight on Johnson & Johnson, Lowers Price Target to $150",2020-04-02 09:07:00-04:00,JNJ,negative
706904.0,Credit Suisse Compiles List Of Corporations With Most And Least Cash,2020-04-02 06:57:00-04:00,JNJ,positive
706905.0,"Stifel Maintains Hold on Johnson & Johnson, Lowers Price Target to $140",2020-04-01 10:19:00-04:00,JNJ,negative
706906.0,Shares of several healthcare companies are trading lower amid market weakness as growing coronavirus concerns in the US weigh on equities.,2020-04-01 09:20:00-04:00,JNJ,negative
706907.0,The Prize No One Wanted: Dow On Pace For Steepest Q1 Loss Ever As Quarter Finally Ends,2020-03-31 09:50:00-04:00,JNJ,negative
706908.0,Johnson & Johnson shares are trading higher on continued strength after the company announced a Coronavirus vaccine candidate. The company anticipates the first batches of the vaccine could be available for emergency use as early as 2021.,2020-03-31 09:05:00-04:00,JNJ,positive
706909.0,Afternoon Market Stats in 5 Minutes,2020-03-30 14:05:00-04:00,JNJ,neutral
706910.0,"UPDATE On BZ NOTE For J&J, Abbott Headline: J&J Earlier Suggested Promise For Potential Coronavirus Vaccine Candidate, Sees Phase 1 Human Trials Starting Sept. 2020 With Results From Phase 3 Trials By End Of 2020",2020-03-30 12:10:00-04:00,JNJ,positive
706911.0,"J&J, Abbott Shares Unaffected Amid Circulation Of Headline From FT Suggesting Co.'s Announce A Potential Coronavirus Vaccine, Rapid Test; BZ NOTE: Reminder J&J Announced Details About An Isolated Coronavirus Candidate At 7 a.m. EDT Mon.",2020-03-30 12:09:00-04:00,JNJ,positive
706912.0,"COVID-19 Vaccine Updates: J&J Identifies Lead Candidate, IMV Eyes Clinical Testing In Summer, Altimmune Partners With University Of Alabama",2020-03-30 09:59:00-04:00,JNJ,neutral
706913.0,Johnson & Johnson Gets Boost After Announcing September Trials Of Vaccine Planned,2020-03-30 09:40:00-04:00,JNJ,positive
706914.0,Johnson & Johnson shares are trading higher after the company announces a Coronavirus vaccine candidate. The company anticipates the first batches of the vaccine could be available for emergency use as early as 2021.,2020-03-30 08:53:00-04:00,JNJ,negative
706915.0,"Benzinga Pro's Stock To Watch For Mon., Mar. 30, 2020: Johnson & Johnson (JNJ)",2020-03-30 08:11:00-04:00,JNJ,neutral
706916.0,UPDATE: Johnson & Johnson Anticipates First Batches Of A Vaccine Could Be Available For Emergency Use Authorization In Early 2021,2020-03-30 07:25:00-04:00,JNJ,negative
706917.0,Johnson & Johnson Announces Coronavirus Vaccine Candidate,2020-03-30 07:23:00-04:00,JNJ,neutral
706918.0,"Morgan Stanley Maintains Overweight on Johnson & Johnson, Lowers Price Target to $160",2020-03-27 09:44:00-04:00,JNJ,negative
706919.0,"Shares of several healthcare companies are trading lower, selling off from this week's strength. While the US stimulus legislation has boosted economic optimism, demand concerns still exist amid the coronavirus outbreak.",2020-03-27 09:22:00-04:00,JNJ,positive
706920.0,"Argus Research Reiterates Buy on Johnson & Johnson, Lowers Price Target to $155",2020-03-27 09:02:00-04:00,JNJ,negative
706921.0,"Citigroup Maintains Buy on Johnson & Johnson, Lowers Price Target to $150",2020-03-27 08:50:00-04:00,JNJ,negative
706922.0,"Shares of several healthcare companies are trading higher following Senate passage of a $2 trillion economic stimulus package, which has lifted stocks across sectors.",2020-03-26 11:49:00-04:00,JNJ,positive
706923.0,"EU Antitrust Regulators Open In-depth Investigation Into Johnson & Johnson's Buy Of Takeda's Surgical Patch Product Tachosil; Say Deal May Reduce Potential Competition, Innovation For The Supply Of Dual Haemostatic, Set Aug. 10 Deadline For Decision",2020-03-25 11:03:00-04:00,JNJ,positive
706924.0,"Shares of several healthcare companies are trading higher as equities gain amid hopes of a US stimulus agreement. Additionally, the coronavirus outbreak has increased demand for certain medical supplies.",2020-03-24 12:20:00-04:00,JNJ,positive
706925.0,"The Daily Biotech Pulse: Milestone Pharma Flunks Late-Stage Study, CytomX Strikes Cancer Drug Collaboration, BARDA Grant For GenMark's COVID-19 Test",2020-03-24 08:20:00-04:00,JNJ,negative
706926.0,Shares of several healthcare companies are trading lower amid market volatility. Sunday's fiscal stimulus bill failed a procedural senate vote while the Fed Monday morning announced further stimulus measures to support liquidity.,2020-03-23 11:31:00-04:00,JNJ,negative
706927.0,Stocks That Hit 52-Week Lows On Monday,2020-03-23 10:34:00-04:00,JNJ,negative
706928.0,COVID-19: Where It's From And Where We're Going,2020-03-20 15:21:00-04:00,JNJ,neutral
706929.0,"Janssen Announces Health Canada Approval Of Cabenuva, First Long-acting Regimen For Treatment Of HIV; Studies Showed Cabenuva Was As Effective As Continuing Daily, Oral, Antiretroviral Regimens In Maintaining Viral Suppression During 48-week Study",2020-03-20 09:49:00-04:00,JNJ,positive
706930.0,"The Daily Biotech Pulse: Pfizer's Eczema Drug Aces Latestage Study, Orphan Drug Designation For Dicerna, Dyadic's COVID-19 Connection",2020-03-19 07:37:00-04:00,JNJ,neutral
706931.0,J&J's Janssen Submits Ponesimod New Drug Application As Treatment For Adults With Relapsing Multiple Sclerosis,2020-03-18 16:01:00-04:00,JNJ,neutral
706932.0,'J&J hopes to start human trials for coronavirus vaccine in November' -CNBC,2020-03-17 15:45:00-04:00,JNJ,positive
706933.0,8 Biotechs With Coronavirus Vaccines In Development,2020-03-16 10:42:00-04:00,JNJ,neutral
706934.0,Shares of several healthcare companies are trading lower in sympathy with the overall market on continued downward momentum caused by the coronavirus. The virus has had a negative impact on the global economy.,2020-03-16 09:40:00-04:00,JNJ,negative
706935.0,J&J Says Sees No Evidence Darunavir Has Effect Against Coronavirus Infection,2020-03-16 09:39:00-04:00,JNJ,negative
706936.0,"J&J Says Experiencing Increased Consumer-Driven Demand For Products, Particularly Within Our Self Care Portfolio, Including Tylenol; Says It Is Shipping Stock Of Tylenol In A Controlled Manner",2020-03-13 12:38:00-04:00,JNJ,positive
706937.0,J&J Reports Collaboration With Beth Israel Deaconness Medical Center To Accelerate Coronavirus Vaccine Development,2020-03-13 09:42:00-04:00,JNJ,neutral
706938.0,Shares of several healthcare companies are trading higher as the market rebounds following Thursday's selloff. NOTE: Since the coronavirus outbreak the healthcare sector has been extremely volatile.,2020-03-13 09:29:00-04:00,JNJ,positive
706939.0,J&J Says Does Not Expect Pharma Supply Interruptions Related To Coronavirus,2020-03-13 08:59:00-04:00,JNJ,negative
706940.0,Stocks That Hit 52-Week Lows On Thursday,2020-03-12 12:10:00-04:00,JNJ,negative
706941.0,Shares of several healthcare companies are trading lower as equities sell off amid continued global coronavirus concerns. The virus has caused global economic disruption and negatively impacted stocks across sectors.,2020-03-12 09:26:00-04:00,JNJ,negative
706942.0,"The Daily Biotech Pulse: NY State Endorses Mallinckrodt's Opioid Settlement, Kamada To Work On COVID-19 Treatment",2020-03-11 08:03:00-04:00,JNJ,positive
706943.0,Shares of several healthcare companies are trading lower. Movement appears market related amid selloff in equities. The global coronavirus outbreak has caused volatility in global markets and impacted stocks across sectors.,2020-03-11 07:15:00-04:00,JNJ,neutral
706944.0,How Close Are Biotechs To Bringing A COVID-19 Treatment To Market?,2020-03-10 17:24:00-04:00,JNJ,neutral
706945.0,J&J's Janssen Announces FDA Breakthrough Therapy Designation Granted For JNJ-6372 For The Treatment Of Non-Small Cell Lung Cancer,2020-03-10 16:03:00-04:00,JNJ,negative
706946.0,Shares of several healthcare companies are trading higher as markets rebound following Monday's selloff. US President Trump on Monday indicated the US may implement payroll tax cuts and other measures to support the economy amid the coronavirus outbreak.,2020-03-10 07:54:00-04:00,JNJ,positive
706947.0,52 Healthcare Stocks Moving In Monday's Pre-Market Session,2020-03-09 08:04:00-04:00,JNJ,neutral
706948.0,What You Need To Know About Publicly-Traded Psychedelics Companies,2020-03-06 13:49:00-05:00,JNJ,neutral
706949.0,"Credit Suisse Maintains Outperform on Johnson & Johnson, Lowers Price Target to $159",2020-03-06 10:30:00-05:00,JNJ,positive
706950.0,"Benzinga's Top Upgrades, Downgrades For March 5, 2020",2020-03-05 10:05:00-05:00,JNJ,positive
706951.0,"Citigroup Initiates Coverage On Johnson & Johnson with Buy Rating, Announces $163 Price Target",2020-03-05 04:52:00-05:00,JNJ,neutral
706952.0,"Hearing Citi Initiates Coverage On J&J, Boston Scientific, Zimmer Biomet, Stryker, Medtronic, Insulet With Buy Ratings",2020-03-04 17:47:00-05:00,JNJ,neutral
706953.0,"The Daily Biotech Pulse: Takeda Jumps Into The COVID-19 Fray, Exact Sciences Buys Cancer Diagnostics Companies",2020-03-04 07:37:00-05:00,JNJ,negative
706954.0,Shares of several healthcare-related companies are trading higher after Joe Biden secured several key wins in Super Tuesday. Biden's more 'moderate' healthcare policies have been seen as more favorable for the sector.,2020-03-04 07:16:00-05:00,JNJ,positive
706955.0,Janssen Submits EMA Application for Ponesimod for Treatment of Adults with Relapsing MS,2020-03-04 05:17:00-05:00,JNJ,neutral
706956.0,Shares of several healthcare companies are trading lower in sympathy with the overall market. The Fed cut rates to combat the coronavirus outbreak which caused an initial spike but then continued to trade lower.,2020-03-03 11:55:00-05:00,JNJ,negative
706957.0,Pfizer Works On Compounds That May Help Stop Coronaviruses,2020-03-03 06:53:00-05:00,JNJ,positive
706958.0,How The COVID-19 Outbreak Is Benefiting Biotech Investors,2020-03-02 14:27:00-05:00,JNJ,neutral
706959.0,Shares of several healthcare companies are trading lower as the global coronavirus spread continues to cause equities across sectors to sell off amid worsened economic outlook.,2020-02-28 09:06:00-05:00,JNJ,negative
706960.0,"J&J Issues Press Release To Highlight Launch Of Janssen Pharma's Open Enrollment for Heartline Study With Apple, Will Explore If Heartline Study App On iPhone, Heart Health Features On Apple Watch Can Improve Health Outcomes",2020-02-25 08:33:00-05:00,JNJ,positive
706961.0,Some Market Stats In 5 Minutes,2020-02-21 14:30:00-05:00,JNJ,neutral
706962.0,J&J Shares At Session Highs With Broader Stock Market; Hearing Co.'s Janssen Pharma To Expand Its Existing Partnership With BARDA To Seek Treatment Solutions For Coronavirus,2020-02-18 10:11:00-05:00,JNJ,positive
706963.0,21 States Reject $18B Offer From Drug Wholesalers To Settle Opioid Litigation,2020-02-14 10:10:00-05:00,JNJ,negative
706964.0,"The Daily Biotech Pulse: Epizyme's Tazemetostat sNDA Accepted For Priority Review, Eisai To Withdraw Weight Loss Drug, Sol-Gel Prices Offering",2020-02-14 08:23:00-05:00,JNJ,negative
706965.0,"The Daily Biotech Pulse: J&J Intensifies Efforts On COVID-19 Cure, Adamas Reports Positive, Long-Term Gocovri Data",2020-02-12 09:18:00-05:00,JNJ,positive
706966.0,Johnson & Johnson Announces Collaboration With US Department of Health & Human Services To 'Accelerate Development of a Potential Novel Coronavirus Vaccine',2020-02-11 16:30:00-05:00,JNJ,positive
706967.0,"The Daily Biotech Pulse: LogicBio Slapped With Clinical Hold, Agile Inks Debt Deal Ahead of Twirla Approval, Gilead Builds Stake In Sierra Oncology",2020-02-11 07:23:00-05:00,JNJ,positive
706968.0,"New York Opioid Case A Significant Risk For Pharma Stocks, Says Bearish BofA",2020-02-10 14:43:00-05:00,JNJ,negative
706969.0,3 Leveraged Healthcare ETFs Soaring This Month,2020-02-10 09:39:00-05:00,JNJ,neutral
706970.0,Johnson & Johnson Hit with $750M Punitive Damages Verdict for Failing to Warn about Cancer-Causing Asbestos in Talc Products,2020-02-07 12:36:00-05:00,JNJ,negative
706971.0,"The Daily Biotech Pulse: Assertio To Sell Opioid Pain Drug, Milestone Payment For Aduro, Myriad Genetics CEO Resigns",2020-02-07 07:32:00-05:00,JNJ,negative
706972.0,J&J Says Judge Reducing NJ Talc Verdict To $185M,2020-02-06 15:36:00-05:00,JNJ,positive
706973.0,J&J Ordered To Pay $750M In Punitive Damage Over Talc Case,2020-02-06 14:52:00-05:00,JNJ,negative
706974.0,Stocks That Hit 52-Week Highs On Thursday,2020-02-06 10:39:00-05:00,JNJ,neutral
706975.0,"The Daily Biotech Pulse: Tonix Slumps On Failed Study, Applied Genetic Announces Offering, Beam Therapeutics, PPD Price IPOs",2020-02-06 07:47:00-05:00,JNJ,negative
706976.0,WHO Says There's No Effective Coronavirus Treatment Yet,2020-02-05 15:00:00-05:00,JNJ,positive
706977.0,Stocks That Hit 52-Week Highs On Wednesday,2020-02-05 10:16:00-05:00,JNJ,neutral
706978.0,"The Daily Biotech Pulse: Merck Spins Off Slow-Growth Businesses, ZioPharm Announces Offering, PhaseBio Data",2020-02-05 07:43:00-05:00,JNJ,neutral
706979.0,Stocks That Hit 52-Week Highs On Tuesday,2020-02-04 10:18:00-05:00,JNJ,neutral
706980.0,"Barron's Picks And Pans: Intel, Johnson & Johnson, T-Mobile And More",2020-02-01 15:28:00-05:00,JNJ,neutral
706981.0,"The Daily Biotech Pulse: Sanofi Reports Positive Readout, Tonix Vaccine Candidate Aces Animal Study, Hologix's Weak Guidance",2020-01-30 09:26:00-05:00,JNJ,positive
706982.0,Johnson & Johnson Also Says Providing Supplies Of Antiviral Medicines To China For Investigational Use,2020-01-29 08:50:00-05:00,JNJ,neutral
706983.0,Johnson & Johnson Says Initiating Coronavirus Vaccine Development,2020-01-29 08:49:00-05:00,JNJ,neutral
706984.0,"The Daily Biotech Pulse: Novartis Earnings, Hepion's NASH Candidate Beats Rival Drugs, Annovis Bio To Debut",2020-01-29 08:30:00-05:00,JNJ,neutral
706985.0,Health Canada Approves New Indication For Invokana To Reduce Risks Associated With Diabetic Kidney Disease In Patients With Type 2 Diabetes,2020-01-28 07:33:00-05:00,JNJ,positive
706986.0,"Johnson & Johnson Is 'Confident' In Ability To Treat Coronavirus, But Vaccine Could Take Time",2020-01-27 09:16:00-05:00,JNJ,positive
706987.0,10 Biggest Price Target Changes For Monday,2020-01-27 08:56:00-05:00,JNJ,neutral
706988.0,Health Canada Has Approved Janssen's Stelara For Treatment Of Adult Patients With Moderately To Severely Active Ulcerative Colitis,2020-01-27 07:35:00-05:00,JNJ,positive
706989.0,"Credit Suisse Maintains Outperform on Johnson & Johnson, Raises Price Target to $170",2020-01-27 07:27:00-05:00,JNJ,positive
706990.0,Janssen Announces European Commission Approves Expanded Use Of Stelara For Treatment Of Paediatric Patients With Moderate To Severe Plaque Psoriasis,2020-01-23 11:22:00-05:00,JNJ,neutral
706991.0,10 Biggest Price Target Changes For Thursday,2020-01-23 08:13:00-05:00,JNJ,neutral
706992.0,"Raymond James Maintains Outperform on Johnson & Johnson, Raises Price Target to $161",2020-01-23 07:51:00-05:00,JNJ,neutral
706993.0,Mid-Afternoon Market Update: FuelCell Energy Falls On Downbeat Q4 Results; Neurotrope Shares Rise,2020-01-22 14:24:00-05:00,JNJ,positive
706994.0,Mid-Day Market Update: Crude Oil Down Over 2%; One Stop Systems Shares Surge,2020-01-22 12:26:00-05:00,JNJ,negative
706995.0,Mid-Morning Market Update: Markets Open Higher; Johnson & Johnson Posts Mixed Q4 Results,2020-01-22 10:13:00-05:00,JNJ,neutral
706996.0,"IBM, Netflix Earnings Greeted With Enthusiasm, And Texas Instruments Up Later Today",2020-01-22 09:53:00-05:00,JNJ,positive
706997.0,Johnson & Johnson Says Independent Research Continues To Find No Link Between Talc And Cancer,2020-01-22 08:59:00-05:00,JNJ,negative
706998.0,"Johnson & Johnson Says Off-Patent Drugs Were Able To Retain Business A Little Longer Than Expected In 2019, And Expects It To Continue In 2020",2020-01-22 08:54:00-05:00,JNJ,neutral
706999.0,Johnson & Johnson Exec Says 2020 Forecast Does Not Assume Any Major Acquisitions Or Other Major Uses Of Cash,2020-01-22 08:53:00-05:00,JNJ,neutral
707000.0,"The Daily Biotech Pulse: Johnson & Johnson Earnings, FDA Nod For Horizon Therapeutics, Slew Of Secondary Offerings",2020-01-22 08:25:00-05:00,JNJ,neutral
707001.0,Here's How Much Investing $100 In Johnson & Johnson Stock Back In 2010 Would Be Worth Today,2020-01-22 08:22:00-05:00,JNJ,positive
707002.0,Johnson & Johnson Reports Mixed Q4 Earnings,2020-01-22 07:19:00-05:00,JNJ,neutral
707003.0,A Peek Into The Markets: US Stock Futures Climb Ahead Of Earnings,2020-01-22 06:54:00-05:00,JNJ,neutral
707004.0,Genmab Highlights 2019 Net DARZALEX Sales By Johnson & Johnson Of $2.998B,2020-01-22 06:35:00-05:00,JNJ,neutral
707005.0,"Johnson & Johnson Sees FY20 Adj. Operational EPS $9.00-$9.15, Operational Sales $85.8B-$86.6B",2020-01-22 06:32:00-05:00,JNJ,neutral
707006.0,"Johnson & Johnson Q4 Adj. EPS $1.88 Beats $1.87 Estimate, Sales $20.75B Miss $20.78B Estimate",2020-01-22 06:31:00-05:00,JNJ,negative
707007.0,"8 Stocks To Watch For January 22, 2020",2020-01-22 04:17:00-05:00,JNJ,neutral
707008.0,"Earnings Scheduled For January 22, 2020",2020-01-22 04:06:00-05:00,JNJ,neutral
707009.0,Johnson & Johnson's Q4 Earnings Outlook,2020-01-21 13:43:00-05:00,JNJ,neutral
707010.0,Stocks That Hit 52-Week Highs On Tuesday,2020-01-21 10:11:00-05:00,JNJ,neutral
707011.0,"Coronavirus Outbreak, IMF Forecast, Impeachment Trial Weigh On Investor Sentiment",2020-01-21 09:58:00-05:00,JNJ,neutral
707012.0,"3 ETFs To Consider For The Week Ahead: Big Earnings For Airlines, Chips And Consumers",2020-01-21 07:28:00-05:00,JNJ,neutral
707013.0,"The Week Ahead In Biotech: Focus On Epizyme, Merck Ahead Of PDUFA Dates, J&J To Kickstart Big Pharma Earnings",2020-01-20 14:04:00-05:00,JNJ,neutral
707014.0,Hearing Johnson & Johnson's Risperdal Verdict Lowered From $8B to $6.8B,2020-01-17 13:32:00-05:00,JNJ,neutral
707015.0,Stocks That Hit 52-Week Highs On Friday,2020-01-17 13:23:00-05:00,JNJ,neutral
707016.0,"Record Run: Stocks Keep Rolling To New Highs as Housing Data, Earnings Look Solid",2020-01-17 09:43:00-05:00,JNJ,positive
707017.0,J&N's Janssen Announced Submission Of A Type II Variation Application To European Medicines Agency For Spravato Nasal Spray,2020-01-15 07:46:00-05:00,JNJ,neutral
707018.0,"'California Gov. Gavin Newsom wants the state to become the first to create its own generic drug label, an attempt to create more competition and bring down prices.' -Axios, From Earlier",2020-01-10 12:55:00-05:00,JNJ,positive
707019.0,"Wells Fargo Maintains Overweight on Johnson & Johnson, Raises Price Target to $165",2020-01-09 08:39:00-05:00,JNJ,negative
707020.0,"Kaleido Biosciences Announces Collaboration With Janssen To Explore Potential For Microbiome Metabolic Therapies To Prevent Childhood-Onset Of Atopic, Immune And Metabolic Conditions By Promoting Healthy Function Of The Gut Microbiome",2020-01-09 08:01:00-05:00,JNJ,positive
707021.0,J&J Shares Briefly Turn Positive After U.S. Researchers Find No Clear Talc Link To Ovarian Cancer In Largest Study Yet,2020-01-07 11:09:00-05:00,JNJ,positive
707022.0,Investor Movement Index Summary: December 2019,2020-01-07 07:40:00-05:00,JNJ,neutral
707023.0,"Protagonist Therapeutics Achieves Milestone In Janssen Collaboration, Triggering $5M Payment",2020-01-07 07:10:00-05:00,JNJ,neutral
707024.0,Johnson & Johnson Reportedly Settles California Talc Case Midtrial,2020-01-06 14:18:00-05:00,JNJ,neutral
707025.0,"'Johnson & Johnson Settles California Talc Case Midtrial, likely avoiding a huge judgement against them' -Law 360",2020-01-06 13:40:00-05:00,JNJ,neutral
707026.0,"Speaker Of The House Nancy Pelosi Says ""Enough is enough. @HouseDemocrats passed the bipartisan #LowerDrugCosts Now Act last year to stop Big Pharma from charging Americans more for our medicines than what they charge for the same drugs overseas.""",2020-01-02 16:36:00-05:00,JNJ,negative
707027.0,Washington State Sues Johnson & Johnson Over Opioid Epidemic,2020-01-02 14:05:00-05:00,JNJ,neutral
707028.0,Pulmatrix Shares Soar On Licensing Agreement With Johnson & Johnson,2020-01-02 13:45:00-05:00,JNJ,positive
707029.0,Pulmatrix Announces Kinase Inhibitor Licensing Agreement with Lung Cancer Initiative at Johnson & Johnson,2020-01-02 09:00:00-05:00,JNJ,negative
707030.0,Provention Bio 8-K Shows Co. Was Informed By J&J's Janssen Pharma It No Longer Intends To Take Up Option To Buy Back Rights For PRV-6527 Compound,2019-12-26 16:43:00-05:00,JNJ,negative
707031.0,How The Dow Jones Industrial Average Changed Over The Past Decade,2019-12-22 10:00:00-05:00,JNJ,neutral
707032.0,Stocks That Hit 52-Week Highs On Friday,2019-12-20 11:59:00-05:00,JNJ,neutral
707033.0,"The Daily Biotech Pulse: Axovant Surges On Gene Therapy Study Results, FDA Approves Merck's Ebola Vaccine, Abeona Announces Offering",2019-12-20 08:12:00-05:00,JNJ,positive
707034.0,"J&J To Purchase Remaining Stake In Verb Surgical, No Terms Disclosed",2019-12-20 06:46:00-05:00,JNJ,negative
707035.0,"PreMarket Prep Recap: Earnings Movers, Finding Sellers In Johnson & Johnson",2019-12-19 12:37:00-05:00,JNJ,neutral
707036.0,"Benzinga's Top Upgrades, Downgrades For December 19, 2019",2019-12-19 09:51:00-05:00,JNJ,positive
707037.0,"Barclays Upgrades Johnson & Johnson to Overweight, Raises Price Target to $173",2019-12-19 06:37:00-05:00,JNJ,negative
707038.0,"UPDATE: Morgan Stanley Upgrades Johnson & Johnson To Overweight, Raises Target To $170 Notes Co's 'defensiveness is down but not out. Legal liabilities appear more than reflected, the pharma segment should accelerate and the business is now more balanced'",2019-12-17 12:24:00-05:00,JNJ,negative
707039.0,"Benzinga's Top Upgrades, Downgrades For December 17, 2019",2019-12-17 11:16:00-05:00,JNJ,positive
707040.0,"Benzinga Pro's Top 5 Stocks To Watch For Tues., Dec. 17, 2019: BA, AAPL, BLPH, JNJ, LLY",2019-12-17 08:50:00-05:00,JNJ,positive
707041.0,"Morgan Stanley Upgrades Johnson & Johnson to Overweight, Announces $170 Price Target",2019-12-17 06:25:00-05:00,JNJ,negative
707042.0,Janssen Announces Results From Phase 3 CANDOR Study; DARZALEX Regimen Showed 'Significant Increase in Progression-Free Survival in Treatment of Patients with Relapsed/Refractory Multiple Myeloma',2019-12-10 08:00:00-05:00,JNJ,positive
707043.0,"The Daily Biotech Pulse: ASH Meeting Wraps, Fast Track Designation For Equillium, Pfizer To Buy $3M In ContraFect Shares",2019-12-10 07:56:00-05:00,JNJ,positive
707044.0,Johnson & Johnson Emerging Out Of A Dark Place,2019-12-09 11:56:00-05:00,JNJ,neutral
707045.0,Janssen and Hitgent to Collaborate on Novel DNA-Encoded Libraries,2019-12-09 08:12:00-05:00,JNJ,positive
707046.0,Vaccine Regimen from Janssen and Bavarian Nordic to Support Republic of Rwanda's Preparedness Against Ebola Outbreak,2019-12-09 05:26:00-05:00,JNJ,positive
707047.0,"Janssen Presents Initial Results for BCMA CAR-T Therapy JNJ-4528 Showing Early, Deep and High Responses in the Treatment of Relapsed or Refractory Multiple Myeloma at ASH 2019",2019-12-07 13:42:00-05:00,JNJ,neutral
707048.0,"The Week Ahead In Biotech: ASH Presentations Pick Up Steam, Correvio Awaits Adcom Ruling",2019-12-07 08:35:00-05:00,JNJ,positive
707049.0,XBiotech Announces Agreement to Sell True Human Antibody Bermekimab Targeting IL-1a to Janssen for $750M in Cash Plus Milestone Payments Up to $600M,2019-12-07 07:40:00-05:00,JNJ,positive
707050.0,Johnson & Johnson Option Alert: Jan 17 $145 Calls Sweep (2) near the Ask: 3425 @ $1.44 vs 13950 OI; Earnings 1/21 Before Open [est] Ref=$141.31,2019-12-06 09:52:00-05:00,JNJ,positive
707051.0,Genmab Achieves $100M Sales Milestone in DARZALEX Collaboration with Janssen,2019-12-05 05:04:00-05:00,JNJ,neutral
707052.0,Johnson & Johnson Option Alert: Dec 20 $140 Calls at the Ask: 2650 @ $1.41 vs 10265 OI; Earnings 1/21 Before Open [est] Ref=$139.22,2019-12-04 14:24:00-05:00,JNJ,positive
707053.0,J&J Shares Tick Lower On Slighty Uptick In Volume Amid Headline FDA Says It Stands By Study Showing Asbestos In J&J's Baby Powder,2019-12-04 13:39:00-05:00,JNJ,neutral
707054.0,Johnson & Johnson Says Investigation Reaffirmed FDA Finding Of No Asbestos In Baby Powder,2019-12-03 17:47:00-05:00,JNJ,negative
707055.0,U.S. Considers Scaling Back IP Protections For Big Drugmakers To Help Win Democratic Support For New Trade Pact With Mexico And Canada,2019-12-02 16:09:00-05:00,JNJ,positive
707056.0,Attention Biotech Investors: Mark Your Calendar For These December PDUFA Dates,2019-11-29 08:13:00-05:00,JNJ,neutral
707057.0,"National Business Daily Reports Drugmakers including Johnson & Johnson, Roche, Novartis and Merck have Agreed to Massively Cut the Prices of Some Drugs to Get Included in China's Medical Reimbursement List",2019-11-29 05:38:00-05:00,JNJ,neutral
707058.0,"Health Care ETFs Are Breaking Out, But Political Risks Linger In 2020",2019-11-27 09:35:00-05:00,JNJ,negative
707059.0,Pharma Companies Shares Tank As Feds Investigate Opioid Crisis,2019-11-27 06:14:00-05:00,JNJ,negative
707060.0,"McKesson, In Response To Report On Probe Of Opioid Makers, Distributors, Says Information About Co Getting A Subpoena Was Disclosed In Most Recent 10-Q",2019-11-26 15:53:00-05:00,JNJ,neutral
707061.0,Meg Tirrell On CNBC Says Opioid Investigation Is Not New,2019-11-26 14:20:00-05:00,JNJ,neutral
707062.0,"J&J $70 Million Award Upheld In Court, May Face Addition Court Hearing For Punitive Damages",2019-11-26 13:34:00-05:00,JNJ,negative
707063.0,Shares of opioid-related drugmakers are trading lower on reports federal prosecutors have opened a criminal probe of opioid manufacturers.,2019-11-26 13:08:00-05:00,JNJ,negative
707064.0,"Brooklyn Federal Prosecutors Open Criminal Probe Of Opioid Manufacturers, Distributors; Mallinckrodt, AmerisourceBergen, Johnson & Johnson and Amneal Say They Have Received Subpoenas",2019-11-26 12:51:00-05:00,JNJ,negative
707065.0,"Trump Says he Will Release a Plan to Let States Import Prescription Drugs Which are ""MUCH CHEAPER""",2019-11-22 14:08:00-05:00,JNJ,neutral
707066.0,This Dividend ETF Is Having Its Day,2019-11-21 08:00:00-05:00,JNJ,neutral
707067.0,"Benzinga's Top Upgrades, Downgrades For November 20, 2019",2019-11-20 09:37:00-05:00,JNJ,positive
707068.0,"Cantor Fitzgerald Initiates Coverage On Johnson & Johnson with Overweight Rating, Announces $160 Price Target",2019-11-20 06:41:00-05:00,JNJ,negative
707069.0,Janssen Receives EU Marketing Authorisation For Darzalex In Combination With Lenalidomide And Dexamethasone For Patients With Newly Diagnosed Multiple Myeloma Who Are Transplant Ineligible,2019-11-19 14:17:00-05:00,JNJ,neutral
707070.0,"Barron's Picks And Pans: Medtronic, Tesla, Walmart And More",2019-11-17 12:49:00-05:00,JNJ,neutral
707071.0,"J&J To Appeal Revised Oklahoma Judgment In Opioid Case, Argues Judgment Not Supported By Facts Or The Law",2019-11-15 15:21:00-05:00,JNJ,negative
707072.0,Oklahoma Judge Reduces $572M J&J Owes In Opioid Case To $465M,2019-11-15 14:56:00-05:00,JNJ,neutral
707073.0,Shares of several healthcare companies are trading higher after President Trump discussed transparency around pricing & processing in the healthcare industry,2019-11-15 14:51:00-05:00,JNJ,positive
707074.0,Johnson & Johnson Ebola Vaccine Begins Rollout in Congo,2019-11-14 06:46:00-05:00,JNJ,neutral
707075.0,12 Dow Stocks With At Least 2% Dividend Yields,2019-11-13 15:45:00-05:00,JNJ,neutral
707076.0,J&J's Actelion Pharmaceuticals Withdraws Regulatory Filings To Extend Indication Of OPSUMIT In CTEPH,2019-11-12 08:34:00-05:00,JNJ,positive
707077.0,Janssen Announces New Analysis from Landmark CREDENCE Study Shows the Efficacy and Safety Profiles of INVOKANA are Consistent Across Various Levels of Kidney Function,2019-11-09 17:06:00-05:00,JNJ,positive
707078.0,Biotech Stock On The Radar: Alkermes At A Crossroads,2019-11-07 11:53:00-05:00,JNJ,neutral
707079.0,Johnson & Johnson Announces Submission of European Marketing Authorisation Applications for Janssen's Investigational Ebola Vaccine Regimen,2019-11-07 06:14:00-05:00,JNJ,neutral
707080.0,Estee Lauder Reports Outstanding First Quarter Results But Cuts Estimates,2019-11-04 08:57:00-05:00,JNJ,negative
707081.0,"J&J Shares Unaffected As Hearing Co. Has Recalled Surgical Tool After Death Of Patient, Serious Injuries",2019-10-31 10:44:00-04:00,JNJ,negative
707082.0,Johnson & Johnson Says Independent Labs Found No Asbestos In Recalled Powder,2019-10-30 09:50:00-04:00,JNJ,negative
707083.0,Johnson & Johnson shares are trading higher after the company announced several tests from the same bottle of the company's baby powder that was previously tested by the FDA had no Asbestos.,2019-10-30 08:22:00-04:00,JNJ,neutral
707084.0,J&J's Janssen Announces Health Canada Approval Of Darzalex In Combination With Lenalidomide And Dexamethasone For Newly Diagnosed Patients With Multiple Myeloma Who Are Transplant Ineligible,2019-10-30 07:36:00-04:00,JNJ,positive
707085.0,13 Healthcare Stocks Moving In Wednesday's Pre-Market Session,2019-10-30 07:32:00-04:00,JNJ,neutral
707086.0,22 Stocks Moving in Wednesday's Pre-Market Session,2019-10-30 07:15:00-04:00,JNJ,neutral
707087.0,"J&J's Own Expert, Working for FDA, Found Asbestos in Baby Powder",2019-10-30 06:10:00-04:00,JNJ,neutral
707088.0,8 Stocks Moving In Tuesday's After-Hours Session,2019-10-29 17:05:00-04:00,JNJ,neutral
707089.0,Johnson & Johnson shares are trading higher after the company announced several tests from the same bottle of the company's baby powder that was previously tested by the FDA had no Asbestos.,2019-10-29 16:53:00-04:00,JNJ,neutral
707090.0,Johnson & Johnson Shares Resume Trade,2019-10-29 16:15:00-04:00,JNJ,positive
707091.0,UPDATE: Lab Undertook Probe And Determined That Portable Air Conditioner In Use In Auxiliary Room Was Contaminated With Asbestos,2019-10-29 15:59:00-04:00,JNJ,positive
707092.0,"UPDATE: Additional 48 New Tests Of Samples From Single Lot Of Oct. 18 Recalled J&J Baby Powder Confirm It Does Not Contain Asbestos; Following Recall, Co. Contracted 2 3rd-party Laboratories To Expedite Large Number Of Tests Of Recalled Lot Of Baby Powder",2019-10-29 15:55:00-04:00,JNJ,positive
707093.0,Johnson & Johnson Says 15 New Tests From Same Bottle Of Co.'s Baby Powder Previously Tested By FDA Find No Asbestos; Over 60 New Tests Of Recalled Lot Conducted By Two Third Party Laboratories Find No Asbestos,2019-10-29 15:52:00-04:00,JNJ,negative
707094.0,"Johnson & Johnson Shares Halted, News Pending",2019-10-29 15:33:00-04:00,JNJ,positive
707095.0,"J&J Says All Product Returned To Company, Whether From Recalled Lot Or Not, Will Be Removed From Marketplace Permanently",2019-10-25 12:07:00-04:00,JNJ,neutral
707096.0,Target Says Has Removed All J&J Baby Powder 22 oz Bottles From Stores And Website,2019-10-25 10:59:00-04:00,JNJ,neutral
707097.0,"Rite Aid Informed Its Stores To Pull All 22-ounce J&J Baby Powder Bottles On Oct. 18, Immediately After The Recall Was Announced",2019-10-24 16:44:00-04:00,JNJ,neutral
707098.0,"J&J, On CVS Health Removing J&J Baby Powder, Says Co Has Been Informed By CVS It Is A Temporary Removal In Response To The One SKU Of 22 oz Bottles",2019-10-24 15:37:00-04:00,JNJ,neutral
707099.0,CVS Pulling All 22oz Johnson & Johnson Baby Powder From Shelves Amid Recall,2019-10-24 14:44:00-04:00,JNJ,neutral
707100.0,"Credit Suisse Maintains Outperform on Johnson & Johnson, Raises Price Target to $163",2019-10-24 07:20:00-04:00,JNJ,positive
707101.0,"J&J Confirms Deal In Principle To Settle Opioid Litigation As Publicly Announced, Outlined By Committee Of State Attorneys General",2019-10-23 17:28:00-04:00,JNJ,negative
707102.0,'Fast Money Halftime Report' Picks From October 23,2019-10-23 16:47:00-04:00,JNJ,neutral
707103.0,Biotech Stock On The Radar: Immunomedics' Long Wait For Redemption,2019-10-23 16:27:00-04:00,JNJ,neutral
707104.0,"J&J Medical Devices Unit Auris Health Reports Results From BENEFIT Study Showing Safety, Feasibility Of Monarch Platform",2019-10-23 11:00:00-04:00,JNJ,positive
707105.0,"Mixed Bag: Better Outlooks From Lockheed, United Technologies, But McDonald's Misses",2019-10-22 10:14:00-04:00,JNJ,positive
707106.0,How Much Litigation Risk Is Priced Into Johnson & Johnson?,2019-10-21 11:40:00-04:00,JNJ,negative
707107.0,"Earnings Roll On With Light Schedule Today But McDonald's, Biogen On Tuesday Calendar",2019-10-21 10:00:00-04:00,JNJ,neutral
707108.0,"J&J's Actelion Pharma Reports Safety, Tolerability Findings From Trial Of Opsumit, Tadalafil Combo Therapy Consistent vs Previous Trials, Was Well Tolerated",2019-10-21 09:09:00-04:00,JNJ,positive
707109.0,"4 Pharma Companies Settle Opioid Lawsuits Ahead Of Trial With Ohio Counties; 2,300 Cases Remain",2019-10-21 09:08:00-04:00,JNJ,negative
707110.0,46 Biggest Movers From Friday,2019-10-21 05:37:00-04:00,JNJ,neutral
707111.0,"Barron's Picks And Pans: Boeing, Comcast, Conoco, Emerson And More",2019-10-20 08:13:00-04:00,JNJ,neutral
707112.0,"Benzinga's Bulls And Bears Of The Week: Beyond Meat, Netflix, Johnson & Johnson And More",2019-10-19 12:40:00-04:00,JNJ,neutral
707113.0,WeTrader Competition: Round Two Wrap-up,2019-10-18 16:05:00-04:00,JNJ,neutral
707114.0,"FDA Alerts Consumers Of Voluntary Recall Of Johnson & Johnson's Baby Powder; Says That Testing Has Found That A Sample For One Lot Of The Product Contains Chrysotile Fibers, A Type Of Asbestos",2019-10-18 14:26:00-04:00,JNJ,neutral
707115.0,38 Stocks Moving In Friday's Mid-Day Session,2019-10-18 12:30:00-04:00,JNJ,neutral
707116.0,From J&J Conference Call To Discuss Powder Recall: Probe Into Asbestos Contamination Of Talc Could Take Up To 30 Days Or More,2019-10-18 11:40:00-04:00,JNJ,neutral
707117.0,Johnson & Johnson Voluntarily Recalls A Batch Of Baby Powder,2019-10-18 09:10:00-04:00,JNJ,neutral
707118.0,Johnson & Johnson shares are trading lower after the company recalled 1 lot of baby powder due to trace levels of asbestos.,2019-10-18 09:09:00-04:00,JNJ,neutral
707119.0,UPDATE: J&J Reports Its Consumer Unit's Recall Of Baby Powder Related To 'test indicating the presence of sub-trace levels of chrysotile asbestos contamination',2019-10-18 08:45:00-04:00,JNJ,neutral
707120.0,J&J's Consumer Unit To Voluntarily Recall1 Lot Of Johnson's Baby Powder,2019-10-18 08:40:00-04:00,JNJ,neutral
707121.0,"The Daily Biotech Pulse: Intuitive Surgical Earnings, Paratek Pulls Out European Application For Antibiotic, Amgen's Evenity In Europe",2019-10-18 07:07:00-04:00,JNJ,neutral
707122.0,European Medicines Agency Reports Positive Opinion From CHMP For J&J's Combo Treatment In Adults With Treatment-Resistant Major Depressive Disorder,2019-10-18 06:52:00-04:00,JNJ,negative
707123.0,J&J's Janssen Presents Four-Year TREMFYA Data Showing Maintained Rates Of Skin Clearance In Adult Patients With Moderate To Severe Plaque Psoriasis,2019-10-17 16:05:00-04:00,JNJ,negative
707124.0,"Ohio AG Yost Says Multi-State Settlement Requires Johnson & Johnson, Ethicon Inc To Pay About $117M For 'Deceptive Marketing Of Transvaginal Surgical Mesh Devices'",2019-10-17 12:11:00-04:00,JNJ,negative
707125.0,Ohio AG Dave Yost Announces $117M Multi-State Settlement With Johnson & Johnson,2019-10-17 12:09:00-04:00,JNJ,neutral
707126.0,"PreMarket Prep Recap: Stormy Outlook For Cloud Stocks, Opioid Makers Rally On Settlement Talks",2019-10-16 17:24:00-04:00,JNJ,neutral
707127.0,Large Option Traders Aren't Buying The Johnson & Johnson Rally,2019-10-16 15:19:00-04:00,JNJ,neutral
707128.0,"Benzinga's Top Upgrades, Downgrades For October 16, 2019",2019-10-16 14:57:00-04:00,JNJ,positive
707129.0,"Analysts, Investors Like Johnson & Johnson's Improvement, But Lawsuits Loom",2019-10-16 14:26:00-04:00,JNJ,negative
707130.0,Opioid Drug Companies Rally On Hopes of Broader Settlement,2019-10-16 11:56:00-04:00,JNJ,positive
707131.0,"Bank Of America Results Keep Financial Sector Flowing, With Netflix In Focus Later",2019-10-16 10:27:00-04:00,JNJ,neutral
707132.0,"Credit Suisse Maintains Outperform on Johnson & Johnson, Raises Price Target to $158",2019-10-16 09:50:00-04:00,JNJ,positive
707133.0,"Wells Fargo Maintains Outperform on Johnson & Johnson, Lowers Price Target to $155",2019-10-16 09:20:00-04:00,JNJ,positive
707134.0,Johnson & Johnson shares are trading higher after it was reported the company has offered $4 billion to settle opioid claims. Atlantic Equities analysts also upgraded the company's stock from Underweight to Neutral.,2019-10-16 08:31:00-04:00,JNJ,positive
707135.0,17 Healthcare Stocks Moving In Wednesday's Pre-Market Session,2019-10-16 07:57:00-04:00,JNJ,neutral
707136.0,A Peek Into The Markets: US Stock Futures Down; Bank of America Profit Tops Estimates,2019-10-16 06:58:00-04:00,JNJ,positive
707137.0,Atlantic Equities Upgrades Johnson & Johnson to Neutral,2019-10-16 06:37:00-04:00,JNJ,neutral
707138.0,J&J Makes $4B Offer to Settle Opioid Claims,2019-10-16 03:43:00-04:00,JNJ,neutral
707139.0,UPDATE: J&J Also In Talks To Contribute Added Money For Opioid Litigation,2019-10-15 16:20:00-04:00,JNJ,negative
707140.0,Missouri Appeals Court Overturns Talc Case In Which Jury Had Awarded $110M To Virginia Woman,2019-10-15 15:15:00-04:00,JNJ,positive
707141.0,"PreMarket Prep Recap: Impressive Bank Earnings, Aphria Sparks Rally In Marijuana Sector",2019-10-15 15:01:00-04:00,JNJ,positive
707142.0,"Bank Earnings Quartet Mostly In Tune, Led By Strength At JPMorgan, Citigroup",2019-10-15 10:13:00-04:00,JNJ,positive
707143.0,Relmada Shares Hit 4-Year High As Depression Drug Aces Midstage Trial,2019-10-15 10:00:00-04:00,JNJ,negative
707144.0,"Johnson & Johnson Trades Higher On Q3 Beat-And-Raise, Despite Legal Entanglements",2019-10-15 08:08:00-04:00,JNJ,negative
707145.0,22 Healthcare Stocks Moving In Tuesday's Pre-Market Session,2019-10-15 08:04:00-04:00,JNJ,neutral
707146.0,"The Daily Biotech Pulse: Reata Leaps On Positive Readout, Takeda Divests, FDA Nod For Akorn, J&J Earnings",2019-10-15 07:50:00-04:00,JNJ,positive
707147.0,Johnson & Johnson shares are trading higher after the company reported better-than-expected Q3 EPS and sales results. The company also raised its FY19 EPS guidance.,2019-10-15 07:25:00-04:00,JNJ,positive
707148.0,"A Peek Into The Markets: US Stock Futures Rise Ahead Of Goldman Sachs, Citigroup Earnings",2019-10-15 06:58:00-04:00,JNJ,neutral
707149.0,Johnson & Johnson Raises FY19 Adj. Operational EPS Guidance From $8.73-$8.83 To $8.84-$8.89,2019-10-15 06:46:00-04:00,JNJ,neutral
707150.0,"Johnson & Johnson Q3 Adj. EPS $2.12 Beats $2 Estimate, Sales $20.73B Beat $20.09B Estimate",2019-10-15 06:44:00-04:00,JNJ,neutral
707151.0,"10 Stocks To Watch For October 15, 2019",2019-10-15 04:34:00-04:00,JNJ,neutral
707152.0,"Earnings Scheduled For October 15, 2019",2019-10-15 04:23:00-04:00,JNJ,neutral
707153.0,"Earnings, Econ Numbers And The Beige Book Pepper The Second Round of The WeTrader Competition",2019-10-14 10:06:00-04:00,JNJ,neutral
707154.0,"Raymond James Maintains Outperform on Johnson & Johnson, Lowers Price Target to $145",2019-10-14 08:34:00-04:00,JNJ,negative
707155.0,Congo to Begin Using J&J Ebola Vaccine in November,2019-10-14 04:59:00-04:00,JNJ,neutral
707156.0,"The Week Ahead In Biotech: FDA Decisions, Johnson & Johnson Among Big Pharma Earnings",2019-10-13 16:33:00-04:00,JNJ,neutral
707157.0,"Barron's Picks And Pans: Apple, Boeing, GE, Kellogg And More",2019-10-12 16:59:00-04:00,JNJ,neutral
707158.0,"Benzinga's Bulls And Bears Of The Week: Apple, Boeing, Facebook, Nike And More",2019-10-12 16:17:00-04:00,JNJ,neutral
707159.0,Shares of several healthcare companies are trading higher after President Trump made positive remarks on the U.S.-China trade talks as traders grew more optimistic over the possibility of a limited trade deal. Trump is scheduled to meet with Chinese Vice Premier Liu He at the White House today.,2019-10-11 11:19:00-04:00,JNJ,positive
707160.0,"Benzinga's Top Upgrades, Downgrades For October 11, 2019",2019-10-11 10:10:00-04:00,JNJ,positive
707161.0,28 Healthcare Stocks Moving In Friday's Pre-Market Session,2019-10-11 08:42:00-04:00,JNJ,neutral
707162.0,"The Daily Biotech Pulse: Therapix Extends Merger Deadline, Five Prime Restructures, Gilead-Galapagos Rheumatism Drug Readout",2019-10-11 08:14:00-04:00,JNJ,positive
707163.0,Bernstein Upgrades Johnson & Johnson to Outperform,2019-10-11 07:41:00-04:00,JNJ,neutral
707164.0,Mid-Afternoon Market Update: Dow Rises Over 200 Points; Ocugen Shares Spike Higher,2019-10-09 15:25:00-04:00,JNJ,positive
707165.0,Mid-Day Market Update: Crude Oil Up 1%; James River Group Shares Plunge,2019-10-09 12:55:00-04:00,JNJ,negative
707166.0,Mid-Morning Market Update: Markets Open Higher; Johnson & Johnson Hit With $8B Verdict In Risperdal Lawsuit,2019-10-09 10:27:00-04:00,JNJ,negative
707167.0,Johnson & Johnson Hit With $8B Verdict In Risperdal Lawsuit,2019-10-09 09:05:00-04:00,JNJ,negative
707168.0,13 Healthcare Stocks Moving In Wednesday's Pre-Market Session,2019-10-09 07:54:00-04:00,JNJ,neutral
707169.0,Jury Says J&J Must Pay $8B In Case Over Male Breast Growth Linked To Risperdal,2019-10-09 07:49:00-04:00,JNJ,positive
707170.0,"The Daily Biotech Pulse: Arbutus Halts Hepatitis B Study, Positive Readout For MEI Pharma's Blood Cancer Drug, Ovid Offering",2019-10-04 07:32:00-04:00,JNJ,negative
707171.0,J&J's Janssen Reports FDA Breakthrough Therapy Designation Granted For Niraparib For Treatment Of Metastatic Castration-Resistant Prostate Cancer,2019-10-03 16:18:00-04:00,JNJ,negative
707172.0,J&J's Janssen Submits Supplemental New Drug Application To FDA For SPRAVATO CIII Nasal Spray For The Rapid Reduction Of Depressive Symptoms In Adults With Major Depressive Disorder Who Have Active Suicidal Ideation With Intent,2019-10-02 16:04:00-04:00,JNJ,negative
707173.0,Sell-Side Positive On Johnson & Johnson's Unexpected Ohio Opioid Settlement,2019-10-02 15:06:00-04:00,JNJ,positive
707174.0,Johnson & Johnson shares are trading higher after the company reached a settlement agreement with two Ohio counties ahead of upcoming opioid trial. The company will pay a total of $20.4 million in relation to the settlement.,2019-10-02 09:42:00-04:00,JNJ,positive
707175.0,UPDATE: JNJ To Pay $5M Of Ohio Counties' Legal Fees And Will Direct $5.4M To Opiod-Related Charitable Programs,2019-10-02 08:21:00-04:00,JNJ,positive
707176.0,"The Daily Biotech Pulse: J&J Settles Ohio Opioid Lawsuit, Teligent Explores Options For Certain Assets, Novartis Reports Cosentyx Data",2019-10-02 07:17:00-04:00,JNJ,positive
707177.0,Johnson & Johnson Reaches Settlement Agreement with Two Ohio Counties Ahead of Upcoming Opioid Trial; JNJ to Pay $10M to Cuyahoga and Summit Counties,2019-10-01 20:07:00-04:00,JNJ,positive
707178.0,Attention Biotech Investors: Mark Your Calendar For These October PDUFA Dates,2019-09-30 16:32:00-04:00,JNJ,neutral
707179.0,California Jury Returns $40M Talc Verdict Against Johnson & Johnson,2019-09-30 11:22:00-04:00,JNJ,positive
707180.0,"Credit Suisse Reiterates Outperform, $156 Target On Johnson & Johnson As Firm Notes Co. 'appears to be tracking ahead of our Q3 US Pharma estimates, based on our updated analysis of intra-quarter scrips and IMS-reported sales trends for both July and Aug'",2019-09-30 10:19:00-04:00,JNJ,positive
707181.0,"The Daily Biotech Pulse: ESMO Conference Gets Underway, J&J's Darzalex Snags Another Approval, Kaleido Biosciences CFO To Leave",2019-09-27 07:56:00-04:00,JNJ,positive
707182.0,"J&N's Janssen Announces Receives FDA Approval For Of Darzalex (Daratumumab) Combination Regimen For Newly Diagnosed, Transplant-Eligible Patients With Multiple Myeloma",2019-09-26 14:15:00-04:00,JNJ,positive
707183.0,"The Daily Biotech Pulse: Enanta Aces Midstage NASH Study, Takeda's Ulcerative Colitis Drug Found Superior To AbbVie's, Decision Day For J&J",2019-09-26 07:54:00-04:00,JNJ,positive
707184.0,"Biotech Stock On The Radar: Anavex, A Neurology-Focused Precision Medicine Company",2019-09-25 17:32:00-04:00,JNJ,neutral
707185.0,"Barron's Picks And Pans: Coca-Cola, McDonald's, Ford, Nike And More",2019-09-22 16:48:00-04:00,JNJ,neutral
707186.0,The Week Ahead In Biotech: Spotlight On ESMO Conference,2019-09-22 16:22:00-04:00,JNJ,neutral
707187.0,Shares of several drug companies are trading higher after Senate Majority Leader McConnell suggested a new Democratic drug price reform proposal would be dead on arrival.,2019-09-20 13:00:00-04:00,JNJ,negative
707188.0,J&J's Janssen Announced New Real-World Evidence Confirming Xarelto Reduced Risk Of Recurrent Venous Thromboembolism In Patients Who Are Morbidly Obese,2019-09-20 08:36:00-04:00,JNJ,negative
707189.0,"J&J To Report Q3 Earnings On Tues., Oct 15, 2019 Before Market Open",2019-09-18 16:07:00-04:00,JNJ,neutral
707190.0,Axsome Shares Flirt With Record High: How Much Upside Is Left?,2019-09-18 14:08:00-04:00,JNJ,positive
707191.0,"The Daily Biotech Pulse: NewLink Genetics Rallies, Breakthrough Designation For Roche, IGM Biosciences Debuts",2019-09-18 07:39:00-04:00,JNJ,neutral
707192.0,Purdue Pharma Files For Bankruptcy: What You Need To Know,2019-09-16 10:58:00-04:00,JNJ,neutral
707193.0,MorphoSys Reports Licensee Janssen R&D Issued Press Release Highlighting Submission Of Supplemental Biologics License Application Seeking Approval Of Tremfya,2019-09-16 08:18:00-04:00,JNJ,positive
707194.0,Janssen Pharmaceutical Announces New DARZALEX Data from GRIFFIN Study Show High Response Rate and Depth of Response in Patients with Newly Diagnosed Multiple Myeloma Who are Transplant-Eligible,2019-09-15 08:12:00-04:00,JNJ,neutral
707195.0,"J&J, McKesson Face $8B Damage Demand in Ohio Opioid Trial",2019-09-14 15:06:00-04:00,JNJ,negative
707196.0,J&J Spokesperson Says A New Jersey Jury Has Found Co. Liable For $37M In Trial Claiming Talc Powder Caused Cancer,2019-09-11 12:15:00-04:00,JNJ,negative
707197.0,Johnson & Johnson To Pay $37.2M To Group Blaming Powder For Cancers,2019-09-11 11:53:00-04:00,JNJ,negative
707198.0,Watching J&J Shares Amid Report New Head-To-Head Phase 3 Data For Janssen's Ponesimod Was Superior Compared To Aubagio 14 mg in Adults With Relapsing Multiple Sclerosis,2019-09-11 10:05:00-04:00,JNJ,positive
707199.0,J&J Says New Data From Spravato CIII Nasal Spray Phase 3 Studies Showed Rapid Reduction Of Depressive Symptoms In Adult Patients With Major Depressive Disorder,2019-09-09 09:04:00-04:00,JNJ,negative
707200.0,European Commission Has Approved Expanded Use Of J&J's Janssen's Ustekinumab For Treatment Of Adults With Moderately To Sever Ulcerative Colitis,2019-09-04 09:16:00-04:00,JNJ,positive
707201.0,"Cardinal Health, J&J Shares Tick Lower As Hearing Cos. Must Face Cities Opioid-Conspiracy Claims",2019-09-03 14:50:00-04:00,JNJ,neutral
707202.0,"The Week Ahead In Biotech: Cardiology, Analyst Conferences In The Spotlight",2019-09-02 15:13:00-04:00,JNJ,neutral
707203.0,"Bulls And Bears Of The Week: Altria, Apple, Netflix, Slack And More",2019-08-31 15:37:00-04:00,JNJ,neutral
707204.0,"Citi Turns Bullish On Jabil, Says Customer Risk Concentration 'Played Out'",2019-08-29 17:18:00-04:00,JNJ,positive
707205.0,'Fast Money' Traders Give Their Opinion On Johnson & Johnson And Papa John's,2019-08-29 07:23:00-04:00,JNJ,neutral
707206.0,Fitch Says Oklahoma's Ruling On J&J May Not Set  Standard For Other Companies As Other States Could Employ Legal Approaches Other Than Public Nuisance Law,2019-08-28 14:59:00-04:00,JNJ,positive
707207.0,Attention Biotech Investors: Mark Your Calendar For These September PDUFA Dates,2019-08-28 08:02:00-04:00,JNJ,neutral
707208.0,Arrowhead Collaborator Janssen Begins REEF-1 Phase 2b Combination Study in Patients With Chronic Hepatitis B Infection; Arrowhead Earns $25M Milestone Payment In Connection With Trial Initiation,2019-08-28 07:32:00-04:00,JNJ,neutral
707209.0,46 Stocks Moving In Tuesday's Mid-Day Session,2019-08-27 14:47:00-04:00,JNJ,neutral
707210.0,"Barclays Maintains Equal Weight, $140 Target On Johnson & Johnson As Firm Believes 'shares are likely to continue to trade at a discount to its sum-of-the-parts valuation due to the litigation overhang'",2019-08-27 13:28:00-04:00,JNJ,positive
707211.0,"BMO Maintains Outperform On Johnson & Johnson, Maintains $157 Target As Firm Notes 'We remind investors that litigation is long, lengthy, and difficult to read, and while the amount is less than it could have been, we would expect an extended resolution'",2019-08-27 13:15:00-04:00,JNJ,negative
707212.0,Why One Johnson & Johnson Analyst Sees Oklahoma Opioid Ruling As Near-Term Sentiment Positive,2019-08-27 13:03:00-04:00,JNJ,positive
707213.0,Raymond James On Johnson & Johnson Also Notes The 'judge ordered J&J to pay ~$572M for an abatement plan' And 'The state was looking for $17B from J&J and we believe investor expectations were for ~$2-3B. J&J ended 2Q19 with ~$14B in net cash',2019-08-27 12:03:00-04:00,JNJ,negative
707214.0,"Raymond James Maintains Outperform On Johnson & Johnson As Firm Notes 'After speaking with management, we remain optimistic in the defense case for J&J when heading to the appellate courts'",2019-08-27 12:03:00-04:00,JNJ,positive
707215.0,"A Look At Benzinga Pro's Most-Searched Tickers For August 27, 2019",2019-08-27 11:42:00-04:00,JNJ,neutral
707216.0,"Chubb, Salesforce And More 'Fast Money' Picks For August 27",2019-08-27 11:15:00-04:00,JNJ,neutral
707217.0,"Johnson & Johnson shares are trading higher after an Oklahoma Judge finds the company liable in the lawsuit claiming that it helped fuel opioid epidemic, will pay $572 million in damages. Investors were potentially expecting the company to pay more in fin",2019-08-27 10:46:00-04:00,JNJ,negative
707218.0,"Benzinga Pro's Top 10 Most-Searched Tickers For Morning of Tuesday., August 27, 2019",2019-08-27 10:29:00-04:00,JNJ,positive
707219.0,"Neutral Zone: Stocks, Bonds Both Up As Next Moves In Trade War Anxiously Awaited",2019-08-27 10:09:00-04:00,JNJ,negative
707220.0,"UPDATE: Morgan Stanley On Johnson & Johnson Also Notes 'Given that many investors feared a more substantial judgment against J&J, we expect opioid-exposed specialty pharmaceutical companies to trade higher on Tuesday Aug 27'",2019-08-27 08:50:00-04:00,JNJ,negative
707221.0,"UPDATE: Morgan Stanley Maintains Equal-Weight On Johnson & Johnson, Maintains $145 Target As Firm Notes 'we suggested Base case exposure of $6bn and Bear case exposure of $16bn and yesterday's judgement does not alter our view'",2019-08-27 08:50:00-04:00,JNJ,neutral
707222.0,"Morgan Stanley Maintains Equal-Weight on Johnson & Johnson, Maintains $145 Price Target",2019-08-27 08:46:00-04:00,JNJ,neutral
707223.0,26 Stocks Moving in Tuesday's Pre-Market Session,2019-08-27 08:05:00-04:00,JNJ,neutral
707224.0,"The Daily Biotech Pulse: Nuvectra Explores Strategic Options, J&J To Contend Opioid Ruling, Sesen Bio Gets New CFO",2019-08-27 07:29:00-04:00,JNJ,positive
707225.0,"Everyday Health Group Acquires BabyCenter From Johnson & Johnson, Terms Not Disclosed",2019-08-27 07:05:00-04:00,JNJ,neutral
707226.0,Judge Orders Johnson & Johnson To Pay $572M In Opioid Case,2019-08-26 16:27:00-04:00,JNJ,negative
707227.0,"Johnson & Johnson shares are trading higher after an Oklahoma Judge finds the company liable in the lawsuit claiming that it helped fuel opioid epidemic, will pay $572 million in damages. Investors were potentially expecting the company to pay more in fines.",2019-08-26 16:15:00-04:00,JNJ,negative
707228.0,Johnson & Johnson Says It Will Appeal Oklahoma Judge's Ruling In Opioid Case,2019-08-26 16:13:00-04:00,JNJ,neutral
707229.0,Oklahoma Judge Finds Johnson & Johnson Liable In Lawsuit Claiming Drugmaker Helped Fuel Opioid Epidemic; Co. To Pay $572M In Damages,2019-08-26 16:05:00-04:00,JNJ,negative
707230.0,"Johnson & Johnson Shares Now Falling, Reversing From Spike",2019-08-26 16:04:00-04:00,JNJ,positive
707231.0,Johnson & Johnson Shares Spike; Oklahoma Judge Preparing To Reveal Decision In Opioid Lawsuit,2019-08-26 16:03:00-04:00,JNJ,positive
707232.0,"Kohl's, Snap And More 'Fast Money' Picks For August 22",2019-08-22 10:58:00-04:00,JNJ,neutral
707233.0,"The Daily Biotech Pulse: ViiV's Long-Acting HIV Drug Meets Study Goal, Chinese Cheer For FibroGen, Retrophin Flunks Late-Stage Study",2019-08-22 07:18:00-04:00,JNJ,positive
707234.0,'Oklahoma judge to rule on Monday in opioid lawsuit against J&J ' -Reuters,2019-08-21 16:43:00-04:00,JNJ,negative
707235.0,"'Trump says his solution to the epidemic of veteran suicides is some new ""stimulant"" produced by Johnson & Johnson that he's instructed the government to buy in large quantities' -Tweets Aaron Rupar",2019-08-21 13:23:00-04:00,JNJ,positive
707236.0,'It's A Huge Thing': Avicanna Receives Unique Canadian Cannabinoid Research License,2019-08-20 14:45:00-04:00,JNJ,positive
707237.0,﻿Shares of several healthcare companies are trading higher with the overall market after the U.S. announced it is excluding and delaying the additional 10% tariff on certain products.,2019-08-13 11:53:00-04:00,JNJ,positive
707238.0,Lilly's Psoriasis Drug Found Superior To J&J's Tremfya In Phase 4 Study,2019-08-13 11:40:00-04:00,JNJ,positive
707239.0,"XOMA Reports J&J's Janssen Has Elected to Accelerate Base Annual License Fee Obligation, Will Make 1-Time $2.5M Payment To Co.",2019-08-12 07:34:00-04:00,JNJ,neutral
707240.0,"Biotech Stock On The Radar: Veru, A Catalyst-Rich Biopharma",2019-07-31 13:50:00-04:00,JNJ,neutral
707241.0,"In June, FTC Issued Civil Investigative Demand To J&J On Investigation Of Whether Janssen's Remicade Contracting Practices Violate Antitrust Laws",2019-07-29 16:30:00-04:00,JNJ,negative
707242.0,"Host Of Earnings Loom With Beyond Meat, Apple Among Highlights Ahead Of Fed, Payrolls",2019-07-29 09:50:00-04:00,JNJ,negative
707243.0,KBL Merger Corp Acquires Cannabis-Focused Biotech Company,2019-07-28 16:36:00-04:00,JNJ,neutral
707244.0,"The Daily Biotech Pulse: Obseva Gets The Greenlight, Verastem Climbs On Licensing Deal, Merit Medical Earnings Disappoint",2019-07-26 07:26:00-04:00,JNJ,neutral
707245.0,Social Media Earnings: Facebook And Twitter Prepare To Share,2019-07-23 16:35:00-04:00,JNJ,positive
707246.0,"With Earnings On Tap, A Stir In This Leveraged Pharmaceuticals ETF",2019-07-23 09:27:00-04:00,JNJ,neutral
707247.0,"Benzinga's Bulls And Bears: Apple, Boeing, Disney, Johnson & Johnson And More",2019-07-21 14:15:00-04:00,JNJ,neutral
707248.0,The Week Ahead In Biotech: Pharma Earnings Pick Up Pace,2019-07-20 09:53:00-04:00,JNJ,neutral
707249.0,From Coffee To Cannabis: Colombia's Choice Between Economic Development And 'CannaMercantilism',2019-07-19 11:30:00-04:00,JNJ,neutral
707250.0,Intuitive Surgical's Q2 Performance Lauded By Bullish Analysts,2019-07-19 10:23:00-04:00,JNJ,neutral
707251.0,Halozyme Reports J&J's Janssen Submitted Extension Application To EMA For Subcutaneous Formulation Of DARZALEX Utilizing ENHANZE Technology,2019-07-19 07:03:00-04:00,JNJ,neutral
707252.0,Janssen Seeks EMA Approval for Novel Subcutaneous Formulation of Darzalex,2019-07-19 06:00:00-04:00,JNJ,positive
707253.0,FlexShares Makes A Big Low Vol ETF Splash,2019-07-17 13:33:00-04:00,JNJ,negative
707254.0,"After Earnings Beat, Wall Street Talks Johnson & Johnson Litigation Risk",2019-07-17 13:24:00-04:00,JNJ,negative
707255.0,"Raymond James Maintains Outperform on Johnson & Johnson, Lowers Price Target to $146",2019-07-17 07:46:00-04:00,JNJ,negative
707256.0,"Mostly Strong Results For Big Banks, And J&J Another Solid Earnings Performer",2019-07-16 10:06:00-04:00,JNJ,positive
707257.0,J&J Executive Says Taking A $190M Charge In The Quarter Related To Talc Litigation For Defense Costs Only,2019-07-16 10:06:00-04:00,JNJ,negative
707258.0,From J&J Q2 Earnings Conference Call: Exec Commenting On Oklahoma Opioid Case Says Facts Do Not Align With What State Is Claiming,2019-07-16 09:37:00-04:00,JNJ,neutral
707259.0,"From J&J Q2 Earnings Conference Call: Sees Largest Impact From Generic, Biosimilars In Q3, Has Resumed Distribution Of Its Surgical Staplers To Customers In Jun. Following Recall",2019-07-16 09:10:00-04:00,JNJ,neutral
707260.0,"A Peek Into The Markets: US Stock Futures Edge Lower Ahead Of Citigroup, Wells Fargo Earnings",2019-07-16 07:14:00-04:00,JNJ,negative
707261.0,Johnson & Johnson Trades Higher On Q2 Earnings Beat,2019-07-16 06:55:00-04:00,JNJ,neutral
707262.0,Johnson & Johnson Reaffirms FY19 Adj. EPS Guidance Of $8.53-$8.63 vs $8.60 Est.,2019-07-16 06:43:00-04:00,JNJ,neutral
707263.0,Johnson & Johnson Raises FY19 Operational Sales Guidance From $82B-$82.8B To $82.4B-$83.2B; Raises Est. Reported Sales From $80.4B-$81.2B To $80.8B-$81.6B,2019-07-16 06:43:00-04:00,JNJ,neutral
707264.0,"Johnson & Johnson Q2 Adj. EPS $2.58 Beats $2.43 Estimate, Sales $20.56B Beat $20.29B Estimate",2019-07-16 06:41:00-04:00,JNJ,neutral
707265.0,"11 Stocks To Watch For July 16, 2019",2019-07-16 04:54:00-04:00,JNJ,neutral
707266.0,"Earnings Scheduled For July 16, 2019",2019-07-16 04:12:00-04:00,JNJ,neutral
707267.0,Johnson & Johnson Q2 Earnings Outlook,2019-07-15 14:37:00-04:00,JNJ,neutral
707268.0,"Earnings Season Starts With Beat From Citigroup; Other Banks, Netflix Report Later In Week",2019-07-15 10:24:00-04:00,JNJ,neutral
707269.0,The Week Ahead In Biotech: Johnson & Johnson Kickstarts Big Pharma Earnings,2019-07-13 17:04:00-04:00,JNJ,neutral
707270.0,Johnson & Johnson Falls On Report Of Justice Department Probe,2019-07-12 14:47:00-04:00,JNJ,positive
707271.0,"J&J, In Response To Report About Criminal Probe In Talc Case, Says Implication That There Has Been A New Development In This Matter Is Flatly Wrong",2019-07-12 12:44:00-04:00,JNJ,negative
707272.0,Halozyme Therapeutics Reports J&J's Janssen Submitted Biologics License Application To FDA For Subcutaneous Delivery Of DARZALEX For Patients With Multiple Myeloma,2019-07-12 12:01:00-04:00,JNJ,neutral
707273.0,Johnson & Johnson shares are trading lower following reports of a US criminal probe into the company's denial of asbestos in baby powder.,2019-07-12 11:54:00-04:00,JNJ,negative
707274.0,J&J Shares Fall As Hearing Co. Denials Of Asbestos In Baby Powder Have Spurred A US Criminal Probe,2019-07-12 11:45:00-04:00,JNJ,negative
707275.0,J&J's Janssen Says Is In the Process Of Submitting Regulatory Applications To Respective Health Authorities Related To Preventive HIV Vaccine,2019-07-12 10:27:00-04:00,JNJ,positive
707276.0,"Novartis, Amgen Scrap Pivotal Study Of Alzheimer's Prevention Drug",2019-07-12 10:19:00-04:00,JNJ,neutral
707277.0,"Benzinga's Top Upgrades, Downgrades For July 12, 2019",2019-07-12 08:55:00-04:00,JNJ,positive
707278.0,"Credit Suisse Initiates Coverage On Johnson & Johnson with Outperform Rating, Announces $156 Price Target",2019-07-12 07:59:00-04:00,JNJ,positive
707279.0,Avicanna Gets Conditional Approval To List On Toronto Stock Exchange Senior Board As R&D Issuer,2019-07-11 14:00:00-04:00,JNJ,positive
707280.0,'Johnson & Johnson's stranglehold on the blockbuster drug Remicade' -Recent Axios Article,2019-07-11 08:33:00-04:00,JNJ,positive
707281.0,Johnson & Johnson Wins New Trial In Talc Case,2019-07-10 14:40:00-04:00,JNJ,positive
707282.0,"J&J Says ""Pleased With The California Appellate Court's Review"" Of The Talc Case; Says Pleased That Court Agreed With Judge Nelson's Finding That Punitive Damages Should Not Have Been Awarded",2019-07-10 13:25:00-04:00,JNJ,negative
707283.0,Johnson & Johnson To Get Trial After $417M Verdict In Talc Case,2019-07-10 12:31:00-04:00,JNJ,positive
707284.0,Vaxart Enters Into Research Collaboration With Janssen To Evaluate Oral Universal Influenza Vaccine,2019-07-09 08:21:00-04:00,JNJ,neutral
707285.0,Johnson & Johnson Janssen Announces Results From Phase 3 Einstein-Jr Study Of Xarelto; Study Met All Pre Specified Endpoints,2019-07-08 08:41:00-04:00,JNJ,neutral
707286.0,J&J's Janssen Reports Received Positive CHMP Opinion Recommending Expanded Use Of Imbruvica For 2 Indications,2019-06-28 07:55:00-04:00,JNJ,positive
707287.0,Morphic Holding IPO: What You Need To Know,2019-06-26 14:31:00-04:00,JNJ,neutral
707288.0,Minerva Spikes Higher After Novel Insomnia Drug Aces Mid-Stage Trial,2019-06-24 11:00:00-04:00,JNJ,positive
707289.0,Fitch Affirms J&J 'AAA' Rating,2019-06-19 16:11:00-04:00,JNJ,neutral
707290.0,Janssen Reports Top-Line Phase 3 Results For Tremfya In Adults With Active Psoriatic Arthritis,2019-06-14 16:03:00-04:00,JNJ,positive
707291.0,UPDATE: Recent Bloomberg Report Indicates J&J And Colgate Ordered To Pay Almost $10M In Talc Case,2019-06-12 15:52:00-04:00,JNJ,negative
707292.0,"J&J, Colgate-Palmolive Lose Verdict In Talc-Cancer Case",2019-06-12 15:50:00-04:00,JNJ,negative
707293.0,J&J Says Co 'Will Pursue An Appeal Because Johnson's Baby Powder Does Not Contain Asbestos Or Cause Cancer',2019-06-12 14:50:00-04:00,JNJ,negative
707294.0,Hearing Johnson & Johnson And Colgate-Palmolive Have Closed Jury Verdict In Talc Cancer Case,2019-06-12 14:02:00-04:00,JNJ,negative
707295.0,Janssen Invokana Incidence Rates Of Adverse Events & Serious Adverse Events Were Numerically Lower For Patients Treated With Invokana Vs Placebo,2019-06-11 12:34:00-04:00,JNJ,negative
707296.0,Janssen Invokana Significantly Reduced Major Cardiovascular Events & Kidney Failure In Patients With Type 2 Diabetes & Chronic Kidney Disease In New Credence Analysis,2019-06-11 12:33:00-04:00,JNJ,negative
707297.0,"The Daily Biotech Pulse: Lilly Reports Positive Long-Term Efficacy Data For Psoriasis Drug, Provention Bio Offering",2019-06-11 07:34:00-04:00,JNJ,positive
707298.0,Shares of several healthcare companies are trading higher with the overall US market. Recent comments out of China and Mexico has renewed trade optimism and lifted economic outlook.,2019-06-04 13:07:00-04:00,JNJ,positive
707299.0,'I believe it is wrong to charge Americans astronomical prices for life-saving drugs developed with taxpayer dollars. You will not find me encouraging pharmaceutical companies to continue ripping off Americans like my Republican colleagues.' -Sen Sanders,2019-06-04 11:42:00-04:00,JNJ,negative
707300.0,Obalon Clinches First US Patent For Obesity Treatment Placement System,2019-06-04 11:42:00-04:00,JNJ,neutral
707301.0,Johnson & Johnson's Janssen Pharmaceutical Highlights Presentation Of Imbruvica Long-Term Data From Two Pivotal Phase 3 Studies At ASCO And EHA Demonstrating Sustained Efficacy And Safety In Patients With Chronic Lymphocytic Leukemia,2019-06-03 09:07:00-04:00,JNJ,positive
707302.0,Johnson & Johnson To Pay $300M In Punitive Damages In Olson Talc Cancer Case,2019-05-31 13:30:00-04:00,JNJ,negative
707303.0,UPDATE: J&J Spokesperson Says Talc Trial Had 'Significant Legal And Evidentiary Errors' Which Co. Believes Will Warrant Reversal Amid Appeal,2019-05-31 12:54:00-04:00,JNJ,neutral
707304.0,UPDATE: J&J Says $300M Punitive Award In Solson Talc Trial Is On Top Of $25M Compensatory Damages Awarded Last Week,2019-05-31 12:50:00-04:00,JNJ,positive
707305.0,Hearing J&J To Pay $300M Punitive Award In New York Calc Case,2019-05-31 12:30:00-04:00,JNJ,negative
707306.0,Johnson & Johnson Analyst: 3 Takeaways On Opioid Litigation,2019-05-30 13:56:00-04:00,JNJ,negative
707307.0,64 Biggest Movers From Yesterday,2019-05-30 05:08:00-04:00,JNJ,neutral
707308.0,Obalon Closes Above $1 Following Questionable Takeover Rumor,2019-05-29 16:57:00-04:00,JNJ,negative
707309.0,42 Stocks Moving In Wednesday's Mid-Day Session,2019-05-29 12:36:00-04:00,JNJ,neutral
707310.0,Shares of several healthcare companies are trading lower after the US state of Oklahoma filed a multi-billion dollar lawsuit against Johnson & Johnson relating to opioid abuse; Oklahoma settled an opioid lawsuit with Teva Pharmaceuticals earlier this week,2019-05-29 10:47:00-04:00,JNJ,negative
707311.0,Johnson & Johnson shares are trading lower after the company's trial in Oklahoma regarding its role in opioid addiction began on Tuesday.,2019-05-29 10:35:00-04:00,JNJ,neutral
707312.0,"Obalon Therapeutics Shares Up 15% Just After Wednesday's Open; Chatter Of Earlier Questionable, Unconfirmed Seeking Alpha Blogpost From Stellar Wealth Mgmt. 'JNJ Makes Bid For OBLN At $8/Share'",2019-05-29 09:44:00-04:00,JNJ,positive
707313.0,FDA Grants Priority Review For J&J's Janssen Pharma's INVOKANA,2019-05-22 09:10:00-04:00,JNJ,positive
707314.0,"The Daily Biotech Pulse: Tocagen Tumbles, OncoSec Offering, Novartis Asthma Combo Drug Study",2019-05-22 07:34:00-04:00,JNJ,neutral
707315.0,J&J Shares Indicated Slightly Lower On No Volume Amid Report Co. Said South Carolina Jury Cleared Co. Of Its Liability In Suit Alleging Asbestos In Talc Caused Women's Cancer,2019-05-21 17:22:00-04:00,JNJ,negative
707316.0,Johnson & Johnson Issues Statement On May 21 Verdict In New York; Says The Trial Suffered From Significant Legal And Evidentiary Errors; Says It Believes The Errors Will Warrant A Reversal On Appeal,2019-05-21 14:06:00-04:00,JNJ,negative
707317.0,J&J Shares Fall Midday Amid Report Co. Lost A $25M Verdict In New York Over Talc Powder,2019-05-21 12:28:00-04:00,JNJ,positive
707318.0,PreMarket Prep Opening NYSE Imbalance Update: GE 215k Shares To Sell; Alibaba 69k To Sell; Pfizer 131k To Sell; Coca-Cola 58k To Sell; J&J 32k To Sell,2019-05-20 08:33:00-04:00,JNJ,positive
707319.0,"Bulls And Bears Of The Week: Apple, Chevron, FedEx, Uber And More",2019-05-18 15:18:00-04:00,JNJ,neutral
707320.0,FDA Has Identified Ethicon's Recall Of Circular Staplers As Class I Recall,2019-05-17 10:23:00-04:00,JNJ,neutral
707321.0,"'FBI targets Johnson & Johnson, Siemens, GE, Philips in Brazil graft case' -Reuters",2019-05-17 06:35:00-04:00,JNJ,neutral
707322.0,Johnson & Johnson Analysts Laud Accelerating Pharma Business,2019-05-16 10:20:00-04:00,JNJ,neutral
707323.0,"Credit Suisse Maintains Outperform on Johnson & Johnson Common Stock, Raises Price Target to $156",2019-05-16 09:03:00-04:00,JNJ,positive
707324.0,"J&J Highlights Will Host Meeting Today With Industry Analysts 'to review the strategy of its Janssen Pharmaceutical Companies to deliver above-market, compound annual growth through 2023'",2019-05-15 06:45:00-04:00,JNJ,positive
707325.0,J&J Patent On Zytiga Ruled Invalid By US Appeals Court,2019-05-14 10:21:00-04:00,JNJ,neutral
707326.0,Minerva Neurosciences Sinks To Lowest Level In A Year On Cloudy Midstage Trial Results For Depression Drug,2019-05-13 11:01:00-04:00,JNJ,negative
707327.0,"The Daily Biotech Pulse: FibroGen Kidney Disease Trial Disappoints, Medtronic To Buy Titan Spine, Puma's Weak Breast Cancer Drug Sales",2019-05-10 08:00:00-04:00,JNJ,negative
707328.0,Drug Prices Will Be Included In TV Ads Under New Trump Admin Rule,2019-05-09 15:13:00-04:00,JNJ,neutral
707329.0,"J&J Shares Unaffected As WHO's Strategic Advisory Group Recommended A Change In Ebola Vaccine Strategy, Has Expanded Eligible Population And Introduced Co.'s Experimental Vaccine",2019-05-07 11:57:00-04:00,JNJ,positive
707330.0,J&J Will Pay $1B To Resolve Pinnacle-Hip Suits,2019-05-07 10:54:00-04:00,JNJ,positive
707331.0,Shares of several healthcare companies are trading lower after several companies in the space reported weak earnings with Mylan leading the selloff.,2019-05-07 10:25:00-04:00,JNJ,negative
707332.0,PreMarket Prep Opening NYSE Imbalance Update: Alibaba 316k Shares To Sell; Citigroup 67k To Sell; Bank Of America 319k To Sell; JP Morgan 110K To Sell; GE 557k To Sell; Johnson & Johnson 32k To Sell,2019-05-06 08:31:00-04:00,JNJ,positive
707333.0,2 New ETFS For 'Biblically Responsible Investing',2019-05-02 16:33:00-04:00,JNJ,positive
707334.0,Vistagen Shares Fall Under $1 After Depression Drug Flunks Midstage Trial,2019-05-02 12:13:00-04:00,JNJ,negative
707335.0,Attention Biotech Investors: Mark Your Calendar For These May PDUFA Dates,2019-04-30 13:00:00-04:00,JNJ,neutral
707336.0,J&J Raises Qtr. Dividend From $0.90 To $0.95/Share,2019-04-25 10:41:00-04:00,JNJ,neutral
707337.0,"Jim Cramer Gives His Opinion On Barrick Gold, Canopy Growth, EA, Johnson & Johnson And More",2019-04-24 07:51:00-04:00,JNJ,positive
707338.0,"Shares of several healthcare stocks are trading higher in a potential rebound from last week's selloff. In an upgrade of HCA Healthcare, Raymond James analysts noted the selloff was 'based on legislation that has almost no chance of passing'",2019-04-23 11:52:00-04:00,JNJ,positive
707339.0,"UroGen Pharma Reports Early-Stage Feasibility Deal With J&J's Janssen, No Terms Disclosed",2019-04-23 08:00:00-04:00,JNJ,negative
707340.0,6 Cannabis Execs On The Strengths Of Their Businesses,2019-04-22 11:45:00-04:00,JNJ,positive
707341.0,3 Options Trading Ideas For The Upcoming Earnings Season,2019-04-22 10:07:00-04:00,JNJ,neutral
707342.0,"The Week Ahead In Biotech: Conferences, Clinical Trial Readouts, Earnings And IPOs",2019-04-21 14:06:00-04:00,JNJ,neutral
707343.0,Buyer's Remorse? OTC Stock Zoom Technologies Zooms Higher Amid Potential Buyer Confusion,2019-04-18 12:11:00-04:00,JNJ,negative
707344.0,Analysts View Johnson & Johnson's Organic Growth Guidance As Conservative,2019-04-17 10:55:00-04:00,JNJ,positive
707345.0,"BMO Capital Maintains Outperform on Johnson & Johnson, Raises Price Target to $157",2019-04-17 10:40:00-04:00,JNJ,neutral
707346.0,"Credit Suisse Maintains Outperform on Johnson & Johnson, Raises Price Target to $152",2019-04-17 10:06:00-04:00,JNJ,positive
707347.0,"Morgan Stanley Maintains Equal-Weight on Johnson & Johnson, Raises Price Target to $145",2019-04-17 09:56:00-04:00,JNJ,neutral
707348.0,"Hot, Fresh Earnings On The Menu As Netflix, Morgan Stanley Results In Focus",2019-04-17 09:56:00-04:00,JNJ,positive
707349.0,"Raymond James Maintains Outperform on Johnson & Johnson, Raises Price Target to $147",2019-04-17 08:50:00-04:00,JNJ,neutral
707350.0,"FDA Determines Boston Scientific Hasn't Showed Reasonable Assurance Of Safety, Effectiveness For Surgical Meshes",2019-04-16 14:27:00-04:00,JNJ,positive
707351.0,Banks On Parade: Bank of America Becomes Latest Big Financial Company To Report,2019-04-16 10:19:00-04:00,JNJ,neutral
707352.0,J&J Expects To See Largest Impact From Generic And Biosimilar Erosion In 2019,2019-04-16 09:38:00-04:00,JNJ,neutral
707353.0,J&J Says 800 Sites Now Certified For New Depression Drug SPRAVATO,2019-04-16 09:38:00-04:00,JNJ,negative
707354.0,Johnson & Johnson shares are trading higher after the company reported better-than-expected Q1 EPS and revenue results and issued FY19 adjusted EPS guidance above the analyst estimate.,2019-04-16 08:20:00-04:00,JNJ,positive
707355.0,"The Daily Biotech Pulse: J&J Earnings, FDA Nod For Medicinova, Proteon To Explore Strategic Alternatives",2019-04-16 08:10:00-04:00,JNJ,neutral
707356.0,A Peek Into The Markets: US Stock Futures Higher Ahead Of Earnings,2019-04-16 06:47:00-04:00,JNJ,neutral
707357.0,"Johnson & Johnson Raises FY19 Adj. EPS Guidance From $8.65-$8.80 To $8.73-$8.83 vs $8.58 Est., Raises Sales Guidance From $81.6B-$82.4B To $82.0B-$82.8B vs $81.05B Est.",2019-04-16 06:43:00-04:00,JNJ,neutral
707358.0,"Johnson & Johnson Q1 Adj. EPS $2.1 Beats $2.08 Estimate, Sales $20.02B Beat $19.63B Estimate",2019-04-16 06:40:00-04:00,JNJ,neutral
707359.0,"10 Stocks To Watch For April 16, 2019",2019-04-16 05:24:00-04:00,JNJ,neutral
707360.0,"Earnings Scheduled For April 16, 2019",2019-04-16 05:01:00-04:00,JNJ,neutral
707361.0,"Earnings Parade Rolls Along As Citigroup, Goldman Sachs Report And SPX Now Tops 2900",2019-04-15 10:02:00-04:00,JNJ,positive
707362.0,Granted Accelerated Approval To Johnson & Johnson's Balversa Targeted Therapy For Metastatic Bladder Cancer,2019-04-12 13:31:00-04:00,JNJ,negative
707363.0,Nanocap Biotech Tracon Falls 50% After Shelving Study,2019-04-12 09:21:00-04:00,JNJ,neutral
707364.0,J&J's Janssen Presents New Data From First Phase 3 Trial Of Single-Tablet Regimen In Rapid Initiation Model Of Care,2019-04-11 08:00:00-04:00,JNJ,positive
707365.0,"Geron's Blood Cancer Candidate Creates Buying Opportunity, Needham Says In Upgrade",2019-04-09 14:50:00-04:00,JNJ,negative
707366.0,PreMarket Prep Opening NYSE Imbalance Update: GE 652k Shares To Sell; ExxonMobil 66k Shares To Sell; BofA 123 To Sell; Citi 52k To Sell; P&G 40k sell; J&J 41k To sell; Pfizer 96k To Sell,2019-04-09 08:34:00-04:00,JNJ,positive
707367.0,What's Been Going On With Emerald Bioscience?,2019-04-08 15:26:00-04:00,JNJ,neutral
707368.0,Immunomedics Reports Promotion Deal In Which Co. Will Provide Detailing Services To J&J's Janssen For Erdafitinib In US,2019-04-08 09:02:00-04:00,JNJ,neutral
707369.0,Janssen Announces Investigational CAR-T Therapy JNJ-68284528 Granted PRIME Designation by EMA,2019-04-04 06:00:00-04:00,JNJ,positive
707370.0,Johnson & Johnson Says TV Ads For Bloodthinner Xarelto To Give $448 A Month List Price Starting Friday,2019-03-28 11:25:00-04:00,JNJ,neutral
707371.0,J&J's Janssen Reports FDA Submission Of Supplemental New Drug Application For INVOKANA For Treatment Of Chronic Kidney Disease In Patients With Type 2 Diabetes,2019-03-28 08:32:00-04:00,JNJ,neutral
707372.0,Plaintiff Lawyer Says Johnson & Johnson Has Settled Three Mesothelioma Talc Cases Brought In State Courts,2019-03-27 18:13:00-04:00,JNJ,neutral
707373.0,J&J Spokesperson Says Jersey Jury Cleared Co. Of Liability In Mesothelioma Talc Trial,2019-03-27 12:53:00-04:00,JNJ,negative
707374.0,6 Gene Therapy M&A Targets On The Radar,2019-03-27 12:45:00-04:00,JNJ,neutral
707375.0,Axsome Adds To Strong Gains After FDA Grants Breakthrough Designation For Depression Drug,2019-03-27 10:44:00-04:00,JNJ,positive
707376.0,"Janssen Seeks Expanded Use of DARZALEX®▼ (daratumumab) Combination Therapy for Newly Diagnosed, Transplant Eligible Patients with Multiple Myeloma",2019-03-27 06:12:00-04:00,JNJ,neutral
707377.0,J&J's Janssen Reports Submission Of Application For Darzalex Combo Thearpy,2019-03-26 09:53:00-04:00,JNJ,neutral
707378.0,"Genmab Reports FDA Submission Of Supplemental Biologics License Application For Daratumumab In Combo With Bortezomib, Thalidomide, Dexamethasone, Says J&J Sees Publishing Detailed Data From Phase 3 CASSIOPEIA Study This Year",2019-03-26 09:34:00-04:00,JNJ,neutral
707379.0,OxyContin Manufacturer Purdue Agrees to Settlement in Oklahoma Lawsuit,2019-03-26 04:30:00-04:00,JNJ,neutral
707380.0,Raymond James Expects Johnson & Johnson's Growth To Accelerate Into 2020,2019-03-25 15:04:00-04:00,JNJ,positive
707381.0,"Court Records Show Bayer, J&J Have Settled XARELTO Litigation For $775M",2019-03-25 10:32:00-04:00,JNJ,negative
707382.0,A New Look For The Barron's 400 ETF,2019-03-19 08:51:00-04:00,JNJ,neutral
707383.0,"Actelion Pharmaceuticals-Patients Treated With Opsumit Showed Significant Improvement In Right Ventricular Function, Reduced Pulmonary Vascular Resistance",2019-03-15 11:21:00-04:00,JNJ,positive
707384.0,"The Daily Biotech Pulse: AEterna Zentaris Explores Options, Verastem Plunges On Weak Copiktra Sales, FDA Nod For Aerie",2019-03-13 07:27:00-04:00,JNJ,negative
707385.0,J&J's Janssen Submits Application Seeking Approval Of Darzalex Combo For Patients With Newly-Diagnosed Multiple Myeloma Who Are Transplant Ineligible,2019-03-12 16:33:00-04:00,JNJ,positive
707386.0,"'Oklahoma says Johnson & Johnson was the ""kingpin"" behind the opioid crisis' -Axios",2019-03-12 07:00:00-04:00,JNJ,negative
707387.0,Janssen's Phase 3 Study of STELARA Met its Primary and Some Secondary Endpoints,2019-03-11 08:10:00-04:00,JNJ,neutral
707388.0,"The Week Ahead In Biotech: Conferences, PDUFA Dates, Earnings, IPOs",2019-03-10 14:32:00-04:00,JNJ,neutral
707389.0,Another ESG ETF Enters The Fold,2019-03-07 14:48:00-05:00,JNJ,neutral
707390.0,"J&J's Janssen Reports Results Of 2 Phase 3 Studies Which Showed Long-Acting Injectable HIV Treatment Regimen Of Rilpivirine, Cabotegravir Showed Comparable Safety, Efficacy To Daily Oral HIV Therapy",2019-03-07 13:47:00-05:00,JNJ,positive
707391.0,Allergan's Depression Drug Letdown Largely Expected: Analysts Focus On Remainder Of Pipeline,2019-03-07 10:54:00-05:00,JNJ,negative
707392.0,"Daily Biotech Pulse: Allergan's Depression Drug Flunks Late-Stage Trial, Apellis Offering, ShockWave Medical IPO",2019-03-07 07:48:00-05:00,JNJ,negative
707393.0,J&J Says Weighted Average Cost Of Spravato Is $590-$885/Treatment Session,2019-03-06 11:52:00-05:00,JNJ,neutral
707394.0,Johnson & Johnson Option Alert: Mar 15 $142 Calls Sweep (2) near the Ask: 1000 @ $0.201 vs 260 OI; Earnings 4/16 Before Open [est] Ref=$138.94,2019-03-06 11:52:00-05:00,JNJ,positive
707395.0,FDA Approves Major Novel Depression Drug For First Time In 3 Decades,2019-03-06 09:25:00-05:00,JNJ,positive
707396.0,"The Daily Biotech Pulse: Horizon Pharma Under DoJ Radar, FDA Greenlights J&J's Depression Drug, Endologix Reverse Split",2019-03-06 07:39:00-05:00,JNJ,negative
707397.0,"The Daily Biotech Pulse: Novartis Psoriasis Drug Found Superior, Ascendis Offering, Adamas Earnings",2019-03-05 07:24:00-05:00,JNJ,positive
707398.0,Attention Biotech Investors: Mark Your Calendar For These March PDUFA Dates,2019-03-04 11:50:00-05:00,JNJ,neutral
707399.0,"The Week Ahead In Biotech: Conferences, PDUFA Dates, Clinical Trials, Earnings, IPOs",2019-03-03 09:41:00-05:00,JNJ,neutral
707400.0,It Could Be Time For This Pharma ETF,2019-02-26 09:42:00-05:00,JNJ,neutral
707401.0,"Citigroup Maintains Neutral on Johnson & Johnson, Raises Price Target to $147",2019-02-25 10:33:00-05:00,JNJ,neutral
707402.0,The Latest From Johnson & Johnson's Asbestos Scandal,2019-02-21 10:00:00-05:00,JNJ,negative
707403.0,'Johnson & Johnson receives federal subpoenas related to baby powder litigation' -Reuters Earlier Reported,2019-02-21 07:54:00-05:00,JNJ,negative
707404.0,A Chat With The CEO Behind The Cannabis Company With The 'BOSS' Ticker: 'There Isn't A Single Route To Success',2019-02-21 07:37:00-05:00,JNJ,positive
707405.0,"Morphic Therapeutic Reports Integrin R&D Collaboration With J&J's Janssen; Janssen To Pay Co. Undisclosed Upfront Payment, Will Fund Research Activities; Co. Will Receive From Janssen Multiple Preclinical Development, Clinical, Commercial Milestones",2019-02-21 06:44:00-05:00,JNJ,negative
707406.0,"Supreme Court Rejects Maryland's Bid To Revive A Law Aimed At Preventing Price Gouging By Pharmaceutical Companies, Reuters Reports",2019-02-19 10:04:00-05:00,JNJ,positive
707407.0,"Pot Stocks, ETFs, Top News And Data From The Cannabis Industry This Week",2019-02-15 16:31:00-05:00,JNJ,positive
707408.0,"The Week Ahead In Biotech: Conferences, Clinical Trials And Earnings",2019-02-15 14:00:00-05:00,JNJ,neutral
707409.0,J&J's Talc Supplier Seeks Bankruptcy,2019-02-13 12:39:00-05:00,JNJ,neutral
707410.0,Penny Stock Auris Medical Spikes On Case Of Mistaken Identity,2019-02-13 10:57:00-05:00,JNJ,negative
707411.0,Johnson & Johnson Wins FDA Panel Backing For Nasal Spray Depression Drug; PDUFA Date Awaits,2019-02-13 09:38:00-05:00,JNJ,positive
707412.0,"Johnson & Johnson To Acquire Auris Health For $3.4B In Cash, with Additional Contingent Payments Of $2.5B Upon Certain Milestones",2019-02-13 09:01:00-05:00,JNJ,positive
707413.0,"The Daily Biotech Pulse: Exelixis Q4 Results, FDA Panel Greenlights J&J's Depression Drug, MacroGenics Prices Offering",2019-02-13 07:49:00-05:00,JNJ,negative
707414.0,FDA Panel Votes In Favor Of Johnson & Johnson's Nasal Spray For Treatment-Resistant Depression; Says Benefits Outweigh Risks,2019-02-12 14:45:00-05:00,JNJ,negative
707415.0,"The Daily Biotech Pulse: NASH Disappointment For Gilead, Xeris To Offer Shares",2019-02-12 08:04:00-05:00,JNJ,negative
707416.0,FDA Panel Reviews Johnson & Johnson's Treatment-Resistant Depression Candidate: What To Expect,2019-02-11 16:00:00-05:00,JNJ,negative
707417.0,"The Week Ahead In Biotech: Conferences, PDUFA Dates And Clinical Trials",2019-02-10 17:37:00-05:00,JNJ,neutral
707418.0,"The Daily Biotech Pulse: Big Miss For Seattle Genetics; Hematology Conference Presentations; Gossamer Bio, Harpoon IPOs",2019-02-08 09:17:00-05:00,JNJ,negative
707419.0,Drugmakers Offered C$9.6B in Price Cuts; Freeze of Drug Prices in Response to Proposed Crackdown by Canada Regulator,2019-02-06 04:18:00-05:00,JNJ,negative
707420.0,'Research Announcement: Moody's - Talc-related lawsuits could increase risk to Johnson & Johnson's strong credit profile' -Moody's,2019-02-05 10:56:00-05:00,JNJ,positive
707421.0,Johnson & Johnson Talc-related Lawsuits Could Increase Risk To Johnson & Johnson's Strong Credit Profile,2019-02-05 10:54:00-05:00,JNJ,positive
707422.0,"J&J's Janssen Reports Global Collaboration, License Deal With MeiraGTx To Develop Gene Therapy Programs For Inherited Retinal Diseases",2019-01-31 06:38:00-05:00,JNJ,neutral
707423.0,Janssen Enters Worldwide Collaboration And License Agreement With Meiragtx To Develop Gene Therapy Programs For Inherited Retinal Diseases,2019-01-31 06:32:00-05:00,JNJ,positive
707424.0,"The Week Ahead In Biotech: Conferences, PDUFA Dates, Clinical Trials And Earnings",2019-01-27 16:07:00-05:00,JNJ,neutral
707425.0,"Geopolitics Aside, How About Those Earnings? Investors Appear To Switch Focus",2019-01-23 10:15:00-05:00,JNJ,neutral
707426.0,Analysts Stand By Johnson & Johnson Despite Earnings Pullback,2019-01-23 08:50:00-05:00,JNJ,neutral
707427.0,Johnson & Johnson Said to be Pursuing Acquisition of Auris Health,2019-01-23 04:22:00-05:00,JNJ,neutral
707428.0,Mid-Afternoon Market Update: Dow Down Over 400 Points; UQM Technologies Shares Spike Higher,2019-01-22 14:44:00-05:00,JNJ,positive
707429.0,Mid-Day Market Update: Crude Oil Down Over 3%; Staffing 360 Solutions Shares Jump,2019-01-22 12:02:00-05:00,JNJ,negative
707430.0,"Wakeup Call: World, China Growth Data Fail To Impress, Pushing Down Global Markets",2019-01-22 10:18:00-05:00,JNJ,positive
707431.0,Mid-Morning Market Update: Markets Open Lower; Johnson & Johnson Profit Tops Expectations,2019-01-22 10:17:00-05:00,JNJ,positive
707432.0,J&J Executive Says Does Not See Long-run Strategic Impact To Its Consumer Business Related To Talc,2019-01-22 09:55:00-05:00,JNJ,neutral
707433.0,From J&J Conference Call: CFO Says Co. Plans For Continued Price Decreases On A Net Basis In The Near Future,2019-01-22 09:40:00-05:00,JNJ,neutral
707434.0,J&J CFO Says Stronger US Dollar Will Likely Result In Negative Impact On Reported Results In 2019,2019-01-22 09:33:00-05:00,JNJ,negative
707435.0,A Peek Into The Markets: US Stock Futures Drop Ahead Of Earnings,2019-01-22 06:44:00-05:00,JNJ,negative
707436.0,"Johnson & Johnson Sees FY19 Adj. EPS $8.50-$8.65 vs $8.61 Est., Sales $80.4B-$81.2B vs $82.68B Est.",2019-01-22 06:43:00-05:00,JNJ,neutral
707437.0,"Johnson & Johnson Q4 Adj. EPS $1.97 Beats $1.95 Estimate, Sales $20.4B Beat $20.17B Estimate",2019-01-22 06:42:00-05:00,JNJ,neutral
707438.0,"10 Stocks To Watch For January 22, 2019",2019-01-22 04:35:00-05:00,JNJ,neutral
707439.0,"Earnings Scheduled For January 22, 2019",2019-01-22 04:01:00-05:00,JNJ,neutral
707440.0,"The Daily Biotech Pulse: Regulatory Roadblock For Immunomedics, AdCom Split On Lexicon's Diabetes Drug",2019-01-18 07:49:00-05:00,JNJ,neutral
707441.0,"MediPharm Labs, Pure Global Cannabis, Weekend Unlimited, Plus Products, Trulieve Make Elevator Pitches",2019-01-17 17:20:00-05:00,JNJ,neutral
707442.0,Johnson & Johnson Announces Research Study With Apple Watch To Help Improve AFib Outcomes Including Stroke Prevention,2019-01-17 08:35:00-05:00,JNJ,positive
707443.0,"The Daily Biotech Pulse: FDA Panel Backs Amgen's Hypertension Drug, Adamis Allergy Drug Launched In US",2019-01-17 08:06:00-05:00,JNJ,positive
707444.0,Johnson & Johnson's Actelion Pharmaceuticals Receives Complete Response Letter From FDA Regarding Its New Drug Application For OPSUMIT; Letter Indicates Additional Data Needed To Evaluate Drug For CTEPH Treatment,2019-01-16 16:32:00-05:00,JNJ,neutral
707445.0,J&J's Janssen Pharma Says European Commission Approved Erleada For Non-Metastatic Castration-Resistance Prostate Cancer Patients,2019-01-16 08:26:00-05:00,JNJ,negative
707446.0,Cannabis Company Avicanna Eyes Canadian IPO,2019-01-15 11:42:00-05:00,JNJ,neutral
707447.0,Hearing Dealreporter Says JNJ May Be 'Gearing Up' For A Takeover Of Boston Scientific,2019-01-15 09:37:00-05:00,JNJ,neutral
707448.0,How To Approach Q4 Earnings: The Global Perspective,2019-01-14 11:29:00-05:00,JNJ,neutral
707449.0,10 Biggest Price Target Changes For Monday,2019-01-14 09:56:00-05:00,JNJ,neutral
707450.0,"Wells Fargo Maintains Outperform on Johnson & Johnson, Lowers Price Target to $152",2019-01-14 09:16:00-05:00,JNJ,positive
707451.0,"J&J Recommends Rejection Of  Below-Market ""Mini-Tender"" Offer By Peer & Peri LLC",2019-01-11 17:00:00-05:00,JNJ,negative
707452.0,Johnson & Johnson Raised U.S. Prices On ~Two Dozen Prescription Drugs On Thursday,2019-01-11 04:55:00-05:00,JNJ,neutral
707453.0,20 Women Set To Dominate The International Cannabis Space In 2019,2019-01-10 13:54:00-05:00,JNJ,negative
707454.0,"'Halftime Report' Picks For January 7: Mastercard, Twilio And More",2019-01-07 14:40:00-05:00,JNJ,neutral
707455.0,"Jon Najarian Sees Big Options Activity In Johnson & Johnson, Nvidia",2019-01-07 14:24:00-05:00,JNJ,neutral
707456.0,"Barron's Picks And Pans: Apple, Exxon, Morgan Stanley And More",2019-01-06 09:06:00-05:00,JNJ,neutral
707457.0,India Government May Offer More Compensation To J&J Faulty Hip Implant Patients,2019-01-04 04:54:00-05:00,JNJ,negative
707458.0,Veracyte shares are trading up after the company announced a strategic collaboration with J&J Innovation for lung cancer detection.,2019-01-03 11:00:00-05:00,JNJ,negative
707459.0,"UPDATE: Veracyte Reports Will Combine Clinical Study Cohorts Involving 5K+ Patients, Multiple Years Of Clinical Outcome Data",2019-01-03 07:16:00-05:00,JNJ,neutral
707460.0,Veracyte Reports Strategic Collaboration With J&J Innovation For Lung Cancer Detection,2019-01-03 07:15:00-05:00,JNJ,negative
707461.0,"Morgan Stanley Maintains Equal-Weight on Johnson & Johnson, Lowers Price Target to $130",2019-01-02 09:46:00-05:00,JNJ,negative
707462.0,Johnson & Johnson Option Alert: Jan 18 $150 Calls at the Ask: 10000 @ $0.03 vs 28534 OI; Earnings 1/22 Before Open Ref=$124.33,2018-12-27 12:14:00-05:00,JNJ,positive
707463.0,"Barron's Picks And Pans: Unicorns, European Treasures, Health Care Bargains And More",2018-12-23 09:25:00-05:00,JNJ,positive
707464.0,"The Daily Biotech Pulse: Proteostasis Delays Data, Akron Gets New CEO, Pfizer Halts Vaccine Trial",2018-12-21 07:58:00-05:00,JNJ,neutral
707465.0,"Bangladesh To Collect, Test Samples Of Johnson & Johnson Baby Powder",2018-12-21 05:31:00-05:00,JNJ,neutral
707466.0,J&J's Janssen Reports Submission Of Application For STELARA For Treatment Of Moderately To Severely Active Ulcerative Colitis,2018-12-20 16:35:00-05:00,JNJ,negative
707467.0,"J&J Says Is In Full Compliance With Current Regulatory Requirements For Manufacturing, Testing Of Its Talc In India",2018-12-20 13:39:00-05:00,JNJ,neutral
707468.0,"Indian Drugs Regulator Orders Johnson & Johnson To Stop Using Raw Material At Two Baby Power Factories In India, Says Co. Can't Produce Baby Powder With Current Raw Materials Until It Is Shown To Be Free Of Asbestos",2018-12-20 09:46:00-05:00,JNJ,positive
707469.0,'$JNJ --that was not an appeal in MO it was a request to overturn to the same judge who first ruled against them. Now it will be appealed to a higher court -CNBC's Jim Cramer Tweets,2018-12-19 14:29:00-05:00,JNJ,neutral
707470.0,"Hearing Morgan Stanley On Johnson & Johnson Baby Powder Verdict Clarifies That Co. Lost Some Post Trials Motions Which Are Customary After Verdict, But Notes Co. Has Been Successful In Other Post Trial Motions.",2018-12-19 14:21:00-05:00,JNJ,positive
707471.0,Jury Upholds $4.69B Verdict In Johnson & Johnson Baby Powder Case,2018-12-19 13:49:00-05:00,JNJ,positive
707472.0,J&J Shares Fall ~0.5% Following NY Times Article 'Johnson & Johnson Loses Bid to Overturn a $4.7 Billion Baby Powder Verdict',2018-12-19 12:47:00-05:00,JNJ,positive
707473.0,J&J Shares Unaffected Midday Amid NY Times Report 'Johnson & Johnson Loses Bid to Overturn a $4.7 Billion Baby Powder Verdict',2018-12-19 12:45:00-05:00,JNJ,positive
707474.0,"J&J To Report Q4 Earnings On Tues., Jan. 22, 2019 Before Market Open",2018-12-19 11:17:00-05:00,JNJ,neutral
707475.0,"J&J Says Indian Authorities Visited Some Of Its Facilities On Wednesday; Says  ""Unequivocally Stand By The Safety Of Our Products, Are Fully Compliant With Regulatory Standards And Requirements In India""",2018-12-19 04:56:00-05:00,JNJ,positive
707476.0,"Benzinga Pro's Top 10 Most-Searched Tickers For Afternoon Of Tues., Dec. 18, 2018",2018-12-18 15:26:00-05:00,JNJ,positive
707477.0,Johnson & Johnson And Imerys To Pay More Than $1.5M In Talc Case,2018-12-18 13:33:00-05:00,JNJ,negative
707478.0,Fed Meeting Starts With Market Off To Worst December Start in 38 Years,2018-12-18 11:37:00-05:00,JNJ,negative
707479.0,"Hearing CNBC's Jim Cramer, On 'Squawk On The Street,' Called J&J 'Absolutely A Buy'",2018-12-18 09:20:00-05:00,JNJ,neutral
707480.0,"Benzinga Pro's Top 10 Most-Searched Tickers For Morning Of Tues., Dec. 18, 2018",2018-12-18 09:15:00-05:00,JNJ,positive
707481.0,Johnson & Johnson CEO Tells Cramer 'Thousands Of Studies' Refute Asbestos Allegations,2018-12-18 08:45:00-05:00,JNJ,neutral
707482.0,"The Daily Biotech Pulse: Puma Aces Late-Stage Trial, Chinese Cheer For FibroGen, J&J $5B Buyback Plan",2018-12-18 08:00:00-05:00,JNJ,positive
707483.0,"'EXCLUSIVE: Johnson & Johnson CEO Alex Gorsky tells CNBC's @JimCramer that ""we unequivocally believe that our talc, our baby powder, does not contain asbestos"" ' -CNBC",2018-12-17 17:03:00-05:00,JNJ,neutral
707484.0,"J&J Reaffirms FY18 Outlook: Adj. EPS $8.13-$8.18 vs $8.16 Estimate, Sales $81B-$81.4B vs $81.3B Est.",2018-12-17 16:50:00-05:00,JNJ,neutral
707485.0,Johnson & Johnson Reports $5B Buyback,2018-12-17 16:23:00-05:00,JNJ,neutral
707486.0,Johnson & Johnson CEO Alex Gorsky Issues Video Message In Defense Of Co.'s Baby Powder,2018-12-17 14:25:00-05:00,JNJ,positive
707487.0,Johnson & Johnson shares are trading lower on continued weakness following Friday reports indicating the company did not disclose prior knowledge of asbestos in its baby powder products; NOTE: Some analysts have are out defending the stock.,2018-12-17 13:44:00-05:00,JNJ,negative
707488.0,"Benzinga Pro's Top 10 Most-Searched Tickers For Morning Of Mon., Dec. 17, 2018",2018-12-17 11:51:00-05:00,JNJ,positive
707489.0,Johnson & Johnson's Asbestos Woes: Experts Speak Up,2018-12-17 11:05:00-05:00,JNJ,negative
707490.0,Hearing Johnson & Johnson CEO Alex Gorsky To Appear On Jim Cramer's 'Mad Money' Tonight,2018-12-17 10:26:00-05:00,JNJ,negative
707491.0,"BMO On Johnson & Johnson: Firm Thinks The Stock Move Was An Overreaction; Notes The 'last time JNJ finished down more than 10% was on July 19, 2002, declining 16%; it recovered six days later'; Reiterates Outperform, $154 Target",2018-12-17 09:54:00-05:00,JNJ,negative
707492.0,"Morgan Stanley On Johnson & Johnson: Believes 'the stock reaction is not supported by science and may inflate potential legal exposure'; Sees Comparisons To Recent Legal Issues At Bayer (BAYRY) As Flawed; Maintains Overweight, $153 Target",2018-12-17 08:01:00-05:00,JNJ,negative
707493.0,41 Biggest Movers From Friday,2018-12-17 05:35:00-05:00,JNJ,neutral
707494.0,Wells Fargo Note Cites Bausch Health Acquiring Shower to Shower Body Powder from J&J; Named as Defendant in 160+ Lawsuits,2018-12-14 14:36:00-05:00,JNJ,positive
707495.0,Hearing Wells Fargo Out Negative on Bausch Health Off J&J Reuters Report,2018-12-14 14:34:00-05:00,JNJ,negative
707496.0,"J&J Issues Statement On Reuters Talc Report: '...article is one-sided, false and inflammatory. Simply put, the Reuters story is an absurd conspiracy theory'",2018-12-14 13:57:00-05:00,JNJ,negative
707497.0,Citi Says J&J Has Completely Refuted Premise Of Reuters Article Related To Talc,2018-12-14 12:35:00-05:00,JNJ,neutral
707498.0,Hearing JP Morgan Now Also Out Giving Defensive Comments On J&J,2018-12-14 12:21:00-05:00,JNJ,positive
707499.0,26 Stocks Moving In Friday's Mid-Day Session,2018-12-14 12:21:00-05:00,JNJ,neutral
707500.0,Hearing Wells Fargo Analyst Said J&J Shares Appear Oversold Amid Talc Report,2018-12-14 11:48:00-05:00,JNJ,positive
707501.0,Johnson & Johnson Falls Following Baby Powder Asbestos Report,2018-12-14 11:47:00-05:00,JNJ,neutral
707502.0,Hearing Susquehanna Says J&J Has Been Facing Talc Litigation For Years,2018-12-14 10:27:00-05:00,JNJ,negative
707503.0,Johnson & Johnson shares are trading lower following reports indicating the company did not disclose prior knowledge of asbestos in its baby powder products.,2018-12-14 10:18:00-05:00,JNJ,neutral
707504.0,Johnson & Johnson Option Alert: Fri $145 Puts Sweep (3) near the Ask: 1713 @ $1.5 vs 2434 OI; Earnings 1/22 Before Open [est] Ref=$143.711,2018-12-14 09:32:00-05:00,JNJ,positive
707505.0,J&J Says 'Thousands of independent tests' Show Talc Is Safe,2018-12-14 09:20:00-05:00,JNJ,positive
707506.0,J&J Failed To Tell FDA Of Talc Tests Showing Asbestos From 1970s,2018-12-14 09:17:00-05:00,JNJ,negative
707507.0,J&J's Janssen Reports Submitted Supplemental New Drug Application To FDA For XARELTO To Prevent Venous Thromboembolism In Acute Medically Ill Patients,2018-12-14 08:37:00-05:00,JNJ,negative
707508.0,"J&J Drafted Into A Fight Over Shareholder Suits, Co. Asked SEC To Omit Proposal From 2019 Proxy Statement",2018-12-13 16:37:00-05:00,JNJ,negative
707509.0,Hearing JNJ To Pay Average Of $125K Per Pinnacle-Hip Case,2018-12-12 15:08:00-05:00,JNJ,negative
707510.0,Novartis Exec On J&J Call To Discuss TREMFYA Says 'We believe data from ECLIPSE trial...will have limited clinical relevance',2018-12-12 10:29:00-05:00,JNJ,negative
707511.0,BiomX Enters Collaboration With Johnson & Johnson Innovation For Discovery Of Microbiome-Based Biomakers For IBD,2018-12-12 07:38:00-05:00,JNJ,positive
707512.0,"The Daily Biotech Pulse: AbbVie Halts Lung Cancer Trial, Oncomed Merges With Mereo, Momenta Offering",2018-12-06 07:56:00-05:00,JNJ,negative
707513.0,"J&J's Janssen Reports New Phase 3 CASSINI Data Presented On Use Of XARELTO, Composite Primary Endpoint Of VTE Occurrence Did Not Reach Statistical Significance During Full-Study Period",2018-12-04 10:33:00-05:00,JNJ,negative
707514.0,"J&J's Janssen Reports New Darzalex Phase 3 Study Showed Efficacy, Safety Data On Anti-CD38 Monoclonal Activity In Newly-Diagnosed Transplant Patients, Says Median Progression-Free Survival Has Not Yet been Reached",2018-12-04 10:31:00-05:00,JNJ,positive
707515.0,"The Daily Biotech Pulse: ASH Presentations Take The Spotlight, Eiger Gets A New CFO",2018-12-04 07:59:00-05:00,JNJ,neutral
707516.0,Janssen Affiliate Cilag GmbH International Enters Worldwide Collaboration and License Agreement with Argenx for Cancer Immunotherapy Cusatuzumab,2018-12-03 04:18:00-05:00,JNJ,negative
707517.0,"The Week Ahead In Biotech: ASH Presentations Pick Up Pace, PDUFA Dates, Clinical Trials And IPOs",2018-12-02 17:51:00-05:00,JNJ,neutral
707518.0,GlaxoSmithKline and J&J's HIV Drug Juluca Received Approval In Japan,2018-11-27 14:43:00-05:00,JNJ,positive
707519.0,"Stocks Trading Ex Dividend For Mon., Nov. 26, 2018",2018-11-26 10:43:00-05:00,JNJ,neutral
707520.0,9 Policy Catalysts For Health Care Investors To Watch Before Year's End,2018-11-25 09:35:00-05:00,JNJ,positive
707521.0,"Stocks That Will Be Trading Ex Dividend Mon., Nov. 26, 2018",2018-11-23 09:06:00-05:00,JNJ,neutral
707522.0,A US Appeals Court Has Declined To Block The Sale Of Generic Versions Of J&J's ZYTIGA,2018-11-21 14:28:00-05:00,JNJ,negative
707523.0,"Stocks Which Set New 52-Week High Yesterday, Tues., Nov. 20, 2018",2018-11-21 08:38:00-05:00,JNJ,neutral
707524.0,"Hearing Appeals Court Says JNJ Can't Prevent Sales Of Generic Zytiga; Says Teva, Mylan Can Enter Market",2018-11-20 16:02:00-05:00,JNJ,neutral
707525.0,"Stocks Which Set New 52-Week High Yesterday, Mon., Nov. 19, 2018",2018-11-20 09:11:00-05:00,JNJ,neutral
707526.0,"The Daily Biotech Pulse: Denali's Positive Results, Novartis' Substance Abuse Therapy Launch, Medtronic Earnings",2018-11-20 08:29:00-05:00,JNJ,negative
707527.0,CHMP Says J&J's Janssen Pharma's ERLEADA Receive Positive Opinion For Treatment Of Non-Metastatic Castration Resistant Prostate Cancer,2018-11-16 07:57:00-05:00,JNJ,negative
707528.0,Johnson & Johnson Vision Announces Health Canada Has Announced Medical Device License For CUVUE OASYS Contact Lens With Transitions Light Intelligent Technology,2018-11-07 12:38:00-05:00,JNJ,positive
707529.0,"Fundstrat, Reality Shares Partner On New Multi-Factor ETF",2018-11-05 14:22:00-05:00,JNJ,positive
707530.0,Eli Lilly Gets Ready For First Report Post-Elanco IPO,2018-11-05 12:09:00-05:00,JNJ,positive
707531.0,Why Apple Will Likely Remain Sole Member Of $1 Trillion Club For A While,2018-11-04 13:58:00-05:00,JNJ,neutral
707532.0,"These Are The Biggest Stocks Reporting Earnings This Week, And Their Recent Track Records",2018-10-29 10:39:00-04:00,JNJ,neutral
707533.0,Johnson & Johnson Late Friday Reported A US District Court Ruled Invalidated All Asserted Claims Of Patent For ZYTIGA; Johnson & Johnson Said 'Strongly Disagrees' With Courts Decision,2018-10-29 08:35:00-04:00,JNJ,negative
707534.0,TESARO Announces Achievement Of ZEJULA Prostate Cancer Development Milestones By Janssen; Receives $18M Milestone Payment From Janssen,2018-10-29 08:08:00-04:00,JNJ,negative
707535.0,'A New Way To Treat The Brain': Stanford University Scientists Launch Cannabis Pharma Company,2018-10-26 13:14:00-04:00,JNJ,positive
707536.0,Janssen's Stelara Demonstrated Sustained Efficiency In Improving Clinical Remission Rates In Chron's Patients Throughout Three Years; Safety Events Were Not Higher Amongst All Ustekinumab-Treated Patients Entering Long-Term Extension Study vs Placebo,2018-10-24 07:45:00-04:00,JNJ,positive
707537.0,"'6 kids dead, 12 sick in viral outbreak at New Jersey rehabilitation center' -ABC 7 NY",2018-10-23 15:00:00-04:00,JNJ,negative
707538.0,"Johnson & Johnson Announces Offer to Acquire Ci:z Holdings Co.,  for ~ ¥230B",2018-10-23 04:14:00-04:00,JNJ,neutral
707539.0,"Citigroup Maintains Neutral on Johnson & Johnson, Raises Price Target to $148",2018-10-22 11:43:00-04:00,JNJ,neutral
707540.0,J&J's Janssen Reports 3-Year TREMFYA Data Showed 'Stably Maintained Rates of Skin Clearance in Patients with Moderate to Severe Plaque Psoriasis',2018-10-19 09:05:00-04:00,JNJ,negative
707541.0,"Credit Suisse Maintains Outperform on Johnson & Johnson, Raises Price Target to $152",2018-10-17 11:09:00-04:00,JNJ,positive
707542.0,"After Basking In The Glow Of Netflix Results And Tuesday Rally, Pressure Seems Possible",2018-10-17 10:24:00-04:00,JNJ,negative
707543.0,Watching Boston Scientific As Traders Circulate Speculation From Dealreporter J&J Could Be Interested In Co.,2018-10-17 09:41:00-04:00,JNJ,positive
707544.0,"Raymond James Maintains Outperform on Johnson & Johnson, Raises Price Target to $149",2018-10-17 09:01:00-04:00,JNJ,neutral
707545.0,A Peek Into The Markets: US Stock Futures Down Ahead Of Fed Minutes,2018-10-17 07:16:00-04:00,JNJ,neutral
707547.0,Bank Earnings To The Rescue? Market Seeing Some Green After Strong Results,2018-10-16 10:43:00-04:00,JNJ,positive
707548.0,J&J CFO On Conference Call Says 'Not Satisfied With The Performance In Medical Devices',2018-10-16 09:28:00-04:00,JNJ,negative
707549.0,"The Daily Biotech Pulse: Enzo's Q4 Loss, Sanofi's Positive Trial Results, ImmunoCellular To Delist",2018-10-16 08:52:00-04:00,JNJ,positive
707550.0,A Peek Into The Markets: US Stock Futures Rise,2018-10-16 07:23:00-04:00,JNJ,neutral
707551.0,"Johnson & Johnson Raises FY18 Adj. EPS Outlook From $8.07-$8.1 To $8.13-$8.18 vs $8.15 Est., Sees FY18 Sales $81.0B-$81.4B vs $81.21B Est.",2018-10-16 06:42:00-04:00,JNJ,neutral
707552.0,J&J Raises Guidance,2018-10-16 06:40:00-04:00,JNJ,neutral
707553.0,"Johnson & Johnson Q3 EPS $2.05 Beats $2.03 Estimate, Sales $20.348B Beat $20.03B Estimate",2018-10-16 06:40:00-04:00,JNJ,neutral
707554.0,"12 Stocks To Watch For October 16, 2018",2018-10-16 05:21:00-04:00,JNJ,neutral
707555.0,"Earnings Scheduled For October 16, 2018",2018-10-16 04:37:00-04:00,JNJ,neutral
707556.0,Johnson & Johnson Q3 Earnings Preview,2018-10-15 14:32:00-04:00,JNJ,neutral
707557.0,"The Week Ahead: Q3 Earnings Season, Canada Decriminalizes Cannabis",2018-10-15 12:06:00-04:00,JNJ,neutral
707558.0,"As New Week Begins, Markets Still Seem To Be Playing ""D"" Amid Host of Earnings",2018-10-15 09:41:00-04:00,JNJ,positive
707559.0,4 Major Market Opportunities For The Cannabis Industry,2018-10-14 13:26:00-04:00,JNJ,positive
707560.0,FDA Approves Janssen Pharmaceuticals' Xarelto To Reduce Risk Of Major Cardiovascular Events,2018-10-11 15:54:00-04:00,JNJ,positive
707561.0,"Morgan Stanley Maintains Equal-Weight on Johnson & Johnson, Raises Price Target to $153",2018-10-11 09:34:00-04:00,JNJ,neutral
707562.0,FDA Commissioner Scott Gottlieb Issues Statement On 'new efforts to advance the development of generic copies of complex drugs to improve patient access to medicines',2018-10-09 11:19:00-04:00,JNJ,positive
707563.0,Analysts React To Arrowhead's Janssen Collaboration: Downside In Stock May Be 'Misguided',2018-10-04 13:53:00-04:00,JNJ,negative
707564.0,Arrowhead Announces $3.7B License Agreement With Janssen For Gene-Silencing Drug,2018-10-04 10:12:00-04:00,JNJ,positive
707565.0,"Arrowhead Pharmaceuticals On Conference Call Says Working On HBV With J&J, Not Going To Create A Competing HBV Product",2018-10-04 08:51:00-04:00,JNJ,negative
707566.0,"The Daily Biotech Pulse: AtriCure's Guidance, Guardant Health And Kodiak To Debut",2018-10-04 07:59:00-04:00,JNJ,neutral
707567.0,"Jim Cramer Shares His Thoughts On AbbVie, Clorox, Sirius XM And More",2018-10-04 07:53:00-04:00,JNJ,positive
707568.0,"Arrowhead Reports $3.7B License, Collaboration Deal With J&J's Janssen",2018-10-04 07:31:00-04:00,JNJ,neutral
707569.0,J&J's Janssen Pharmaceuticals Reports Switching To Symtuza Results In Maintained High Virologic Suppression And No Resistance Development Up To 96 Weeks In Virologically Suppressed Adults With HIV-1,2018-10-03 16:05:00-04:00,JNJ,negative
707570.0,"The Week Ahead In Biotech: Conferences, PDUFA Dates, Clinical Trial Results And IPOs",2018-09-30 10:14:00-04:00,JNJ,neutral
707571.0,Geron Plunges As Johnson & Johnson Unit Discontinues Blood Cancer Drug Collaboration,2018-09-27 09:51:00-04:00,JNJ,negative
707572.0,"The Daily Biotech Pulse: Hologic Goes Shopping, Johnson & Johnson Snaps Ties With Geron",2018-09-27 08:20:00-04:00,JNJ,neutral
707573.0,Geron Reports Discontinuation OF Imetelstat Collaboration With Janssen,2018-09-27 06:03:00-04:00,JNJ,neutral
707574.0,"Geron to Provide an Update on the Imetelstat Collaboration with Janssen on September 27, 2018",2018-09-26 20:51:00-04:00,JNJ,neutral
707575.0,"Hearing Johnson & Johnson California Talcum Powder Case Has Ended In Mistrial, Unconfirmed",2018-09-24 14:05:00-04:00,JNJ,negative
707576.0,"The Week Ahead In Biotech: Conferences, PDUFA Dates, Clinical Trial Results And IPOs",2018-09-23 16:10:00-04:00,JNJ,neutral
707577.0,Johnson & Johnson Option Alert: Jun 21 $160 Calls at the Bid: 500 @ $2.0 vs 750 OI; Earnings 10/16 Before Open Ref=$141.87,2018-09-20 12:01:00-04:00,JNJ,positive
707578.0,"The Daily Biotech Pulse: Johnson & Johnson's Generic Unit Files NDA For Urinary Tract Cancer Drug, G1 Therapeutics Prices Offering",2018-09-19 08:47:00-04:00,JNJ,negative
707579.0,"The Week Ahead In Biotech (Sept. 16-22): Conferences, PDUFA Dates, Clinical Trial Results And IPOs",2018-09-16 14:22:00-04:00,JNJ,neutral
707580.0,"Pacira Shares Look Expensive, Stifel Says In Bearish Initiation",2018-09-14 15:55:00-04:00,JNJ,positive
707581.0,"'I still believe $JNJ will drop $GERN imetelstat. I guess we wait for later this month to see if I'm right or wrong. Nothing today changes my bearish view. If anything, NOT focusing on imetelstat today is a negative.'-Stat's Adam Feuerstein Tweets",2018-09-13 11:30:00-04:00,JNJ,negative
707582.0,"Stat News' Adam Feuerstein Retweets That Johnson and Johnson Looking At Imetelstat Data Right Now, No Decision Made Yet",2018-09-13 11:23:00-04:00,JNJ,negative
707583.0,Johnson and Johnson Holding Investor Conference Call On Its Pharma Business Today,2018-09-13 05:53:00-04:00,JNJ,neutral
707584.0,J&J's Janssen Reports TREMFYA Improves Long-Term Patient-reported Outcomes In Patients With Moderate To Severe Plaque Psoriasis,2018-09-12 08:36:00-04:00,JNJ,positive
707585.0,PreMarket Prep Opening NYSE Imbalance Update: Alibaba 109k Shares To Sell; General Electric 163k To Sell; Taiwan Semiconductor 79k To Sell; AT&T 117K To Buy; Home Depot 15k To Buy; Johnson & Johnson 37k To Sell,2018-09-11 08:56:00-04:00,JNJ,positive
707586.0,"The Week Ahead: Apple's Special Event, Mobile World Congress, US Inflation Data On Deck",2018-09-10 12:17:00-04:00,JNJ,positive
707587.0,"The Week Ahead In Biotech: Conferences, Clinical Trial Results, Earnings And IPOs",2018-09-09 16:46:00-04:00,JNJ,neutral
707588.0,Janssen Submits Esketamine Nasal Spray New Drug Application to U.S. FDA for Treatment-Resistant Depression,2018-09-04 08:05:00-04:00,JNJ,negative
707589.0,"The Week Ahead In Biotech: Conferences, PDUFA Dates, Clinical Trials And Earnings",2018-09-02 09:41:00-04:00,JNJ,neutral
707590.0,J&J's Janssen Reports European Commission Approval For Darzalex For Treatment Of Newly-Diagnosed Patients With Multiple Myeloma Who Are Transplant Ineligible,2018-08-31 16:15:00-04:00,JNJ,positive
707591.0,Sympathy Move: Portola Upgraded After Competitor Reports Sour Data,2018-08-27 10:31:00-04:00,JNJ,positive
707592.0,AbbVie's Rare Blood Cancer Drug Combo Snags FDA Approval,2018-08-27 09:38:00-04:00,JNJ,negative
707593.0,"Stocks Trading Ex Dividend For Mon., Aug. 27, 2018",2018-08-27 09:13:00-04:00,JNJ,neutral
707594.0,FDA Approves Johnson & Johnson and Abbvie's IMBRUVICA Plus Rituximab As First Chemotherapy-Free Combo Treatment In Adults With Waldenstrom's Macroglobulinemia,2018-08-27 07:01:00-04:00,JNJ,positive
707595.0,What's Going On With Geron?,2018-08-24 13:53:00-04:00,JNJ,neutral
707596.0,"Geron Shares Fall Modestly, ~3.7%, As J&J Spokesperson Suggests Recent Job Posting Mentioning Imetelstat Is Not Related To An Expected Decision For A Licensing Deal, And Includes 'Responsibilities For A Variety Of Disease Areas'",2018-08-24 12:54:00-04:00,JNJ,positive
707597.0,Hearing J&J Spokesperson Has Issued Response Related To Recent Job Posting: Says Posting Not Related To Expected Decision On Licensing Deal,2018-08-24 12:52:00-04:00,JNJ,neutral
707598.0,"Stocks That Will Be Trading Ex Dividend Mon., Aug. 27, 2018",2018-08-24 11:01:00-04:00,JNJ,neutral
707599.0,"Geron Shares Remain Elevated, Up 28.3% With Some Attributing Upside To Johnson & Johnson Job Posting For a Strategic Pricing Manager For Imbruvica & Imetelstat, Drugs Its Partnered On With AbbVie and Geron, Respectively",2018-08-24 10:42:00-04:00,JNJ,positive
707600.0,"'$GERN trading +30% on a JNJ job posting that mentions imetelstat. Yes, it's that ridiculous. Summer Fridays!'-STAT's Adam Feuerstein Tweets",2018-08-24 10:17:00-04:00,JNJ,positive
707602.0,5 Execs Talk Business Models At Cannabis Capital Conference,2018-08-20 14:37:00-04:00,JNJ,neutral
707603.0,"Barron's Picks And Pans: AT&T, Starbucks, State Street, Verizon And More",2018-08-19 12:07:00-04:00,JNJ,neutral
707604.0,Johnson & Johnson Option Alert: Aug 31 $132 Calls Sweep (34) near the Ask: 787 @ $0.961 vs 385 OI; Ref=$131.58,2018-08-16 10:40:00-04:00,JNJ,positive
707605.0,"J&J's Janssen Reports Submission Of US, EU Regulatory Applications Seeking Approval For DARZALEX Split-Dosing Regimen",2018-08-08 07:39:00-04:00,JNJ,positive
707606.0,"Daabon Strikes Deal With Avicanna, Becoming The Largest Agro Company To Enter The Cannabis Industry",2018-08-06 16:07:00-04:00,JNJ,negative
707607.0,"Price Action In Several Major Healthcare Names Mixed, Stocks Appear Largely Unaffected Following Late-Tues. NY Times Article 'Justice Dept. Investigating Claims That Drug Companies Funded Terrorism in Iraq'",2018-08-01 10:59:00-04:00,JNJ,negative
707608.0,Johnson & Johnson Wins a $227M Defense Contract,2018-07-30 07:10:00-04:00,JNJ,positive
707609.0,What It Takes To Be A Dividend King,2018-07-26 15:01:00-04:00,JNJ,neutral
707610.0,Janssen Presents Switch Data for New HIV-1 Treatment SYMTUZA  and Second Study Supporting its Use in a Rapid Initiation Scenario at AIDS 2018,2018-07-24 06:09:00-04:00,JNJ,positive
707611.0,"Benzinga's Daily Biotech Pulse: Novartis Earnings, J&J's HIV Combo Clears FDA Hurdle, Cara To Offer Shares",2018-07-18 08:42:00-04:00,JNJ,positive
707612.0,J&J Reports FDA Approval Of Symtuza For Treatment Of HIV-1 Infection,2018-07-17 17:32:00-04:00,JNJ,positive
707613.0,Hearing Johnson & Johnson Nears Sale Of Sylvant To Eusa Pharma,2018-07-17 13:40:00-04:00,JNJ,neutral
707614.0,"Benzinga's Daily Biotech Pulse: Bellicum CFO Resigns, Roche's Trial Meets Endpoints, Avid Bioservices Turns To Black In Q4",2018-07-17 08:37:00-04:00,JNJ,neutral
707615.0,A Peek Into The Markets: US Stock Futures Edge Lower Ahead Of Goldman Sachs Earnings,2018-07-17 06:48:00-04:00,JNJ,negative
707616.0,"Johnson & Johnson Sees FY18 Of $80.5-$81.3B vs $81.47B Reflecting An Increase In Expected Operational Growth Of 4.5-5.5%, Sees FY18 Adj. EPS $8.07-$8.17 vs $8.12 Est.",2018-07-17 06:43:00-04:00,JNJ,positive
707617.0,"Johnson & Johnson Q2 EPS $2.10 Beats $2.06 Estimate, Sales $20.83B Beat $20.37B Estimate",2018-07-17 06:42:00-04:00,JNJ,neutral
707618.0,"8 Stocks To Watch For July 17, 2018",2018-07-17 04:44:00-04:00,JNJ,neutral
707619.0,"Earnings Scheduled For July 17, 2018",2018-07-17 04:04:00-04:00,JNJ,neutral
707620.0,Johnson & Johnson Q2 Earnings Preview,2018-07-16 17:20:00-04:00,JNJ,neutral
707621.0,"The Week Ahead: Netflix Earnings, Comic-Con, 'IPO Thursday' And More",2018-07-16 16:54:00-04:00,JNJ,neutral
707622.0,J&J's Janssen Pharma Reports Phase 3 CREDENCE Trial Of INVOKANA Stopped Early For Positive Efficacy Findings,2018-07-16 16:24:00-04:00,JNJ,positive
707623.0,"Upcoming Earnings: Netflix To Report Monday, Subscriber Growth A Focus",2018-07-16 11:08:00-04:00,JNJ,positive
707624.0,Earnings Preview: Healthcare Giant Johnson & Johnson Set To Report Tuesday Morning,2018-07-16 10:31:00-04:00,JNJ,neutral
707625.0,Back To Banks: More Financial Results In Ahead of Powell Testimony Later This Week,2018-07-16 10:14:00-04:00,JNJ,neutral
707626.0,"Round Two Of Bank Earnings Coming Up With Bank of America, Goldman Sachs And Morgan Stanley",2018-07-16 09:35:00-04:00,JNJ,neutral
707627.0,PreMarket Prep Opening NYSE Imbalance Update: ExxonMobil 55k Shares To Sell; Pfizer 50k To Sell; Merck 26k To Sell; Coca-Cola 54k To Sell; Johnson & Johnson 54k To Sell; Ford 103k To Sell; Kroger 90k To Sell,2018-07-16 09:02:00-04:00,JNJ,positive
707628.0,Jury Returns $4.7B Verdict Against Johnson & Johnson In Asbestos-Laced Talcum Case,2018-07-13 09:40:00-04:00,JNJ,positive
707629.0,PreMarket Prep Opening NYSE Imbalance Update: AT&T 167k Shares To Sell; Bank Of America 101k To Buy; JNJ 75k To Sell; Alibaba 55k To Buy,2018-07-13 09:01:00-04:00,JNJ,positive
707630.0,"The Market In 5 Minutes: AT&T-Time Warner Appeal, Johnson & Johnson Lawsuit, Theresa May And More",2018-07-13 08:19:00-04:00,JNJ,negative
707631.0,24 Stocks Moving In Friday's Mid-Day Session,2018-07-13 08:03:00-04:00,JNJ,neutral
707632.0,"J&J Says Deeply Disappointed in Verdict of St Louis Court, Unfair Process",2018-07-12 21:17:00-04:00,JNJ,negative
707633.0,J&J Ordered to Pay $4.14B in Punitive Damages in Talc Cancer Case,2018-07-12 19:10:00-04:00,JNJ,negative
707634.0,Courtroom Video Shows J&J Ordered To Pay $550M In Compensatory Damages In Missouri Trial Which Claimed Asbestos In Talc Caused Cancer In 22 Women,2018-07-12 16:14:00-04:00,JNJ,negative
707635.0,"Bank Earnings: JPMorgan, Wells Fargo And Citigroup Are Slated To Report Friday Morning",2018-07-12 13:42:00-04:00,JNJ,positive
707636.0,"Goldman Sachs Swaps Perrigo, Johnson & Johnson Ratings",2018-07-12 10:28:00-04:00,JNJ,neutral
707637.0,"Benzinga's Top Upgrades, Downgrades For July 12, 2018",2018-07-12 09:20:00-04:00,JNJ,positive
707638.0,Goldman Sachs Upgrades Johnson & Johnson to Neutral,2018-07-12 08:20:00-04:00,JNJ,neutral
707639.0,"Benzinga's Daily Biotech Pulse: Pfizer To Defer Price Hikes, Idera-BioCryst Merger Falls Through, ArQule To Offer Shares",2018-07-11 08:15:00-04:00,JNJ,neutral
707640.0,Johnson & Johnson Option Alert: Aug 17 $120 Puts Sweep (29) near the Bid: 932 @ $0.653 vs 3925 OI; Earnings 7/17 Before Open Ref=$127.295,2018-07-10 15:20:00-04:00,JNJ,positive
707641.0,Health Care Sector Outlook: Checking In Ahead Of Q2 Earnings Reports,2018-07-09 14:39:00-04:00,JNJ,positive
707642.0,A Look At Biotech In 2018 And The Biggest Catalysts Coming Up In The Second Half Of The Year,2018-07-05 12:25:00-04:00,JNJ,neutral
707643.0,Johnson & Johnson Option Alert: Jul 13 $125 Calls Sweep (28) near the Ask: 539 @ $0.693 vs 660 OI; Earnings 7/17 Before Open Ref=$123.78,2018-07-05 10:03:00-04:00,JNJ,positive
707644.0,'The success of $XLRN luspatercept is bad for $GERN and another reason for $JNJ to sever the imetelstat relationship in Q3.'-STAT's Adam Feuerstein Tweets,2018-06-29 10:01:00-04:00,JNJ,positive
707645.0,"Benzinga's Top Upgrades, Downgrades For June 27, 2018",2018-06-27 10:14:00-04:00,JNJ,positive
707646.0,"Bernstein Initiates Coverage On Johnson & Johnson with Market Perform Rating, Announces $129 Price Target",2018-06-27 07:59:00-04:00,JNJ,neutral
707647.0,Janssen Pharmaceutical Signs License Agreement With Saladax Biomedical,2018-06-26 10:34:00-04:00,JNJ,positive
707648.0,AbbVie Announces sNDA For Ibrutinib Accepted For Review By FDA,2018-06-25 09:00:00-04:00,JNJ,positive
707649.0,A Look Back At What's Happened To Each Sector Through The First Half Of 2018 (Part 2),2018-06-19 11:57:00-04:00,JNJ,neutral
707650.0,"'$GERN wants $JNJ to continue a drug development partnership, but new data weaken its case'-STAT's Adam Feuerstein Tweets",2018-06-18 11:48:00-04:00,JNJ,negative
707651.0,Johnson & Johnson Announces FDA Approval of iDESIGN Refractive Studio For LASIK Treatment,2018-06-18 08:28:00-04:00,JNJ,positive
707652.0,"J&J's Janssen Reports XARELTO Associated with Significantly Reduced Hospital Time, Decreased Costs With Low-Risk Pulmonary Embolism",2018-06-14 08:33:00-04:00,JNJ,neutral
707653.0,"Johnson & Johnson Announces Acceptance Of Binding Offer From Platinum Equity To Acquire LifeScan, Inc.  For Approximately $2.1B",2018-06-12 16:01:00-04:00,JNJ,positive
707654.0,"VIVUS Reports Has Met Closing Conditions For Purchase Of US, Canadian Rights To PANCREAZE Capsules For Treatment Of EPI From J&J's Janssen Pharma For $135M",2018-06-11 07:34:00-04:00,JNJ,neutral
707655.0,"Benzinga's Daily Biotech Pulse: Johnson & Johnson to Dispose Sterilization Products Business, Mixed Results From Protesostasis' Cystic Fibrosis Study",2018-06-07 07:58:00-04:00,JNJ,neutral
707656.0,Fortive Reports Binding Offer To Buy Advanced Sterilization Products Business From J&J for ~$2.7B In Cash,2018-06-06 16:30:00-04:00,JNJ,positive
707657.0,J&J Shares Ticker Slightly Higher Over Last Few Mins.; Hearing Jim Cramer Mentioned Stock/Co. Positively On CNBC,2018-06-04 12:52:00-04:00,JNJ,positive
707658.0,Janssen Says Phase 3 Study Shows Esketamine Nasal Spray Plus Oral Antidepressant Delayed Time To Relapse In Patients With Treatment-Resistant Depression,2018-05-31 12:42:00-04:00,JNJ,negative
707659.0,J&J's Janssen Pharma Earlier Reported Initiation Of Phase 1b/2 Development Program Evaluating JNJ-68284528 Car-T Cells For Treatment Of Multiple Myeloma,2018-05-30 09:54:00-04:00,JNJ,neutral
707660.0,"Stocks That Made New 52-Week Lows Today Include: Patterson Companies, Philip Morris, Coty, and Johnson & Johnson",2018-05-29 11:06:00-04:00,JNJ,negative
707661.0,"Pot Stocks, ETFs, Top News And Data From The Cannabis Industry This Week",2018-05-27 11:38:00-04:00,JNJ,positive
707662.0,"Barron's Picks And Pans: Best CEOs, Altice USA, Micron Technology And More",2018-05-27 11:29:00-04:00,JNJ,positive
707663.0,Novartis Gets Approval For Remicade Biosimilar In Europe,2018-05-25 13:51:00-04:00,JNJ,positive
707664.0,An ETF Play For Quality Stocks At A Fair Price,2018-05-24 13:35:00-04:00,JNJ,positive
707665.0,"The Week Ahead In Biotech: PDUFA Dates, IPOs And More",2018-05-21 07:40:00-04:00,JNJ,neutral
707666.0,Janssen Announces European Commission Approval of JULUCA,2018-05-21 06:15:00-04:00,JNJ,positive
707667.0,12 Dow 30 Companies With Above-Average Salaries,2018-05-19 17:21:00-04:00,JNJ,neutral
707668.0,How To Get Quality In The Core,2018-05-17 13:19:00-04:00,JNJ,neutral
707669.0,"Jim Cramer Shares His Thoughts On Johnson & Johnson, Nike And More",2018-05-17 07:30:00-04:00,JNJ,positive
707670.0,Analyst: Morphosys Is Well-Positioned To Continue Success With Antibody Discovery Platforms,2018-05-14 15:26:00-04:00,JNJ,positive
707671.0,"Benzinga's Daily Biotech Pulse: Valeant Earnings, Lipocine's FDA Watch, Invivo CFO Departure",2018-05-08 07:55:00-04:00,JNJ,neutral
707672.0,"Jim Cramer Advises His Viewers On Prestige Brands, CVS Health And More",2018-05-08 07:32:00-04:00,JNJ,neutral
707673.0,Janssen Pharmaceuticals Announces New Phase 3 Data Show Esketamine Nasal Spray Demonstrated Rapid Improvements in Depressive Symptoms in Patients with Treatment-Resistant Depression,2018-05-06 07:40:00-04:00,JNJ,negative
707674.0,"Stocks That Made New 52-Week Lows Today Include Colgate-Palmolive, Philip Morris, Regeneron, Corning, Hanesbrands, Bed Bath & Beyond, Pepsi, Coca-Cola, Paccar, Johnson & Johnson, Mallinckrodt, CBS, DISH Network, Goodyear Tire, Chubb, Hershey, and AT&T",2018-05-03 11:31:00-04:00,JNJ,negative
707675.0,HC2 Reports BeneVir Biopharm To Be Purchased By J&J's Janssen Biotech For Up To $1.04B,2018-05-02 07:05:00-04:00,JNJ,neutral
707676.0,Attention Biotech Investors: Mark Your Calendar For These May PDUFA Action Dates,2018-05-01 15:39:00-04:00,JNJ,neutral
707677.0,VIVUS Acquires PANCREAZE from Jannsen for $135M,2018-05-01 07:11:00-04:00,JNJ,neutral
707678.0,Johnson & Johnson Raises Qtr. Dividend From $0.84 To $0.90/Share,2018-04-26 10:27:00-04:00,JNJ,neutral
707679.0,"Credit Suisse Maintains Outperform on Johnson & Johnson, Lowers Price Target to $151.00",2018-04-20 08:36:00-04:00,JNJ,positive
707680.0,'An Incredible Signal': 4 Experts Weigh In On Positive FDA Panel Vote For GW Pharma's Epidiolex,2018-04-19 16:37:00-04:00,JNJ,positive
707681.0,Big Bank Season Rolls On As Morgan Stanley Easily Beats Expectations,2018-04-18 10:08:00-04:00,JNJ,positive
707682.0,"Stifel Nicolaus Maintains Hold on Johnson & Johnson, Lowers Price Target to $135.00",2018-04-18 07:24:00-04:00,JNJ,negative
707683.0,"A Peek Into The Markets: US Stock Futures Surge, Goldman Sachs Earnings In Focus",2018-04-17 07:07:00-04:00,JNJ,neutral
707684.0,"Johnson & Johnson Reaffirms FY 2018 Adj. EPS Guidance, Raises FY 2018 Sales Guidance From $80.6B-$81.4B to $81.0B-$81.8B vs $81.1B Est.",2018-04-17 06:42:00-04:00,JNJ,neutral
707685.0,"Johnson & Johnson Reports Q1 Adj. EPS $2.06 Beats $2.01 Est., Sales $20.0B Beats $19.4B Est.",2018-04-17 06:41:00-04:00,JNJ,neutral
707686.0,"12 Stocks To Watch For April 17, 2018",2018-04-17 04:35:00-04:00,JNJ,neutral
707687.0,"Earnings Scheduled For April 17, 2018",2018-04-17 04:14:00-04:00,JNJ,neutral
707688.0,Bristol-Myers Announces Collaboration With Johnson & Johnson's Janssen to Develop and Commercialize Next-Gen Cardiovascular Therapy,2018-04-16 16:32:00-04:00,JNJ,neutral
707689.0,Upcoming Earnings: Johnson & Johnson And IBM Are Scheduled To Report This Week,2018-04-16 13:09:00-04:00,JNJ,neutral
707690.0,"The Week Ahead: Netflix Earnings, Big Bank Results, FDA Actions Abound",2018-04-16 12:10:00-04:00,JNJ,neutral
707691.0,"Earnings Parade Continues This Week After Missile Attacks, With Banks, Netflix On Way",2018-04-16 10:00:00-04:00,JNJ,negative
707692.0,Netflix Earnings Preview: International Subscriber Growth In Focus,2018-04-16 09:28:00-04:00,JNJ,positive
707693.0,"Benzinga's Top Analyst Calls From April 13, 2018",2018-04-13 13:09:00-04:00,JNJ,positive
707694.0,"Next Week's Round Of Bank Earnings Includes Bank Of America, Goldman Sachs And Morgan Stanley",2018-04-13 13:06:00-04:00,JNJ,neutral
707695.0,"Chardan: Assembly Biosciences Hep B Antiviral Data 'Positive,' But Undifferentiated From Competitor Johnson & Johnson",2018-04-13 10:31:00-04:00,JNJ,neutral
707696.0,"Upcoming Earnings: Big Banks JP Morgan, Wells Fargo And Citigroup To Kick Off Q1 Season",2018-04-12 10:37:00-04:00,JNJ,positive
707697.0,UPDATE: J&J's Janssen Says Canagliflozin Reduced Urinary Albumin To Creatinine Ratio,2018-04-12 08:08:00-04:00,JNJ,positive
707698.0,J&J's Janssen Pharma Says INVOKANA Showed Significant Renal Protective Benefits In Patients with Type-2 Diabetes,2018-04-12 08:08:00-04:00,JNJ,positive
707699.0,"Courtroom Video Shows J&J, Imerys Subsidiary Ordered To Pay $80M In Punitive Damages In New Jersey Case Blaming Talc For Mesothelioma",2018-04-11 14:55:00-04:00,JNJ,negative
707700.0,FDA Cleared Acuvue Oasys Contact Lenses With Transitions Light Intelligent Tech To Johnson & Johnson,2018-04-10 13:11:00-04:00,JNJ,positive
707701.0,"Morgan Stanley Maintains Equal-Weight on Johnson & Johnson, Lowers Price Target to $143.00",2018-04-10 10:35:00-04:00,JNJ,negative
707702.0,"Pot Stocks, ETFs, Top News And Data From The Cannabis Industry This Week",2018-04-06 17:38:00-04:00,JNJ,positive
707703.0,DWS Quantifies Quality In A New ETF,2018-04-06 11:41:00-04:00,JNJ,neutral
707704.0,"Smoking Is Just One Way To Use Marijuana: An Introduction To Vaporizers, Edibles, Oils, Tinctures, Dabs And Other Cannabis Products",2018-03-30 09:37:00-04:00,JNJ,neutral
707705.0,"ICYMI: GameStop, Omeros, Congress Impacts Biotechs",2018-03-23 06:56:00-04:00,JNJ,neutral
707706.0,Biotech Winners And Losers From Congress' Latest Funding Bill,2018-03-22 11:46:00-04:00,JNJ,negative
707707.0,Johnson & Johnson CFO Dominic Caruso to Retire,2018-03-20 16:15:00-04:00,JNJ,neutral
707708.0,Checking In On The Healthcare Sector Ahead Of Q1 Earnings Season,2018-03-20 11:29:00-04:00,JNJ,neutral
707709.0,Johnson & Johnson Gets $2.1B Offer For LifeScan Diabetes Device Unit,2018-03-20 11:05:00-04:00,JNJ,neutral
707710.0,A Dividend Alternative To Broad Market Exposure,2018-03-20 09:38:00-04:00,JNJ,neutral
707711.0,Johnson & Johnson Receives Takeover Offer for its LifeScan Business to Platinum Equity for $2.1B,2018-03-16 07:32:00-04:00,JNJ,neutral
707712.0,"J&J, Macleods in Talks for Licence Deal of Tuberculosis Drug Bedaquiline -Economic Times",2018-03-13 05:24:00-04:00,JNJ,neutral
707713.0,Jannsen Announces INVOKANA Significantly Reduces Risk of Heart Failure-Related Outcomes in Type 2 Diabetes Patients at Risk for or With a History of Cardiovascular Disease,2018-03-11 17:10:00-04:00,JNJ,negative
707714.0,"Johnson & Johnson and Bayer Announce Judge's Order Sets 1,200 Xarelto Product Liability Lawsuits for Separate Jury Trials",2018-03-08 16:54:00-05:00,JNJ,negative
707715.0,Zosano Pharma Is The Latest Low Float Stock To Make A Huge Move,2018-03-08 15:43:00-05:00,JNJ,positive
707716.0,Height Casts 65% Odds That Congress Rolls Back Pharma Discounts,2018-03-07 11:31:00-05:00,JNJ,neutral
707717.0,Analyst: Insulet On Track For Profitability In 2018,2018-03-06 11:51:00-05:00,JNJ,positive
707718.0,MedTech's Long-Term Prospects Outweigh Near-Term Risks,2018-03-01 10:55:00-05:00,JNJ,neutral
707719.0,"Jim Cramer Advises His Viewers On Johnson & Johnson, Nokia And More",2018-03-01 07:30:00-05:00,JNJ,neutral
707720.0,"Citigroup Maintains Neutral on Johnson & Johnson, Lowers Price Target to $146.00",2018-02-27 09:40:00-05:00,JNJ,negative
707721.0,Aldeyra Therapeutics Announces Collaborative Agreement with Johnson & Johnson Innovation to Advance Novel Immune-Modulating Drugs for Systemic Inflammatory Diseases,2018-02-27 08:02:00-05:00,JNJ,positive
707722.0,Sierra Oncology and Janssen Sign Supply Agreement for Prostate Cancer Study,2018-02-27 07:42:00-05:00,JNJ,negative
707723.0,PreMarket Prep Opening NYSE Imbalance Update: Bank Of America 379k Shares To Sell; Johnson & Johnson 25k Shares To Buy; General Electric 66k Shares To Sell; HPQ 49k Shares To Buy,2018-02-22 08:35:00-05:00,JNJ,positive
707724.0,Form 4 Filing Late Tuesday Showed Johnson & Johnson Chief Scientific Officer Paulus Stoffels Sold 155.342K Shares at $129.858,2018-02-21 11:03:00-05:00,JNJ,positive
707725.0,Quantifying Quality With An iShares ETF,2018-02-20 10:34:00-05:00,JNJ,neutral
707726.0,J&J's Janssen Wins Health Canada Approval For New ZYTIGA Indication For Treatment Of Newly-Diagnosed Metastatic Prostate Cancer,2018-02-15 07:50:00-05:00,JNJ,positive
707727.0,J&J Shares Unaffected As FDA Says Erleada By Co.'s Janssen Pharma Approved,2018-02-14 13:35:00-05:00,JNJ,positive
707728.0,Cramer Looks At The Dow's Biggest Losers,2018-02-14 10:31:00-05:00,JNJ,negative
707729.0,Janssen Submits Marketing Authorisation Application to EMA for Apalutamide to Treat Patients with High-Risk Non-Metastatic Castration-Resistant Prostate Cancer,2018-02-09 04:23:00-05:00,JNJ,negative
707730.0,19 Biotech Stocks With Clinical Trial Outcomes In February,2018-02-08 16:41:00-05:00,JNJ,neutral
707731.0,The Alzheimer's Drug Pipeline: High Failure Rates In Research On An Increasingly Common Disease,2018-02-08 09:41:00-05:00,JNJ,negative
707732.0,Theravance Biopharma Reports Entered Global Collaboration With J&J's Janssen For TD-1473 In Inflammatory Intestinal Diseases,2018-02-07 07:38:00-05:00,JNJ,neutral
707733.0,"J&J Shares Fall 3.5%, Quickly Rebound From Lows But Still Down ~2.5% For Session; Traders Circulate Mesothelioma.net Article 'Johnson & Johnson Mesothelioma Trial Likely to Expose Company Documents'",2018-02-05 11:50:00-05:00,JNJ,negative
707734.0,"Jim Cramer Weighs In On Johnson & Johnson, STMicroelectronics, And More",2018-02-01 07:43:00-05:00,JNJ,neutral
707735.0,11 Dividend Growth Stocks To Watch In 2018,2018-01-29 13:23:00-05:00,JNJ,positive
707736.0,"Protagonist Therapeutics 'Poised For Upside,' Stifel Says",2018-01-29 12:14:00-05:00,JNJ,positive
707737.0,"PFE, LLY, MRK Write Up 'Scripts For Q4",2018-01-29 10:52:00-05:00,JNJ,neutral
707738.0,Why GW Pharma's Epidiolex Results Could Shape The Future Of Cannabis-Based Therapeutics,2018-01-25 15:51:00-05:00,JNJ,neutral
707739.0,"J&J No Longer Candidate For Purchase Of Pfizer's Consumer Unit; GlaxoSmithKline, Reckitt Benickser Working With Banks To Make A Bid",2018-01-25 09:34:00-05:00,JNJ,negative
707740.0,Mid-Afternoon Market Update: Crude Oil Up 1.4%; ResMed Shares Rise On Earnings Beat,2018-01-23 14:41:00-05:00,JNJ,negative
707741.0,Mid-Day Market Update: Netflix Climbs Following Q4 Results; Insmed Shares Plummet,2018-01-23 12:04:00-05:00,JNJ,positive
707742.0,Biotech M&A Off To A Strong Start In 2018: More Deals To Follow?,2018-01-23 10:58:00-05:00,JNJ,positive
707743.0,"J&J Shares Unaffected Amid Word US Appeals Court Invalidated Co. Patent On Remicade, Ruling Prevents Co. From Challenging Pfizer's '16 Launch Of Cheaper Version Of Remicade",2018-01-23 10:41:00-05:00,JNJ,positive
707744.0,Mid-Morning Market Update: Markets Mixed; Johnson & Johnson Beats Q4 Views,2018-01-23 10:09:00-05:00,JNJ,neutral
707745.0,"Johnson & Johnson Shares Down 2.02%; Earlier Co. Reported Q4 Beat, Announced FY18 Guidance, Sees Adj. EPS $8-$8.20 vs $7.87 Est., Sales $80.6B-$81.4B vs $80.7B Est.",2018-01-23 10:08:00-05:00,JNJ,positive
707746.0,Johnson & Johnson On Conf. Call Says $12B Of Overseas Cash Will 'Come Back Immediately',2018-01-23 09:44:00-05:00,JNJ,neutral
707747.0,Benzinga Pro's 5 Stocks To Watch Today,2018-01-23 09:30:00-05:00,JNJ,neutral
707748.0,A Peek Into The Markets: U.S. Stock Futures Mostly Higher Ahead Of Earnings,2018-01-23 07:22:00-05:00,JNJ,neutral
707749.0,"Johnson & Johnson Reports Q4 Adj. EPS $1.74 vs $1.72 Est., Sales $20.20B vs $20.07B Est.",2018-01-23 06:48:00-05:00,JNJ,neutral
707750.0,"Earnings Scheduled For January 23, 2018",2018-01-23 04:43:00-05:00,JNJ,neutral
707751.0,"10 Stocks To Watch For January 23, 2018",2018-01-23 04:38:00-05:00,JNJ,neutral
707752.0,A CURE For The Typical Healthcare Trade,2018-01-22 16:55:00-05:00,JNJ,neutral
707753.0,"The Week Ahead: IPOs, Earnings, And FDA Actions Provide Catalysts",2018-01-22 15:35:00-05:00,JNJ,neutral
707754.0,Earnings Preview: Johnson & Johnson And Procter & Gamble Take The Stage Tomorrow Morning,2018-01-22 12:13:00-05:00,JNJ,neutral
707755.0,Upcoming Earnings: Verizon To Report Q4 Results Tomorrow Morning,2018-01-22 11:22:00-05:00,JNJ,neutral
707756.0,"Washington Shutdown Takes Center Stage, But Market Impact Only Slight So Far",2018-01-22 10:26:00-05:00,JNJ,neutral
707757.0,Will Johnson & Johnson's Pharma Segment Pull Up Its Q4 Earnings?,2018-01-19 12:48:00-05:00,JNJ,neutral
707758.0,Upcoming Netflix Earnings: Subscriber Growth And Price Hikes In Focus,2018-01-19 11:16:00-05:00,JNJ,positive
707759.0,"Intel, Johnson & Johnson, UPS: 'Fast Money' Picks For January 18",2018-01-18 07:15:00-05:00,JNJ,neutral
707760.0,"BTG Says Previous Guidance on Zytiga Royalties Is Unchanged, Despite U.S. Administrative Court Decision to Invalidate Patent -Reuters",2018-01-18 04:45:00-05:00,JNJ,neutral
707761.0,UPDATE: J&J Says 'We believe the '438 patent is valid and will continue to vigorously defend it.',2018-01-17 17:06:00-05:00,JNJ,positive
707762.0,J&J Issues Response Following ZYTIGA IPR: 'strongly disagree...are evaluating our options with respect to a request for rehearing and/or appeal.',2018-01-17 17:04:00-05:00,JNJ,positive
707763.0,UPDATE: Traders Attributing Move Lower In J&J Shares To News From Indonesian Source Suggesting Zytiga Received A Negative IPR Decision,2018-01-17 14:17:00-05:00,JNJ,negative
707764.0,"J&J Shares Down ~$2 Over Last Min., Stock Down 0.6% For Session",2018-01-17 14:15:00-05:00,JNJ,positive
707765.0,"Earnings Preview: IBM to Report on Thursday, Strategic Imperatives in Focus",2018-01-17 13:12:00-05:00,JNJ,neutral
707766.0,Chinese Bidders Looking at JNJ Diabetes Business in Deal that Could be Valued at $4B -Reuters,2018-01-17 06:04:00-05:00,JNJ,positive
707767.0,Dow Earnings: Analysts Expect Goldman Sachs Revenue Decline,2018-01-16 12:30:00-05:00,JNJ,neutral
707768.0,"Upcoming Earnings: Bank Of America, Goldman Sachs And Morgan Stanley To Report This Week",2018-01-16 11:26:00-05:00,JNJ,neutral
707769.0,Putting On The Brakes: Rally Takes Breather As Bond Yields Hit 10-Month High,2018-01-10 11:13:00-05:00,JNJ,neutral
707770.0,4 Tailwinds Driving Raymond James' Insulet Bull Case,2018-01-08 12:22:00-05:00,JNJ,neutral
707771.0,The 'Bomb Cyclone' Portfolio: Winners And Losers,2018-01-05 11:58:00-05:00,JNJ,negative
707772.0,"Benzinga's Top Upgrades, Downgrades For January 2, 2018",2018-01-02 09:29:00-05:00,JNJ,positive
707773.0,"The Market In 5 Minutes: Oil's Strong Open, Cohen's Comeback, And A Look Back At 2017's Best And Worst Stocks",2018-01-02 09:00:00-05:00,JNJ,positive
707774.0,"Syros Announces Clinical Supply Agreement with Janssen to Evaluate SY-1425, Its First-in-Class Selective RARα Agonist",2018-01-02 08:18:00-05:00,JNJ,positive
707775.0,JP Morgan Downgrades Johnson & Johnson to Neutral,2018-01-02 06:19:00-05:00,JNJ,positive
707776.0,The Companies That Led 2017's Biotech Rally,2017-12-22 09:50:00-05:00,JNJ,neutral
707777.0,Vetr Upgrades Johnson & Johnson As The Stock Tests Resistance,2017-12-22 07:32:00-05:00,JNJ,neutral
707778.0,J&J's Janssen Says J&J Reaffirmed FY17 Adj. EPS Outlook Of $7.25-$7.30 vs $7.28 Est.,2017-12-21 17:31:00-05:00,JNJ,neutral
707779.0,"J&J's Janssen Reports Global Collaboration, License Deal With Units Of Genscript, Will Make Upfront Payment Of $350M",2017-12-21 17:31:00-05:00,JNJ,neutral
707780.0,"Earlier Chicago Tribune Report Detailed 5 Illinois Counties Suing Drug Cos. Over Opioid Abuses; Shares Of Cos. Mentioned Seem Largely Unaffected: TEVA +5.3%, ABT -0.33%, JNJ +0.03%, ENDP +0.12%",2017-12-21 14:42:00-05:00,JNJ,negative
707781.0,"FDA Grants Priority Review For Johnson & Johnson's Janssen NDA For Apalutamide, PDUFA Target Date April 2018",2017-12-21 09:11:00-05:00,JNJ,positive
707782.0,3 Biotech Pipeline Areas To Keep An Eye On In 2018,2017-12-20 12:37:00-05:00,JNJ,neutral
707783.0,"ASH 2017 Highlights: Gilead, Novartis, Juno, Bluebird Bio And More",2017-12-13 12:31:00-05:00,JNJ,neutral
707784.0,A Trendy New ETF From Pacer,2017-12-13 10:10:00-05:00,JNJ,neutral
707785.0,3 Stocks In Focus As Biotech M&A Hopes For 2018 Rise,2017-12-11 12:52:00-05:00,JNJ,positive
707786.0,"Bayer, Johnson & Johnson Reportedly Ordered By Philadelphia Jury To Pay $29M In Xarelto Lawsuit",2017-12-05 12:53:00-05:00,JNJ,negative
707787.0,"REMINDER: Tuesday Is Estimated FDA PDUFA Date For: Johnson & Johnson for Rilpivirine and In Partnership with GlaxoSmithKline For Dolutegravir, and Novo Nordisk for Semaglutide",2017-12-04 15:49:00-05:00,JNJ,neutral
707788.0,Eli Lilly's Taltz Gets Approval For Label Expansion in US,2017-12-04 12:39:00-05:00,JNJ,positive
707789.0,"The Week Ahead For December 4: The Biggest Catalysts, Conferences, And Investor Events",2017-12-04 11:23:00-05:00,JNJ,neutral
707790.0,GlaxoSmithKline Begins Phase III Study On Injection To Prevent HIV,2017-12-01 12:38:00-05:00,JNJ,neutral
707791.0,"Missouri Judge Upholds $110 Million Talc Verdict Awarded To Virgina Women Who Claims Decades Of Daily Use Of Johnson & Johnson's Talcum Powder Caused Her OVarian Cancer, Jurisdiction Established By New Evidence In Ovarian Cancer Claim",2017-11-30 10:47:00-05:00,JNJ,negative
707792.0,A Lazarus Act For This Pharma ETF,2017-11-29 17:03:00-05:00,JNJ,neutral
707793.0,"Endpoint News Co-Founder John Carroll Tweets: J&J spokesperson says Telegraph story about axing JLABS in UK is ""completely unfounded"" asking for a retraction. 
$JNJ",2017-11-28 10:45:00-05:00,JNJ,neutral
707794.0,Stocks Going Ex Dividend The Fifth Week Of November,2017-11-22 11:41:00-05:00,JNJ,neutral
707795.0,J&J's Janssen Submits FDA Application For Expansion Of Indication For DARZALEX Combo Therapy For Patients With Newly-Diagnosed Multiple Myeloma Who Are Transplant Ineligible,2017-11-21 11:40:00-05:00,JNJ,neutral
707796.0,Johnson & Johnson's Janssen Gets European Commission Approval to Broaden Marketing Authorization for Zytiga,2017-11-20 08:38:00-05:00,JNJ,positive
707797.0,"PR Confirms Earlier Johnson & Johnson Legal Headline, Federal Jury Returns $247 Million Verdict in Defective Hip Implants Case; DePuy Orthopaedics Found Liable For Metal-on-Metal Implant Failures",2017-11-16 14:25:00-05:00,JNJ,negative
707798.0,Johnson & Johnson Wins Trial In Lawsuit Claiming Asbestos In Talc Products Caused Cancer,2017-11-16 13:28:00-05:00,JNJ,negative
707799.0,Watching J&J Shares Amid Report Jury Has Returned $247M Verdict Against Co. Unit Depuy Related To Defective Hip Implant Suit,2017-11-16 12:57:00-05:00,JNJ,neutral
707800.0,Pharma ETFs Down Post Q3 Earnings,2017-11-09 12:34:00-05:00,JNJ,neutral
707801.0,J&J's Janssen R&D Reports STELARA Showed Positive Results In Treatment Of Systemic Lupus Erythematosus In Phase 2 Trial,2017-11-06 08:16:00-05:00,JNJ,positive
707802.0,A Dividend ETF For November And Beyond,2017-11-04 13:07:00-04:00,JNJ,neutral
707803.0,UPDATE: Halozyme Will Receive $15M Milestone Payment From J&J's Janssen Following Dosing Of 3rd Patient In Phase 3 Trial,2017-10-31 08:40:00-04:00,JNJ,neutral
707804.0,How Surgeons Are Responding To TransEnterix's Senhance Following FDA Approval,2017-10-30 10:40:00-04:00,JNJ,positive
707805.0,Johnson & Johnson's Janssen Gets FDA Approval for the 10MG Dose of Xarelto,2017-10-30 08:15:00-04:00,JNJ,positive
707806.0,Janssen Reports Imbruvica As First Approved Treatment For Chronic Graft-Versus-Host Disease Granted By Health Canada Priority Review,2017-10-30 07:34:00-04:00,JNJ,positive
707807.0,REMINDER: Johnson & Johnson Has PDUFA Date Expected For XARELTO Oct. 28,2017-10-27 17:00:00-04:00,JNJ,neutral
707808.0,Vetr Upgrades Johnson & Johnson Following Post-Earnings Dip,2017-10-25 16:59:00-04:00,JNJ,neutral
707809.0,J&J's Janssen Reports Darunavir-Based Single Tablet Regimen Showed Effective Viral Suppression In HIV-1 Patients,2017-10-25 07:59:00-04:00,JNJ,positive
707810.0,This Week's Most And Least Crowded Trades,2017-10-24 09:01:00-04:00,JNJ,neutral
707811.0,5 Biggest Price Target Changes For Monday,2017-10-23 09:50:00-04:00,JNJ,neutral
707812.0,The Week Ahead: Earnings Season Starts In Earnest,2017-10-23 09:00:00-04:00,JNJ,positive
707813.0,This Factor ETF Could Be Ready To Shine,2017-10-23 08:22:00-04:00,JNJ,positive
707814.0,"J&J's Janssen Reports Received 2 FDA Approvals For SIMPONI ARIA For Treatment Of Adults with Active Psoriatic Arthritis, Active Ankylosing Spondyilitis",2017-10-20 16:25:00-04:00,JNJ,positive
707815.0,White House 'Shenanigans' Represent A Buying Opportunity: Cramer,2017-10-19 12:02:00-04:00,JNJ,positive
707816.0,"Johnson & Johnson to Acquire Software Company Surgical Process Institute, Terms Not Disclosed",2017-10-19 06:09:00-04:00,JNJ,neutral
707817.0,Benzinga's Option Alert Recap From October 18,2017-10-18 17:01:00-04:00,JNJ,positive
707818.0,Cramer Breaks Down 3 Cheap Stocks That Crushed Earnings,2017-10-18 11:16:00-04:00,JNJ,negative
707819.0,5 Biggest Price Target Changes For Wednesday,2017-10-18 10:11:00-04:00,JNJ,neutral
707820.0,"J&J Option Alert: Jan, 2019 $140 Puts Sweep (27) at the Bid: 658 @ $9.504 vs 301 OI; Ref=$140.23",2017-10-18 10:10:00-04:00,JNJ,positive
707821.0,"Pre-Market Imbalance Update: IBM 219K Shares To Buy, Alibaba 133K To Buy, Coca-Cola 131K To Sell, Twitter 88K To Sell, Square 79K To Buy, AT&T 73K To Buy, Pfizer 71K To Sell, Ford 67K To Sell, J&J 55K To Sell",2017-10-18 09:06:00-04:00,JNJ,positive
707822.0,Johnson & Johnson Makes New All-Time High By A Wide Margin,2017-10-17 15:15:00-04:00,JNJ,neutral
707823.0,Hearing Court Papers Show Missouri Appeals Court Has Overturned $72M Verdict Against J&J Related To Talc Case,2017-10-17 12:43:00-04:00,JNJ,positive
707824.0,"Can The Dow Pass Another Milestone? Financials Feed Frenzy, But Might It Be Enough?",2017-10-17 10:52:00-04:00,JNJ,negative
707825.0,A Peek Into The Markets: U.S. Stock Futures Flat; Goldman Sachs Earnings In Focus,2017-10-17 07:20:00-04:00,JNJ,neutral
707826.0,Johnson & Johnson Discontinues its Study of Talacotuzumab in Patients with Acute Myeloid Leukemia,2017-10-17 06:48:00-04:00,JNJ,neutral
707827.0,Johnson & Johnson Says it Will Not Pursue Approvals of Sirukumab for Rheumatoid Arhritis,2017-10-17 06:43:00-04:00,JNJ,neutral
707828.0,"Johnson & Johnson Sees FY 2017 EPS $7.25-$7.30 from $7.12-$7.22, Sales $76.1B-$76.5B from $75.8B-$76.1B",2017-10-17 06:42:00-04:00,JNJ,neutral
707829.0,Johnson & Johnson Raises Guidance,2017-10-17 06:41:00-04:00,JNJ,neutral
707830.0,"Johnson & Johnson Q3 EPS $1.90 vs $1.80 Est., Sales $19.7B vs $19.3B Est.",2017-10-17 06:40:00-04:00,JNJ,neutral
707831.0,"10 Stocks To Watch For October 17, 2017",2017-10-17 04:30:00-04:00,JNJ,neutral
707832.0,"Earnings Scheduled For October 17, 2017",2017-10-17 04:06:00-04:00,JNJ,neutral
707833.0,10 Most/Least Crowded Trades Of Week Ended Oct. 13,2017-10-16 15:53:00-04:00,JNJ,neutral
707834.0,Cerveau Technologies Reports Research Collaboration With Janssen Pharmaceuticals For Use Of [F-18]MK-6240,2017-10-16 14:52:00-04:00,JNJ,neutral
707835.0,"The Week Ahead: Earnings, Earnings, And More Earnings",2017-10-16 10:49:00-04:00,JNJ,neutral
707836.0,5 Biggest Price Target Changes For Monday,2017-10-16 09:49:00-04:00,JNJ,neutral
707837.0,"Pharma Stock Roundup: Pfizer Mulls Options For Consumer Healthcare, Eli Lilly's Pipeline Setback",2017-10-13 12:19:00-04:00,JNJ,neutral
707838.0,"REMINDER: Johnson & Johnson Has PDUFA Date For Stelara Over the Weekend, Oct. 15th",2017-10-13 11:35:00-04:00,JNJ,neutral
707839.0,JNJ And IBM Report Q3 Earnings Early Next Week: What Might Be In Store?,2017-10-13 11:19:00-04:00,JNJ,neutral
707840.0,Janssen-Cilag Intl. CHMP Issues Positive Opinion On Zytiga To Include Earlier Stage Prostate Patients,2017-10-13 07:52:00-04:00,JNJ,positive
707841.0,"Pre-Market Imbalance Update: Verizon 60K Shares To Sell, J&J 42K To Sell",2017-10-12 09:05:00-04:00,JNJ,positive
707842.0,"10 Of The Most Crowded Trades, And 10 Of The Least Crowded",2017-10-11 16:26:00-04:00,JNJ,neutral
707843.0,Why Jefferies Upgraded Johnson & Johnson,2017-10-11 15:47:00-04:00,JNJ,neutral
707844.0,J&J's Janssen Earlier Reported Submission Of NDA For ARN-509 To Treat Men With Non-Metastatic Castration-Resistant Prostate Cancer,2017-10-11 09:13:00-04:00,JNJ,negative
707845.0,"Benzinga's Top Upgrades, Downgrades For October 11, 2017",2017-10-11 09:13:00-04:00,JNJ,positive
707846.0,"The Market In 5 Minutes: Alibaba's Expansion, Uber's Warning",2017-10-11 08:31:00-04:00,JNJ,negative
707847.0,A Peek Into The Markets: U.S. Stock Futures Edge Lower Ahead Of Fed Minutes,2017-10-11 07:23:00-04:00,JNJ,negative
707848.0,Jefferies Upgrades Johnson & Johnson to Buy,2017-10-11 06:13:00-04:00,JNJ,neutral
707849.0,Jefferies Upgrades J&J to Buy from Hold; Raises PT to $157 from $145,2017-10-11 04:31:00-04:00,JNJ,neutral
707850.0,"Benzinga's Top Upgrades, Downgrades For October 9, 2017",2017-10-09 09:15:00-04:00,JNJ,positive
707851.0,Wells Fargo Upgrades Johnson & Johnson to Outperform,2017-10-09 08:51:00-04:00,JNJ,positive
707852.0,Heaps Of Healthy Health Care ETFs,2017-10-06 10:02:00-04:00,JNJ,positive
707853.0,"J&J Diabetes Care Cos., Animas, Announces Intention To Discontinue Manufacturing, Sale Of Vibe, OneTouch Ping Insulin Pumps, Close Operations, Exit Insulin Pump Business",2017-10-05 07:12:00-04:00,JNJ,positive
707854.0,Morgan Stanley Catches Flack For Colgate-Palmolive Upgrade,2017-10-02 14:49:00-04:00,JNJ,neutral
707855.0,J&J's Janssen Reports Submission Of sNDA Seeking New Indication For INVOKANA To Reduce Risk Of Major Adverse Cardiovascular Events Based On Landmark CANVAS Program,2017-10-02 08:21:00-04:00,JNJ,negative
707856.0,Janssen Submits sNDA To FDA Seeking New Indication For INVOKANA To Reduce Risk Of Major Adverse Cardiovascular Events Based On Landmark Canvas Programs,2017-10-02 08:17:00-04:00,JNJ,negative
707857.0,"Attention Biotech Investors, Here's Your PDUFA Primer For October",2017-09-28 10:51:00-04:00,JNJ,neutral
707858.0,"A.I. Summit in San Francisco Concludes Today, Attendees Include Morgan Stanley, Johnson & Johnson, Bank of America, IBM, Nvidia, Microsoft, Amazon and Footlocker",2017-09-28 08:37:00-04:00,JNJ,positive
707859.0,"Jim Cramer Weighs In On Johnson & Johnson, Ford And More",2017-09-28 08:24:00-04:00,JNJ,neutral
707860.0,FTC Says It Requires Divestiture Of 5 Medical Device Product Lines As Condition Of Integra Acquiring Johnson & Johnson's Codman Neuro Division,2017-09-27 11:08:00-04:00,JNJ,neutral
707861.0,"Bloomberg Earlier Reported Apple, Samsung, Roche Holding Will Participate In FDA Pilot Program For Digital Health Software",2017-09-26 14:10:00-04:00,JNJ,neutral
707862.0,Cramer's Guide To Profit From Market Rotations,2017-09-23 08:56:00-04:00,JNJ,positive
707863.0,A Venerable Vanguard Dividend ETF,2017-09-21 09:08:00-04:00,JNJ,neutral
707864.0,Johnson & Johnson Downgraded On Hefty Valuation Compared To Peers,2017-09-20 11:49:00-04:00,JNJ,neutral
707865.0,Goldman Sachs Downgrades Johnson & Johnson to Sell,2017-09-20 08:59:00-04:00,JNJ,neutral
707866.0,Johnson & Johnson Shares Down 1.64% Premarket,2017-09-20 08:29:00-04:00,JNJ,positive
707867.0,"UPDATE: NY AG Schneiderman Served Subpoenas To Endo Int'l, J&J's Janssen Pharma, Teva, Allergan",2017-09-19 12:35:00-04:00,JNJ,neutral
707868.0,Janssen's Guselkumab Drug for the Treatment of Plaque Psoriasis Recommended by the EU Medicines Agency for Approval,2017-09-15 07:41:00-04:00,JNJ,positive
707869.0,Johnson & Johnson's Janssen Announces Submission of sNDA To FDA For Zytiga,2017-09-14 16:10:00-04:00,JNJ,neutral
707870.0,A Hidden Gem Among Dividend ETFs,2017-09-12 08:42:00-04:00,JNJ,neutral
707871.0,"Wall Street's M&A Chatter From September 11: Western Digital-Toshiba, Pilgrim's Pride-Moy Park, Gigamon And More",2017-09-12 07:52:00-04:00,JNJ,neutral
707872.0,Your Easy Guide To Credit Suisse's New Top Stocks List,2017-09-11 09:21:00-04:00,JNJ,positive
707873.0,Janssen Terminates Worldwide Collaboration for Hepatitis C With Achillion Pharmaceuticals,2017-09-11 04:00:00-04:00,JNJ,neutral
707874.0,What Pharmaceuticals Spend On Lobbying To Influence Trump,2017-09-09 16:28:00-04:00,JNJ,negative
707875.0,"New Mexico Said To Be Suing Johnson & Johnson, Endo, Teva, Allergan & Others Over Their Role In Opioid Drug Epidemic",2017-09-07 15:05:00-04:00,JNJ,negative
707876.0,"This Drug, An Alternative To Marijuana And Ketamine, Could Treat Suicidal Depression And PTSD",2017-09-07 13:02:00-04:00,JNJ,negative
707877.0,Attention Biotech Investors: September Ushers In Another Slew Of PDUFA Catalysts,2017-09-01 14:03:00-04:00,JNJ,neutral
707878.0,"MacroGenics Reports Termination Of Duvortuxizumab Collab., License Deal With J&J's Janssen",2017-08-31 16:30:00-04:00,JNJ,neutral
707879.0,Johnson & Johnson Management Meetings Leave UBS Reiterating Stock As A Top Pick,2017-08-31 12:28:00-04:00,JNJ,positive
707880.0,Protagonist Therapeutics Announces Receipt Of $50M Upfront Payment From JNJ's Jansse License Deal For PTG-200,2017-08-24 16:02:00-04:00,JNJ,neutral
707881.0,"Playing The US Pharma Space: Buy Portola, Hold Corvus, Sell Teva",2017-08-24 13:46:00-04:00,JNJ,positive
707882.0,"Explaining A 'Crowded Trade,' And The Top 10 Cramped Plays Right Now",2017-08-23 15:19:00-04:00,JNJ,positive
707883.0,"Pre-Market Imbalance Update: Sprint 223K Shares To Buy, Square 139K To Buy, GE 90K To Buy, Snap 54K To Buy, Coca-Cola 53K Shares To Sell, Alibaba 53K To Buy, J&J 49K To Sell",2017-08-22 08:56:00-04:00,JNJ,positive
707884.0,Jury Awards Woman $417 Million On Allegation Johnson & Johnson Talcum Powder Gave Her Cancer,2017-08-22 08:40:00-04:00,JNJ,negative
707885.0,"Premarket Prep Host Dennis Dick Tweets: Notable opening imbalances: $SNAP +354K, $GE -262K, $PFE -122K, $JNJ -92K, $BABA +81K",2017-08-21 09:25:00-04:00,JNJ,negative
707886.0,"Meg Tirrell Tweets: $JNJ says president's more recent comments ""changed our decision to participate in the White House Manufacturing Advisory Council""",2017-08-16 13:33:00-04:00,JNJ,neutral
707887.0,Genmab CEO Says It's Moving Forward 'Aggressively' Together With Janssen On Subcutaneous Formulation Of daratumumab,2017-08-09 14:05:00-04:00,JNJ,neutral
707888.0,"Every Generation Has Its Drug: How People Are Dealing With Opioids, The New (Old) Thing",2017-08-07 11:55:00-04:00,JNJ,neutral
707889.0,"Wall Street's M&A Chatter From August 4-7: Acadia Pharma, United Technologies-Rockwell Collins, United Therapeutics",2017-08-07 07:19:00-04:00,JNJ,positive
707890.0,Hearing FDA Panel Has Said Safety Profile Of J&J's Sirukumab Not Adequate To Support Approval,2017-08-02 14:59:00-04:00,JNJ,positive
707891.0,Key FDA Events To Watch Out For In August 2017,2017-08-01 12:39:00-04:00,JNJ,neutral
707892.0,August PDUFA Dates: Biotech Investors Stay Tuned To A Month Of Plenty,2017-08-01 09:20:00-04:00,JNJ,neutral
707893.0,Johnson & Johnson Granted Orphan Drug Desiganation for Bedaquiline,2017-07-31 08:17:00-04:00,JNJ,positive
707894.0,"On, Wisconsin: University Wins Half Billion In iPhone Patent Suit, Another Sign Schools Are Research Cash Cows",2017-07-27 16:11:00-04:00,JNJ,positive
707895.0,"Samsung, Amazon — Everyone Is Getting Into Pharmaceuticals",2017-07-27 08:36:00-04:00,JNJ,positive
707896.0,"Wall Street's M&A Chatter From July 26: Biomarin, Sigma Designs, Colgate-Palmolive, Markel-State National",2017-07-27 07:24:00-04:00,JNJ,neutral
707897.0,"Meet Avicanna, The First Marijuana Company To Be Accepted Into Johnson & Johnson Innovation, JLABS @ Toronto",2017-07-25 12:29:00-04:00,JNJ,positive
707898.0,4 Benefits ETF Investing May Add To Your Portfolio,2017-07-25 11:48:00-04:00,JNJ,positive
707899.0,2 Ways To Trade This Week's Healthcare Earnings,2017-07-24 11:51:00-04:00,JNJ,neutral
707900.0,JNJ Announces Encouraging First-In-Human Clinical Data For Investigational HIV Preventive Vaccine,2017-07-24 04:08:00-04:00,JNJ,positive
707901.0,"6 Months In, Trump Has Filled Only 27 Out Of More Than 200 Envoy Posts, Mostly With Cronies",2017-07-22 16:27:00-04:00,JNJ,neutral
707902.0,"Dow 30 Earnings Score Card From The Past Week: IBM, Visa, Goldman And More",2017-07-22 16:09:00-04:00,JNJ,neutral
707903.0,Johnson & Johnson Shares Might Break Lower Before They Break Out,2017-07-21 09:53:00-04:00,JNJ,neutral
707904.0,Atlantic Equities Downgrades Johnson & Johnson to Underweight,2017-07-21 08:26:00-04:00,JNJ,neutral
707905.0,BTIG Research Downgrades Johnson & Johnson to Sell,2017-07-21 07:43:00-04:00,JNJ,neutral
707906.0,"Johnson & Johnson Shares Strong Since Actelion Acquisition, But Potential For Upside Remains",2017-07-20 11:40:00-04:00,JNJ,positive
707907.0,The Market In 5 Minutes,2017-07-20 09:05:00-04:00,JNJ,neutral
707908.0,"Credit Suisse Reinstates Outperform on Johnson & Johnson, Announces $148.00 Price Target",2017-07-20 07:52:00-04:00,JNJ,positive
707909.0,Caution Still The Watchword But Stocks Hit Record Highs As Earnings Mostly Strong,2017-07-19 10:08:00-04:00,JNJ,positive
707910.0,Finding A Way: Banks Beat Expectations Despite Struggles As Earnings Go Into High Gear,2017-07-18 10:51:00-04:00,JNJ,positive
707911.0,A Peek Into The Markets: U.S. Stock Futures Mostly Flat Ahead Of Goldman Sachs Earnings,2017-07-18 07:19:00-04:00,JNJ,neutral
707912.0,"Johnson & Johnson Sees FY 2017 EPS $7.12-$7.22 from $7.00-$7.15 vs $7.10 Est., See Sales $75.8B-$76.1B from $75.4B-$76.1B vs $75.7B Est.",2017-07-18 06:44:00-04:00,JNJ,neutral
707913.0,Johnson & Johnson Raises FY 2017 Guidance,2017-07-18 06:42:00-04:00,JNJ,neutral
707914.0,"Johnson & Johnson Q2 EPS $1.83 vs $1.80 Est, Sales $18.84B vs $18.95B Est",2017-07-18 06:41:00-04:00,JNJ,neutral
707915.0,"10 Stocks To Watch For July 18, 2017",2017-07-18 05:19:00-04:00,JNJ,neutral
707916.0,"Earnings Scheduled For July 18, 2017",2017-07-18 04:29:00-04:00,JNJ,neutral
707917.0,"Earnings Roundup: JNJ, IBM, And LMT Report Q2 Results Tomorrow",2017-07-17 14:59:00-04:00,JNJ,neutral
707918.0,"Earnings Preview: Financial Giants BAC, GS, And MS Report Q2 Results This Week",2017-07-17 14:42:00-04:00,JNJ,neutral
707919.0,4 Sell-Ranked Drug Stocks To Avoid Ahead Of Q2 Earnings,2017-07-17 14:21:00-04:00,JNJ,negative
707920.0,FDA's 60-Day Extension For Medical Device Defects Not Likely Obstructive To Public Health,2017-07-14 08:26:00-04:00,JNJ,negative
707921.0,J&J Announces FDA Approval For Janssen's Plaque Psoriasis Treatment TREMFYA,2017-07-13 16:13:00-04:00,JNJ,positive
707922.0,J&J To Commence Pharma Q2 Earnings Season: What's Up?,2017-07-12 14:44:00-04:00,JNJ,neutral
707923.0,The Royalty-Amassing Strategy Of Royalty Pharma,2017-07-10 16:11:00-04:00,JNJ,neutral
707924.0,The Japanese Government's Pension Fund Made A Cool $70 Billion Last Year,2017-07-08 08:58:00-04:00,JNJ,positive
707925.0,Focusing On An Alternative To S&P 500 ETFs,2017-07-06 09:19:00-04:00,JNJ,neutral
707926.0,"Pre-Market Imbalance Update: Sprint 84K Shares To Buy, GE 80K Shares To Sell, Twitter 41K To Sell, Coca-Cola 37K To Sell, P&G 35K To Buy, Citi 28K To Buy, BofA 26K To Buy, Wells Fargo 25K To Buy, J&J 22K To Sell",2017-07-06 09:17:00-04:00,JNJ,positive
707927.0,5 Biggest Price Target Changes For Wednesday,2017-07-05 10:19:00-04:00,JNJ,neutral
707929.0,Janssen Says FDA Accepted For Priority Review A SNDA For Xarelto,2017-06-28 08:34:00-04:00,JNJ,positive
707930.0,Attention To Details: Neos' ADHD Portfolio,2017-06-26 09:05:00-04:00,JNJ,neutral
707931.0,A New ETF For Low Vol ETFs,2017-06-23 12:11:00-04:00,JNJ,negative
707932.0,"Benzinga PMP Host Dennis Dick Tweets: A few large imbalances this morning: $GE +825K, $JNJ -157K, $F -118K, $BAC +110K, $WFC +66K, $JPM +61K",2017-06-23 09:19:00-04:00,JNJ,negative
707936.0,"If Colgate's Looking To Sell Itself, Would Berkshire Be Looking To Buy?",2017-06-22 15:38:00-04:00,JNJ,neutral
707937.0,"Wall Street's M&A Chatter From June 21: Staples-Sycamore Partners, Diageo-Casamigos, Bristol-Myers, Acadia Pharma",2017-06-22 07:06:00-04:00,JNJ,neutral
707940.0,Non-Horrible Bosses: Meet The Best CEOs Of 2017,2017-06-21 07:06:00-04:00,JNJ,positive
707943.0,"FDA Reports Approval Of J&J's Janssen's Darzalex In Combo With Pomalidomide, Dexamethasone For Patients With Multiple Myeloma",2017-06-16 14:17:00-04:00,JNJ,positive
707945.0,JNJ Completes Acquisition of Actelion,2017-06-16 04:27:00-04:00,JNJ,neutral
707946.0,"Johnson & Johnson's Janssen Present Phase 3 Data On Sirukumab, Says Long-Term Efficacy Is 'Encouraging'",2017-06-14 11:29:00-04:00,JNJ,neutral
707947.0,Cramer: 3M's Stock Quietly Hit All-Time Highs Thanks To Weak US Dollar,2017-06-14 09:58:00-04:00,JNJ,neutral
707949.0,UPDATE: Tesaro Says Janssen Anticipates Re-opening Enrollment for Galahad Trial Soon -8-K,2017-06-12 06:13:00-04:00,JNJ,neutral
707950.0,"Tesaro Says on June Janssen Updated Clinicaltrials.gov Website to Reflect Janssen had Placed Temporary Enrollment Hold in  Galahad Trial; Says Galahad Trial Not on Clinical Hold, Temporary Enrollment Hold Not Due to Safety Concerns",2017-06-12 06:12:00-04:00,JNJ,negative
707951.0,Janssen and TESARO GALAHAD Trial Puts Patient Enrollment on Temporary Hold,2017-06-12 06:12:00-04:00,JNJ,neutral
707952.0,"Johnson & Johnson, Tesaro Niraparib Trial Enrollment Suspension Not Related To Safety",2017-06-09 12:18:00-04:00,JNJ,negative
707953.0,Tesaro Volatile After Johnson & Johnson Suspends Enrollment In Prostate Cancer Trial,2017-06-09 12:10:00-04:00,JNJ,negative
707954.0,"JNJ Spokesperson Says, 'Our team put a temporarily hold on enrollment so we could assess the enrolled currently patients against the protocol criteria.  We need to make sure we don't over-enroll some patient types and under-enroll others.'",2017-06-09 12:01:00-04:00,JNJ,positive
707955.0,"Johnson & Johnson Spokesperson Tells Benzinga TESARO's Niraparib Study Enrollment Is, 'on temporary hold and we anticipate re-opening enrollment soon.  The hold is not related to safety.'",2017-06-09 11:59:00-04:00,JNJ,neutral
707956.0,Johnson & Johnson Acquisition of Actelion is Approved by the EU,2017-06-09 07:32:00-04:00,JNJ,positive
707958.0,"Barron's Picks And Pans: AT&T, Express Scripts, Accenture And More",2017-06-04 18:27:00-04:00,JNJ,neutral
707959.0,Trial Results Show Johnson & Johnson's Zytiga Lowers Death Risk by 38% in Newly Diagnosed Advanced Prostate Cancer #ASCO2017,2017-06-03 11:42:00-04:00,JNJ,negative
707960.0,States Are Firing Back At Opioid Drug Producers,2017-06-01 10:48:00-04:00,JNJ,negative
707961.0,"Shares Of Johnons & Johnson, Teva Pharma, Endo Int'l, And Allergan All Higher Today Despite News State Of Ohio Has Sued These Companies For Alleged Role In Opioid Epidemic",2017-05-31 12:59:00-04:00,JNJ,positive
707962.0,Protagonist Therapeutics Spikes to High of $14.85 Following Announcement of Worldwide Agreement with Janssen,2017-05-30 09:34:00-04:00,JNJ,positive
707963.0,Tracking The Busy June PDUFA Calendar,2017-05-30 08:58:00-04:00,JNJ,neutral
707964.0,"Protagonist Therapeutics Enters into Worldwide Agreement with Janssen to Co-Develop and Commercialize PTG-200, Protagonist to Gets $50M Upfront Payment",2017-05-30 07:03:00-04:00,JNJ,positive
707965.0,"3 Most Likely Suitors For Colgate-Palmolive, In Jefferies' View",2017-05-18 11:21:00-04:00,JNJ,neutral
707966.0,"Pre-Market Imbalance Update: GE 179K Shares to Sell, Twitter 167K to Sell, General Mills 114K to Sell, J&J 47K to Sell, Morgan Stanley 36K to Sell",2017-05-17 09:17:00-04:00,JNJ,positive
707967.0,Johnson & Johnson Holding Pharmaceutical Business Review Today,2017-05-17 09:05:00-04:00,JNJ,neutral
707968.0,Johnson & Johnson Says Expecting to Launch or File for Regulatory Approval for 10 New Products from 2017 to 2021 and 50 Line Extensions of Existing Products,2017-05-17 06:54:00-04:00,JNJ,positive
707969.0,"Johnson & Johnson's Sales Slump Has Played Itself Out, Could Reaccelerate This Year",2017-05-15 11:10:00-04:00,JNJ,positive
707970.0,"Benzinga's Top Upgrades, Downgrades For May 15, 2017",2017-05-15 09:19:00-04:00,JNJ,positive
707971.0,JP Morgan Upgrades Johnson & Johnson to Overweight,2017-05-15 06:05:00-04:00,JNJ,neutral
707972.0,"Top Picks For The Rest Of 2017, Courtesy Of UBS",2017-05-12 15:25:00-04:00,JNJ,positive
707973.0,Apple Is The World's Biggest Dividend Payer,2017-05-03 10:07:00-04:00,JNJ,neutral
707974.0,Exclusive: Capricor CEO Talks Exondys Competition,2017-05-03 07:53:00-04:00,JNJ,positive
707975.0,"Weed Vs. Opioids: Nontraditional And Traditional Biotech Take On Wall Street, But Who's Winning?",2017-04-30 12:38:00-04:00,JNJ,positive
707976.0,Johnson & Johnson Increases Qtr. Dividend From $0.80/Share To $0.84/Share,2017-04-27 10:47:00-04:00,JNJ,neutral
707977.0,"Companies Holding Shareholder Meetings Today Include: Akorn, AstraZeneca, HCA Holdings, Johnson & Johnson, & Lockheed Martin",2017-04-27 08:41:00-04:00,JNJ,neutral
707978.0,Janssen Holding Announces 92.51% of Actelion Shares Tendered,2017-04-27 04:11:00-04:00,JNJ,positive
707979.0,"Earnings: Caterpillar, Lockheed Martin, and Eli Lilly Report Tomorrow",2017-04-24 13:45:00-04:00,JNJ,neutral
707980.0,How Family Office Manager Julio Gonzalez Is Helping Keep Jobs In The U.S. Using Tax Engineering,2017-04-24 09:13:00-04:00,JNJ,positive
707981.0,Jim Cramer Gives His Opinion On Johnson & Johnson And PPG Industries,2017-04-24 06:54:00-04:00,JNJ,neutral
707982.0,What Would A $5.8 Billion NIH Cut Look Like? Devastation,2017-04-20 13:38:00-04:00,JNJ,negative
707983.0,The Lucky Beneficiaries Of Tax Day,2017-04-20 08:23:00-04:00,JNJ,positive
707984.0,"JMP Calls Alteryx A Compelling Investment, Sees 23% Upside",2017-04-18 12:12:00-04:00,JNJ,positive
707985.0,Johnson & Johnson Pummeled After Mixed Q1 Report,2017-04-18 11:39:00-04:00,JNJ,neutral
707986.0,"Meg Tirrell Tweets: $JNJ says it's seeing higher discounting on drugs for favorable coverage; increased rx assistance, discounts hit Q1 results by $200m per JPM",2017-04-18 08:45:00-04:00,JNJ,positive
707987.0,A Peek Into The Markets: U.S. Stock Futures Mostly Lower Ahead Of Earnings,2017-04-18 07:50:00-04:00,JNJ,negative
707988.0,Johnson & Johnson Sees FY 2017 EPS $7.00 to $7.15 vs $7.05 Est,2017-04-18 06:41:00-04:00,JNJ,neutral
707989.0,"Johnson & Johnson Q1 EPS $1.83 vs $1.77 Est, Sales $17.8B vs $18.0B Est",2017-04-18 06:40:00-04:00,JNJ,neutral
707990.0,"10 Stocks To Watch For April 18, 2017",2017-04-18 05:47:00-04:00,JNJ,neutral
707991.0,"Earnings Scheduled For April 18, 2017",2017-04-18 05:24:00-04:00,JNJ,neutral
707992.0,"Earnings: Another Financial Roundup With BAC, GS, and MS",2017-04-17 14:27:00-04:00,JNJ,neutral
707993.0,Johnson & Johnson's Janssen Data From 2 Phase 3 Studies Supported New Approval Darzalex In Canada,2017-04-17 07:32:00-04:00,JNJ,positive
707994.0,United Airlines Should Learn From How These 6 Companies Handled PR Disasters,2017-04-14 16:50:00-04:00,JNJ,negative
707995.0,Healthcare Sector Earnings: Making A Comeback In Q1 2017?,2017-04-12 11:46:00-04:00,JNJ,neutral
707996.0,From Conf Call: Geron Says Jansen has Right to Terminate Agreement at Any Time for Any Reason,2017-04-10 08:19:00-04:00,JNJ,positive
707997.0,"Adam Feuerstein Tweets: $JNJ reluctance to commit to imetelstat, disclosed in last sentence of $GERN PR, is most important point.",2017-04-10 07:41:00-04:00,JNJ,positive
707998.0,There Is Value To Be Had With The Right Healthcare ETFs,2017-04-05 08:32:00-04:00,JNJ,positive
707999.0,"50 Advertisers Boycott YouTube Advertising, And It Won't Mean More Than A 1% Dip In Google's Top Line",2017-04-01 08:45:00-04:00,JNJ,negative
708000.0,"Pre-Market Imbalance Update: AT&T 90K Shares to Buy, Salesforce 70K to Sell, BofA 64K to Buy, CVS 64K to Sell, Twitter 42K to Sell, J&J 38K to Sell, Walmart 25K to Sell",2017-03-31 09:12:00-04:00,JNJ,positive
708001.0,JNJ Subsidiary Janssen Declares Tender Offer for Actelion Successful,2017-03-31 04:19:00-04:00,JNJ,positive
708002.0,Here's Every Major Corporation That's Pulled Ads From YouTube,2017-03-27 08:59:00-04:00,JNJ,neutral
708003.0,Watch These 5 Huge Put Purchases In Monday Trade,2017-03-27 05:29:00-04:00,JNJ,positive
708004.0,Benzinga's Option Alert Recap From March 24,2017-03-24 16:15:00-04:00,JNJ,positive
708005.0,Option Alert: JNJ May $120 Put; 2800 @ Bid @$0.90; Ref=$125.79,2017-03-24 12:30:00-04:00,JNJ,positive
708006.0,YouTube's Ad Controversy Not Going Away Yet; Will It Prove To Be Temporary?,2017-03-24 11:36:00-04:00,JNJ,neutral
708007.0,"Johnson & Johnson Unit Mentor Spokeswoman Tells Benzinga, 'We fully support the FDA's efforts to gather additional data and study BIA-ALCL in patients with breast implants,' Will Continue To Work To Understand Associated Risks And Causes",2017-03-24 09:37:00-04:00,JNJ,positive
708008.0,"American Express, Johnson & Johnson, Square, Vale: Fast Money Picks For March 24",2017-03-24 07:07:00-04:00,JNJ,neutral
708009.0,Allergan Continues Educational Strategy Amid FDA's Report Linking Breast Implants To Rare Cancer,2017-03-22 10:19:00-04:00,JNJ,negative
708010.0,"Premarket Prep Host Dennis Dick Tweets: $BAC -1.2M, $C -179K, $MS -82K, $WFC -48K, $NKE -113K, $BABA -67K, $TWTR -51K, $JNJ -84K, $GE -163K, $F +344K",2017-03-22 09:18:00-04:00,JNJ,negative
708011.0,FDA Links Breast Implants To A Rare Form Of Cancer,2017-03-21 17:26:00-04:00,JNJ,negative
708012.0,"Watch For Weakness In Sientra, Johnson & Johnson, and Allergan NBC News  Reports That FDA Says Breast Implants Can Cause A Rare Form Of Cancer That May Have Killed At Least 9 People",2017-03-21 16:49:00-04:00,JNJ,negative
708013.0,That Was Fast: Healthcare ETF Races To New Highs,2017-03-16 08:09:00-04:00,JNJ,neutral
708014.0,"Barclays Global Healthcare Conference Begins Today; Presenters Include Johnson & Johnson, Alnylam, Axovant, Paraxel, Gilead, bluebird bio, Envision Healthcare, & Tenet Healthcare",2017-03-14 08:20:00-04:00,JNJ,neutral
708015.0,How The Ultra-Wealthy Are Helping Advance Health And Life Sciences,2017-03-10 15:58:00-05:00,JNJ,positive
708016.0,"Jim Cramer Advises His Viewers On Johnson & Johnson, Corecivic, Urban Outfitters And Realty Income",2017-03-10 06:42:00-05:00,JNJ,neutral
708017.0,Fast Money Picks For March 8,2017-03-08 08:59:00-05:00,JNJ,neutral
708018.0,Concerns From Valeant's 10-K: $8 Billion Of Asset Sales Is Now A Mirage,2017-03-07 07:46:00-05:00,JNJ,positive
708019.0,"Benzinga Premarket Prep Host Dennis Dick Tweets: Notable opening imbalances: $XRX +467K, $BAC -353K, $PFE -133K, $CRM -129K, $PEP -89K, $JNJ -72K, $PG -50K",2017-03-06 09:18:00-05:00,JNJ,negative
708020.0,"J&J's Janssen Reports Results from Second Phase 3 Study of Guselkumab vs Humira for Treatment of Moderate-to-Severe Plaque Psoriasis Show Significant Efficacy, Superiority",2017-03-03 07:08:00-05:00,JNJ,positive
708021.0,Johnson & Johnson In 10-K Filing Says Janssen Pharma Subsidiary Received Civil Investigative Demand From DoJ Related To Allegations Concerning Sales & Marketing Practices Of Olysio,2017-02-27 17:08:00-05:00,JNJ,negative
708022.0,J&J Reports Expected Charge Of $2B-$2.4B Related To Medical Devices Unit Restructuring,2017-02-27 17:07:00-05:00,JNJ,neutral
708023.0,Johnson & Johnson Received Subpoena From Massachusetts Seeking Records Related To Payments To Any 501(C)(3) Charitable Organizations That Provide Assistance To Medicare Patients,2017-02-27 17:05:00-05:00,JNJ,positive
708024.0,How Trump's Tax Policy Could Affect Large Companies Like Apple,2017-02-27 12:05:00-05:00,JNJ,positive
708025.0,Dan Nathan's Bearish Johnson & Johnson Trade,2017-02-26 15:27:00-05:00,JNJ,neutral
708026.0,Hearing Johnson and Johnson Searching For Medical Device Partnerships At RBC Conf.,2017-02-23 10:19:00-05:00,JNJ,neutral
708027.0,"RBC Capital Markets Healthcare Conference Concludes Today; Presenters Include Spark Therapeutics, Johnson & Johnson, HCA Holdings, Ocular Therapeutix, Valeant & Agile Therapeutics",2017-02-23 08:04:00-05:00,JNJ,positive
708028.0,10 Companies With The Best Corporate Reputations,2017-02-22 13:57:00-05:00,JNJ,positive
708029.0,Icahn Takes Bristol-Myers Stake With M&A In Mind; Who Could Be The Acquirer?,2017-02-21 16:48:00-05:00,JNJ,neutral
708030.0,"Exclusive: Following Up Akebia, Johnson & Johnson's Research And License Agreement",2017-02-17 10:21:00-05:00,JNJ,positive
708031.0,"J&J Medical Devices' Ethicon Reports Deal to Buy Torax Medical, No Terms Disclosed",2017-02-17 10:03:00-05:00,JNJ,negative
708032.0,Wall Street's M&A Chatter From February 16,2017-02-17 06:39:00-05:00,JNJ,neutral
708033.0,Swiss Takeover Commission Says J&J Offer for Actelion Meets Legal Requirements,2017-02-16 04:40:00-05:00,JNJ,positive
708034.0,J&J Publishes Prospectus for Actelion Tender Offer,2017-02-16 04:02:00-05:00,JNJ,neutral
708035.0,"A Peek Into The Markets: U.S. Stock Futures Mostly Higher Ahead Of Economic Data, Yellen Speech",2017-02-15 07:44:00-05:00,JNJ,neutral
708036.0,Integra Acquires Codman Neurosurgery Business From Johnson & Johnson for $1.045B Cash,2017-02-15 07:02:00-05:00,JNJ,neutral
708037.0,ACADIA Shares Up $0.80 Over Last Min as Hearing Dealreporter Suggesting J&J Could Approach Co.,2017-02-14 13:26:00-05:00,JNJ,positive
708038.0,Johnson & Johnson's Janssen Pharmaceuticals Enters Agreement To Give Investigational New Drug File For Stresscopin To Renova Therapeutics,2017-02-06 11:04:00-05:00,JNJ,positive
708039.0,Donald Trump Calls Johnson & Johnson A 'Good Company',2017-01-31 09:51:00-05:00,JNJ,positive
708040.0,A CEO Who's Who Of Trump's Manufacturing Council,2017-01-27 16:36:00-05:00,JNJ,neutral
708041.0,Missouri Supreme Court Denies Request To Delay Johnson & Johnson Talc-Product Cancer Allegation Trials,2017-01-26 14:59:00-05:00,JNJ,negative
708042.0,"Benzinga's Top Upgrades, Downgrades For January 26, 2017",2017-01-26 09:22:00-05:00,JNJ,positive
708043.0,"The Market In 5 Minutes: Earnings, Trump And Dow20k",2017-01-26 09:02:00-05:00,JNJ,neutral
708044.0,A Peek Into The Markets: U.S. Stock Futures Up Ahead Of Earnings,2017-01-26 07:24:00-05:00,JNJ,neutral
708045.0,Wells Fargo Downgrades Johnson & Johnson To Market Perform,2017-01-26 06:46:00-05:00,JNJ,positive
708046.0,JNJ to Acquire Actelion for $280/Share in Cash; Actelion to Spin Out Drug Discovery Operations and Early-Stage Clinical Development Assets,2017-01-26 03:47:00-05:00,JNJ,positive
708047.0,Dow 10K's Hottest Stocks: Where Are They Now?,2017-01-25 15:17:00-05:00,JNJ,neutral
708048.0,Trump Helps Send Markets To New Highs With Keystone Pipeline Order,2017-01-25 10:59:00-05:00,JNJ,positive
708049.0,Q4 Earnings Thus Far A Reality Check For The Trump Rally?,2017-01-24 16:11:00-05:00,JNJ,neutral
708050.0,Q4 2016 Real-Time Call Brief,2017-01-24 14:56:00-05:00,JNJ,neutral
708051.0,Johnson & Johnson Takes A Hit After Mixed Q4 Report,2017-01-24 11:42:00-05:00,JNJ,neutral
708052.0,Stocks Could Remain Range-Bound Until Trump Policy Details Become Clearer,2017-01-24 10:31:00-05:00,JNJ,neutral
708053.0,Johnson and Johnson Says To Expect 10 New Product Launches By 2019 With $1B In Sales Potential,2017-01-24 09:04:00-05:00,JNJ,neutral
708054.0,"The Market In 5 Minutes: Alibaba Beats, Verizon Disappoints",2017-01-24 09:02:00-05:00,JNJ,negative
708055.0,A Peek Into The Markets: U.S. Stock Futures Flat Ahead Of Earnings Reports,2017-01-24 07:29:00-05:00,JNJ,neutral
708056.0,Johnson & Johnson Says Evaluating Strategic Options for Diabetes Care Companies,2017-01-24 06:42:00-05:00,JNJ,positive
708057.0,Johnson & Johnson Sees FY EPS $6.93 to $7.08 vs $7.11 Est,2017-01-24 06:41:00-05:00,JNJ,neutral
708058.0,"Johnson & Johnson Q4 EPS $1.58 vs $1.56 Est, Revenue $18.1B vs $18.3B Est",2017-01-24 06:40:00-05:00,JNJ,neutral
708059.0,12 Stocks You Should Be Watching Today,2017-01-24 05:53:00-05:00,JNJ,neutral
708060.0,"Earnings Scheduled For January 24, 2017",2017-01-24 05:03:00-05:00,JNJ,neutral
708061.0,"J&J Chair, CEO, Alex Gorsky, Offers Statement Following Manufacturer Meeting with Trump",2017-01-23 16:42:00-05:00,JNJ,neutral
708062.0,"Earnings: Last Call for Yahoo? Johnson & Johnson, Alibaba Also Release This Week",2017-01-23 12:00:00-05:00,JNJ,neutral
708063.0,"ReutersBiz Tweets: BREAKING: Executives from Whirlpool, Under Armour, Tesla, Lockheed Martin, Johnson & Johnson and more attend Trump meeting on manufacturing",2017-01-23 09:16:00-05:00,JNJ,neutral
708064.0,"Execs from Tesla, J&J, Lockheed, Under Armour, Whirlpool Attend Trump Meeting with Key US Manufacturers",2017-01-23 09:12:00-05:00,JNJ,neutral
708065.0,"Dow Earnings: High Hopes For Chevron, Johnson & Johnson",2017-01-23 08:31:00-05:00,JNJ,positive
708066.0,Health Canada Wants Warning Stickers on Prescription Painkillers -Reuters,2017-01-23 04:26:00-05:00,JNJ,negative
708067.0,Inauguration Day: Trump Speech In Focus As New President Prepares To Take Office,2017-01-20 10:00:00-05:00,JNJ,neutral
708068.0,"Johnson and Johnson Unit Ethicon Acquires Megadyne Medical Products, Terms Not Disclosed",2017-01-20 08:30:00-05:00,JNJ,neutral
708069.0,Does Luxottica Now Have A Monopoly On The Eyeglass Space?,2017-01-17 15:15:00-05:00,JNJ,neutral
708070.0,Quality Dividends On The Cheap With This ETF,2017-01-17 08:40:00-05:00,JNJ,neutral
708071.0,Johnson & Johnson Deal With Actelion Said To Be Valued At $250-$260/Share,2017-01-12 12:57:00-05:00,JNJ,positive
708072.0,J&J and Actelion Said TO Reach Tentative Agreement On Price,2017-01-11 16:08:00-05:00,JNJ,positive
708073.0,The Fentanyl Abuse Epidemic,2017-01-10 07:02:00-05:00,JNJ,negative
708074.0,"JP Morgan Healthcare Conf. Begins Today; Presenters Include Insulet, Teladoc, Incyte, Johnson & Johnson, Acadia Healthcare, & Teva Pharmaceuticals",2017-01-09 08:49:00-05:00,JNJ,positive
708075.0,"J&J, Actelion Discuss Deal with Swiss Takeover Board -Tages-Anzeiger",2017-01-06 04:57:00-05:00,JNJ,neutral
708076.0,Execs Giving CES Keynote Speeches Could Create Volatility For Shareholders,2017-01-05 16:07:00-05:00,JNJ,positive
708077.0,A Peek Into The Markets: U.S. Stock Futures Rise On Final Trading Day Of 2016,2016-12-30 07:27:00-05:00,JNJ,neutral
708078.0,Wall Street's M&A Chatter From December 29,2016-12-30 06:38:00-05:00,JNJ,neutral
708079.0,Hearing J&J is Negotiating Placing Actelion's R&D Assets Into a Separate Co.,2016-12-29 10:54:00-05:00,JNJ,positive
708080.0,UPDATE: Achillion Receives $15M Milestone Payment from J&J's Janssen Research & Development,2016-12-28 06:07:00-05:00,JNJ,neutral
708081.0,Achillion Reports Clinical Milestone for Advancement of JNJ-4178 in Phase 2B Development for Chronic HPV,2016-12-28 06:07:00-05:00,JNJ,neutral
708082.0,"The Market In 5 Minutes: GDP, Jobless Claims And Micron",2016-12-22 09:11:00-05:00,JNJ,neutral
708083.0,Wall Street's M&A Chatter From December 21,2016-12-22 06:35:00-05:00,JNJ,neutral
708084.0,Johnson & Johnson Confirms Exclusive Negotiations With Actelion In Press Release,2016-12-21 11:41:00-05:00,JNJ,positive
708085.0,Actelion and Johnson & Johnson Enter Into Exclusive Discussion,2016-12-21 11:37:00-05:00,JNJ,positive
708086.0,"J&J's Janssen Announces Submission of Two FDA Applications for Approval of SIMPONI ARIA for Treatment of Active Psoriatic Arthritis, Active Ankylosing Spondyllitis",2016-12-20 16:46:00-05:00,JNJ,positive
708087.0,Janssen Sciences Ireland UC Announces  Positive Results From First Phase III Studies of Investigational Two-Drug HIV Treatment Regimen,2016-12-19 18:16:00-05:00,JNJ,positive
708088.0,Jefferies' 2017 Global Pharma Outlook,2016-12-19 10:56:00-05:00,JNJ,neutral
708089.0,Janssen Submits Application Seeking FDA Approval Of Stelara For Treatment Of Adolescents With Moderate-To-Severe Plaque Psoriasis,2016-12-16 07:46:00-05:00,JNJ,positive
708090.0,Wall Street's M&A Chatter From December 14,2016-12-15 06:57:00-05:00,JNJ,neutral
708091.0,Watch These 7 Huge Call Purchases In Thursday Trade,2016-12-15 04:03:00-05:00,JNJ,positive
708092.0,Who Else Might Johnson & Johnson Seek To Acquire With Actelion Now Out Of Its Crosshairs?,2016-12-14 13:56:00-05:00,JNJ,neutral
708093.0,Option Alert: JNJ Dec16 119 Calls Sweep: 1482 @  ASK  $0.12: 1482 traded vs 230 OI:  Earnings 1/24 Before Open  $116.87 Ref,2016-12-14 09:36:00-05:00,JNJ,positive
708094.0,The Market In 5 Minutes: All Eyes On The Fed,2016-12-14 09:02:00-05:00,JNJ,neutral
708095.0,Wall Street's M&A Chatter From December 13,2016-12-14 07:04:00-05:00,JNJ,neutral
708096.0,Actelion  Confirms J&J has Withdrawn from Discussions With Actelion; Says Engaged in Discussions with Another Party,2016-12-13 20:12:00-05:00,JNJ,positive
708097.0,JNJ Confirms it Ended Discussions with Actelion,2016-12-13 19:23:00-05:00,JNJ,neutral
708098.0,Vetr Calls For A Hold On Johnson & Johnson Amid Sector Competition,2016-12-12 14:32:00-05:00,JNJ,neutral
708099.0,"Barron's Picks And Pans: Goodyear, Johnson & Johnson And More",2016-12-12 06:50:00-05:00,JNJ,neutral
708100.0,"Facebook, Google Make Glassdoor's List Of Top 50 Places To Work",2016-12-07 15:03:00-05:00,JNJ,positive
708101.0,"Pfizer, J&J, Other Big Pharma Names Dip Lower Just After the Open",2016-12-07 09:34:00-05:00,JNJ,negative
708102.0,Karyopharm Therapeutics' Top Execs Talk Recent Results In Multiple Myeloma And Acute Myeloid Leukemia,2016-12-06 15:41:00-05:00,JNJ,positive
708103.0,"The Market In 5 Minutes: Lower Oil Prices, Higher Apple Watch Sales",2016-12-06 08:57:00-05:00,JNJ,negative
708104.0,"Actelion Large Shareholder Would Back Johnson & Johnson Acquisition Takeover for 246 SFR or Higher, According to Reuters",2016-12-06 06:55:00-05:00,JNJ,neutral
708105.0,Sanofi Said To Explore Actelion Counterbid To Johnson & Johnson,2016-12-05 16:12:00-05:00,JNJ,neutral
708106.0,Johnson & Johnson Shares Trading Down 0.3% Pre-Market on $1B Verdict On Faulty Pinnacle Hip Implants From Its DePuy Orthopedics Unit,2016-12-02 08:26:00-05:00,JNJ,positive
708107.0,Achillion Says Dosing of Phase 2B Study Initiated by Janssen,2016-11-30 06:24:00-05:00,JNJ,neutral
708108.0,"Barclays Downgrades 5 Biopharma Stocks, Upgrades Pfizer And Alexion",2016-11-29 10:39:00-05:00,JNJ,neutral
708109.0,J&J Said To Raise Actelion Takeover Offer As Talks Advance,2016-11-29 09:51:00-05:00,JNJ,neutral
708110.0,7 Biggest Price Target Changes For Tuesday,2016-11-29 09:39:00-05:00,JNJ,neutral
708111.0,Benzinga's Top Downgrades,2016-11-29 09:17:00-05:00,JNJ,positive
708112.0,"Jim Cramer Shares His Thoughts On Johnson & Johnson, Anheuser Busch And Starbucks",2016-11-29 06:36:00-05:00,JNJ,positive
708113.0,Barclays Downgrades Johnson & Johnson to Equal-Weight,2016-11-29 05:56:00-05:00,JNJ,neutral
708114.0,"Financial Times Reporting, 'Actelion weighs complicated deal to combine with part of J&J'",2016-11-28 13:49:00-05:00,JNJ,neutral
708115.0,"The Market In 5 Minutes: Castro, Trump And Oil In Focus",2016-11-28 08:59:00-05:00,JNJ,neutral
708116.0,Wall Street's M&A Chatter From November 25-27,2016-11-28 06:54:00-05:00,JNJ,neutral
708117.0,Johnson & Johnson Press Release Confirms Prelim Discussions With Actelion Pharma Regarding To Potential Acquisition,2016-11-25 12:00:00-05:00,JNJ,neutral
708118.0,Actelion Issues Press Release Confirming Co. Has Been Approached by J&J Related to Possible Transaction,2016-11-25 11:01:00-05:00,JNJ,neutral
708119.0,The Market In 5 Minutes: Black Friday Closes Shortened Trading Week,2016-11-25 09:33:00-05:00,JNJ,neutral
708120.0,Johnson & Johnson Said to Approach Actelion Regarding Potential Takeover -Bloomberg,2016-11-25 06:32:00-05:00,JNJ,neutral
708121.0,Technical Alert - Johnson & Johnson Lower For Third Day In A Row,2016-11-22 10:10:00-05:00,JNJ,neutral
708122.0,Johnson & Johnson Opens Slightly Lower; JNJ's Janssen Reported FDA Approval Of DARZALEX Yesterday,2016-11-22 09:39:00-05:00,JNJ,positive
708123.0,Janssen Submits Application To FDA Seeking guselkumab Approval For Treatment Of Plaque Psoriasis,2016-11-17 08:05:00-05:00,JNJ,positive
708124.0,UPDATE: Janssen Reports Safety Observations Through 24 Weeks For guselkumab Show 36% of Patients Experienced Adverse Events vs. 32.7% Of Placebo,2016-11-15 08:09:00-05:00,JNJ,positive
708125.0,"Janssen Reports guselkumab Phase 2 Results In Psoriatic Arthritis Follow Positive Phase 3 Study In Plaque Psoriasis, 2 Serious Adverse Events Were Reported, Safety Observations",2016-11-15 08:08:00-05:00,JNJ,positive
708126.0,"13F from Paulson & Co. Shows New Stakes in eBay, HP Enterprises, Infblox, Carmike, Increased Stake in Facebook, Boston Scientific, Reduced Stake in J&J, Liquidated Stakes in EMC, B/E Aerospace",2016-11-14 17:46:00-05:00,JNJ,positive
708127.0,Johnson And Johnson New Phase 3 Data Shows Simponi Aria Significantly Improved Signs & Symptoms In Patients With Ankylosing Spondylitis,2016-11-14 08:10:00-05:00,JNJ,positive
708128.0,9 Of The Most Successful Veterans Turned CEOs,2016-11-11 11:00:00-05:00,JNJ,positive
708129.0,Janssen REports Clinical Trial Partnership And Supply Agreement With Amgen To Evaluate daratumumab In Combination With carfilzomib,2016-11-10 08:36:00-05:00,JNJ,positive
708130.0,UPDATE: Bayer Says Statements Published in Handelsblatt are Misleading -Reuters,2016-11-09 06:28:00-05:00,JNJ,negative
708131.0,Handlelsblatt Reports Test Equipment Used in Pivotal Trial of Bayer's Xarelto was Defective,2016-11-09 06:27:00-05:00,JNJ,negative
708132.0,"In Latest Johnson & Johnson 10-Q, Company Reported A Patient Death In Janssen's IMBbark and IMerge With Adverse Events Associated With Geron's imetelstat",2016-11-04 10:00:00-04:00,JNJ,negative
708133.0,Are The Drugs Working? Pfizer Updates Financials And Disease Therapy Performances,2016-10-31 12:00:00-04:00,JNJ,neutral
708134.0,Can You Guess This Chart?,2016-10-28 07:44:00-04:00,JNJ,neutral
708135.0,Jury Awards $70M in Johnson & Johnson Cancer Suit,2016-10-28 04:25:00-04:00,JNJ,negative
708136.0,Goldman Says These 25 Healthcare Stocks Are Immune To The Election,2016-10-24 10:55:00-04:00,JNJ,positive
708137.0,"Fed Speakers And Beige Book, Bank Earnings, Rising Crude Take Center Stage",2016-10-19 12:38:00-04:00,JNJ,negative
708138.0,Johnson & Johnson's Robust Pipeline Supports Its Above-Average Valuation,2016-10-19 12:07:00-04:00,JNJ,positive
708139.0,Technical Alert: Johnson & Johnson Craters After Q3 Report,2016-10-18 13:49:00-04:00,JNJ,positive
708140.0,"Earnings Roll On, With Goldman, Netflix Results Giving Market A Lift",2016-10-18 11:46:00-04:00,JNJ,positive
708141.0,"The Market In 5 Minutes: Netflix Dominates, Goldman Sachs Keeps Banks Flowing",2016-10-18 08:57:00-04:00,JNJ,positive
708142.0,A Peek Into The Markets: U.S. Stock Futures Surge; Goldman Sachs Earnings In Focus,2016-10-18 07:34:00-04:00,JNJ,neutral
708143.0,Johnson & Johnson Delivers Another Earnings Beat,2016-10-18 07:11:00-04:00,JNJ,neutral
708144.0,"Johnson & Johnson Sees FY EPS $6.68 to $6.73 vs $6.69 est, Revenue $71.5B to $72.2B vs $72.2B est",2016-10-18 06:41:00-04:00,JNJ,neutral
708145.0,"Johnson & Johnson Q3 EPS $1.68 vs $1.65 est, Revenue $17.8B vs $17.7B est",2016-10-18 06:40:00-04:00,JNJ,neutral
708146.0,"10 Stocks To Watch For October 18, 2016",2016-10-18 05:18:00-04:00,JNJ,neutral
708147.0,"Earnings Scheduled For October 18, 2016",2016-10-18 04:02:00-04:00,JNJ,neutral
708148.0,Technical Alert: Johnson & Johnson Finds Support,2016-10-17 13:07:00-04:00,JNJ,positive
708149.0,"Earnings: Who's At Bat Next? Netflix, IBM, And More.",2016-10-17 11:28:00-04:00,JNJ,neutral
708150.0,Plenty To Chew On As Heart Of Earnings Season Approaches; Fed Speakers On Prowl,2016-10-17 09:01:00-04:00,JNJ,neutral
708151.0,Kevin Kelly's Johnson & Johnson Trade,2016-10-11 17:31:00-04:00,JNJ,neutral
708152.0,Can You Guess This Chart?,2016-10-11 07:52:00-04:00,JNJ,neutral
708153.0,J&J Warns Diabetic Patients that Insulin Pump is Vulnerable to Hacking -Reuters,2016-10-04 08:28:00-04:00,JNJ,negative
708154.0,Here's Everything You Need To Know About Blue Chip Stocks,2016-09-28 14:02:00-04:00,JNJ,neutral
708155.0,"vTv Therapeutics Shares Initiated With Buy Rating, $13 Target",2016-09-26 11:46:00-04:00,JNJ,positive
708156.0,J&J's Janssen Reports FDA Approval of STELARA for Treatment of Adults With Moderately To Severely Active Crohn's Disease,2016-09-26 09:09:00-04:00,JNJ,positive
708157.0,First Trust Gets Smart With New Sector ETFs,2016-09-26 08:24:00-04:00,JNJ,positive
708158.0,The Market In 5 Minutes: No Interest Rate Hike...Yet,2016-09-22 09:04:00-04:00,JNJ,positive
708159.0,Can You Guess This Chart?,2016-09-22 07:31:00-04:00,JNJ,neutral
708160.0,"Shares of Johnson & Johnson Volatile, Traders Attribute Action To Negative Comments From Favus Research",2016-09-21 09:43:00-04:00,JNJ,negative
708161.0,Credit Suisse Can Clearly See Why Johnson & Johnson Acquired Abbott's Optics Division,2016-09-19 10:16:00-04:00,JNJ,positive
708162.0,"Alere Shares Up ~$0.60 Over Last Few Mins as Traders Seemingly Responding to J&J, Abbott Deal",2016-09-16 15:05:00-04:00,JNJ,positive
708163.0,UPDATE: Abbott Labs Says Net Impact Of J&J Transaction Will Not Effect Abbott's Targeted EPS In 2017,2016-09-16 15:03:00-04:00,JNJ,neutral
708164.0,Johnson & Johnson To Acquire Abbott Medical Optics For $4.325B Cash,2016-09-16 15:01:00-04:00,JNJ,neutral
708165.0,Hearing Johnson & Johnson Nearing Deal To Buy Abbott's Eye-Surgery Equipment Unit,2016-09-16 12:30:00-04:00,JNJ,neutral
708166.0,"BZ NOTE: J&J Shares Appear Rangebound Over the Last Hour, Trading Between $118.40 and $118.60",2016-09-16 11:17:00-04:00,JNJ,positive
708167.0,J&J Shares Up ~$0.13 Over Last Min; Upside Attributing to Unconfirmed Chatter of Bill Ackman Stake,2016-09-16 11:17:00-04:00,JNJ,positive
708168.0,"J&J's Janssen Says Following Positive CHMP Opinion on Ustekinumab, Final Decision from EC Expected Later in '16",2016-09-16 09:48:00-04:00,JNJ,positive
708169.0,The Market In 5 Minutes: Apple Helps Lead Stocks Higher,2016-09-15 08:58:00-04:00,JNJ,positive
708170.0,Can You Guess This Chart?,2016-09-15 07:22:00-04:00,JNJ,neutral
708171.0,J&J Reports WHO Will Review Co.'s Ebola Vaccine Regiment for EUAL,2016-09-12 14:39:00-04:00,JNJ,neutral
708172.0,Geron +13.64% @$3.25 Following Update on  Imetelstat,2016-09-12 07:38:00-04:00,JNJ,neutral
708173.0,"Reads For The Weed-Kend: Marijuana Roadside Testing, Pregnancy And Depression",2016-09-11 17:09:00-04:00,JNJ,negative
708174.0,"Achillion Pharma Reports 100% SVR Reported in Janssen's Phase 2a Trial Evaluating Triple Combination of Odalasvir, AL-335, and Simeprevir for Genotype 1 Treatment-Naive HCV",2016-09-09 06:20:00-04:00,JNJ,neutral
708175.0,How Does Amazon's Meteoric Rise Compare To Those Of Its Mega-Cap Peers?,2016-09-08 11:34:00-04:00,JNJ,neutral
708176.0,Another Election Year View On Healthcare ETFs,2016-09-08 11:12:00-04:00,JNJ,neutral
708177.0,FDA Orders Stores To Cleanse Their Shelves Of Ineffective Hand Soaps,2016-09-06 10:55:00-04:00,JNJ,positive
708178.0,"Out With The Old, In With The New: State Agencies Seem To Prefer Marijuana Over Opioids",2016-09-06 10:26:00-04:00,JNJ,neutral
708179.0,Johnson & Johnson Gets Patent For Ortho Regenerate Technologies,2016-09-01 10:51:00-04:00,JNJ,neutral
708180.0,"Pre-Market Prep Host Dennis Dick Tweets Notable Opening Imbalance: Notable opening imbalances: $BAC +1.1M, $ABX -234K, $GE -56K, $JNJ +35K, $VEEV +40K, $F -90K, $MS -40K, $C +35K",2016-08-31 09:24:00-04:00,JNJ,negative
708181.0,Option Alert: JNJ Fri 8/26 119 Puts (Wkly): 2000 @  ASK  $0.55: 2398 traded vs 1999 OI:  Earnings 10/11  $118.80 Ref,2016-08-24 15:03:00-04:00,JNJ,positive
708182.0,Write A Prescription For More Pharma M&A With This ETF,2016-08-24 10:00:00-04:00,JNJ,neutral
708183.0,Janssen Submit European Application To Expand Darzalex Use - Reuters,2016-08-23 06:59:00-04:00,JNJ,positive
708184.0,Goldman Sachs Talks Pfizer's Acquisition Deal Of Medivation,2016-08-22 08:17:00-04:00,JNJ,neutral
708185.0,Geron Shares Seen Range-Bound On Lack Of Major Data Until Late 2017,2016-08-19 12:28:00-04:00,JNJ,neutral
708186.0,"10 Notable Stocks Trading Ex-Dividend Friday, August 19",2016-08-18 15:59:00-04:00,JNJ,neutral
708187.0,Deutsche Takes A Look At Johnson & Johnson's Patent Woes,2016-08-18 14:53:00-04:00,JNJ,negative
708188.0,Recent Patent Ruling A Positive For Pfizer,2016-08-18 14:26:00-04:00,JNJ,positive
708189.0,"Johnson & Johnson Reaffirms Sales Guidance For FY16 Of 3-4%, Not Including Possibility Of A Biosimilar Launch On Or After Oct. 3th 2016",2016-08-17 13:57:00-04:00,JNJ,neutral
708190.0,Johnson & Johnson Says Janssen Continuing Appeal Process In Proceedings Related To '471 Patent Before USPTO,2016-08-17 13:56:00-04:00,JNJ,neutral
708191.0,JNJ Spikes to High of $121.19 on Volume,2016-08-17 13:39:00-04:00,JNJ,neutral
708192.0,J&J's Janssen R&D Unit Says Esketamine Receives Breakthrough Therapy Designation from FDA Related to Major Depressive Disorder with Imminent Risk for Suicide,2016-08-16 09:02:00-04:00,JNJ,negative
708193.0,Biogen Cancels Out Of Citigroup Conference Following Weeks Of Rumors,2016-08-11 15:02:00-04:00,JNJ,negative
708194.0,Canada's Plan To Fight Opioid Addiction Might Hurt Its Weakest Patients,2016-08-08 16:59:00-04:00,JNJ,negative
708195.0,"Biogen Shares Unaffected Amid Dealreporter Report Suggesting Pfizer, J&J Could Also Be Looking at Co.",2016-08-08 11:28:00-04:00,JNJ,positive
708196.0,Deutsche Downgrades Ligand As Risk/Reward Becomes Challenging,2016-08-05 14:25:00-04:00,JNJ,positive
708197.0,Another Jobs Report Bonanza: Big July Job Gains Lend Support To Stock Market,2016-08-05 10:39:00-04:00,JNJ,positive
708198.0,3 Things The Market Is Focused On This Week,2016-07-25 12:35:00-04:00,JNJ,positive
708199.0,Johnson & Johnson Subsidiary Acclarent To Pay $18M To Settle False Claims Act Allegations,2016-07-22 10:46:00-04:00,JNJ,negative
708200.0,"Opioid Addiction: What To Do When A Loved One Is Hooked, According To Science",2016-07-21 08:40:00-04:00,JNJ,positive
708201.0,Argus Boosts Price Target On Johnson & Johnson Following Strong Quarter,2016-07-20 12:02:00-04:00,JNJ,positive
708202.0,Option Alert: JNJ Sep16 130 Calls: 2500 @  ASK  $0.41: 2556 traded vs 1057 OI: $125.51 Ref,2016-07-20 10:16:00-04:00,JNJ,positive
708203.0,7 Biggest Price Target Changes For Wednesday,2016-07-20 09:31:00-04:00,JNJ,neutral
708204.0,"The Market In 5 Minutes: Microsoft Beat, Disney Downgrade And Donald Trump",2016-07-20 09:09:00-04:00,JNJ,neutral
708205.0,Benzinga's Top Upgrades,2016-07-20 08:51:00-04:00,JNJ,positive
708206.0,"Argus Research Upgrades Johnson & Johnson to Buy, Raises PT to $145.00",2016-07-20 07:08:00-04:00,JNJ,neutral
708207.0,Earnings: HAL's Tie to Oil Prices Could Set Stage for Quarterly Loss,2016-07-19 12:06:00-04:00,JNJ,negative
708208.0,Stocks Hitting 52-Week Highs,2016-07-19 10:09:00-04:00,JNJ,neutral
708209.0,"The Market In 5 Minutes: Netflix Earnings Disappoint, Goldman Sachs Has Big Beat",2016-07-19 08:48:00-04:00,JNJ,negative
708210.0,12 Stocks Moving In Tuesday's Pre-Market Session,2016-07-19 08:20:00-04:00,JNJ,neutral
708211.0,A Peek Into The Markets: U.S. Stock Futures Down Ahead Of Earnings,2016-07-19 07:55:00-04:00,JNJ,neutral
708212.0,Investors Cheer Johnson & Johnson's Q2 Results,2016-07-19 07:48:00-04:00,JNJ,positive
708213.0,Ionis Pharma Reports Licensing of First Oral Antisense Drug Acting Locally in GT Tract to J&J's Janssen,2016-07-19 07:06:00-04:00,JNJ,positive
708214.0,"Johnson & Johnson Q2 EPS $1.74 vs $1.68 est, Revenue $18.5B vs $18.0B est",2016-07-19 06:41:00-04:00,JNJ,neutral
708215.0,"Keep an Eye on These 12 Stocks for July 19, 2016",2016-07-19 05:02:00-04:00,JNJ,neutral
708216.0,"Earnings Scheduled For July 19, 2016",2016-07-19 04:09:00-04:00,JNJ,neutral
708217.0,Johnson & Johnson Dividend Offers 2.6% Yield,2016-07-18 15:35:00-04:00,JNJ,neutral
708218.0,Can NFLX Grow its Subscriber Base?,2016-07-18 11:12:00-04:00,JNJ,neutral
708219.0,"Bank Earnings Keep Coming In New Week, But Economic Data Flow to Slow",2016-07-18 10:32:00-04:00,JNJ,neutral
708220.0,The Market In 5 Minutes: Earnings Season Is Upon Us,2016-07-18 08:52:00-04:00,JNJ,neutral
708221.0,A Shark Of An ETF In The Dividend ETF Tank,2016-07-18 08:16:00-04:00,JNJ,neutral
708222.0,Benzinga's Weekend M&A Chatter,2016-07-17 20:45:00-04:00,JNJ,neutral
708223.0,Amazon Moves Cloud Service Focus From Startups Like Lyft To Big Enterprises Like Netflix And Capital One,2016-07-14 14:26:00-04:00,JNJ,positive
708224.0,"Amazon's Cloud Services Could Add $1 Billion To Revenue, Says Pacific Crest",2016-07-14 10:24:00-04:00,JNJ,neutral
708225.0,UPDATE: CI:Z Will Receive Two Board Members From Johnson & Johnson,2016-07-11 14:14:00-04:00,JNJ,neutral
708226.0,"UPDATE: A Johnson & Johnson Subsidiary Will Buy A 19.9% Stake In CI:Z, Becoming 2nd Largest Shareholder",2016-07-11 14:12:00-04:00,JNJ,neutral
708227.0,Johnson & Johnson To Buy 20% Stake In Japanese Cosmetics Maker,2016-07-11 14:11:00-04:00,JNJ,neutral
708228.0,"Barclays Morning Research Summary: Commodities, Comcast And Healthcare In Focus",2016-07-08 13:35:00-04:00,JNJ,neutral
708229.0,Achillion Shares Rally Following JMP's Upgrade To Market Outperform,2016-07-07 10:52:00-04:00,JNJ,positive
708230.0,Be Aware Of These Key Technical Levels As You Trade Today,2016-07-06 14:36:00-04:00,JNJ,neutral
708231.0,Johnson & Johnson Subsidiary DePuy Orthopaedics Says Patients Suffering From Company's Pinnacle Metal-on-Metal Hip Implants Will Be Heard In September,2016-07-06 13:20:00-04:00,JNJ,negative
708232.0,No Tears In Johnson & Johnson,2016-06-27 12:54:00-04:00,JNJ,negative
708233.0,Invega Trinza Approved By Health Canada For Schizophrenia,2016-06-27 07:09:00-04:00,JNJ,positive
708234.0,Baird Says Buy Cooper Companies At Current Levels,2016-06-24 09:48:00-04:00,JNJ,neutral
708235.0,Gilead Sciences Get European Commission Grant For Marketing Authorization Of Its Single Tablet Regimen Odefsey,2016-06-23 11:30:00-04:00,JNJ,positive
708236.0,European Commission Grants Marketing Authorization for Gilead's Single Tablet Regimen Odefsey for the Treatment of HIV,2016-06-23 07:55:00-04:00,JNJ,positive
708237.0,Technology Forces Advertisers To Get Creative,2016-06-22 14:12:00-04:00,JNJ,positive
708238.0,S&P 500 Index Futures Trading Higher,2016-06-22 10:48:00-04:00,JNJ,neutral
708239.0,A Peek Into The Markets: U.S. Stock Futures Edge Higher Ahead Of Yellen Speech,2016-06-22 07:54:00-04:00,JNJ,neutral
708240.0,Johnson & Johnson Names Joseph Wolk As VP Of Investor Relations In Place Of Louise Mehrotra,2016-06-22 07:24:00-04:00,JNJ,neutral
708241.0,Arbutus Biopharma Taken Off Of Chardan's Sell List,2016-06-16 09:29:00-04:00,JNJ,neutral
708242.0,5 Pharmaceutical Price Target Raises From Jefferies,2016-06-14 15:13:00-04:00,JNJ,neutral
708243.0,February 27 Earnings Update,2016-06-14 11:28:00-04:00,JNJ,neutral
708244.0,Janssen Announces EPREX Demonstrates Effectiveness as Treatment for Anaemia in Patients with Low or Intermediate-1 Risk Myelodysplastic Syndromes at EHA,2016-06-11 08:56:00-04:00,JNJ,negative
708245.0,Johnson & Johnson's Janssen R&D Reports Phase 3 POLLUX Trial Shows daratumumab Achieved 63% Reduction In Risk Of Disease Progression or Death Compared To lenalidomide and dexamethasone Alone,2016-06-10 07:07:00-04:00,JNJ,negative
708246.0,S&P 500 Index Futures Trading Lower,2016-06-09 10:37:00-04:00,JNJ,negative
708247.0,4 Key Takeaways From ASCO,2016-06-06 17:32:00-04:00,JNJ,neutral
708248.0,"Johnson & Johnson Continues Winning Streak, Makes Another New All-Time High",2016-06-06 14:33:00-04:00,JNJ,positive
708249.0,S&P 500 Index Futures Trading Higher,2016-06-06 11:32:00-04:00,JNJ,neutral
708250.0,Amyris +22% Premarket @ $0.65; Co Announced Collaboration With J&J on Biosynthetic Drug Discovery,2016-06-06 09:17:00-04:00,JNJ,neutral
708251.0,S&P 500 Index Futures Trading Lower In Choppy Session,2016-06-02 10:47:00-04:00,JNJ,negative
708252.0,"The Market In 5 Minutes: Draghi, iPhones And Warriors",2016-06-02 08:58:00-04:00,JNJ,neutral
708253.0,Johnson & Johnson Announces Acquisition of Vogue International for $3.3B Cash,2016-06-02 06:45:00-04:00,JNJ,neutral
708254.0,Janssen Pharmaceutica NV Idylla Ebola Virus Triage Test Granted Emergency Use Authorization by FDA -Reuters,2016-06-01 05:00:00-04:00,JNJ,negative
708255.0,The Market In 5 Minutes: National Send A Nude Day?,2016-05-20 09:50:00-04:00,JNJ,neutral
708256.0,Benzinga's Top Initiations,2016-05-20 09:30:00-04:00,JNJ,positive
708257.0,Standpoint Research Initiates Coverage on Johnson & Johnson at Sell,2016-05-20 07:37:00-04:00,JNJ,neutral
708258.0,One Analyst's Top 5 Takeaways From Johnson & Johnson's Analyst Day,2016-05-19 17:51:00-04:00,JNJ,positive
708259.0,5 Reasons Arrowhead Pharma Is A Hepatitis B Leader,2016-05-19 12:38:00-04:00,JNJ,neutral
708260.0,Johnson & Johnson Aligns With HP To Create Personalized Healthcare Solutions,2016-05-17 10:18:00-04:00,JNJ,positive
708261.0,"Johnson & Johnson, HP Partner On 3D Printing Technologies  To Reduce Costs and Improve Healthcare",2016-05-17 08:49:00-04:00,JNJ,positive
708262.0,An ETF That Takes Investors To Dividend Growth,2016-05-16 15:53:00-04:00,JNJ,positive
708263.0,Benzinga's Top Downgrades,2016-05-13 09:19:00-04:00,JNJ,positive
708264.0,What To Expect This 13F Season (And Which Hedge Funds To Watch),2016-05-13 06:50:00-04:00,JNJ,neutral
708265.0,"BTIG Downgrades Johnson & Johnson, Admits Buy Thesis 'Had Some Hits & Misses'",2016-05-13 06:46:00-04:00,JNJ,positive
708266.0,BTIG Research Downgrades Johnson & Johnson to Neutral,2016-05-12 18:10:00-04:00,JNJ,neutral
708267.0,"Jefferies Updates Price Targets In Global Pharma, Sees 'Rich Catalyst Environment' Ahead",2016-05-11 13:05:00-04:00,JNJ,positive
708268.0,The Market In 5 Minutes: Don't Stop Me Now,2016-05-11 09:34:00-04:00,JNJ,positive
708269.0,A Trusted Dividend ETF,2016-05-10 09:48:00-04:00,JNJ,positive
708270.0,J&J's Janssen Pharma Unit Reports Received CID in Mar. Related to Contractual Relationships with Pharmacy Benefit Managers,2016-05-10 07:30:00-04:00,JNJ,positive
708271.0,S&P 500 Index Futures Turn Lower,2016-05-05 13:56:00-04:00,JNJ,negative
708272.0,Johnson & Johnson Loses Another Court Case Over Claims Its Talcum Powder Causes Cancer,2016-05-03 09:20:00-04:00,JNJ,negative
708273.0,GeoInvesting Says Anavex Life Sciences' Stock Has A Book Value Of Just $0.36,2016-05-02 12:25:00-04:00,JNJ,positive
708274.0,"JPMorgan Doesn't See A Competing Bid For St. Jude Medical, Downgrades To Neutral",2016-04-29 11:58:00-04:00,JNJ,neutral
708275.0,Johnson & Johnson Boosts Dividend By 6.7%,2016-04-28 12:23:00-04:00,JNJ,positive
708276.0,Biotech Boom May Continue Through Earnings Season,2016-04-28 12:00:00-04:00,JNJ,neutral
708277.0,Johnson & Johnson Raises Dividend 6.7% from $0.75 to $0.80,2016-04-28 10:35:00-04:00,JNJ,neutral
708278.0,"3 Put Spread Strategies For The Next Week: McDonald's, Johnson & Johnson And Nvidia",2016-04-27 17:04:00-04:00,JNJ,neutral
708279.0,"What's Weighing on Markets? AAPL, Tech Stocks",2016-04-27 11:18:00-04:00,JNJ,neutral
708280.0,"Johnson & Johnson Consumer Inc. to Acquire NeoStrata Company, Inc., Terms Not Disclosed",2016-04-26 16:08:00-04:00,JNJ,neutral
708281.0,"The Heart Of Major Pharma Q1 Earnings Season: Eli Lilly, AbbVie, Bristol-Myers",2016-04-25 13:57:00-04:00,JNJ,neutral
708282.0,Cramer: What To Know About Perrigo,2016-04-22 14:07:00-04:00,JNJ,neutral
708283.0,Johnson & Johnson Makes New All-Time High,2016-04-20 11:05:00-04:00,JNJ,neutral
708284.0,"Argus Research Maintains Buy on Johnson & Johnson, Raises PT to $130.00",2016-04-20 07:05:00-04:00,JNJ,neutral
708285.0,"Buy Bank Of America, Sell JPMorgan: Fast Money Picks For April 20",2016-04-20 06:21:00-04:00,JNJ,neutral
708286.0,"Goldman Sachs Maintains Neutral on Johnson & Johnson, Raises PT to $114.00",2016-04-20 05:44:00-04:00,JNJ,neutral
708287.0,"Barclays Maintains Overweight on Johnson & Johnson, Raises PT to $120.00",2016-04-20 05:44:00-04:00,JNJ,negative
708288.0,All Eyes on Markets: They're Reaching for Fresh Highs,2016-04-19 10:38:00-04:00,JNJ,positive
708289.0,"Johnson & Johnson Q1 Adjusted EPS Tops Estimations, Boosts Full Year Outlook",2016-04-19 07:49:00-04:00,JNJ,positive
708290.0,"Johnson & Johnson Sees FY 2016 EPS $6.53 to $6.68 vs $6.54 est, Revenue $71.2B to $71.9B vs $71.6B est",2016-04-19 06:44:00-04:00,JNJ,neutral
708291.0,"Johnson & Johnson Q1 EPS $1.68 vs $1.65 est, Revenue $17.5B vs $17.5B est",2016-04-19 06:42:00-04:00,JNJ,neutral
708292.0,"Disney, Twitter And More Fast Money Picks For April 19",2016-04-19 06:28:00-04:00,JNJ,neutral
708293.0,"Keep an Eye on These 10 Stocks for April 19, 2016",2016-04-19 04:56:00-04:00,JNJ,neutral
708294.0,"Earnings Scheduled For April 19, 2016",2016-04-19 04:01:00-04:00,JNJ,neutral
708295.0,Cost Efficiency And Quality With This Dividend ETF,2016-04-18 16:10:00-04:00,JNJ,positive
708296.0,Flextronics Hires John Carlson As President For Flex Medical Solutions,2016-04-18 14:17:00-04:00,JNJ,positive
708297.0,"Earnings: IBM, NFLX, GS and JNJ Join the Earnings Parade",2016-04-18 12:08:00-04:00,JNJ,positive
708298.0,"Notable Imbalances Before Friday's Open: Telecom Pair Trade, Health Care Stocks In Focus",2016-04-15 09:44:00-04:00,JNJ,positive
708299.0,Johnson & Johnson Approaches All-Time High,2016-04-14 13:50:00-04:00,JNJ,neutral
708300.0,New Tax Inversions Rules: Threats To Healthcare ETFs?,2016-04-06 15:33:00-04:00,JNJ,negative
708301.0,"PPH May Be Home To Hedge Fund Hotels, But This ETF Can Endure",2016-04-06 14:26:00-04:00,JNJ,neutral
708302.0,SocGen Picks New Favorites In Big Pharma,2016-04-06 13:44:00-04:00,JNJ,positive
708303.0,3 Options Trades Goldman Is Watching With Catalysts Coming,2016-04-06 12:19:00-04:00,JNJ,neutral
708304.0,Societe Generale Initiates Coverage on Johnson & Johnson at Hold,2016-04-06 11:47:00-04:00,JNJ,neutral
708305.0,Pfizer Receives FDA Approval For Cheaper Version Of Johnson & Johnson's Top Drug Remicade,2016-04-06 10:45:00-04:00,JNJ,positive
708306.0,"Goldman Offers 3 Options Trades For Upcoming Catalyst In AMG, JNJ, LPLA",2016-04-06 06:43:00-04:00,JNJ,neutral
708307.0,Johnson & Johnson Launches New Global Public Health Strategy,2016-04-06 04:23:00-04:00,JNJ,neutral
708308.0,"FDA Approved Inflectra (Infliximab-Dyyb) For Multiple Indications; Shares of JNJ Maker of Remicade, Sell off on News",2016-04-05 16:12:00-04:00,JNJ,positive
708309.0,"Inflectra, Biosimilar To Johnson and Johnson's Remicade, Approved By FDA; Shares Fell To $107.37 After Hours Before Trading Up Back At $108.7/Share",2016-04-05 16:11:00-04:00,JNJ,positive
708310.0,S&P 500 Index Futures Trading Lower,2016-04-05 10:50:00-04:00,JNJ,negative
708311.0,"Genmab Announces Patent Infringement Suit Against Co., Janssen in US Related to DARZALEX",2016-04-04 14:13:00-04:00,JNJ,negative
708312.0,MorphoSys Sues Janssen Biotech and Genmab for Patent Infringement,2016-04-04 11:52:00-04:00,JNJ,negative
708313.0,Make A House Call With A Familiar Healthcare ETF,2016-04-04 08:28:00-04:00,JNJ,neutral
708314.0,EU Medicines Agency Recommends Approval of JNJ & Genmab A/S's Daratumimab,2016-04-01 11:20:00-04:00,JNJ,positive
708315.0,CORRECTION: Janssen Announces Discontinuation Of Fulranumab Phase 3 Development Program In Osteoarthritis Pain,2016-03-31 16:13:00-04:00,JNJ,negative
708316.0,Janssen Announces Discontinuation Of Fulranumab Phase 3 Development Program In Osteoarthritis Pain,2016-03-31 16:10:00-04:00,JNJ,negative
708317.0,Johnson & Johnson Approaches All-Time High,2016-03-23 13:30:00-04:00,JNJ,neutral
708318.0,UPDATE: Janssen Research & Development LLC Signs Clinical Trial Collaboration With Roche Group Memeber 'Genentech',2016-03-21 13:22:00-04:00,JNJ,neutral
708319.0,Janssen Announces Initiation Of 2 Studies Evaluating Daratumumab & Atezolizumab In Multiple Myeloma & Solid Tumor,2016-03-21 13:21:00-04:00,JNJ,negative
708320.0,Johnson & Johnson Phase 3 Data Shows Treatment W/ Stelara Induced Clinical Response And Clinical Remission,2016-03-18 09:04:00-04:00,JNJ,neutral
708321.0,J&J Unit Says to Appeal Jury Verdicts in Ultamet Metal-on-Metal Hip Trial -DJ,2016-03-17 15:35:00-04:00,JNJ,positive
708322.0,Dallas Jury Awards Nearly $500 Million Against J&J Unit in Bellwether Hip Implant Trial,2016-03-17 14:20:00-04:00,JNJ,positive
708323.0,Option Alert: JNJ Mar16 106 Puts Sweep: 1000 @  ASK  $0.18: 1525 traded vs 2546 OI:  Earnings 4/19 Before Open  $106.78 Ref,2016-03-17 13:38:00-04:00,JNJ,positive
708324.0,Benzinga's Top Upgrades,2016-03-14 09:07:00-04:00,JNJ,positive
708325.0,"Goldman Upgrades Johnson & Johnson, Removes From America's Sell List",2016-03-14 08:13:00-04:00,JNJ,neutral
708326.0,"Goldman Sachs Says J&J Conglomerate Structure Has Caused Shareholder Value To Be Trapped, Goldman Continues To Advocate For A Break-Up Of Co To Maximize Value",2016-03-14 05:51:00-04:00,JNJ,positive
708327.0,"Goldman Sachs Upgrades Johnson & Johnson to Neutral, Raises PT to $112.00",2016-03-14 05:40:00-04:00,JNJ,neutral
708328.0,"The Market In 5 Minutes: Tuesday, March 8, 2016",2016-03-08 12:26:00-05:00,JNJ,neutral
708329.0,Sum-Of-The-Parts Analysis Suggests J&J Stock Price Of $124,2016-03-08 08:49:00-05:00,JNJ,neutral
708330.0,The Other Sector ETF Player,2016-03-07 14:26:00-05:00,JNJ,neutral
708331.0,A Winning Dividend ETF Idea For March,2016-03-03 09:52:00-05:00,JNJ,positive
708332.0,"P&G Reports Divestiture of Hipoglos Brand to J&J Consumer, No Terms Disclosed",2016-03-02 09:02:00-05:00,JNJ,negative
708333.0,Galapagos Shares -$0.58 Premarket @$43.37; Co Announced Transparency Notification from JNJ on Tuesday,2016-03-02 07:37:00-05:00,JNJ,positive
708334.0,"Watch Pharma Names Following FDA Issuance Of New Mandatory Clinical Study For Bayer's 'Essure', Requires Product Labeling, Including Box Warnings And Patient Decision Checklist",2016-02-29 15:39:00-05:00,JNJ,negative
708335.0,Cramer Says He Likes Bargain Stores: It's All About Value,2016-02-27 15:51:00-05:00,JNJ,positive
708336.0,Option Alert: JNJ Fri 3/4 106 Calls (Wkly): 4000 @  ASK  $0.86: 4024 traded vs 862 OI:  Earnings 4/12  $105.78 Ref,2016-02-26 10:29:00-05:00,JNJ,positive
708337.0,Love This Low Volatility Dividend ETF,2016-02-25 07:50:00-05:00,JNJ,positive
708338.0,J&J Selling 2.5M Galapagos Shares-BBG,2016-02-22 12:43:00-05:00,JNJ,neutral
708339.0,Should Johnson & Johnson Break Up?,2016-02-22 09:01:00-05:00,JNJ,neutral
708340.0,"Morgan Stanley Says Johnson & Johnson Could Possibly Operate Better If Broken Up, Cautions Breakup Unlikely To Resonate WIth Investors",2016-02-22 06:19:00-05:00,JNJ,negative
708341.0,New Dividend ETF Proves To Be A Worthy Hideout,2016-02-18 15:57:00-05:00,JNJ,positive
708342.0,S&P 500 Index Futures Treading Water,2016-02-18 10:51:00-05:00,JNJ,neutral
708343.0,Everything You Might Have Missed This 13F Season: Part 2,2016-02-17 15:58:00-05:00,JNJ,negative
708344.0,"The Stocks That Moved The S&P, Dow And Nasdaq Yesterday",2016-02-13 22:44:00-05:00,JNJ,neutral
708345.0,The Generic Drug Battle,2016-02-10 09:13:00-05:00,JNJ,negative
708346.0,FDA Panel Has Backed Approval of Celltrion's Biosimilar Version of J&J's Remicade,2016-02-09 17:07:00-05:00,JNJ,positive
708347.0,"Icahn, Gilead, GE Lead Top Insider Trades Of The Week",2016-02-09 16:07:00-05:00,JNJ,positive
708348.0,How To Invest In An Aging World With The 'Live Long & Prosper' ETF,2016-02-08 10:53:00-05:00,JNJ,neutral
708349.0,S&P 500 Index Futures Sharply Lower,2016-02-08 10:27:00-05:00,JNJ,negative
708350.0,A Checkup On A Big Healthcare ETF,2016-02-05 13:19:00-05:00,JNJ,neutral
708351.0,How To Build A Defensive Portfolio,2016-02-04 15:13:00-05:00,JNJ,neutral
708352.0,"Bull Market, Bear Market Or Just A Trading Range?",2016-02-01 09:41:00-05:00,JNJ,neutral
708353.0,Warm Up With This Low Volatility ETF,2016-02-01 09:41:00-05:00,JNJ,negative
708354.0,"Benzinga's M&A Chatter for Thursday January 28, 2015",2016-01-28 23:27:00-05:00,JNJ,neutral
708355.0,7 Biotech Traders Pick Their Favorite Stocks For 2016,2016-01-28 16:53:00-05:00,JNJ,positive
708356.0,Large Johnson & Johnson Shareholder Just Revealed 8 Major Concerns,2016-01-28 15:27:00-05:00,JNJ,neutral
708357.0,Stocks To Play In A Zika Virus Pandemic,2016-01-28 13:25:00-05:00,JNJ,positive
708358.0,"TRXC Bidding War Ramping Up According To Report, JNJ/GOOGL Both Focused On TRXC According To MoneyMorning Report",2016-01-28 12:54:00-05:00,JNJ,negative
708359.0,Hearing Unconfirmed Market Chatter of Potential JNJ Deal to Acquire GlaxoSmithKline,2016-01-28 11:19:00-05:00,JNJ,negative
708360.0,"Artisan Partners Urges J&J to Adopt New, Publicly-Disclosed Financial Targets for Medical Devices, Consumer Businesses",2016-01-28 09:56:00-05:00,JNJ,positive
708361.0,UPDATE: Artisan Partners Global Value's Daniel O'Keefe Sends Letter to J&J Board,2016-01-28 09:53:00-05:00,JNJ,neutral
708362.0,Artisan Partners Global Value's Daniel O'Keefe Sends Letter to J&J Board,2016-01-28 09:52:00-05:00,JNJ,neutral
708363.0,UPDATE: FT Article Citing A Source Speculates On Turnaround Catalyst For JNJ's Recent Poor Performance,2016-01-27 13:46:00-05:00,JNJ,negative
708364.0,"Johnson & Johnson Shares Steadily Gain Over Past 20 Min, Reports Shareholders Pushing Activists For 'shake up'",2016-01-27 13:43:00-05:00,JNJ,positive
708365.0,Johnson & Johnson Continues To Rally,2016-01-27 10:41:00-05:00,JNJ,neutral
708366.0,S&P 500 Index Futures Lower,2016-01-27 10:16:00-05:00,JNJ,negative
708367.0,Earnings Recap For January 26,2016-01-26 17:15:00-05:00,JNJ,neutral
708368.0,S&P 500 Index Futures Sharply Higher,2016-01-26 13:57:00-05:00,JNJ,neutral
708369.0,"No Shortage of Stock Drivers: Oil Swivels, Fed Meets, Apple Reports",2016-01-26 10:59:00-05:00,JNJ,negative
708370.0,"Johnson and Johnson Sees FY EPS $6.43 to $6.58 vs $6.38 est, Revenue $70.8B to $71.5B vs $71.9B est",2016-01-26 06:42:00-05:00,JNJ,neutral
708371.0,"Johnson and johnson Q4 EPS $1.44 vs $1.42 est, Revenue $17.8B vs $17.9B est",2016-01-26 06:41:00-05:00,JNJ,neutral
708372.0,7 Stocks You Should Be Watching Today,2016-01-26 04:15:00-05:00,JNJ,neutral
708373.0,"Earnings Scheduled For January 26, 2016",2016-01-26 04:03:00-05:00,JNJ,neutral
708374.0,"JNJ Kicks Off Health Care Earnings—What About Deals, Buybacks?",2016-01-25 11:43:00-05:00,JNJ,positive
708375.0,US Big Pharma: What To Watch For In Q4 Results,2016-01-25 11:16:00-05:00,JNJ,neutral
708376.0,"Johnson & Johnson Details $1 Billion Cost Saving Initiative For Its Medical Devices Segment, Will 'Deliver More Value To Customers'",2016-01-19 15:24:00-05:00,JNJ,positive
708377.0,"Najarian Brothers See Unusual Activity In Johnson & Johnson And Cisco Systems, Inc.",2016-01-19 15:23:00-05:00,JNJ,neutral
708378.0,"Johnson & Johnson Restructures Medical Devices Unit, Sees Nearly $1 Billion In Annual Cost Savings",2016-01-19 13:04:00-05:00,JNJ,neutral
708379.0,"UPDATE: J&J Reaffirms FY15 Adj. EPS Outlook of $6.15-$6.20 vs $6.18 Est., Sales $70B-$71B vs $70.1B Est.",2016-01-19 07:17:00-05:00,JNJ,neutral
708380.0,"UPDATE: J&J Restructuring Related to Medical Devices Unit; Consumer Medical Devices, Vision Care, Diabetes Care Units Will Not Be Impacted by Restructuring",2016-01-19 07:17:00-05:00,JNJ,positive
708381.0,"J&J Shares Indicated ~$1.25 Higher; Co. Announced Restructuring with Projected, Annualized Pre-Tax Cost Savings $800M-$1B, Sees $2B-$2.4B Charge; Affirms FY15 Outlook",2016-01-19 07:15:00-05:00,JNJ,positive
708382.0,Dividend Aristocrats ETF Joins The $1 Billion Club,2016-01-15 13:17:00-05:00,JNJ,neutral
708383.0,Write A Prescription For This Healthcare ETF,2016-01-15 08:24:00-05:00,JNJ,neutral
708384.0,11 Different Ways To Play The Bear Market (From 11 Traders),2016-01-14 14:38:00-05:00,JNJ,positive
708385.0,How Will Dividend Stocks Perform This Year?,2016-01-14 08:48:00-05:00,JNJ,neutral
708386.0,J&J's Janssen Reports Health Canada Has Approved Stelara for Treatment of Chronic Moderate-to-Severe Plaque Psoriasis in Adolescents,2016-01-13 07:06:00-05:00,JNJ,positive
708387.0,Chemdiv Achieves Development Milestone In Drug Recovery Collaboration With Janssen,2016-01-11 14:01:00-05:00,JNJ,neutral
708388.0,"For This Low Vol ETF, It's Not All About Sector Selection",2016-01-08 08:31:00-05:00,JNJ,negative
708389.0,Sino Biopharmaceutical Says Chia Tai-Tianqing Pharmaceutical Entered Into Exclusive License Agreement With Janssen Pharmaceuticals Under Johnson & Johnson -Reuters,2016-01-08 06:14:00-05:00,JNJ,positive
708390.0,Johnson and Johnson Along With Janssen Agree To Develop and Commercialize HBV Treatments WIth Chia Tai,2016-01-07 08:10:00-05:00,JNJ,positive
708391.0,Apple Is The Second Cheapest Mega-Cap On A Free Cash Flow Basis,2016-01-06 15:44:00-05:00,JNJ,positive
708392.0,The Two Best Sector SPDR ETFs For January,2016-01-02 20:29:00-05:00,JNJ,positive
708393.0,A Sound ETF Idea For 2016,2015-12-30 13:29:00-05:00,JNJ,neutral
708394.0,"Hearing Kentucky Attorney General Announcing Settlement Related to Purdue Pharma, J&J's Janssen Case Related to Oxycontin, Risperdal",2015-12-23 16:45:00-05:00,JNJ,neutral
708395.0,Not All Of Clinton's Policies Are Bad For Pharmaceuticals,2015-12-23 14:13:00-05:00,JNJ,negative
708396.0,Peering Through The Fog To Find The Best Sectors Into Year End,2015-12-23 13:08:00-05:00,JNJ,positive
708397.0,Intrexon To Partner With Johnson & Johnson For Type 2 Diabetes Innovative Therapies,2015-12-22 08:02:00-05:00,JNJ,positive
708398.0,Medivir Announces Development of AL-704 Terminated by Janssen Following Completion of Phase I Clinical Studies,2015-12-21 04:17:00-05:00,JNJ,neutral
708399.0,Dan Nathan Reduces Risk On His Utilities SPDR (ETF) Trade,2015-12-20 18:52:00-05:00,JNJ,negative
708400.0,Credit Suisse Offers 2016 U.S. Large-Cap Pharma Outlook,2015-12-19 17:08:00-05:00,JNJ,positive
708401.0,"Atlantic Equities Initiates Coverage on Johnson & Johnson at Neutral, Announces $95.00 PT",2015-12-18 08:54:00-05:00,JNJ,neutral
708402.0,"Janney Lists Top 'Bond Surrogate Stocks' By Sector, Identified By Beta, Dividend Yield, And Forward P/E",2015-12-16 15:31:00-05:00,JNJ,positive
708403.0,J&J Reports Formation of Verb Surgical,2015-12-10 09:01:00-05:00,JNJ,neutral
708404.0,"J&J's Janssen Issues Release Showing IMBRUVICA RESONATE-2 Data Demonstrated Significant Improvements in Progression-Free, Overall Survival vs Chlorambucil",2015-12-08 09:16:00-05:00,JNJ,positive
708405.0,S&P 500 Index Futures Under Pressure,2015-12-07 11:24:00-05:00,JNJ,negative
708406.0,Carter Worth And Mike Khouw's Johnson & Johnson Trade,2015-12-07 07:03:00-05:00,JNJ,positive
708407.0,Barclays' Biopharmaceuticals Blueprint For 2016,2015-12-01 11:54:00-05:00,JNJ,neutral
708408.0,Benzinga's Top Upgrades,2015-12-01 08:55:00-05:00,JNJ,positive
708409.0,"J&J's 'Steady Cash Flow Is Key,' Barclays Upgrades To Overweight",2015-12-01 08:26:00-05:00,JNJ,negative
708410.0,US Stock Futures Signal Higher Start On Wall Street,2015-12-01 06:55:00-05:00,JNJ,neutral
708411.0,"Barclays Upgrades Johnson & Johnson to Overweight, Raises PT to $115.00",2015-12-01 05:04:00-05:00,JNJ,negative
708412.0,A Look At Investment Firms' Favorite Stocks In Q3,2015-11-21 13:58:00-05:00,JNJ,positive
708413.0,8 Value Stocks For Investors Worried About Risk,2015-11-16 15:44:00-05:00,JNJ,negative
708414.0,"Hanmi Pharmaceuticals Signs an Exclusive License Agreement with Janssen to Develop Treatment for Diabetes, Obesity",2015-11-09 07:10:00-05:00,JNJ,positive
708415.0,Goldman's First ETF Is Off To A Stellar Start,2015-11-06 10:24:00-05:00,JNJ,neutral
708416.0,Johnson & Johnson to Acquire Novira Therapeutics; Financial Terms Not Dislcosed,2015-11-04 12:02:00-05:00,JNJ,neutral
708417.0,S&P 500 Index Futures Unchanged,2015-11-04 10:31:00-05:00,JNJ,neutral
708418.0,Johnson & Johnson Moves Up,2015-10-29 16:13:00-04:00,JNJ,neutral
708419.0,Aduro Biotech Announces Received Up-Front $30M Milestone Payment from J&J's Janssen for Acceptance of IND App for ADU-214 in Lung Cancer,2015-10-29 08:14:00-04:00,JNJ,negative
708420.0,Genmab Announces $3M Milestone Payment in DuoBody Platform Collaboration with Janssen,2015-10-25 17:52:00-04:00,JNJ,neutral
708421.0,Some New Multi-Factor ETFs Look Appealing,2015-10-21 15:08:00-04:00,JNJ,neutral
708422.0,Counting On Quality With ETFs,2015-10-19 13:42:00-04:00,JNJ,neutral
708423.0,"J&J's Janssen Reports R&D Segment Showed UNITI-2 Study Meet Primary Endpoint, Major Secondary Endpoints Showed Clinical Remission Significantly Higher Than Placebo",2015-10-19 08:14:00-04:00,JNJ,neutral
708424.0,"Hearing J&J's Stelara for Crohn's Disease Showed Clinical Response, Statistically Higher Remission for Candidate Than Placebo",2015-10-19 08:05:00-04:00,JNJ,neutral
708425.0,"Achillion Announces Janssen Initiated Phase 2a Study to Evaluate Combination of AL-335, ACH-3102, and Simeprevir for Treatment of Genotype 1 Chronic HCV",2015-10-16 06:07:00-04:00,JNJ,neutral
708426.0,J&J's Janssen Reports Collaboration Deal with Novera for Acceleration of Development of Promising Small Molecule Drug Candidates for Hematological Cancers,2015-10-14 08:07:00-04:00,JNJ,positive
708427.0,enGene Announces Strategic Collaboration With Johnson & Johnson Innovation To Develop Novel Gene Delivery Products For Inflammatory Bowel Disease,2015-10-14 08:06:00-04:00,JNJ,positive
708428.0,Mid-Afternoon Market Update: Ryder System Declines On Lowered Forecast; NewBridge Bancorp Shares Spike Higher,2015-10-13 15:17:00-04:00,JNJ,positive
708429.0,Johnson & Johnson Sales Fall: What The Street Is Saying Now,2015-10-13 12:25:00-04:00,JNJ,neutral
708430.0,Mid-Day Market Update: Wausau Paper Jumps On Acquisition News; AIXTRON Shares Slide,2015-10-13 12:18:00-04:00,JNJ,positive
708431.0,Mid-Morning Market Update: Markets Down; Johnson & Johnson Posts Mixed Q3 Results,2015-10-13 10:05:00-04:00,JNJ,neutral
708432.0,"Johnson & Johnson Posts Upbeat Q3 Earnings, But Sales Drop",2015-10-13 08:02:00-04:00,JNJ,negative
708433.0,Johnson & Johnson Reports Q3 Adj Eps $1.49 Vs Est $1.45,2015-10-13 07:34:00-04:00,JNJ,neutral
708434.0,J&J Raises FY15 EPS to $6.15-$6.20 vs $6.16 Est.,2015-10-13 07:31:00-04:00,JNJ,neutral
708435.0,US Stock Futures Down; JPMorgan Earnings In Focus,2015-10-13 07:31:00-04:00,JNJ,neutral
708437.0,JNJ Announces $10B Share Buyback Program,2015-10-13 06:45:00-04:00,JNJ,positive
708438.0,J&J Announces $10B Buyback Plan,2015-10-13 06:45:00-04:00,JNJ,neutral
708439.0,7 Stocks You Should Be Watching Today,2015-10-13 04:55:00-04:00,JNJ,neutral
708440.0,"Earnings Scheduled For October 13, 2015",2015-10-13 04:01:00-04:00,JNJ,neutral
708441.0,Johnson & Johnson Is First Of Big Pharma Earnings Reports: Will Price Debate Dominate?,2015-10-12 12:18:00-04:00,JNJ,negative
708442.0,Johnson & Johnson Announces Start of Safety and Immunogenicity Clinical Trial of Ebola Vaccine Regimen in Sierra Leone,2015-10-09 04:21:00-04:00,JNJ,positive
708443.0,"Benzinga's M&A Chatter for Wednesday October 7, 2015",2015-10-07 19:27:00-04:00,JNJ,neutral
708444.0,Singapore  Ministry of Health Convenes Independent Review Committee on Report of Cluster of 22 Acute Cases of Hepatitis C Among Kidney Patients -Reuters,2015-10-06 09:40:00-04:00,JNJ,neutral
708445.0,"Earnings Outlook: Is Street Already Positioned For Same Story Of Global Woes, Oil Stain?",2015-10-05 13:41:00-04:00,JNJ,negative
708446.0,Energy Weakness Skews Earnings View — Can The Rest Of Corporate America Deliver?,2015-10-05 13:29:00-04:00,JNJ,negative
708447.0,Genmab Reaches $3M Milestone Payment in DuoBody Platform Collaboration with Janssen,2015-10-05 09:53:00-04:00,JNJ,positive
708448.0,Benzinga's Top Upgrades,2015-09-29 09:16:00-04:00,JNJ,positive
708449.0,Johnson & Johnson Collaborates With UBIVAC To Develop And Test A Oral Cancer Vaccine To be Tested In Preclinical Trials,2015-09-29 09:04:00-04:00,JNJ,negative
708450.0,Johnson & Johnson Seen As 'Safe Haven' By These Experts,2015-09-29 08:48:00-04:00,JNJ,positive
708451.0,Deutsche Bank Upgrades Johnson & Johnson to Buy,2015-09-29 06:28:00-04:00,JNJ,neutral
708452.0,Patients To Benefit From Latest Tech Trends,2015-09-28 14:21:00-04:00,JNJ,positive
708453.0,J&J's Consumer Unit Reports Closing of Divestiture of SPLENDA Brand,2015-09-25 16:15:00-04:00,JNJ,neutral
708454.0,5 U.S. Stocks Likely To Hike Their Dividends,2015-09-25 10:24:00-04:00,JNJ,neutral
708455.0,Genmab Announces CHMP Grants Accelerated Assessment for Daratumumab for Double Refractory Multiple Myeloma,2015-09-25 05:25:00-04:00,JNJ,positive
708456.0,UBS Initiates Coverage on Johnson & Johnson at Buy,2015-09-22 09:27:00-04:00,JNJ,neutral
708457.0,Make The World A Better Place With...Stock Picks?,2015-09-18 15:13:00-04:00,JNJ,positive
708458.0,Bearish On Bucks? Try This ETF,2015-09-18 07:50:00-04:00,JNJ,neutral
708459.0,S&P 500 Index Futures Trading Higher,2015-09-09 10:38:00-04:00,JNJ,neutral
708460.0,MKM Partners Would Sell These Healthcare Stocks On Weaker Relative Trends,2015-09-08 07:59:00-04:00,JNJ,negative
708461.0,S&P 500 Index Retreats From Highs,2015-09-02 10:31:00-04:00,JNJ,neutral
708462.0,"It's Not Shopping, It's Market Research: Talking Investing Trends With TD Ameritrade's Nicole Sherrod",2015-09-01 14:40:00-04:00,JNJ,neutral
708463.0,"Benzinga's M&A Chatter for Tuesday, August 25, 2015",2015-08-25 19:08:00-04:00,JNJ,neutral
708464.0,"Heartland Food Products Group Reports Definitive Deal to Buy J&J Consumer's Splenda Brand, No Terms Disclosed",2015-08-25 13:00:00-04:00,JNJ,negative
708465.0,Heartland Food Products to Acquire Splenda Brand From Johnson & Johnson Consumer Inc.,2015-08-25 13:00:00-04:00,JNJ,neutral
708466.0,Fast Money Traders Give Their Opinion On What To Buy In This Sell-Off,2015-08-24 06:37:00-04:00,JNJ,neutral
708468.0,13F Recap: The Most Popular (And Unpopular) Stocks Of Q2,2015-08-19 08:48:00-04:00,JNJ,positive
708469.0,S&P 500 Index Futures Trading Lower,2015-08-18 10:43:00-04:00,JNJ,negative
708470.0,"When Size Matters, Consider These ETFs",2015-08-13 07:29:00-04:00,JNJ,neutral
708471.0,Johnson & Johnson Cashes Out Of Aquinox Pharmaceuticals' Parabolic Rally,2015-08-12 13:35:00-04:00,JNJ,neutral
708472.0,"Johnson & Johnson Sells 1,514,821 Shares Of Aquinox Pharmaceuticals @$22.41/Share -Form 4",2015-08-12 12:42:00-04:00,JNJ,positive
708473.0,Here's Which IT Stocks Benefit From Healthcare M&A,2015-08-10 12:23:00-04:00,JNJ,positive
708474.0,20 Dividend Growth Stocks To Buy Today For Your Retirement Portfolio,2015-08-09 17:52:00-04:00,JNJ,positive
708475.0,5 U.S. Mega Caps With Less Than 0.1% Insider Ownership,2015-08-04 11:15:00-04:00,JNJ,neutral
708476.0,Achillion Announces Janssen Initiated Phase I Study to Evaluate Effect of Simeprevir and Odalasvir on AL-335 Pharmacokinetics,2015-08-03 04:20:00-04:00,JNJ,neutral
708477.0,S&P 500 Index Futures Trading Higher,2015-07-29 10:26:00-04:00,JNJ,neutral
708478.0,ETFs For The Next Pharma Takeover Candidates,2015-07-28 13:08:00-04:00,JNJ,neutral
708479.0,Johnson & Johnson Q2 Earnings Top Expectations,2015-07-14 08:12:00-04:00,JNJ,positive
708480.0,"UPDATE: Johnson & Johnson 2Q Medical Devices Sales $6.36B, Cardiovascular Sales $544M, Orthopaedics Sales $2.33B",2015-07-14 07:48:00-04:00,JNJ,neutral
708481.0,J&J Raises FY15 Adj. EPS $6.10-$6.20 vs $6.14 Est.,2015-07-14 07:46:00-04:00,JNJ,neutral
708482.0,"Johnson & Johnson Reports Q2 EPS $1.71 vs. Est. $1.67, Rev. $17.8B vs.  Est. $17.57B",2015-07-14 07:45:00-04:00,JNJ,neutral
708483.0,"Earning & Economic Calendar for Tuesday July 14, 2015",2015-07-14 05:34:00-04:00,JNJ,neutral
708484.0,"Earnings Scheduled For July 14, 2015",2015-07-14 04:34:00-04:00,JNJ,neutral
708485.0,7 Stocks You Should Be Watching Today,2015-07-14 04:14:00-04:00,JNJ,neutral
708486.0,"From JPMorgan To Johnson & Johnson, Options Activity Surrounds This Week's Earnings",2015-07-13 17:14:00-04:00,JNJ,neutral
708487.0,Can Johnson & Johnson Deliver Its Best Quarter Ever Despite FX Headwinds?,2015-07-13 14:58:00-04:00,JNJ,positive
708488.0,Strong Dollar? Not So Good For Johnson & Johnson Earnings,2015-07-10 11:41:00-04:00,JNJ,positive
708489.0,"TD Ameritrade Clients Are Buying Apple, Twitter; Selling Facebook, AOL",2015-07-07 15:11:00-04:00,JNJ,neutral
708490.0,"J&J Reports 15.6% Passive Stake In Achillion Pharmaceuticals as of July 1, 2015",2015-07-07 06:06:00-04:00,JNJ,positive
708491.0,S&P 500 Index Futures Trading Higher,2015-06-26 11:38:00-04:00,JNJ,neutral
708492.0,"A 'Gay Friendly' Portfolio Includes Apple, Microsoft & Disney...And It Beats The Market",2015-06-19 10:53:00-04:00,JNJ,positive
708493.0,S&P 500 Index Futures Trading Lower In Volatile Session,2015-06-15 12:27:00-04:00,JNJ,negative
708494.0,S&P 500 Index Futures Trading Higher,2015-06-11 11:45:00-04:00,JNJ,neutral
708495.0,Analyst: Cardinal Health Buying Spree To Boost FY17 EPS,2015-06-09 12:23:00-04:00,JNJ,positive
708496.0,"This Technology Could Disrupt U.S. Pharma Stocks, Credit Suisse Says",2015-06-08 14:03:00-04:00,JNJ,positive
708497.0,S&P 500 Index Futures Trading Lower In Choppy Session,2015-06-08 10:47:00-04:00,JNJ,negative
708498.0,S&P 500 Index Futures Trading Lower In Volatile Session,2015-06-05 11:08:00-04:00,JNJ,negative
708499.0,JMP Securities Boosts Halozyme Price Target On 'Long-Term Value',2015-06-04 10:17:00-04:00,JNJ,positive
708500.0,J&J's Janssen R&D LLC Reported Data from Phase 3 Multicenter Study SAR3007: Showed Significant Improvement in PFS with Trabectedin vs. Dacarbazine,2015-06-01 17:05:00-04:00,JNJ,positive
708501.0,"Healthcare, Yen And Oil ETFs To Watch This Week",2015-05-31 10:59:00-04:00,JNJ,neutral
708502.0,Phase III HELIOS Study Results Show IMBRUVICA Combination Therapy Significantly Increased Progression-Free Survival in Previously-Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma Patients,2015-05-30 09:25:00-04:00,JNJ,positive
708503.0,"1 Positive, 1 Negative For Johnson & Johnson Stock",2015-05-29 08:19:00-04:00,JNJ,neutral
708504.0,J&J Reports Acceptance of Binding Offer from Cordis,2015-05-28 08:00:00-04:00,JNJ,positive
708505.0,UPDATE: J&J Removed the Device from the Market Last Year,2015-05-27 13:10:00-04:00,JNJ,neutral
708506.0,FBI Said to Be Investigating JNJ Surgical Device Tied to Cancer in Women -DJ,2015-05-27 13:09:00-04:00,JNJ,negative
708507.0,S&P 500 Index Futures Trading Lower In Quiet Session,2015-05-22 11:40:00-04:00,JNJ,negative
708508.0,"CHMP Gave Six Recommendations on Extensions of Therapeutic Indication for: Janssen's Simponi and Stelara, Pharmacyclics' Imbruvica, Eisai's Fycompa, BioMarin's Kuvan, Novo's Xultophy",2015-05-22 07:11:00-04:00,JNJ,neutral
708509.0,S&P 500 Index Futures Trading Higher,2015-05-21 11:14:00-04:00,JNJ,neutral
708510.0,Raymond James: Johnson & Johnson Has 'Innovation',2015-05-21 08:49:00-04:00,JNJ,neutral
708511.0,What Does The Johnson & Johnson/Achillion Deal Mean For HCV Competitors?,2015-05-21 08:27:00-04:00,JNJ,neutral
708512.0,The Most Popular Stocks Held By 4 Different Generations Of Investors,2015-05-21 07:45:00-04:00,JNJ,positive
708513.0,Novo Sells License On Autoimmune Disease To Janssen,2015-05-20 10:10:00-04:00,JNJ,neutral
708514.0,Morning Market Losers,2015-05-20 09:56:00-04:00,JNJ,negative
708515.0,JMP Says Stepping To The Sidelines On Achillion,2015-05-20 08:54:00-04:00,JNJ,neutral
708516.0,Benzinga's Top #PreMarket Losers,2015-05-20 08:29:00-04:00,JNJ,negative
708517.0,J&J Announces Pharma Unit Will Continue Driving Above-Industry Growth with Plans to File More than 10 New Products by '19,2015-05-20 07:32:00-04:00,JNJ,positive
708518.0,Achillion Pharmaceuticals Shares Fall ~2% Premarket Following Announcement of Hep C Collaboration With Janssen,2015-05-20 06:26:00-04:00,JNJ,positive
708519.0,"UPDATE: Achillion, Janssen Deal Includes $225M Investment for ~18.4M Newly Issued, Unregistered Shares of Achillion at $12.25/Share",2015-05-19 16:09:00-04:00,JNJ,positive
708520.0,"UPDATE: Achillion, Janssen Collab Includes Up to $1.1B in Potential Development, Regulatory, Sales Milestone Payments, Separate Equity Investment",2015-05-19 16:07:00-04:00,JNJ,neutral
708521.0,Achillion Announces Collaboration for Hep C with J&J's Janssen Pharma,2015-05-19 16:05:00-04:00,JNJ,neutral
708522.0,"From Achillion Events Page: Posts Link for Co., Janssen Discussion for HCV Collab Webcast",2015-05-19 16:05:00-04:00,JNJ,neutral
708523.0,J&J's Janssen Pharma Reports FDA Approval of INVEGA TRINZA for Treatment of Schizophrenia,2015-05-19 08:03:00-04:00,JNJ,positive
708524.0,J&J's Janssen Reports Data Demonstrates Adults with Type 2 Diabetes Achieved Blood Glucose Treatment Goals with Use of INVOKANA,2015-05-18 08:48:00-04:00,JNJ,neutral
708526.0,The FDA's Authority Challenged By Mallinckrodt,2015-05-15 15:07:00-04:00,JNJ,neutral
708527.0,These Charts Explain Why Johnson & Johnson Should Be Approached Tactically,2015-05-15 10:58:00-04:00,JNJ,neutral
708528.0,Morgan Stanley Has 'Cautious Optimism' On Johnson & Johnson,2015-05-15 08:27:00-04:00,JNJ,positive
708529.0,What Current Buyback Levels Mean For The Bull Market,2015-05-14 12:34:00-04:00,JNJ,neutral
708530.0,Bavarian Nordic Announces Presentation of Preliminary Phase 1 Results for Ebola Prime-Boost Vaccine Regimen of MVA-BN Filo and Janssen's AdVac,2015-05-12 14:06:00-04:00,JNJ,neutral
708531.0,IPO Outlook: Galapagos Offers New Hope For CF And RA Sufferers,2015-05-12 13:45:00-04:00,JNJ,negative
708532.0,Bavarian Nordic  Receives €50M Loan from the European Investment Bank to Help Co Develop Ebola Vaccine -Reuters,2015-05-12 10:21:00-04:00,JNJ,positive
708533.0,J&J's Janssen Pharma Announces FDA Issued CRL to sNDA for Expanded Labe on INVEGA SUSTENNA,2015-05-11 17:49:00-04:00,JNJ,neutral
708534.0,"Traders, Here's What You're Doing Wrong (And How To Fix It)",2015-05-11 14:24:00-04:00,JNJ,negative
708535.0,9 Hot (Or Not) IPOs Scheduled To Debut This Week,2015-05-11 08:30:00-04:00,JNJ,neutral
708536.0,Countdown To The Best Public Reputations Company,2015-05-07 14:46:00-04:00,JNJ,positive
708537.0,"Johnson & Johnson, NYU School of Medicine Partner to Evaluate Compassionate Use of Investigational Medicines",2015-05-07 04:29:00-04:00,JNJ,positive
708538.0,"Credit Suisse: We Prefer Pfizer, Bristol Over Pharma Peers",2015-05-05 08:51:00-04:00,JNJ,positive
708539.0,"J&J Announces Further PTO Action Realted to REMICADE: Office Maintained Rejection of Patent, Patent '471 Remains Valid",2015-04-29 16:35:00-04:00,JNJ,negative
708540.0,Technician Breaks Down Johnson & Johnson,2015-04-23 12:22:00-04:00,JNJ,neutral
708541.0,J&J Raises Qtr. Dividend from $0.70 to $0.75/Share,2015-04-23 10:59:00-04:00,JNJ,neutral
708542.0,"J&J's Janssen Reports SVR12 Rates with Twelve Weeks of Treatment with All-Oral, Once-Daily Regimen of Simeprevir Plus Sofosbuvir",2015-04-23 09:19:00-04:00,JNJ,neutral
708543.0,Bank Of America Sees Big Divestitures Upcoming For Johnson & Johnson,2015-04-15 15:43:00-04:00,JNJ,neutral
708544.0,Morgan Stanley Shares What Johnson & Johnson Investors Should Focus On Now,2015-04-15 09:25:00-04:00,JNJ,positive
708545.0,What Specific Role Will Apple Play In IBM's Watson Health Cloud Alliance?,2015-04-15 08:51:00-04:00,JNJ,positive
708546.0,J&J's Janssen Highlights Study Published in JCP Showing Long-Acting INVEGA SUSTENNA Effective Six Months Longer Than Other Oral Antipsychotics,2015-04-15 08:40:00-04:00,JNJ,positive
708547.0,Why Johnson & Johnson's Strong Pharmaceutical Business Is A Concern,2015-04-14 14:45:00-04:00,JNJ,positive
708548.0,The Big Health Data Orgy Happening In The Cloud,2015-04-14 10:14:00-04:00,JNJ,neutral
708549.0,US Stock Futures Down Ahead Of Business Inventories Data,2015-04-14 09:21:00-04:00,JNJ,neutral
708550.0,From J&J Earnings Conference Call: Expecting FY15 Constant Currency Sales $75B-$76B vs $74B Est.,2015-04-14 08:54:00-04:00,JNJ,neutral
708551.0,"Johnson & Johnson Posts Upbeat Q1 Earnings, But Lowers FY15 Forecast",2015-04-14 08:10:00-04:00,JNJ,negative
708552.0,UPDATE: J&J Cuts FY EPS Outlook from $6.12-$6.27 Previously to $6.04-$6.19 vs $6.16 Est.,2015-04-14 07:46:00-04:00,JNJ,negative
708553.0,Johnson & Johnson Cuts Outlook,2015-04-14 07:46:00-04:00,JNJ,negative
708554.0,"Johnson & Johnson Reports Q1 EPS $1.56 Vs Est $1.54, Sales $17.37B Vs Est $17.31B",2015-04-14 07:45:00-04:00,JNJ,neutral
708555.0,"Earnings Scheduled For April 14, 2015",2015-04-14 04:53:00-04:00,JNJ,neutral
708556.0,7 Stocks You Should Be Watching Today,2015-04-14 04:01:00-04:00,JNJ,neutral
708557.0,"Stock Investors Dig In For Bank Earnings, Ready For Next SPX Test",2015-04-13 13:59:00-04:00,JNJ,positive
708558.0,"Ichor Medical Systems Announces Entering Into Product Development Collaboration, Global License Deal with J&J's Janssen Pharma",2015-04-13 08:05:00-04:00,JNJ,neutral
708559.0,MorphoSys AG to Receive Milestone Payment for Guselkumab Program in Psoriatic Arthritis,2015-04-13 05:25:00-04:00,JNJ,neutral
708560.0,13 Stocks To Watch As Earnings Season Ramps Up,2015-04-12 14:57:00-04:00,JNJ,neutral
708561.0,Sector ETFs And Earnings,2015-04-07 14:19:00-04:00,JNJ,neutral
708562.0,"JPMorgan Cut Its Johnson & Johnson Forecast Before Earnings, But Why?",2015-04-06 15:00:00-04:00,JNJ,negative
708563.0,"Janssen Pharmaceuticals, Inc. Finalizes Divestiture of U.S. License Rights to NUCYNTA® (tapentadol), NUCYNTA® ER (tapentadol) extended-release tablets and NUCYNTA® (tapentadol) Oral Solution to Depomed, Inc For $1.05B",2015-04-02 16:10:00-04:00,JNJ,positive
708564.0,Hearing Unconfirmed Market Chatter JNJ to Spinoff Pharma Business from Medical Device Business,2015-04-02 10:17:00-04:00,JNJ,negative
708566.0,J&J's Janssen Announces FDA Approval for Label Update for ZYTIGA to Include Statistically Significant Overall Survival Results in Chemotherapy-Naive Men with Metastatic Castration-Resistant Prostate Cancer,2015-03-30 08:06:00-04:00,JNJ,negative
708567.0,Johnson & Johnson Teams With Google On Surgery Robot Development,2015-03-27 10:34:00-04:00,JNJ,neutral
708568.0,"Watch Shares of Intuitive Surgical Here as Bloomberg Reporting J&J In a Deal with Google Related to Surgical Robotics, Terms Not Disclosed",2015-03-27 09:12:00-04:00,JNJ,positive
708569.0,"J&J, Bausch & Lomb Accused Of Price Fixing, Antitrust Suit Claims Contact Lens Makers Set Minimum Resale Prices",2015-03-24 13:19:00-04:00,JNJ,negative
708570.0,"Benzinga's M&A Chatter for Thursday March 19, 2015",2015-03-19 18:40:00-04:00,JNJ,neutral
708571.0,J&J Announces Janssen Purchase of XO1 Limited,2015-03-19 08:04:00-04:00,JNJ,negative
708572.0,Janssen Acquires XO1 Limited; Terms Not Disclosed,2015-03-19 05:20:00-04:00,JNJ,negative
708573.0,FDA Panel to Discuss Development of Ebola Vaccines in May -Reuters,2015-03-18 08:17:00-04:00,JNJ,neutral
708574.0,PREVIEW: Pharmacyclics Shares to Resume Trading at 3:30 PM ET,2015-03-16 15:07:00-04:00,JNJ,positive
708575.0,UPDATE: Independent Data Monitoring Committee Unanimously Recommends Unblinding of IMBRUVICA,2015-03-16 15:01:00-04:00,JNJ,positive
708576.0,Johnson and Johnson's Janssen Unit Loses Appeal For $11M Topamax Verdict,2015-03-16 14:25:00-04:00,JNJ,negative
708577.0,Lifetime Income Payments Or Lump Sum: How To Decide?,2015-03-10 16:55:00-04:00,JNJ,neutral
708578.0,"J&J's McNeil Consumer Healthcare Unit Announces Deal for Resolution of US DoJ Probe: Will Pay $25M Settlement, Enter Plea for Single Misdemeanor Violation",2015-03-10 15:00:00-04:00,JNJ,negative
708579.0,McNeil Consumer Healthcare Resolves U.S. DOJ Investigation; To Pay Settlement of $25M,2015-03-10 14:58:00-04:00,JNJ,positive
708580.0,J&J Ordered To Pay $5.7M For Incontinence Implant,2015-03-05 15:43:00-05:00,JNJ,negative
708581.0,Johnson & Johnson's Ethicon Unit Ordered to Pay $5.6M from Trial ver Transvaginal Mesh Injuries -Reuters,2015-03-05 14:34:00-05:00,JNJ,negative
708582.0,"Benzinga's M&A Chatter for Wednesday March 4, 2015",2015-03-04 20:47:00-05:00,JNJ,neutral
708583.0,Report: Pharmacyclics Inc. To Be Acquired By Johnson & Johnson,2015-03-04 18:13:00-05:00,JNJ,neutral
708584.0,UPDATE: J&J's Purchase of Pharmacyclics May Be Announced as Soon as Thursday,2015-03-04 17:09:00-05:00,JNJ,neutral
708585.0,Hearing J&J Has Agreed to Purchase Pharmacyclics,2015-03-04 17:08:00-05:00,JNJ,positive
708586.0,Fast Money Halftime Report Final Trade From March 4,2015-03-04 16:36:00-05:00,JNJ,neutral
708587.0,Hearing FT Reporting J&J Near Deal to Purchase Pharmacyclics,2015-03-04 16:02:00-05:00,JNJ,neutral
708588.0,"Benzinga's M&A Chatter for Monday March 2, 2015",2015-03-02 19:29:00-05:00,JNJ,neutral
708589.0,"'Merger Monday' Lives Up To Name: From NXP Semiconductors To eBay, There's At Least $20 Billon In Total Deals",2015-03-02 13:19:00-05:00,JNJ,neutral
708590.0,UPDATE: Johnson & Johnson Announces Binding Offer from Cardinal Health to Acquire Cordis,2015-03-02 07:31:00-05:00,JNJ,neutral
708591.0,Johnson & Johnson Announces Binding Offer from Cardinal Health to Acquire Cordis,2015-03-02 07:30:00-05:00,JNJ,neutral
708592.0,WHO Says Independent Advisory Body to Decide No Earlier than August on Recommendation of Widespread Ebola Vaccinations,2015-02-27 05:30:00-05:00,JNJ,negative
708593.0,"J&J Announces Formation of New Health and Wellness Platform Aimed at Transforming Health Care Delivery, Improve the Patient Experience",2015-02-26 08:04:00-05:00,JNJ,positive
708594.0,"Benzinga's M&A Chatter for Wednesday February 25, 2015",2015-02-25 21:26:00-05:00,JNJ,neutral
708595.0,Deutsche Bank On Pharmacyclics: 'We Do Not See Much Upside',2015-02-25 17:05:00-05:00,JNJ,neutral
708596.0,Bloomberg Reporting JNJ Loses Bid To Get South Carolina Risperdal Verdict Tossed,2015-02-25 12:09:00-05:00,JNJ,negative
708597.0,Ontario Institute for Cancer Research Extends Collaboration With Janssen on Developing Clinical Trials for Prostate Cancer,2015-02-25 09:05:00-05:00,JNJ,negative
708598.0,Johnson & Johnson To Pay $2.5M For Failing to Properly Warn About Risperdal Risks,2015-02-24 14:27:00-05:00,JNJ,negative
708599.0,JNJ Shares Spike Higher After-Hours,2015-02-23 16:40:00-05:00,JNJ,positive
708600.0,3 Companies That Could Be Negatively Impacted By Johnson & Johnson Sale Of Cordis,2015-02-23 13:57:00-05:00,JNJ,neutral
708601.0,Morgan Stanley Analyst Sees Higher Net For Cardinal Health In Johnson & Johnson Deal,2015-02-23 11:45:00-05:00,JNJ,neutral
708602.0,J&J Has Agreed to Pay Additional $420M Related to Deal in ASR Hip Settlement Case,2015-02-23 07:45:00-05:00,JNJ,positive
708603.0,Cardnial Health Potential Buyer for J&J's Cordis Unit -Bloomberg,2015-02-23 04:55:00-05:00,JNJ,neutral
708604.0,"Jefferies Names AbbVie As Top Pharmaceutical Pick, Offers Alternative Choices",2015-02-20 13:10:00-05:00,JNJ,positive
708605.0,10 Stocks Institutional Investors Loved Last Quarter,2015-02-20 11:38:00-05:00,JNJ,positive
708606.0,Sterne Agee To Investors: Caution! Boston Scientific Priced To Perfection,2015-02-20 09:08:00-05:00,JNJ,positive
708607.0,Boston Scientific Closes Up 12%,2015-02-18 16:44:00-05:00,JNJ,neutral
708609.0,Boston Scientific Soars 11% After Settling Dispute With Johnson & Johnson,2015-02-18 14:42:00-05:00,JNJ,negative
708610.0,Mid-Day Market Update: Angie's List Jumps On Upbeat Earnings; MedAssets Shares Tumble,2015-02-18 12:51:00-05:00,JNJ,positive
708611.0,Sterne Agree Weighs In On Boston Scientific-Johnson & Johnson Litigation Settlement,2015-02-18 10:24:00-05:00,JNJ,positive
708612.0,Stocks Hitting 52-Week Highs,2015-02-18 10:05:00-05:00,JNJ,neutral
708613.0,Morning Market Gainers,2015-02-18 09:38:00-05:00,JNJ,neutral
708614.0,Benzinga's Top #PreMarket Gainers,2015-02-18 08:11:00-05:00,JNJ,positive
708615.0,Fast Money Halftime Report Final Trade From February 17,2015-02-17 17:50:00-05:00,JNJ,neutral
708616.0,Boston Scientific Shares Rise 12% After-Hours on JNJ Settlement News,2015-02-17 17:28:00-05:00,JNJ,positive
708617.0,"Boston Scientific Reports Deal with J&J for Resolution of Guidant Litigation, Will Make $600M in Payments, Sees Pretax Charge $600M",2015-02-17 16:06:00-05:00,JNJ,negative
708618.0,8 Stocks Going Ex-Dividend This Week (And 1 Trading Idea),2015-02-16 13:27:00-05:00,JNJ,neutral
708619.0,American Firms In China Feel Anti-Foreign Sentiment Rising In The Wake Of Qualcomm Settlement,2015-02-13 14:25:00-05:00,JNJ,neutral
708620.0,"Bill Ackman Thinks Valeant Is 'Incredibly Disciplined,' And Says He'd Own McDonald's If 3G Capital Was In Charge",2015-02-13 13:06:00-05:00,JNJ,neutral
708621.0,Johnson & Johnson Faces Pressure From U.S. Patent Office,2015-02-13 11:18:00-05:00,JNJ,negative
708622.0,"ITC to Acquire JNJ's Savlon, Shower to Shower Brands -Business Standard",2015-02-13 07:25:00-05:00,JNJ,neutral
708623.0,J&J Announces PTO Action Related to REMICADE: Co. Has 60 Days To Respond,2015-02-12 14:35:00-05:00,JNJ,neutral
708624.0,Johnson & Johnson Under Selling Pressure,2015-02-12 12:01:00-05:00,JNJ,negative
708625.0,J&J Shares Plunge Below $100 Level Few Mins Ahead of Bloomberg Headline Suggesting Co.'s Remicade Patent Claims Have Been Given Final Patent Office Rejection,2015-02-12 11:56:00-05:00,JNJ,negative
708626.0,JNJ Shares Selling Off,2015-02-12 11:21:00-05:00,JNJ,positive
708627.0,Hearing Unconfirmed Market Chatter JNJ has Hired Goldman Sachs to Explore Breakup into 3 Cos,2015-02-10 11:14:00-05:00,JNJ,negative
708628.0,J&J Reports 15.1% Passive Stake in Aquinox Pharmaceuticals as of December 31,2015-02-06 06:24:00-05:00,JNJ,positive
708629.0,U.S. FDA Grants Priority Review for YONDELIS,2015-02-03 12:38:00-05:00,JNJ,positive
708630.0,J&J Sarcoma Drug Yondelis Gets FDA Priority Review,2015-02-03 07:13:00-05:00,JNJ,neutral
708631.0,ETF Spotlight: Dividend Aristocrat Index,2015-01-29 14:58:00-05:00,JNJ,neutral
708632.0,#Premarket Prep Technical Update - Johnson & Johnson Lower,2015-01-29 13:04:00-05:00,JNJ,negative
708633.0,WHO's Aylward Says Running Out of Cash Needed to Fight Ebola; Needs $260M; 4-5 Months Best Case for Virus to Stop -Reuters,2015-01-23 08:56:00-05:00,JNJ,positive
708634.0,Morgan Stanley Analyst Sees FY15 'Trough' For Johnson & Johnson Pharma Growth,2015-01-22 11:54:00-05:00,JNJ,positive
708635.0,Why Minerva Neurosciences Is Trading Higher,2015-01-21 21:21:00-05:00,JNJ,neutral
708636.0,ECB Easing Could Strengthen Headwinds For U.S. Firms,2015-01-21 11:23:00-05:00,JNJ,positive
708637.0,UN's David Nabarro Cites Need for $1B to Fight Ebola -Reuters,2015-01-21 10:06:00-05:00,JNJ,negative
708638.0,Morgan Stanley Sees Balance Sheet & Pipeline As More Critical For Johnson & Johnson,2015-01-21 07:54:00-05:00,JNJ,negative
708639.0,CNBC's Stock Pops & Drops From January 20,2015-01-20 20:35:00-05:00,JNJ,neutral
708640.0,4 Companies Capturing Social Media Attention On Tuesday Morning,2015-01-20 09:57:00-05:00,JNJ,neutral
708641.0,Morning Market Losers,2015-01-20 09:57:00-05:00,JNJ,negative
708642.0,"From Conf Call: J&J CFO Says Expects Better Growth Outlook for Medical Devices, Consumer Products for 2015 vs 2014",2015-01-20 09:43:00-05:00,JNJ,positive
708643.0,UPDATE: Johnson & Johnson Posts Upbeat Q4 Earnings,2015-01-20 08:41:00-05:00,JNJ,neutral
708644.0,Benzinga's Top #PreMarket Losers,2015-01-20 08:24:00-05:00,JNJ,negative
708645.0,"Earning & Economic Calendar for Tuesday January 20, 2015",2015-01-20 05:18:00-05:00,JNJ,neutral
708646.0,"Woman Who Worked with Ebola Patients Taken off United Airlines Flight Monday in Newark, After Showing Ebola Signs; Being Tested at Hackensack University Medical Center",2015-01-20 04:45:00-05:00,JNJ,positive
708647.0,"Earnings Scheduled For January 20, 2015",2015-01-20 04:40:00-05:00,JNJ,neutral
708648.0,7 Stocks You Should Be Watching Today,2015-01-20 04:01:00-05:00,JNJ,neutral
708649.0,Mid-Afternoon Market Update: Precision Castparts Slides After Weak Q3 Outlook; Schlumberger Shares Spike Higher,2015-01-16 15:36:00-05:00,JNJ,negative
708650.0,NIH DIrector Says Study of Experimental Ebola Drug ZMapp Could Start Next Month in West Africa -DJ,2015-01-16 14:43:00-05:00,JNJ,neutral
708651.0,Mid-Day Market Update: U.S. Stocks Rise; SunTrust Shares Surge On Upbeat Earnings,2015-01-16 14:04:00-05:00,JNJ,positive
708652.0,Benzinga's Volume Movers,2015-01-16 11:09:00-05:00,JNJ,neutral
708653.0,Knuckman On Johnson & Johnson And Ford: Surprise Movers?,2015-01-16 11:02:00-05:00,JNJ,positive
708654.0,Stocks Hitting 52-Week Highs,2015-01-16 10:34:00-05:00,JNJ,neutral
708655.0,Morning Market Gainers,2015-01-16 09:49:00-05:00,JNJ,neutral
708656.0,Depomed Surges 8% Following NUCYNTA Acquisition From Janssen Pharmaceuticals,2015-01-16 08:58:00-05:00,JNJ,neutral
708657.0,Benzinga's Top #PreMarket Gainers,2015-01-16 08:11:00-05:00,JNJ,positive
708658.0,US Stock Futures Slip Ahead Of Goldman Sachs Earnings,2015-01-16 07:01:00-05:00,JNJ,neutral
708659.0,UPDATE: J&J Announces Formation of Ebola Vaccine Development Consortia; IMI to Award Consortia Grants Totaling €100M+,2015-01-16 06:34:00-05:00,JNJ,positive
708660.0,Johnson & Johnson Announces Formation Of Ebola Vaccine Development Consortia,2015-01-16 06:29:00-05:00,JNJ,neutral
708661.0,A Pair Trade With Eli Lilly And Johnson & Johnson? Goldman Just Explained Why It's A Solid Idea,2015-01-15 17:40:00-05:00,JNJ,positive
708662.0,Depomed To Acquire Rights To NUCYNTA Franchise For $1.05 Billion,2015-01-15 17:23:00-05:00,JNJ,neutral
708663.0,"DepoMed Shares Resume Trading, Now Up 15%",2015-01-15 16:36:00-05:00,JNJ,positive
708664.0,PREVIEW: Depomed to Resume Trading at 4:30 PM ET,2015-01-15 16:08:00-05:00,JNJ,neutral
708665.0,#Premarket Prep Technical Update - Johnson & Johnson Lower,2015-01-15 12:07:00-05:00,JNJ,negative
708666.0,"Goldman Sachs Downgrades Johnson & Johnson to Sell, Maintains $97.00 PT",2015-01-15 07:16:00-05:00,JNJ,neutral
708667.0,Wall Street's Wheelings And Dealings,2015-01-13 14:49:00-05:00,JNJ,neutral
708668.0,"J&J's Janssen, Johnson & Johnson Innovation Report License Deal with Vedanta Related to Microbiome Pharma Candidate for Inflammatory Bowel Disease",2015-01-13 08:07:00-05:00,JNJ,positive
708669.0,"Bloomberg Reporting Johnson & Johnson, AC Immune Enter Alzheimer's Disease Vaccines Pact",2015-01-12 15:17:00-05:00,JNJ,positive
708670.0,JNJ CEO 'Intends $1B In Operational Savings Over Next 3 Years',2015-01-12 13:40:00-05:00,JNJ,neutral
708671.0,Johnson & Johnson Webcast Presentation Begins,2015-01-12 13:31:00-05:00,JNJ,neutral
708672.0,What Investors Should Expect From Portola Pharmaceutical's Upcoming Data Readouts,2015-01-09 12:43:00-05:00,JNJ,neutral
708673.0,#Premarket Prep Technical Update - Johnson & Johnson Higher,2015-01-08 13:33:00-05:00,JNJ,neutral
708674.0,3 Sectors That Could Survive A Correction,2015-01-07 08:11:00-05:00,JNJ,neutral
708675.0,Healthcare Sector Survives Europe's Slide,2015-01-06 15:58:00-05:00,JNJ,neutral
708676.0,J&J Reports Commencement of Phase 1 Trial of Ebola Virus Vaccine Regimen,2015-01-06 07:53:00-05:00,JNJ,neutral
708677.0,Johnson & Johnson Announces Commencement of Phase 1 Clinical Trial of Ebola Vaccine Regimen,2015-01-06 02:53:00-05:00,JNJ,neutral
708678.0,Isis Pharmaceuticals Shares Rise 4.5% Premarket Following Announcement of Deal with JNJ,2015-01-05 08:14:00-05:00,JNJ,positive
708679.0,Isis Pharmaceuticals Announces Collaboration With Janssen on RNA-Targeted Therapeutics for Autoimmune Diseases in the GI Tract,2015-01-05 07:05:00-05:00,JNJ,neutral
708680.0,Gilead Reports Amended Deals with J&J's Janssen to Develop PREZISTA-Based Single-Tablet Regimen for Treatment of People Living with HIV,2014-12-29 08:31:00-05:00,JNJ,neutral
708681.0,#Premarket Prep Technical Update - Johnson & Johnson Higher,2014-12-26 11:41:00-05:00,JNJ,neutral
708682.0,#Premarket Prep Technical Update - Johnson & Johnson Higher,2014-12-24 11:16:00-05:00,JNJ,neutral
708683.0,"MacroGenics Enters Collaboration, License Agreement with Janssen to Develop MGD011 for Multiple B-Cell Malignancies, MacroGenics to Receive $50M Upfront License Fee, $75M Equity Investment by JNJ",2014-12-22 06:06:00-05:00,JNJ,positive
708684.0,Analysts See No Sweeter Deal For Volcano,2014-12-17 15:34:00-05:00,JNJ,negative
708685.0,UPDATE: Geron Says Initial Payment of $35M Due,2014-12-16 07:17:00-05:00,JNJ,neutral
708686.0,Geron Reports Early HSR Clearance for Global Strategic Collaboration with J&J's Janssen,2014-12-16 07:16:00-05:00,JNJ,neutral
708687.0,Janssen Research Announces Presentation Of Data At SABCS From The Phase 3 EPO-ANE-3010 Study,2014-12-12 12:19:00-05:00,JNJ,neutral
708688.0,Market Mixed Amid Plan To Spend $300 Million On Ebola Vaccines,2014-12-11 14:14:00-05:00,JNJ,neutral
708689.0,#Premarket Prep Technical Update - Johnson & Johnson Lower,2014-12-10 11:31:00-05:00,JNJ,negative
708690.0,#Premarket Prep Technical Update - Johnson & Johnson Lower,2014-12-09 12:26:00-05:00,JNJ,negative
708691.0,J&J's Janssen Reports IMBRUVICA 'Shows Sustained Progression-Free Survival in Patients with High-Risk Chronic Lymphocytic Leukemia with Genetic Mutation',2014-12-09 07:39:00-05:00,JNJ,neutral
708692.0,New ETF For Environmentalists,2014-12-05 12:36:00-05:00,JNJ,neutral
708693.0,Markets Marginally Lower Ahead Of Friday's Jobs Report,2014-12-04 17:00:00-05:00,JNJ,negative
708694.0,Markets Inch Higher Following Encouraging Beige Book Commentary,2014-12-03 17:11:00-05:00,JNJ,positive
708695.0,Report: Johnson & Johnson May Put Splenda On Block,2014-12-03 11:21:00-05:00,JNJ,negative
708696.0,"Reuters Reports Johnson & Johnson Hired Goldman Sachs to Explore Sale of Splenda, According to Sources",2014-12-03 09:43:00-05:00,JNJ,neutral
708697.0,Top 4 Stocks In The Drug Manufacturers-Major Industry With The Highest Operating Margin,2014-12-02 04:38:00-05:00,JNJ,positive
708698.0,"S&P 500 Stocks With Most Active Options Today: PWR, XEL, NSc, BSX, LLTC, JNJ",2014-12-01 13:19:00-05:00,JNJ,positive
708699.0,CORRECTION: FDA Says JNJ's Hysterectomy Device Shouldn't Be Used By Most Women,2014-11-24 10:53:00-05:00,JNJ,neutral
708700.0,FDA Says JNJ's Hysterectomy Device Shouldn't Be Used By Most Women,2014-11-24 10:50:00-05:00,JNJ,neutral
708701.0,Riding The Bull Market With These 2 Momentum ETFs,2014-11-20 15:10:00-05:00,JNJ,neutral
708702.0,J&J's Janssen Reports Submission of NDA for Three-Mo. Paliperidone Palmitate to Treat Schizophrenia,2014-11-19 09:01:00-05:00,JNJ,positive
708703.0,What Johnson & Johnson's 'Chart Watchers' Need To Know,2014-11-12 12:28:00-05:00,JNJ,neutral
708704.0,Jim Cramer Weighs In On Johnson & Johnson And Toyota Motor,2014-11-10 21:09:00-05:00,JNJ,neutral
708705.0,"#PreMarket Primer: Monday, November 10: Nuclear Talks Enter Second Day",2014-11-10 07:54:00-05:00,JNJ,neutral
708706.0,Johnson & Johnson CEO Says Seeks Acquisitions in China -WSJ,2014-11-10 05:03:00-05:00,JNJ,neutral
708707.0,#Premarket Prep Technical Update - Johnson & Johnson Lower,2014-11-07 12:22:00-05:00,JNJ,negative
708708.0,#Premarket Prep Technical Update - Facebook Trading Higher,2014-11-07 12:18:00-05:00,JNJ,neutral
708709.0,Reuters Reports Group of Scientists Proposes US Health Officials Find Ebola Treatment in Survivor's Antibodies -Reuters,2014-11-07 09:27:00-05:00,JNJ,neutral
708710.0,#Premarket Prep Technical Update - Johnson & Johnson Makes New All Time High And Retreats,2014-11-05 14:14:00-05:00,JNJ,neutral
708711.0,Which Mega-Caps Aren't Paying Taxes?,2014-11-05 09:04:00-05:00,JNJ,neutral
708712.0,Ebola Vaccine Contenders,2014-10-30 10:44:00-04:00,JNJ,neutral
708713.0,"UPDATE: GTCR Announces Devicor Medical Products to be Acquired by Danaher Corporation's Leica Biosystems,",2014-10-28 07:36:00-04:00,JNJ,neutral
708714.0,"WHO Says Ebola Death Toll Rises to 4,922 from 10,141 Cases in Eight Countries Through October 23",2014-10-25 07:13:00-04:00,JNJ,negative
708715.0,"Report Mali's First Ebola Case, A 2-Year Old Girl has Died, According to Health Official -Reuters",2014-10-24 15:33:00-04:00,JNJ,negative
708716.0,"Ebola Related Stocks Move Off Lows on Report of Potential New Ebola Case in Houston, TX",2014-10-24 15:14:00-04:00,JNJ,positive
708717.0,CDC Spokesperson Says a Number of Options for Returnees from Africa are on the Table; Changes to Policy Likely,2014-10-24 15:01:00-04:00,JNJ,positive
708718.0,NIH Says Did Not Administer Experimental Drugs to Nina Pham While She Was in Maryland Hospital,2014-10-24 12:06:00-04:00,JNJ,neutral
708719.0,"Dallas Nurse Nina Pham Declared Virus Free, Being Discharged -DJ",2014-10-24 10:49:00-04:00,JNJ,positive
708720.0,UPDATE: WHO Expects First Data on Efficacy of Ebola Vaccines By April 2015,2014-10-24 08:40:00-04:00,JNJ,neutral
708721.0,WHO Says at Least Five More Experimental Ebola Vaccines Scheduled to Begin Clinical Trials Soon; Says 100K Does of Vaccine Should be Ready in H1 2015 -Reuters,2014-10-24 08:17:00-04:00,JNJ,positive
708722.0,Procter & Gamble Co Shares Lower Following Management Change,2014-10-23 13:42:00-04:00,JNJ,neutral
708723.0,Genmab to Receive $10M Milestone Payment for Daratumumab Collaboration With Janssen,2014-10-23 12:53:00-04:00,JNJ,neutral
708724.0,Drug ETFs Attractive Buys On Pullback,2014-10-22 17:10:00-04:00,JNJ,positive
708725.0,Markets Reverse Early Morning Gains Following Canadian Shooting,2014-10-22 16:43:00-04:00,JNJ,positive
708726.0,"#PreMarket Primer: Wednesday, October 22: Johnson & Johnson Develops Ebola Vaccine",2014-10-22 08:13:00-04:00,JNJ,neutral
708727.0,Johnson & Johnson Commits Up to $200M to Speed Ebola Vaccine Development,2014-10-22 05:00:00-04:00,JNJ,neutral
708728.0,J&J's Janssen Announces IMBRUVICA sNDA Submitted to FDA for Waldenstrom's Macroglobulinemia,2014-10-20 08:06:00-04:00,JNJ,neutral
708729.0,Benzinga Weekly Preview: Earnings Season Is In Full Swing,2014-10-19 10:19:00-04:00,JNJ,neutral
708730.0,Sometimes You Need To Close Your Eyes And Buy,2014-10-17 13:22:00-04:00,JNJ,neutral
708731.0,"#PreMarket Primer: Thursday, October 16: This Year's Spending Season Could Be Muted",2014-10-16 07:40:00-04:00,JNJ,neutral
708732.0,Barclays: Johnson & Johnson's Q3 Could Be 'High Water Mark',2014-10-15 16:42:00-04:00,JNJ,neutral
708733.0,UPDATE: Bank Of America Reiterates On Johnson & Johnson On Likely EPS Headwinds,2014-10-15 07:52:00-04:00,JNJ,neutral
708734.0,Markets Unable To Hold On To Gains As Oil Continues To Plunge,2014-10-14 16:47:00-04:00,JNJ,positive
708735.0,Johnson & Johnson Conference Call Highlights,2014-10-14 15:21:00-04:00,JNJ,neutral
708736.0,#Premarket Prep Technical Update - Johnson & Johnson Trading Lower,2014-10-14 14:43:00-04:00,JNJ,negative
708737.0,Deutsche Bank Says Gilead Sciences Stock Reaction Is Overdone,2014-10-14 13:59:00-04:00,JNJ,neutral
708738.0,"Deutsche Bank Just Out with Mid-Day Defense on Gilead, 'weakness on Irish tax, JNJ comments is overdone'",2014-10-14 11:13:00-04:00,JNJ,negative
708739.0,"UPDATE: Johnson & Johnson Posts Better-Than-Expected Q3 Earnings, Lifts Full-Year Forecast",2014-10-14 09:03:00-04:00,JNJ,neutral
708740.0,From J&J Earnings Conference Call: Expecting FY14 Operating Sales Growth (on a Constant Currency Basis) 5.5-6.5%,2014-10-14 08:56:00-04:00,JNJ,positive
708741.0,J&J Worldwide Pharama Sales Growth YoY,2014-10-14 07:55:00-04:00,JNJ,positive
708742.0,Johnson & Johnson 3Q Orthopaedics Sales $2.34B ,2014-10-14 07:48:00-04:00,JNJ,neutral
708743.0,Johnson & Johnson 3Q RisperdalConsta Sales $284M,2014-10-14 07:48:00-04:00,JNJ,neutral
708744.0,Johnson & Johnson 3Q Worldwide Pharmaceutical Sales $8.31B,2014-10-14 07:46:00-04:00,JNJ,neutral
708745.0,Johnson & Johnson 3Q Worldwide Consumer Sales $3.59B,2014-10-14 07:45:00-04:00,JNJ,neutral
708746.0,Johnson & Johnson Sees FY2014 EPS $5.92-5.97 vs $5.93 Est,2014-10-14 07:45:00-04:00,JNJ,neutral
708747.0,Johnson & Johnson Reports Q3 EPS of $1.50 vs $1.43 Est; Revenue of $18.47B vs $18.36B Est.  Raising Guidance,2014-10-14 07:45:00-04:00,JNJ,neutral
708748.0,"Earnings Scheduled For October 14, 2014",2014-10-14 05:23:00-04:00,JNJ,neutral
708749.0,"Stocks To Watch For October 14, 2014",2014-10-14 04:09:00-04:00,JNJ,neutral
708750.0,J&J's Alios BioPharma Reports Presented Positive Results of Anti-RSV Nucleoside Analog AL-8176,2014-10-13 08:35:00-04:00,JNJ,positive
708751.0,"Bristol-Myers, Pharmacyclics, Janssen Report Clinical Collaboration of Evaluate OPDIVO, IMBRUVICA in NHL",2014-10-13 08:01:00-04:00,JNJ,neutral
708752.0," Bavarian Nordic's Shares Rise 8% in Copenhagen on CEO Comments its MVA Technology Can be Used to Improve Ebola Vaccines from JNJ, GSK, Create Biodefense Business",2014-10-13 05:57:00-04:00,JNJ,positive
708753.0,Earnings Expectations For The Week Of October 13: The Crunch Is On,2014-10-12 11:54:00-04:00,JNJ,neutral
708754.0,"Janssen Presents Data from Hepatitis C in European, Israeli Patients at Viral Hepatitis Congress ",2014-10-10 05:34:00-04:00,JNJ,neutral
708755.0,#Premarket Prep Technical Update - Johnson & Johnson Trading Sharply Lower,2014-10-09 14:27:00-04:00,JNJ,negative
708756.0,Strike While the Iron is Hot: Stryker (SYK),2014-10-08 15:36:00-04:00,JNJ,negative
708757.0,"#PreMarket Primer: Wednesday, October 8: IMF Cuts Global Growth Prospects, Puts A Damper On Wall Street",2014-10-08 08:19:00-04:00,JNJ,positive
708758.0,"#PreMarket Primer: Friday, October 3: JP Morgan Suffers Largest Cyberattack Against A Financial Institution",2014-10-03 07:03:00-04:00,JNJ,negative
708759.0,Markets Little Changed Ahead Of Friday's Jobs Report,2014-10-02 17:10:00-04:00,JNJ,neutral
708760.0,Benzinga's Top Initiations,2014-10-02 09:03:00-04:00,JNJ,positive
708761.0,Guggenheim Securities Initiates Johnson & Johnson At Neutral,2014-10-02 09:00:00-04:00,JNJ,positive
708762.0,"Guggenheim Securities Initiates Coverage on Johnson & Johnson at Neutral, Announces $115.00 PT",2014-10-02 06:09:00-04:00,JNJ,positive
708763.0,Johnson & Johnson Falls On Bernstein Downgrade,2014-10-01 15:09:00-04:00,JNJ,neutral
708764.0,Benzinga's Top Downgrades,2014-10-01 08:53:00-04:00,JNJ,positive
708765.0,"Bernstein Downgrades Johnson & Johnson To Market Perform, Shares Drop",2014-10-01 08:13:00-04:00,JNJ,neutral
708766.0,Bernstein Downgrades Johnson & Johnson to Market Perform,2014-10-01 06:48:00-04:00,JNJ,neutral
708767.0,"Achillion Pharmaceuticals, Inc. Less Attractive Amid Johnson & Johnson/Alios BioPharma Deal",2014-09-30 12:19:00-04:00,JNJ,positive
708768.0,J&J Announces Deal to Buy Alios Biopharma for ~$1.75B in Cash,2014-09-30 08:30:00-04:00,JNJ,neutral
708769.0,#Premarket Prep Technical Update - Johnson & Johnson Trading Lower,2014-09-29 15:16:00-04:00,JNJ,negative
708770.0,J&J's Janssen Says ZYTIGA Plus Prednisone Shows Statistically Significant Overall Survival in Men with Advanced Prostate Cancer Prior to Chemotherapy,2014-09-29 07:16:00-04:00,JNJ,negative
708771.0,"#PreMarket Primer: Thursday, September 25: US Airstrikes Do Little To Stem ISIS Advances",2014-09-25 07:27:00-04:00,JNJ,neutral
708772.0,"J&J's Janssen Reports Research Demonstrated Association Between CONNECT Injection Centers, Increased Adherence to Healthcare Provider-Ordered Janssen Long-Acting Treatment for Schizophrenia",2014-09-24 16:42:00-04:00,JNJ,positive
708773.0,#Premarket Prep Technical Update - Johnson & Johnson Approaches All Time High,2014-09-24 11:24:00-04:00,JNJ,neutral
708774.0,#Premarket Prep Technical Update - Johnson & Johnson Makes New All-Time High,2014-09-19 15:38:00-04:00,JNJ,neutral
708775.0,Stocks Hitting 52-Week Highs ,2014-09-19 10:02:00-04:00,JNJ,neutral
708776.0,New Active ETF for All Risk Environments,2014-09-17 10:05:00-04:00,JNJ,positive
708777.0,#Premarket Prep Technical Update - Johnson & Johnson Trading Higher,2014-09-16 15:51:00-04:00,JNJ,neutral
708778.0,3 Companies Investing In Stem Cell Research,2014-09-14 16:34:00-04:00,JNJ,neutral
708779.0,"Janssen, J&J Innovation Announce Establishment of Research Collaboration with University of Toronto",2014-09-08 08:10:00-04:00,JNJ,positive
708780.0,"Jury Finds J&J's Incontinence Sling Caused Woman's Injuries, Co. Ordered to Pay $3.25M - Bloomberg",2014-09-05 12:44:00-04:00,JNJ,negative
708781.0,WHO Says Available Supply of Ebola Drugs Will Be Used in the Field,2014-09-05 12:30:00-04:00,JNJ,neutral
708782.0,"WHO Says Two Promising Ebola Vaccines Identified; Safety Results from Clinical Trials May be Available in Nov 2015, Paving Way for Use",2014-09-05 12:11:00-04:00,JNJ,positive
708783.0,"Johnson & Johnson Metal Hip Might Lead To Poisoning, Facing 6,000+ Suits",2014-09-04 17:16:00-04:00,JNJ,negative
708784.0,"US Stock Futures Gain; ADP, Jobless Claims Data In Focus",2014-09-04 07:35:00-04:00,JNJ,positive
708785.0,Johnson & Johnson to Fast-Track Development of Ebola Vaccine,2014-09-04 05:28:00-04:00,JNJ,neutral
708786.0,Morgan Stanley Sees Johnson & Johnson Taking Rx Estimates Higher,2014-09-02 09:10:00-04:00,JNJ,neutral
708787.0,Bank Of America Remains Optimistic On Johnson & Johnson,2014-08-29 09:13:00-04:00,JNJ,positive
708788.0,Morgan Stanley Sees More Focused Device Strategy Continue For Johnson & Johnson,2014-08-29 08:47:00-04:00,JNJ,positive
708789.0,"WSJ Reporting J&J Looking for Buyers for Cordis Unit, Deal Could Be for Up to $2B",2014-08-28 17:22:00-04:00,JNJ,neutral
708790.0,The 4 Companies Teaming Up For A New Tool To Fight Cancer,2014-08-25 16:03:00-04:00,JNJ,negative
708791.0,"VIVUS Announces Purchase of Topiramate-Related Patents from J&J's Janssen Pharma, Will Dismiss Suit Against VIVUS",2014-08-25 07:12:00-04:00,JNJ,neutral
708792.0,"#PreMarket Primer: Friday, August 22: Draghi, Yellen Set To Speak At Jackson Hole",2014-08-22 07:07:00-04:00,JNJ,neutral
708793.0,"Illumina Announces Strategic Partnerships with AstraZeneca, Janssen, Sanofi",2014-08-21 05:21:00-04:00,JNJ,neutral
708794.0,#Premarket Prep Technical Update - Johnson & Johnson Trading Lower,2014-08-15 13:29:00-04:00,JNJ,negative
708795.0,Earnings Season Is The Right Prescription For Health Care ETFs,2014-08-12 16:53:00-04:00,JNJ,positive
708796.0,Genmab Announces Jannsen to Start New Phase III Study of Daratumumab in Front Line Multiple Myeloma ,2014-08-11 09:26:00-04:00,JNJ,neutral
708797.0,3 Companies That Should Benefit From The New Initiative In Africa,2014-08-07 09:40:00-04:00,JNJ,positive
708798.0,"#PreMarket Primer: Thursday, August 7: Russia Set To Release A List Of Banned Goods",2014-08-07 07:03:00-04:00,JNJ,negative
708799.0,#Premarket Prep Technical Update - Johnson & Johnson Trading Higher,2014-08-06 14:10:00-04:00,JNJ,neutral
708800.0,Unique 3D Startups And The Public Companies That Should Buy Them,2014-08-01 10:31:00-04:00,JNJ,neutral
708801.0,#Premarket Prep Technical Update - Johnson & Johnson Trading Lower,2014-07-31 13:44:00-04:00,JNJ,negative
708802.0,"IBM Announces Alex Gorsky, CEO of Johnson & Johnson Joining Board, Peter Voser Will Also Join Board",2014-07-29 16:36:00-04:00,JNJ,positive
708803.0,"FDA Expands Approved Use, Labeling of Imbruvica For Chronic Lymphocytic Leukemia",2014-07-28 12:20:00-04:00,JNJ,positive
708804.0,Phase 2 COSMOS Study Results Published in The Lancet Demonstrate Efficacy and Safety of Janssen's Once-Daily Simeprevir in All Oral 12-Week Combination with Sofosbuvir for Genotype 1 Chronic Hepatitis C ,2014-07-28 06:16:00-04:00,JNJ,positive
708805.0,"EU Medicines Agency Recommends Johnson & Johnson, Pharmacyclics Leukaemia Drug Ibrutinib",2014-07-25 07:11:00-04:00,JNJ,positive
708806.0,YTD Biggest Buyback Companies Trailing S&P In Stock Appreciation,2014-07-24 16:16:00-04:00,JNJ,positive
708807.0,Organovo Up 19% #PreMarket; In Research Pact With Johnson & Johnson Unit,2014-07-24 09:32:00-04:00,JNJ,neutral
708808.0,Organovo Holdings Enters Agreement With Janssen R&D To Evaluate Use of 3D Bio-Printed Tissue In Drug Discovery Setting,2014-07-24 08:11:00-04:00,JNJ,positive
708809.0,The 10 Most-Respected Corporate Brands ,2014-07-22 10:18:00-04:00,JNJ,neutral
708810.0,"Stocks To Watch For July 22, 2014",2014-07-22 04:12:00-04:00,JNJ,neutral
708811.0,J&J Announces $5B Buyback Plan,2014-07-21 17:00:00-04:00,JNJ,neutral
708812.0,Why Has Wall Street Punished Johnson & Johnson For Its Earnings Beat?,2014-07-18 16:12:00-04:00,JNJ,negative
708813.0,"#PreMarket Primer: Friday, July 18: Tension Between Russia And The West At An All Time High",2014-07-18 07:16:00-04:00,JNJ,negative
708814.0,#Premarket Prep Technical Update - Johnson & Johnson Trading Lower,2014-07-17 14:26:00-04:00,JNJ,negative
708815.0,"Alzheimer's Rates Falling, But Pharma's Search For A Cure Yields No Results",2014-07-17 11:12:00-04:00,JNJ,negative
708816.0,Shares of Minerva Neurosciences Moving Higher Following 13G Filing from J&J Showing 18% Stake in Co.,2014-07-17 11:00:00-04:00,JNJ,positive
708817.0,Earnings Continue Driving Markets Higher,2014-07-16 17:23:00-04:00,JNJ,neutral
708818.0,Which Matters More: Janet Yellen Or Earnings & Economic Data?,2014-07-16 13:08:00-04:00,JNJ,neutral
708819.0,Morgan Stanley Sees Meaningful '15 Headwind For Johnson & Johnson,2014-07-16 09:10:00-04:00,JNJ,positive
708820.0,"#PreMarket Primer: Wednesday, July 16: Yellen Hints At Sooner Than Expected Rate Hike",2014-07-16 07:19:00-04:00,JNJ,neutral
708821.0,"Markets Mixed, NASDAQ Lower As Yellen Suggests Valuations Are Stretched",2014-07-15 16:35:00-04:00,JNJ,negative
708822.0,"Goldman Sachs, JPMorgan Chase Report Strong Earnings; Retail Numbers Fall Below Estimates",2014-07-15 15:20:00-04:00,JNJ,positive
708823.0,U.S. Stocks Sink; JPMorgan Shares Surge On Upbeat Earnings,2014-07-15 13:19:00-04:00,JNJ,positive
708824.0,Markets Rise; Goldman Sachs Profit Beats Estimates,2014-07-15 10:31:00-04:00,JNJ,positive
708825.0,From J&J Call: Sees Sales $74.50B-75.30B vs $74.91B Est,2014-07-15 09:29:00-04:00,JNJ,neutral
708826.0,"Johnson & Johnson, Goldman Sachs Pushing These ETFs Upward",2014-07-15 09:24:00-04:00,JNJ,neutral
708827.0,"UPDATE: Johnson & Johnson Posts Upbeat Q2 Earnings, Lifts Outlook",2014-07-15 08:05:00-04:00,JNJ,neutral
708829.0,UPDATE: Johnson & Johnson Raises FY2014 EPS Guidance from $5.80-5.90 to $5.85-5.92 vs $5.90 Est,2014-07-15 07:47:00-04:00,JNJ,neutral
708830.0,Johnson & Johnson Reports Q2 EPS of $1.66 vs $1.54 Est; Revenue of $19.50B vs $18.86B Est; Raises Outlook,2014-07-15 07:45:00-04:00,JNJ,neutral
708831.0,US Stock Futures Mostly Higher Ahead Of Goldman Sachs Earnings,2014-07-15 07:34:00-04:00,JNJ,neutral
708832.0,"#PreMarket Primer: Tuesday, July 15: Citigroup Settles Mortgage Probe",2014-07-15 07:18:00-04:00,JNJ,neutral
708833.0,"Earnings Scheduled For July 15, 2014",2014-07-15 05:01:00-04:00,JNJ,neutral
708834.0,"Stocks To Watch For July 15, 2014",2014-07-15 04:11:00-04:00,JNJ,neutral
708835.0,Dow Sets New Intraday High; Citigroup Impresses With Earnings,2014-07-14 16:44:00-04:00,JNJ,positive
708836.0,J&J's Janssen Pharma Announces Seeking Expanded Label for Once-Monthly INVEGA Sustenna,2014-07-14 08:06:00-04:00,JNJ,neutral
708837.0,"Earnings Expectations For The Week Of July 14: Big Banks, Tech Giants And More",2014-07-14 06:54:00-04:00,JNJ,neutral
708838.0,Benzinga Weekly Preview: Earnings Season Kicks Into High Gear,2014-07-11 16:44:00-04:00,JNJ,neutral
708839.0,#Premarket Prep Technical Update - Johnson & Johnson Trading Lower,2014-07-11 13:52:00-04:00,JNJ,negative
708840.0,J.P. Morgan: Johnson & Johnson's Drug Segment May Beat Q2 Street Views,2014-07-10 16:31:00-04:00,JNJ,neutral
708841.0,#Premarket Prep Technical Update - Johnson & Johnson Makes New All-Time High,2014-07-07 13:56:00-04:00,JNJ,neutral
708842.0,Genmab Announces Has Reached $25M Milestone in Daratumumab Deal with J&J's Janssen,2014-07-07 10:25:00-04:00,JNJ,positive
708843.0,#Premarket Prep Technical Update - Johnson & Johnson Finds Resistance,2014-07-03 11:55:00-04:00,JNJ,neutral
708844.0,"J&J Settles with State of Oregon, First State Deal Related to Co.'s Hip Implants - Bloomberg",2014-07-02 17:21:00-04:00,JNJ,neutral
708845.0,Markets Little Changed Ahead Of 4th Of July Break,2014-07-02 16:34:00-04:00,JNJ,neutral
708846.0,Barclays Downgrades Pharmaceutical Sector,2014-07-02 15:31:00-04:00,JNJ,neutral
708847.0,AbbVie Has Lost US Court Bid to Revive Patent Case Against J&J - Bloomberg,2014-07-01 11:13:00-04:00,JNJ,neutral
708848.0,Markets Little Changed As The Quarter Comes To An End,2014-06-30 16:34:00-04:00,JNJ,neutral
708849.0,Johnson & Johnson Completes Divestiture Of Ortho-Clinical Diagnostics To The Carlyle Group For $4B,2014-06-30 16:31:00-04:00,JNJ,neutral
708850.0,Johnson and Johnson Submits Marketing Application for Velcade in Europe,2014-06-27 08:19:00-04:00,JNJ,neutral
708851.0,#Premarket Prep Technical Update - Johnson & Johnson Trading Lower,2014-06-23 14:30:00-04:00,JNJ,negative
708852.0,#Premarket Prep Technical Update - Johnson & Johnson Makes New All-Time High,2014-06-20 14:22:00-04:00,JNJ,neutral
708853.0,#Premarket Prep Technical Update - Johnson & Johnson Trading Higher,2014-06-19 14:14:00-04:00,JNJ,neutral
708854.0,"Advances In HIV, Hep C Treatments Could Spark Renewed Interest In Biotech Stocks",2014-06-18 09:38:00-04:00,JNJ,positive
708855.0,J&J's Janssen Announces License Deal with Vertex to Develop Novel Treatment for Influenza A,2014-06-18 08:32:00-04:00,JNJ,positive
708856.0,"J&J Offers New Long-Term Data Showing INVOKANA Reduces Blood Glucose, Also Demonstrates Reductions in Secondary Endpoints",2014-06-16 17:05:00-04:00,JNJ,neutral
708857.0,#Premarket Prep Technical Update - Johnson & Johnson Trading Lower,2014-06-12 13:12:00-04:00,JNJ,negative
708858.0,UPDATE: Viiv Healthcare Collaborates With Janssen to Investigate Single-Tablet Regimen for Maintenance Treatment Of HIV-1,2014-06-12 06:31:00-04:00,JNJ,neutral
708859.0,Janssen Collaborates With Viiv Healthcare to Develop Two-Drug Single Tablet Regimen for Maintenance Treatment HIV,2014-06-12 06:12:00-04:00,JNJ,neutral
708860.0,Takeover Whispers Add To Achillion Pharmaceuticals' Momentum,2014-06-11 16:22:00-04:00,JNJ,neutral
708861.0,#Premarket Prep Technical Update - Johnson & Johnson Trading Lower,2014-06-11 14:50:00-04:00,JNJ,negative
708862.0,#Premarket Prep Technical Update - Johnson & Johnson Makes New All-Time High,2014-06-10 13:46:00-04:00,JNJ,neutral
708863.0,"Hearing Leering Says JNJ, AbbVie, Bristol-Myers Squibb Could Target Achillion Pharmaceuticals",2014-06-09 13:25:00-04:00,JNJ,neutral
708864.0,"Medical Device Companies' Future Remains Bright, Albeit Slow Penetration",2014-06-09 07:54:00-04:00,JNJ,positive
708865.0,#Premarket Prep Technical Update - Johnson & Johnson Trading Lower,2014-06-06 10:48:00-04:00,JNJ,negative
708866.0,#Premarket Prep Technical Update - Johnson & Johnson Makes New All-Time High,2014-06-05 13:39:00-04:00,JNJ,neutral
708867.0,Hearing Unconfirmed Market Chatter Circulating in Chat Rooms of Potential JNJ Interest in Isoray,2014-06-05 11:01:00-04:00,JNJ,positive
708868.0,#Premarket Prep Technical Update - Johnson & Johnson Makes New All-Time High,2014-06-04 13:40:00-04:00,JNJ,neutral
708869.0,ASCO Meeting Day 2: 'Promising' Results From JNJ's Imbruvica & Targeted Therapy,2014-06-04 10:32:00-04:00,JNJ,neutral
708870.0,#Premarket Prep Technical Update - Johnson & Johnson Makes New All-Time High,2014-06-03 14:25:00-04:00,JNJ,neutral
708871.0,UPDATE: Jim Cramer Says JNJ Should Spinoff their Medical Device Business and Merge it with Smith & Nephew,2014-06-02 18:32:00-04:00,JNJ,neutral
708872.0,Jim Cramer Says JNJ Could be a Potential Suitor for Smith & Nephew,2014-06-02 18:28:00-04:00,JNJ,neutral
708873.0,"Is This Time Really Going To Be Different? A True Look at Current Financial Asset Valuations (PG, WMT, JNJ)",2014-06-02 13:35:00-04:00,JNJ,positive
708874.0,#Premarket Prep Technical Update - Johnson & Johnson Trading Higher,2014-06-02 13:01:00-04:00,JNJ,neutral
708875.0,"J&J's Janssen Announces Data on Ibrutinib RESONATE(TM) Showed Significant Improvements in Progression-Free Survival, Overall Survival in Patients with CLL, SLL",2014-06-02 08:08:00-04:00,JNJ,positive
708876.0,UPDATE: Pharmacyclics Shares Rise 9% on Positive IMBRUVICA Data Presented at ASCO,2014-06-02 07:55:00-04:00,JNJ,positive
708877.0,"Pharmacyclics, JNJ Announce IMBRUVICA Shows Durable, Long-Term Responses for Patients with CLL ",2014-05-31 08:07:00-04:00,JNJ,neutral
708878.0,"#PreMarket Primer: Wednesday, May 28: Poroshenko Moves To End Pro-Russian Rebellion",2014-05-28 07:04:00-04:00,JNJ,negative
708879.0,Morgan Stanley Sees Three Debate-Worthy Topics For Johnson & Johnson,2014-05-23 10:32:00-04:00,JNJ,neutral
708880.0,"J&J's Medical Devices & Diagnostics Announces Expansion with Innovative Products, Customer-Focused Solutions",2014-05-22 08:46:00-04:00,JNJ,positive
708881.0,UPDATE: Actavis Shows Co. J&J's Janssen Have Amended Supply Deal for Generic Concerta,2014-05-20 16:22:00-04:00,JNJ,neutral
708882.0,Form 8-K from Actavis Shows Co. J&J's Janssen Have Amended Supply Deal for Generic Concerta,2014-05-20 16:21:00-04:00,JNJ,neutral
708883.0,Dissecting Dividend Growth ETFs,2014-05-20 16:08:00-04:00,JNJ,positive
708884.0,J&J's Janssen Announces Withdraws Application in EU for Approval of IV-Administered SIMPONI,2014-05-19 07:45:00-04:00,JNJ,positive
708885.0,"R&D Tax Credit Passed In The House, Faces Challenges Ahead",2014-05-14 12:08:00-04:00,JNJ,positive
708886.0,Google Celebrates Dorothy Hodgkin & Her Contributions To Chemistry,2014-05-12 16:27:00-04:00,JNJ,positive
708887.0,Benzinga's Weekend M&A Chatter,2014-05-11 22:28:00-04:00,JNJ,neutral
708888.0,"Sanofi Rumored Not to Be Interested in Allergan, J&J Said to Demur on Co.'s Breast Implant Business - Bloomberg",2014-05-09 14:03:00-04:00,JNJ,negative
708889.0,JNJ's Ortho Caps Gmbh Gets Favorable Decision In Patent Dispute in Federal Patent Court In Germany -Reuters,2014-05-09 09:50:00-04:00,JNJ,positive
708890.0,UPDATE: J&J's Janssen Submits sNDA for Olysio,2014-05-07 07:49:00-04:00,JNJ,neutral
708891.0,J&J's Janssen Submits sNDA for Olysio,2014-05-07 07:45:00-04:00,JNJ,neutral
708892.0,"Market Wrap For May 5: Dow Erases Triple-Digit Loss, All Three Major Indices Positive",2014-05-05 16:36:00-04:00,JNJ,positive
708893.0,5 Top Dow Stocks With The Most Upside Potential,2014-05-05 15:41:00-04:00,JNJ,positive
708894.0,#Premarket Technical Update - Johnson & Johnson Trading Higher,2014-05-05 14:16:00-04:00,JNJ,neutral
708895.0,"Benzinga's M&A Chatter for Tuesday April 29, 2014",2014-04-29 20:07:00-04:00,JNJ,neutral
708896.0,"UPDATE: JNJ, Sanofi Spokespersons Decline Comment on Rumored Contact from Allergan",2014-04-29 10:02:00-04:00,JNJ,neutral
708897.0,"Allergan Could Explore Sale to Sanofi, J&J Instead of Valeant - Bloomberg",2014-04-29 09:23:00-04:00,JNJ,neutral
708898.0,J&J Reports New Collaboration with Stop TB Partnership's Global Drug Facility to Enhance Access to Anti-TB Compound,2014-04-29 08:35:00-04:00,JNJ,negative
708899.0,"3 Mega Cap ETFs For Your Portfolio (MGC, OEF, XLG, AAPL, MSFT)",2014-04-28 14:04:00-04:00,JNJ,neutral
708900.0,Form 8-K from J&J Includes Proxy Materials for Annual Shareholder Meeting,2014-04-25 16:35:00-04:00,JNJ,neutral
708901.0,J&J Raises Qtr. Dividend from $0.66 to $0.70/Share,2014-04-24 10:25:00-04:00,JNJ,neutral
708902.0,FDA Approves J&J's Janssen's Sylvant for Rare Castleman's Disease,2014-04-23 17:35:00-04:00,JNJ,positive
708903.0,Johnson & Johnson Crosses Above $100,2014-04-21 15:54:00-04:00,JNJ,neutral
708904.0,"#PreMarket Primer: Thursday, April 17: Violence In Ukraine Could Deter Thursday's Negotiations",2014-04-17 07:05:00-04:00,JNJ,negative
708905.0,Market Wrap For April 16: Markets Hold On To Gains On Positive Yellen Comments And Economic Data,2014-04-16 16:50:00-04:00,JNJ,positive
708906.0,Mylan Launches First Generic ORTHO EVRA Patch,2014-04-16 16:14:00-04:00,JNJ,neutral
708907.0,UPDATE: Bank of America Reiterates on Johnson & Johnson Following Strong Q1 Performance,2014-04-16 10:02:00-04:00,JNJ,positive
708908.0,UPDATE: Deutsche Bank Reiterates on Johnson & Johnson as Defensive Stock,2014-04-16 09:28:00-04:00,JNJ,neutral
708909.0,"Credit Suisse Maintains Underperform on Johnson & Johnson, Raises PT to $100.00",2014-04-16 07:13:00-04:00,JNJ,positive
708910.0,"Bank of America Maintains Neutral on Johnson & Johnson, Raises PO to $106.00",2014-04-16 07:11:00-04:00,JNJ,negative
708911.0,"#PreMarket Primer: Wednesday, April 16: Chinese GDP Slows, But Surpasses Expectations",2014-04-16 07:03:00-04:00,JNJ,neutral
708912.0,Market Wrap For April 15: Who Doesn't Love A Turnaround?,2014-04-15 16:30:00-04:00,JNJ,negative
708913.0,Mid-Afternoon Market Update: Markets Trade in Highly Volatile Session as Talk of a Pull-Back is Widespread,2014-04-15 15:59:00-04:00,JNJ,neutral
708914.0,#Premarket Prep Technical Update - Johnson & Johnson Trading Sharply Higher,2014-04-15 13:53:00-04:00,JNJ,neutral
708915.0,Mid-Day Market Update: US Stocks Turn Red; Pep Boys Shares Drop After Q4 Results,2014-04-15 12:54:00-04:00,JNJ,neutral
708916.0,The Market Is Not Acting Right,2014-04-15 11:50:00-04:00,JNJ,neutral
708917.0,Mid-Morning Market Update: Markets Gain; Johnson & Johnson Profit Beats Street View,2014-04-15 10:27:00-04:00,JNJ,positive
708918.0,"UPDATE: Johnson & Johnson Shares Rise 2.5% Premarket on Earnings Beat, Raised Guidance",2014-04-15 08:44:00-04:00,JNJ,positive
708919.0,"UPDATE: Johnson & Johnson Posts Upbeat Q1 Earnings, Lifts FY14 Outlook",2014-04-15 08:24:00-04:00,JNJ,neutral
708920.0,"Johnson & Johnson Q1 Xarel Sales $319M, Risperdal $310M, Velcade $408M, Remicade $1.61B",2014-04-15 07:54:00-04:00,JNJ,neutral
708921.0,Johnson & Johnson Raises FY2014 EPS Guidance to $5.80-5.90,2014-04-15 07:46:00-04:00,JNJ,neutral
708922.0,Johnson & Johnson Reports Q1 EPS of $1.54 vs $1.48 Est; Revenue of $18.12B vs $18.0B Est,2014-04-15 07:45:00-04:00,JNJ,neutral
708923.0,"ETF Outlook for Tuesday, April 15, 2014 (EWH, FCG, PSP, HDV)",2014-04-15 07:37:00-04:00,JNJ,neutral
708924.0,"#PreMarket Primer: Tuesday, April 15: Hopes For Diplomacy In Ukraine Help Settle Markets",2014-04-15 07:20:00-04:00,JNJ,positive
708925.0,"Earning, Economic and IPO Calendar for Tuesday April 15, 2014",2014-04-15 06:14:00-04:00,JNJ,neutral
708926.0,"Earnings Scheduled For April 15, 2014",2014-04-15 05:11:00-04:00,JNJ,neutral
708927.0,"Stocks To Watch For April 15, 2014",2014-04-15 04:11:00-04:00,JNJ,neutral
708928.0,"Jefferies Downgrades Johnson & Johnson to Hold, Maintains $105.00 PT",2014-04-14 08:50:00-04:00,JNJ,neutral
708929.0,"#PreMarket Primer: Monday, April 14: Military Action In Ukraine Looking More Likely",2014-04-14 07:14:00-04:00,JNJ,neutral
708930.0,"Earnings Expectations For The Week Of April 14: Coca-Cola, Goldman Sachs, Google And More",2014-04-14 06:33:00-04:00,JNJ,neutral
708931.0,"Benzinga Weekly Preview: Short, But Action Packed Week Ahead",2014-04-11 16:57:00-04:00,JNJ,neutral
708932.0,Top 40 Upcoming Earnings Releases  ,2014-04-11 16:08:00-04:00,JNJ,positive
708933.0,"#PreMarket Primer: Thursday, April 10: Job Creation Will Be China's Main Focus",2014-04-10 07:02:00-04:00,JNJ,positive
708934.0,"#PreMarket Primer: Wednesday, April 9: John Kerry Accuses Russia Of Stirring Trouble In Ukraine",2014-04-09 07:18:00-04:00,JNJ,negative
708935.0,Pharmacyclics Says sNDA for Imbruvica Submitted to US FDA,2014-04-08 08:08:00-04:00,JNJ,neutral
708936.0,Is The Market Still Playing Defense?,2014-04-07 14:24:00-04:00,JNJ,positive
708937.0,J&J's Janssen Submits NDA for Fixed-Dose Combo Tablet of Darunavir with Cobicistat to FDA ,2014-04-01 07:46:00-04:00,JNJ,neutral
708938.0,"Benzinga's M&A Chatter for Monday March 31, 2014",2014-03-31 18:28:00-04:00,JNJ,neutral
708939.0,Market Wrap For March 31: Stocks Rally As Yellen Confirms Support For Economy,2014-03-31 16:37:00-04:00,JNJ,positive
708940.0,Stocks Hitting 52-Week Highs,2014-03-31 10:15:00-04:00,JNJ,neutral
708941.0,UPDATE: J&J Announces Acceptance of Binding Offer from Carlyle Group to Buy Ortho-Clinical Diagnostics for ~$4B,2014-03-31 07:46:00-04:00,JNJ,positive
708942.0,J&J Announces Acceptance of Binding Offer from Carlyle Group to Buy Ortho-Clinical Diagnostics for ~$4B,2014-03-31 07:45:00-04:00,JNJ,positive
708943.0,FDA Okays Janssen's Topamax for Migraine Prevention in Adolescents,2014-03-28 15:38:00-04:00,JNJ,positive
708944.0,Fitch Affirms AAA Rating on J&J; Outlook Stable,2014-03-27 14:58:00-04:00,JNJ,positive
708945.0,"ETFs Shrugging Off The Selling (DHS, SMH, IGF, INTC)",2014-03-27 13:23:00-04:00,JNJ,negative
708946.0,Stocks Hitting 52-Week Highs,2014-03-25 10:14:00-04:00,JNJ,neutral
708947.0,Google Honors Activist Dorothy Height & Her Contributions,2014-03-24 14:56:00-04:00,JNJ,positive
708948.0,AP Reporting J&J $1.2B Judgement Overturned by Arkansas Supreme Court,2014-03-20 10:21:00-04:00,JNJ,positive
708949.0,"J&J's Janssen Investigational Treatment for SchizophreniaShows Positive Efficacy, Delays Relapse",2014-03-20 08:05:00-04:00,JNJ,positive
708950.0,Slap The Floor: Market Playing Defense,2014-03-13 15:01:00-04:00,JNJ,positive
708951.0,JNJ's Janssen Receives Positive Recommendation On Stelara From SMC,2014-03-10 13:18:00-04:00,JNJ,positive
708952.0,Reckitt Benckiser to Acquire K-Y Brand from Mcneil PPC; Terms Not Disclosed,2014-03-10 05:52:00-04:00,JNJ,neutral
708953.0,Cramer Recommends J&J For Best Big Pharma Pipeline Play,2014-03-05 14:38:00-05:00,JNJ,positive
708954.0,J&J Says New Data on XEPLION Significantly Delays Time to Relapse,2014-03-04 09:22:00-05:00,JNJ,neutral
708955.0,What Companies Stand To Benefit From The 86th Academy Awards? ,2014-02-28 13:23:00-05:00,JNJ,positive
708956.0,J&J Files Automatic Mixed Securities Shelf,2014-02-26 16:28:00-05:00,JNJ,positive
708957.0,J&J's Biosense Webster Receives FDA Approval for First Catheer Ablation Therapy,2014-02-25 09:04:00-05:00,JNJ,positive
708958.0,J&J's Cordis Receives CE Mark for Renlane Renal Deneveration System,2014-02-21 09:59:00-05:00,JNJ,neutral
708959.0,EMA Isuses New Compassionate-Use Programme,2014-02-21 08:09:00-05:00,JNJ,neutral
708960.0,"Pharma ETFs On The Move Again (IHE, PJP, PPH, ACT, FRX)",2014-02-20 14:17:00-05:00,JNJ,neutral
708961.0,Jefferies: 3D Printers Are About To Burst Across Many Fields,2014-02-19 15:43:00-05:00,JNJ,neutral
708962.0,Bloomberg Reporting J&J Has Persuaded Judge to Throw Out Suit Related to Vaginal-Mesh Sling,2014-02-18 13:51:00-05:00,JNJ,neutral
708963.0,Market Wrap For February 14: Markets End The Week Positive,2014-02-14 16:50:00-05:00,JNJ,positive
708964.0,UPDATE: Pharmacyclics Announces Will Receive $60M Milestone Payment Related to J&J's Imbruvica Deal,2014-02-12 13:22:00-05:00,JNJ,neutral
708965.0,Shares of Pharmacyclics On the Move Higher Following FDA Okay for Imbruvica,2014-02-12 12:53:00-05:00,JNJ,positive
708966.0,FDA Issues Okay for JanssenMD's Imbruvica for Chronic Lymphcytic Leukemia,2014-02-12 12:48:00-05:00,JNJ,positive
708967.0,An Investor's Guide to Hot In Vitro Diagnostics Market,2014-02-12 11:04:00-05:00,JNJ,neutral
708968.0,Three Steps to Overcoming Losses in a Declining Market,2014-02-06 14:31:00-05:00,JNJ,negative
708969.0,Bloomberg Reporting Judge in J&J Vaginal-Mesh Case Found Co. Improperly Destroyed Documents,2014-02-05 15:12:00-05:00,JNJ,negative
708970.0,Market Wrap For January 30: Markets Focus on Good News,2014-01-30 17:06:00-05:00,JNJ,positive
708971.0,Bloomberg Reporting J&J Escapes $482M Verdict Following Rejection of Patent Appeal,2014-01-27 09:31:00-05:00,JNJ,negative
708972.0,"#PreMarket Primer: Monday, January 27: Markets Open The Week On Edge",2014-01-27 07:16:00-05:00,JNJ,neutral
708973.0,Is It Time To Worry Again?,2014-01-24 14:12:00-05:00,JNJ,negative
708974.0,J&J's Flubendazole Wins FDA Orphan Drug Designation,2014-01-24 11:07:00-05:00,JNJ,positive
708975.0,Court Rules in Favor of Covidien in Ethicon Patent Infringement Lawsuit ,2014-01-23 16:10:00-05:00,JNJ,negative
708976.0,Morgan Stanley Maintains on Johnson & Johnson as 2014 Looks Promising,2014-01-22 09:25:00-05:00,JNJ,positive
708977.0,J&J's Janssen Announces Health Canada Approval for Stelara,2014-01-22 08:05:00-05:00,JNJ,positive
708978.0,"#PreMarket Primer: Wednesday, January 22: Syrian Peace Talks Kick Off Surrounded By Doubt",2014-01-22 07:04:00-05:00,JNJ,positive
708979.0,Market Wrap For January 21: Dow Hit by Earnings; S&P And Nasdaq End The Day Positive,2014-01-21 16:51:00-05:00,JNJ,positive
708980.0,Johnson & Johnson Earnings Recap: Beats Estimates By Four Cents,2014-01-21 14:49:00-05:00,JNJ,neutral
708981.0,Johnson & Johnson Shares Lower After Earnngs,2014-01-21 13:43:00-05:00,JNJ,neutral
708982.0,UPDATE: Johnson & Johnson Posts Higher Q4 Earnings,2014-01-21 10:51:00-05:00,JNJ,neutral
708983.0,Johnson & Johnson Sees FY2014 Sales $73.50B-74.30B vs $73.90B Est,2014-01-21 09:54:00-05:00,JNJ,neutral
708984.0,Johnson & Johnson Sees FY2014 EPS $5.75-5.85 vs $5.85 Est,2014-01-21 07:46:00-05:00,JNJ,neutral
708985.0,Johnson & Johnson Reports Q4 EPS of $1.24 vs $1.20 Est; Revenue of $18.40B vs $17.95B Est,2014-01-21 07:45:00-05:00,JNJ,neutral
708986.0,"#PreMarket Primer: Tuesday, January 21: China's Central Bank Adds Record Amount Of Cash To Markets",2014-01-21 07:09:00-05:00,JNJ,neutral
708987.0,"Earnings Scheduled For January 21, 2014",2014-01-21 04:13:00-05:00,JNJ,neutral
708988.0,"Stocks To Watch For January 21, 2014",2014-01-21 04:04:00-05:00,JNJ,neutral
708989.0,Economic Outlook For The Week of January 20: How To Trade With Binary Options  ,2014-01-20 10:36:00-05:00,JNJ,neutral
708990.0,"Earnings Expectations For The Week Of January 20: Microsoft, McDonald's, Netflix And More",2014-01-19 13:27:00-05:00,JNJ,neutral
708991.0,Benzinga Weekly Preview: Earnings Season Continues,2014-01-18 09:28:00-05:00,JNJ,neutral
708992.0,J&J's Janssen Confirms FDA Panel Votes Against Approval of XARELTO for Use in Patients with ACS,2014-01-16 16:48:00-05:00,JNJ,positive
708993.0,FDA Advisory Panel Votes 10-0 J&J/Bayer's Xarelto Should NOT Be Approved,2014-01-16 15:55:00-05:00,JNJ,negative
708994.0,J&J Announces Binding Offer from Carlyle Group to Buy Ortho-Clinical Diagnostics Unit for $4.15B,2014-01-16 07:45:00-05:00,JNJ,neutral
708995.0,UPDATE: J&J Could Sell Ortho Unit to Carlyle for $4B,2014-01-15 15:28:00-05:00,JNJ,neutral
708996.0,Bloomberg Reporting J&J Could Announce Deal with Carlyle as Soon as Tomorrow (Thursday),2014-01-15 15:27:00-05:00,JNJ,neutral
708997.0,WSJ Reporting Carlyle Paying $4-4.2B for J&J's Blood-Testing Unit,2014-01-15 12:54:00-05:00,JNJ,neutral
708998.0,"Carlyle Paying $4B-$4.2B for J&J Blood-Testing Unit, According to Sources -DJ",2014-01-15 12:18:00-05:00,JNJ,neutral
708999.0,Market Wrap For January 14: Markets Rebound On Earnings Season Kickoff,2014-01-14 17:19:00-05:00,JNJ,neutral
709000.0,Reuters Reporting Carlyle Readying $3.7B in Financing for Bid for J&J Unit,2014-01-13 16:36:00-05:00,JNJ,neutral
709001.0,Market Consolidates Ahead Of Major Earnings Reports    ,2014-01-13 13:26:00-05:00,JNJ,neutral
709002.0,"Barclays Downgrades Johnson & Johnson to Equalweight, Maintains $99.00 PT",2014-01-10 08:54:00-05:00,JNJ,neutral
709003.0,Market Wrap For January 9: All Eyes on Tomorrow's Job Report,2014-01-09 16:43:00-05:00,JNJ,neutral
709004.0,"Jefferies Upgrades Johnson & Johnson to Buy, Raises PT to $108.00",2014-01-09 08:20:00-05:00,JNJ,neutral
709005.0,Procter & Gamble vs. Johnson & Johnson: Which is the Better Bet?,2014-01-08 15:42:00-05:00,JNJ,positive
709006.0,Johnson & Johnson: Off To A Good Start In 2014,2014-01-08 13:08:00-05:00,JNJ,positive
709007.0,Market Wrap For January 7: Markets Reverse 3-Day Slump,2014-01-07 16:39:00-05:00,JNJ,neutral
709008.0,UPDATE: RBC Capital Markets Upgrades Johnson & Johnson,2014-01-07 10:50:00-05:00,JNJ,neutral
709009.0,J&J Says IDMC Recommends Early Stopping of Pharmacyclics' Phase 3 Study,2014-01-07 09:43:00-05:00,JNJ,positive
709010.0,"RBC Capital Upgrades Johnson & Johnson to Outperform, Raises PT to $104.00",2014-01-07 07:57:00-05:00,JNJ,neutral
709011.0,"Stocks to Watch for December 27, 2013",2013-12-27 11:44:00-05:00,JNJ,neutral
709012.0,Hearing Carlyle Group Favorite to Acquire Johnson & Johnson's Clinical Diagnostics Unit -Sources,2013-12-23 15:34:00-05:00,JNJ,positive
709013.0,EMA Issues Positive Opinion on Bedaquiline,2013-12-20 07:09:00-05:00,JNJ,positive
709014.0,GlaxoSmithKline Rocked By China Bribery Scandal,2013-12-19 15:48:00-05:00,JNJ,negative
709015.0,"Orion Signs License Pact with Janssen Pharma for Alzheimer's Treatment, Will Receive Upfront Payment of $31M",2013-12-19 12:55:00-05:00,JNJ,neutral
709016.0,Which Companies Hoarded The Most Cash In 2013?,2013-12-18 13:53:00-05:00,JNJ,neutral
709017.0,"UPDATE: EMA Says Will Discuss Voluntary Withdrawal of Janssen's Doribax, Risk-Benefit Balance of ARIAD's Iclusig",2013-12-17 11:55:00-05:00,JNJ,neutral
709018.0,FDA Issues Complete Response Letter for Canagliflozin/Metformin Fixed-Dose Combination Therapy for Type 2 Diabetes,2013-12-12 17:30:00-05:00,JNJ,neutral
709019.0,Johnson & Johnson Shares Under Pressure For Second Day in a Row,2013-12-12 12:48:00-05:00,JNJ,neutral
709020.0,Myriad Genetics Announces Collaboration With Janssen ,2013-12-09 07:01:00-05:00,JNJ,neutral
709021.0,"FDA Announces $1.25M Settlement with J&J's Advanced Sterilization Products, Execs",2013-12-04 16:50:00-05:00,JNJ,positive
709022.0,"J&J Files for Two-Part Note Offering via BofA, Goldman, JP Morgan",2013-12-02 08:57:00-05:00,JNJ,positive
709023.0,J&J Says May Pay $1B in Medical Costs Related to Hip Settlement,2013-11-27 11:48:00-05:00,JNJ,negative
709024.0,"Benzinga's M&A Chatter for Monday November 25, 2013",2013-11-25 17:41:00-05:00,JNJ,neutral
709025.0,Form 8-K from Vertex Pharma Shows J&J's Janssen Will Make $152M Payment Related to Incivo Sales Royalties During Q4,2013-11-22 16:22:00-05:00,JNJ,neutral
709026.0,Reuters Reporting J&J Has Chosen Two Possible Bidders for its Diagnostics Unit Sale,2013-11-21 15:50:00-05:00,JNJ,neutral
709027.0,"Hearing Carlyle Group, Danaher, Blackstone Group in Final Stage of Negotiations for J&J's Diagnostics Unit, According to Sources",2013-11-21 15:46:00-05:00,JNJ,neutral
709028.0,"Market Wrap For November 20: Inflation Data Points To ""No"" Tapering, Fed Meeting Notes Points To ""Yes"" Tapering",2013-11-20 17:02:00-05:00,JNJ,neutral
709029.0,J&J's Janssen Says Galexos Approved by CAnada Priority Review,2013-11-20 07:49:00-05:00,JNJ,positive
709030.0,Vertex Sells INCIVO Product Royalty Rights to  Janssen Pharmaceutica for $152M,2013-11-20 05:46:00-05:00,JNJ,neutral
709031.0,Bloomberg Reporting J&J Will Pay $2.47B to Settle First Round of Hip Suits,2013-11-19 17:06:00-05:00,JNJ,negative
709032.0,WSJ Breaking News Tweets: 'Johnson & Johnson has agreed to pay at least $2.5 billion to settle hip lawsuits.',2013-11-19 09:37:00-05:00,JNJ,positive
709033.0,Top Four Overlooked Stocks for Income-Seeking Investors,2013-11-18 09:36:00-05:00,JNJ,positive
709034.0,Bloomberg Reporting J&J Said Set to Announce ASR Hip-Implant Settlement on Nov. 19th,2013-11-15 16:09:00-05:00,JNJ,neutral
709035.0,"#PreMarket Primer: Thursday, November 14: Markets Primed For Yellen's Big Day",2013-11-14 06:40:00-05:00,JNJ,neutral
709036.0,Pharmacyclics Resumes Trading,2013-11-13 13:10:00-05:00,JNJ,neutral
709037.0,UPDATE: Pharmacyclics Will Hold 1PM Call to Discuss FDA Approval of IMBRUVICA,2013-11-13 12:46:00-05:00,JNJ,positive
709038.0,"Pharmacyclics, J&J's Janssen Now Confirming FDA Approval of IMBRUVICA",2013-11-13 12:42:00-05:00,JNJ,positive
709039.0,Pharmacyclics Halted News Pending,2013-11-13 12:20:00-05:00,JNJ,neutral
709040.0,FDA Approves Ibrutinib for MCL,2013-11-13 12:20:00-05:00,JNJ,positive
709041.0,October Job Numbers a Tale of Two Economies,2013-11-13 10:36:00-05:00,JNJ,neutral
709042.0,Bloomberg Reporting J&J Said to Reach $4B Deal to Settle Hip-Implant Suits,2013-11-12 15:50:00-05:00,JNJ,neutral
709043.0,"Johnson & Johnson, Amazon at Odds Over 3rd Party Sales",2013-11-11 14:20:00-05:00,JNJ,positive
709044.0,Why Did Institutions Sell 29 Million Apple Shares?,2013-11-11 10:14:00-05:00,JNJ,positive
709045.0,Market Wrap For November 8: Markets Erase Thursday's Losses; Dow Companies Dominate Headlines,2013-11-08 16:57:00-05:00,JNJ,negative
709046.0,Johnson & Jonhson Unit Could Fetch Over $4 Billion in Sale ,2013-11-08 14:07:00-05:00,JNJ,neutral
709047.0,"#PreMarket Primer: Tuesday, November 5: Fed Speakers Calm Taper Nerves",2013-11-05 06:39:00-05:00,JNJ,positive
709048.0,"J&J, Gilead Report HCV Combo Shows 93% SVR12 Rate Prior Null Responders, Says Medivir Showed No Benefit from Ribavirin, 12-Week Regimen Similar to 24",2013-11-04 16:34:00-05:00,JNJ,positive
709049.0,J&J Said to Pay More Than $2.2 Billion in Risperdal Accord ,2013-11-04 13:05:00-05:00,JNJ,negative
709050.0,"US DoJ Says J&J Will Pay $2.2B+ Related to Drug Cases, Co. Has Admitted to Promoting Risperdal for Non-Schizophrenic Uses",2013-11-04 11:21:00-05:00,JNJ,positive
709051.0,Bloomberg Reporting J&J's Settlement Related to Risperdal Said to Be Announced Today,2013-11-04 10:33:00-05:00,JNJ,neutral
709052.0,DJ Reporting J&J to Pay $2B to Settle Marketing Probes,2013-11-04 10:01:00-05:00,JNJ,negative
709053.0,J&J's Janssen Must Pay $4.02M Related to Topamax Seizure Case,2013-10-30 14:47:00-04:00,JNJ,negative
709054.0,First Trial Related to J&J's Janssen Product Topamax Seizure Drug Goes to Jury Today,2013-10-30 13:19:00-04:00,JNJ,neutral
709055.0,"#PreMarket Primer: Tuesday, October 29: Fed Meeting Likely Uneventful",2013-10-29 06:47:00-04:00,JNJ,neutral
709056.0,Think Silver: Top Stocks Catering to Seniors,2013-10-28 17:43:00-04:00,JNJ,positive
709057.0,J&J's Janssen Reports Nearly 70% on Simponi Aria at Two Years Had ACR 20 Response,2013-10-28 08:13:00-04:00,JNJ,neutral
709058.0,"Market Primer: Wednesday, October 16: Markets Wobble On Debt Deal Setback",2013-10-16 06:49:00-04:00,JNJ,negative
709059.0,"Market Wrap For Tuesday, October 15: Earnings Reports And White House Progress Send Markets Down",2013-10-15 16:36:00-04:00,JNJ,positive
709060.0,"PreMarket Info Recap for October 15, 2013: Earnings Kick Off Tuesday",2013-10-15 09:28:00-04:00,JNJ,neutral
709061.0,UPDATE: Johnson & Johnson Posts Higher Q3 Profit,2013-10-15 08:21:00-04:00,JNJ,positive
709062.0,Benzinga's Top Pre-Market Gainers,2013-10-15 08:09:00-04:00,JNJ,positive
709063.0,"UPDATE: J&J Reported Q3 Remicade Sales $1.69B, Zytiga Sales $464M, Prezista $410M, Velcade $404M, Stelara $370M, Risperdal Consta $326M",2013-10-15 07:59:00-04:00,JNJ,neutral
709064.0,Johnson & Johnson Raises FY2013 EPS Guidance from $5.40-5.47 to $5.44-5.49 vs $5.46 Est,2013-10-15 07:50:00-04:00,JNJ,neutral
709065.0,Johnson & Johnson Reports Q3 EPS of $1.36 vs $1.32 Est; Revenue of $17.60B vs $17.42B Est; Raises Outlook,2013-10-15 07:45:00-04:00,JNJ,neutral
709066.0,"ETF Outlook for October 15, 2013 (IHE, ITB, EWZ, SMH)",2013-10-15 06:57:00-04:00,JNJ,neutral
709067.0,"Market Primer: Tuesday, October 15: Tuesday Could Be 'Deal Day'",2013-10-15 06:50:00-04:00,JNJ,neutral
709068.0,"Earnings Scheduled For October 15, 2013",2013-10-15 04:56:00-04:00,JNJ,neutral
709069.0,"Stocks To Watch For October 15, 2013",2013-10-15 04:33:00-04:00,JNJ,neutral
709070.0,"Earnings Expectations For The Week Of October 14: Financials, Tech and Consumer Goods",2013-10-13 13:13:00-04:00,JNJ,neutral
709071.0,Benzinga Weekly Preview: Earnings Season Gets Into Full Swing,2013-10-11 16:29:00-04:00,JNJ,neutral
709072.0,UPDATE: Goldman Sachs Upgrades Johnson & Johnson Based on Solid Pharma Business,2013-10-11 10:24:00-04:00,JNJ,positive
709073.0,Benzinga's Top Upgrades,2013-10-11 07:21:00-04:00,JNJ,positive
709074.0,US Stock Futures Up; J.P. Morgan Earnings In Focus,2013-10-11 07:13:00-04:00,JNJ,neutral
709075.0,"Goldman Sachs Upgrades Johnson & Johnson to Neutral, Raises PT to $95.00",2013-10-11 06:28:00-04:00,JNJ,neutral
709076.0,J&J's Janssen Buys Investigational NS5A Inhibitor from Glaxo,2013-10-08 08:03:00-04:00,JNJ,negative
709077.0,"Playing Momentum With ETFs (PDP, PIE, MTUM)",2013-10-07 15:52:00-04:00,JNJ,positive
709078.0,J&J Says Boehringer Doxil Dispute May Cause Year-Long Shortage,2013-10-01 11:57:00-04:00,JNJ,negative
709079.0,"Form 8-K from Endocyte Shows Janssen Pharma Informed Co. of Estimated Doxil Supply Interruption, Sees Sufificient Doxil Supply to Support Patients on Trials",2013-09-26 16:45:00-04:00,JNJ,positive
709080.0,"BioMarin, Celgene Lead Trend in Biotech Short Interest (BRMN, CELG, REGN)",2013-09-25 12:52:00-04:00,JNJ,positive
709081.0,Write A Prescription For Health Care ETFs,2013-09-19 08:06:00-04:00,JNJ,positive
709082.0,Johnson and Johnson near Major Resistance Level,2013-09-18 14:31:00-04:00,JNJ,neutral
709083.0,"Alexion, Pharmacyclics Buck Trend in Biotech Short Interest (ALXN, CELG, PCYC)",2013-09-14 11:47:00-04:00,JNJ,positive
709084.0,Some New ETFs Off To Impressive Starts,2013-09-12 13:18:00-04:00,JNJ,positive
709085.0,"Duke Energy, VIVUS And Others Insiders Have Been Buying",2013-09-07 15:22:00-04:00,JNJ,positive
709086.0,AP Reporting J&J Has Recalled 200K Bottles of Infant Motrin,2013-09-06 16:13:00-04:00,JNJ,neutral
709087.0,DJ Reporting J&J Rumored to Hold Talks to Sell Diagnostics Unit,2013-09-06 13:10:00-04:00,JNJ,neutral
709088.0,Plenty Of ETFs With Favorable Risk Traits,2013-08-30 07:59:00-04:00,JNJ,positive
709089.0,"Short Interest In Celgene, Onyx Continues To Shrink (CELG, ONXX, VRTX)",2013-08-27 13:29:00-04:00,JNJ,positive
709090.0,"Hearing Symbols Impacted by Options Issues: IBKR, IVZ, JLL, JNJ, JNPR, JOE, JOY, JPM, JWN, K, KBR, KEY",2013-08-20 12:23:00-04:00,JNJ,positive
709091.0,J&J Closes Purchase of Aragon Pharma,2013-08-19 16:30:00-04:00,JNJ,neutral
709092.0,Nordstrom Joins UBS List Of Top Dividend Payers,2013-08-17 12:01:00-04:00,JNJ,positive
709093.0,Has Johnson & Johnson Peaked? Time to Book Profits?,2013-08-15 11:22:00-04:00,JNJ,positive
709094.0,"UPDATE: Berkshire Hathaway Shows Increased Stakes In American Express, ConocoPhillips, Costco, Davita Healthcare, Deere, DirecTV, GE, GM, GlaxoSmithKline, J&J, Liberty Media, M&T Bank",2013-08-15 07:14:00-04:00,JNJ,positive
709095.0,How Much Does It Cost To Develop A New Drug?,2013-08-14 09:32:00-04:00,JNJ,neutral
709096.0,Royalty Pharma Partners with Aisling Capital and Clarus Ventures in Recent Ibrutinib Royalty Purchase ,2013-08-12 07:03:00-04:00,JNJ,neutral
709097.0,"Johnson and Johnson Wins Appeal Over Rembrandt's Contact Lens Patent, Court Says JNJ Did Not Infringe On Patent",2013-08-07 11:37:00-04:00,JNJ,positive
709098.0,Buyback ETF Defies Logic,2013-08-06 09:22:00-04:00,JNJ,neutral
709099.0,Biotechnology Stock Wins,2013-08-05 10:41:00-04:00,JNJ,positive
709100.0,Deferred Tax Assets and Liabilities,2013-08-05 09:38:00-04:00,JNJ,neutral
709101.0,Is Procter & Gamble a Strategic Bet?,2013-08-05 09:16:00-04:00,JNJ,neutral
709102.0,S&P: Heaping Praise For Some Health Care ETFs,2013-08-02 16:00:00-04:00,JNJ,positive
709103.0,"Three Soaring, But Overlooked Health Care ETFs",2013-08-02 14:19:00-04:00,JNJ,positive
709104.0,SLIDESHOW: 8 Stocks to Benefit From a Repatriation Deal In Congress,2013-07-30 13:06:00-04:00,JNJ,positive
709105.0,"FDA Issues Warning on J&J's Nizoral Tablets, Says Could Cause Severe Liver Injuries, Could Have Harmful Interactions with Medications",2013-07-26 10:08:00-04:00,JNJ,negative
709106.0,Rookie ETF Offers Exposure to Rising EM Dividends,2013-07-19 16:29:00-04:00,JNJ,neutral
709107.0,J&J Agrees to Pay $22.9M to Settle Case Over Drug Recalls,2013-07-17 16:48:00-04:00,JNJ,positive
709108.0,UPDATE: Citigroup Raises PT on Johnson & Johnson Following Good 2Q Results,2013-07-17 10:43:00-04:00,JNJ,positive
709109.0,UPDATE: Deutsche Bank Downgrades Johnson & Johnson on Valuation,2013-07-17 08:27:00-04:00,JNJ,neutral
709110.0,Benzinga's Top Downgrades,2013-07-17 07:42:00-04:00,JNJ,positive
709111.0,A Peek Into The Market Before The Trading Starts,2013-07-17 07:41:00-04:00,JNJ,neutral
709112.0,"Deutsche Bank Downgrades Johnson & Johnson to Hold, Raises PT to $93.00",2013-07-17 06:41:00-04:00,JNJ,neutral
709113.0,"Benzinga Market Primer: Wednesday, July 17: Bernanke Is Back",2013-07-17 06:30:00-04:00,JNJ,neutral
709114.0,Eli Lilly Tries Again with Alzheimer's Drug as the Race for a Cure Continues (LLY),2013-07-16 11:30:00-04:00,JNJ,neutral
709115.0,UPDATE: Johnson & Johnson Posts Upbeat Q2 Profit,2013-07-16 08:34:00-04:00,JNJ,positive
709116.0,"UPDATE: Johnson and Johnson Q2 EPS Includes Gain On Sale of Elan Stake, Saw Negative Currency Impact of 0.9%",2013-07-16 07:51:00-04:00,JNJ,negative
709117.0,Johnson & Johnson Raises FY2013 EPS Guidance from $5.35-5.45 to $5.40-5.47 vs $5.42 Est,2013-07-16 07:49:00-04:00,JNJ,neutral
709118.0,Johnson & Johnson Reports Q2 EPS of $1.48 vs $1.39 Est; Revenue of $17.90B vs $17.71B Est; Raising Guidance,2013-07-16 07:48:00-04:00,JNJ,neutral
709119.0,"Benzinga Market Primer: Tuesday, July 16: Futures Flat Ahead of Earnings",2013-07-16 06:35:00-04:00,JNJ,neutral
709120.0,"US Stock Futures Edge Higher; Goldman Sachs Earnings, CPI In Focus",2013-07-16 06:18:00-04:00,JNJ,neutral
709121.0,"Earnings Scheduled For July 16, 2013",2013-07-16 05:06:00-04:00,JNJ,neutral
709122.0,"Stocks To Watch For July 16, 2013",2013-07-16 05:01:00-04:00,JNJ,neutral
709123.0,Health Care ETFs Looking Healthy Ahead of Earnings,2013-07-15 15:43:00-04:00,JNJ,positive
709124.0,Earnings Expectations for the Week of July 15,2013-07-14 20:43:00-04:00,JNJ,neutral
709125.0,A Look Ahead: This Week's ETFs to Watch,2013-07-14 20:34:00-04:00,JNJ,neutral
709126.0,Weekly Preview: Earnings Back With A Bang,2013-07-12 16:47:00-04:00,JNJ,neutral
709127.0,UPDATE: Jefferies Raises PT on Johnson & Johnson on Challenges Ahead,2013-07-12 08:49:00-04:00,JNJ,positive
709128.0,"Jefferies Maintains Hold on Johnson & Johnson, Raises PT to $92.00",2013-07-12 07:26:00-04:00,JNJ,neutral
709129.0,"Earnings Expectations for the Week of July 8 (AA, JPM, WFC)",2013-07-07 20:02:00-04:00,JNJ,neutral
709130.0,5 Healthcare Stocks With The Highest Revenue,2013-07-05 07:27:00-04:00,JNJ,neutral
709131.0,ETFs For an Onyx Takeover Battle,2013-07-01 13:02:00-04:00,JNJ,negative
709132.0,Barron's Recap: World's Most Respected Companies,2013-06-30 20:37:00-04:00,JNJ,positive
709133.0,"Short Interest in Biogen Idec and Vertex Shrinks (BIIB, CELG, VRTX)",2013-06-26 13:17:00-04:00,JNJ,positive
709134.0,"Abbott Wins Appeal in Heart Stent Dispute with J&J, Pfizer",2013-06-26 11:12:00-04:00,JNJ,positive
709135.0,Rising 10-Year Yields Could Crush Popular Dividend ETFs,2013-06-21 13:21:00-04:00,JNJ,positive
709136.0,One Simple Measure for Investing in a Volatile Market,2013-06-18 09:28:00-04:00,JNJ,neutral
709137.0,"Benzinga's M&A Chatter for Monday June 17, 2013",2013-06-17 17:33:00-04:00,JNJ,neutral
709138.0,"Market Wrap for Monday, June 17: Stocks Jump to Start Trading Week; Dow Rallies Triple Digits ",2013-06-17 16:21:00-04:00,JNJ,neutral
709139.0,Siemens to Create Companion Diganostic Test for In-Development Janssen Heart Failure Drug,2013-06-17 09:02:00-04:00,JNJ,negative
709140.0,UPDATE: Johnson & Johnson Announces Definitive Agreement To Acquire Aragon Pharma For $650M; Includes Contingent for Possible Additional Payments of up to $350M,2013-06-17 08:03:00-04:00,JNJ,positive
709141.0,"J&J Announces Definitive Deal to Buy Aragon Pharma, to Make $650M Upfront Payment",2013-06-17 08:02:00-04:00,JNJ,neutral
709142.0,"Bloomberg Reporting a J&J Spokesperson Has Said the Company Sold 25.4M Elan Shares Today, This Would Be Nearly Entire Stake",2013-06-13 17:21:00-04:00,JNJ,positive
709143.0,J&J's Janssen Issues Research Study Results for Simponi in Active RA,2013-06-12 08:11:00-04:00,JNJ,positive
709144.0,UPDATE: Jefferies Lowers PT on Johnson & Johnson Following Global Pharma Review,2013-06-07 12:31:00-04:00,JNJ,negative
709145.0,"Jefferies Maintains Hold on Johnson & Johnson, Lowers PT to $91.00",2013-06-07 07:50:00-04:00,JNJ,negative
709147.0,"J&J Innovation Announces Opening of California Innovation Center, Janssen, Second Genome Announce Deal on Microbiome Drug Discovery",2013-06-05 08:04:00-04:00,JNJ,positive
709148.0,"With Bond Yields So Low, Reluctant Investors Are Now Making the Move into These Stocks",2013-06-04 09:44:00-04:00,JNJ,negative
709149.0,"CVR Energy, Warner Chilcott and Other Top Performers in May",2013-06-02 09:35:00-04:00,JNJ,positive
709150.0,Valeant Pharmaceuticals to Buy Bausch & Lomb,2013-05-28 12:20:00-04:00,JNJ,neutral
709151.0,UPDATE: Jefferies Raises PT on Johnson & Johnson Following SOTP Analysis,2013-05-28 10:49:00-04:00,JNJ,neutral
709152.0,"Jefferies Maintains Hold on Johnson & Johnson, Raises PT to $97.00",2013-05-28 08:28:00-04:00,JNJ,neutral
709153.0,"J&J's Janssen Poised to Continue Driving Growth, Outlines 10+ Potential New Product Filings by 2017",2013-05-23 07:33:00-04:00,JNJ,positive
709154.0,"J&J's Janssen Announces Primary Efficacy, Safety Findings from Phase 3 Study of Simeprevir Once Daily",2013-05-21 08:18:00-04:00,JNJ,positive
709155.0,How Understanding the Investment Climate Equals Stock Market Success,2013-05-20 09:34:00-04:00,JNJ,positive
709156.0,Johnson & Johnson Stops Selling Metal Liners in Metal on Metal Hip Replacement Product; Says Decision Stemmed From Low Sales -Bloomberg,2013-05-16 13:29:00-04:00,JNJ,negative
709157.0,"Short Interest in Vertex Rises, in Celgene Falls",2013-05-11 10:45:00-04:00,JNJ,positive
709158.0,S&P Highlights Biotech ETFs,2013-05-10 07:39:00-04:00,JNJ,neutral
709159.0,DJ Reporting J&J Potential $2.2B Settlement with DoJ Help Up,2013-05-09 14:52:00-04:00,JNJ,positive
709160.0,Stock Market Fake-Out: Where Is the Retrenchment?,2013-05-08 12:47:00-04:00,JNJ,neutral
709161.0,Top 4 NYSE Stocks In The Drug Manufacturers-Major Industry With The Lowest PEG Ratio,2013-05-08 04:51:00-04:00,JNJ,negative
709162.0,Three Top Performing Healthcare Stocks to Watch,2013-05-06 15:53:00-04:00,JNJ,positive
709163.0,"DJ Reporting J&J Recalls All Children's Tylenol in South Korea, Recall Doesn't Affect US Products",2013-05-03 15:27:00-04:00,JNJ,neutral
709164.0,Earnings Trigger Volume Spike in Pharma ETF,2013-05-01 14:41:00-04:00,JNJ,neutral
709165.0,Daratumumab Receives Breakthrough Therapy Designation in Double Refractory Multiple Myeloma from U.S. Food and Drug Administration,2013-05-01 12:08:00-04:00,JNJ,neutral
709166.0,"First Manhattan Responds to VIVUS Board Additions, Says Board Still Needs Overhaul",2013-05-01 08:49:00-04:00,JNJ,neutral
709167.0,Form 8-K: J&J Holders Didn't Okay Holder Bid Related to Independent Chair,2013-04-26 16:43:00-04:00,JNJ,negative
709168.0,"Short Sellers Move into Celgene, Regeneron",2013-04-26 13:25:00-04:00,JNJ,neutral
709169.0,"Yes, This ETF Offers Dividend Growth",2013-04-25 14:00:00-04:00,JNJ,positive
709170.0,Johnson & Johnson Announces Dividend Increase of 8.2% to $0.66 per Share,2013-04-25 10:38:00-04:00,JNJ,positive
709171.0,J&J Raises Qtr. Dividend from $0.61 to $0.66/Share,2013-04-25 10:37:00-04:00,JNJ,neutral
709172.0,Go Beyond Large-Cap ETFs For Dividends,2013-04-22 15:06:00-04:00,JNJ,neutral
709173.0,Non-Streak Dividend ETFs Impress,2013-04-19 13:56:00-04:00,JNJ,positive
709174.0,"UPDATE: Jefferies Raises PT on Johnson & Johnson on Unimpressive Q1'13 Earnings, But Strong Sentiment",2013-04-19 10:13:00-04:00,JNJ,positive
709175.0,"Jefferies Maintains Hold on Johnson & Johnson, Raises PT to $90.00",2013-04-19 07:38:00-04:00,JNJ,neutral
709176.0,iShares Bolsters Factor ETF Lineup With 5 New Funds,2013-04-18 14:03:00-04:00,JNJ,neutral
709177.0,"UPDATE: J&J's Janssen to Get $11.25 Per Elan Share, to Record Gain ~$213M in Q2 from Sale",2013-04-18 09:55:00-04:00,JNJ,positive
709178.0,J&J Reports Sale of 82M Elan ADS Held by Janssen Pharma,2013-04-18 09:51:00-04:00,JNJ,neutral
709179.0,Fitch Affirms J&J IDRs at AAA/F1+; Outlook Stable,2013-04-17 09:53:00-04:00,JNJ,positive
709180.0,"Benzinga Market Primer: Wednesday, April 17",2013-04-17 06:45:00-04:00,JNJ,neutral
709181.0,Johnson & Johnson Rises on Healthy Earnings,2013-04-16 10:17:00-04:00,JNJ,positive
709182.0,UPDATE: Johnson & Johnson Posts Drop In Q1 Profit,2013-04-16 09:30:00-04:00,JNJ,positive
709183.0,From J&J Call: Sees FY13 Sales $70.4B-71.1B vs $71.1B Est,2013-04-16 09:06:00-04:00,JNJ,neutral
709184.0,Johnson & Johnson Reports Q1 EPS of $1.44 vs $1.40 Est; Revenue of $17.50B vs $17.46B Est,2013-04-16 07:45:00-04:00,JNJ,neutral
709185.0,"Benzinga Market Primer: Tuesday, April 16",2013-04-16 06:31:00-04:00,JNJ,neutral
709186.0,US Stock Futures Signal Higher Start On Wall Street,2013-04-16 06:18:00-04:00,JNJ,neutral
709187.0,"Earnings Scheduled For April 16, 2013",2013-04-16 04:13:00-04:00,JNJ,neutral
709188.0,"Stocks To Watch For April 16, 2013",2013-04-16 03:36:00-04:00,JNJ,neutral
709189.0,Lawyer Says J&J Jury Should Award $5M for Defective Hip,2013-04-15 15:13:00-04:00,JNJ,positive
709190.0,Earnings Expectations for the Week of April 15,2013-04-14 19:58:00-04:00,JNJ,neutral
709191.0,A Look Ahead: This Week's ETFs to Watch ,2013-04-14 19:52:00-04:00,JNJ,neutral
709192.0,Weekly Preview: Earnings Season Kicks Into High Gear,2013-04-12 16:24:00-04:00,JNJ,neutral
709193.0,"Deutsche Bank Maintains Buy on Johnson & Johnson, Raises PT to $87.00",2013-04-12 07:28:00-04:00,JNJ,neutral
709194.0,ETF Showdown: A Pharma Fight,2013-04-11 16:21:00-04:00,JNJ,negative
709195.0,S&P Bullish on an Array of Dividend ETFs,2013-04-11 12:41:00-04:00,JNJ,neutral
709196.0,"Short Sellers Move Out of Amgen, Celgene, Pharmacyclics",2013-04-10 13:30:00-04:00,JNJ,neutral
709197.0,UPDATE: Jefferies Raises PT on Johnson & Johnson on Attractive Valuation,2013-04-10 12:11:00-04:00,JNJ,positive
709198.0,"Jefferies Maintains Hold on Johnson & Johnson, Raises PT to $85.00",2013-04-10 08:04:00-04:00,JNJ,neutral
709199.0,Johnson & Johnson Receives Positive Mad Money/Jim Cramer Mention -CNBC,2013-04-08 19:15:00-04:00,JNJ,positive
709200.0,"JNJ Finds Support AT 20 EMA $80.29, MACD Forming a Bearish Cross, RSI Retreats Out Of Overbought Territory",2013-04-08 12:38:00-04:00,JNJ,positive
709201.0,Benzinga's Top Pre-Market Losers,2013-04-08 08:50:00-04:00,JNJ,negative
709202.0,UPDATE: J.P. Morgan Downgrades Johnson & Johnson to Neutral on Trading Premium,2013-04-08 08:24:00-04:00,JNJ,neutral
709203.0,"JP Morgan Downgrades Johnson & Johnson to Neutral, Raises PT to $83.00",2013-04-08 06:06:00-04:00,JNJ,positive
709204.0,Earnings Expectations for the Week of April 8,2013-04-07 14:25:00-04:00,JNJ,neutral
709205.0,"Four Dow Components Due for a Dividend Hike (CVX, XOM, IBM, JNJ)",2013-04-04 12:41:00-04:00,JNJ,neutral
709206.0,"J&J Wins Reversal of $482M Patent Verdict Over Stents, Judge SAys J&J Didnt' Infringe Doctor's Patent",2013-04-04 11:07:00-04:00,JNJ,positive
709207.0,FDA Approves J&J's Invokana Tablets for Adults with Type 2 Diabetes,2013-03-29 15:23:00-04:00,JNJ,positive
709208.0,"Short Sellers Dump Amgen, Focus on Celgene, Gilead Sciences",2013-03-28 08:18:00-04:00,JNJ,negative
709209.0,Embrace These 2 Mega-Cap ETFs,2013-03-26 17:19:00-04:00,JNJ,positive
709210.0,13 Drugs Pending FDA Approval in 2013,2013-03-26 13:19:00-04:00,JNJ,positive
709211.0,Risk On Rally? These ETFs Say No,2013-03-26 11:37:00-04:00,JNJ,negative
709212.0,"UBS Maintains Buy on Johnson & Johnson, Raises PT to $87.00",2013-03-26 09:38:00-04:00,JNJ,neutral
709213.0,What Type of Dividend ETFs Are Winning in 2013?,2013-03-25 13:49:00-04:00,JNJ,positive
709214.0,LifeScan Announces Voluntary Recall of All OneTouch Verio IQ Blood Glucose Meters,2013-03-25 08:49:00-04:00,JNJ,neutral
709215.0,Johnson & Johnson's Quest to Knock Botox off the Pedestal ,2013-03-22 14:51:00-04:00,JNJ,neutral
709216.0,S&P Likes a Pair of Low Vol ETFs,2013-03-19 13:44:00-04:00,JNJ,positive
709217.0,PowerShares Low Volatility ETF Tops $4B in AUM,2013-03-18 11:58:00-04:00,JNJ,positive
709218.0,"Short Interest Swings in Biotech Stocks (AMGN, CELG, PCYC)",2013-03-12 13:19:00-04:00,JNJ,positive
709219.0,"J&J's Cordis Buys Flexible Stenting Solutions, No Terms Disclosed",2013-03-12 09:12:00-04:00,JNJ,positive
709220.0,Are Scientists Edging Closer to a Cure for Alzheimer's?,2013-03-11 08:58:00-04:00,JNJ,neutral
709221.0,UPDATE: J&J Did Not Fail to Warn But Must Pay $8.3M in Damages in Hip Case,2013-03-08 12:49:00-05:00,JNJ,negative
709222.0,California Jury Finds J&J Defectively Designed ASR Hip Device,2013-03-08 12:45:00-05:00,JNJ,negative
709223.0,"J&J Hip Implant Jury Has Reached Verdict in Montana Case, to Read Verdict at 9:30AM PST",2013-03-08 12:23:00-05:00,JNJ,positive
709224.0,J&J's Janssen Launches EXPLORER Research Program,2013-03-08 07:33:00-05:00,JNJ,neutral
709225.0,3 Sector ETFs Outpacing Larger Rivals,2013-03-06 13:39:00-05:00,JNJ,neutral
709226.0,3 International Dividend ETFs Your Broker Forgot to Mention,2013-03-06 12:45:00-05:00,JNJ,neutral
709227.0,Hedging The Dow At Its All-Time High,2013-03-06 08:29:00-05:00,JNJ,neutral
709228.0,An HIV Cure Is Great News For These Drug Manufacturers,2013-03-04 15:22:00-05:00,JNJ,positive
709229.0,"If The Market Falls, Try These Low Beta ETFs",2013-02-28 18:27:00-05:00,JNJ,negative
709230.0,"Short Interest Swings in Biotech Stocks (ALXN, AMGN, CELG)",2013-02-28 15:13:00-05:00,JNJ,positive
709231.0,J&J Jury Reaches Verdict on Punitive Win in First Mesh Trial,2013-02-28 11:35:00-05:00,JNJ,positive
709232.0,J&J Trial Expert Says Infection -- Not Defect -- Lead to Hip Failure,2013-02-26 17:10:00-05:00,JNJ,negative
709233.0,Bloomberg Reporting J&J Looking to Avoid Punitive Damages After Losing Mesh Trial Verdict,2013-02-26 12:36:00-05:00,JNJ,negative
709234.0,Bloomberg Reporting J&J Judge Rules Jury Can Weigh Punitive Damages in Mesh Case,2013-02-25 15:22:00-05:00,JNJ,negative
709235.0,J&J Ordered to Pay $3.35M to South Dakota Nurse,2013-02-25 11:04:00-05:00,JNJ,negative
709236.0,NJ Jury Says J&J Failed to Warn of Vaginal Mesh Risks,2013-02-25 11:01:00-05:00,JNJ,negative
709237.0,Hearing Jury in J&J's New Jersey Case Has Verdict in First Vaginal Mesh Case,2013-02-25 10:59:00-05:00,JNJ,positive
709238.0,"J&J Comments on Venezuelan Currency Devaluation, Sees $0.04/Share Charge in Q4, Reaffirms FY EPS Outlook",2013-02-25 07:47:00-05:00,JNJ,neutral
709239.0,"J&J Discloses Government Investigations Related to False Claims Related to Hips, Surgical Mesh - Bloomberg",2013-02-22 07:52:00-05:00,JNJ,neutral
709240.0,Under The Hood: A New Dividend ETF Diva,2013-02-19 17:33:00-05:00,JNJ,neutral
709241.0,Investment Style Rankings For ETFs & Mutual Funds,2013-02-19 14:12:00-05:00,JNJ,neutral
709242.0,"Berkshire Adds Archer-Daniels, Verisign; Boosts GM Stake",2013-02-14 17:23:00-05:00,JNJ,positive
709243.0,AP Reporting J&J Unit DePuy Orthopaedics Recalling 'Thousands' of Adept Hip Implants ,2013-02-14 13:54:00-05:00,JNJ,neutral
709244.0,"Short Interest Swings in Biotech Stocks (AMGN, CELG, ONXX)",2013-02-12 13:29:00-05:00,JNJ,positive
709245.0,UPDATE: Credit Suisse Downgrades Johnson & Johnson to Underperform on Valuation,2013-02-07 10:39:00-05:00,JNJ,positive
709246.0,"Credit Suisse Downgrades Johnson & Johnson to Underperform, Raises PT to $73.00",2013-02-07 08:14:00-05:00,JNJ,positive
709247.0,Johnson & Johnson Breaks Out Over $75 Resistance,2013-02-06 17:04:00-05:00,JNJ,neutral
709248.0,Buying What Buffett Sells? Sometimes it Works,2013-02-03 16:19:00-05:00,JNJ,neutral
709249.0,2 Attractively Valued Blue Chips,2013-01-27 19:19:00-05:00,JNJ,positive
709250.0,"Short Interest Swings in Biotech Stocks (BIIB, CELG, VVUS)",2013-01-26 12:17:00-05:00,JNJ,positive
709251.0,California Jury Finds J&J Failed to Warn of Hip Implant's Risks,2013-01-25 12:42:00-05:00,JNJ,negative
709252.0,J&J Sees FY13 Sales $70.9-71.6B vs $72B Est,2013-01-22 09:56:00-05:00,JNJ,neutral
709253.0,From J&J's Qtr. Conference Call: Will Explore Options for Ortho Clinical Diagnostics Unit,2013-01-22 09:27:00-05:00,JNJ,neutral
709254.0,UPDATE: Johnson & Johnson Posts Higher Q4 Profit,2013-01-22 08:01:00-05:00,JNJ,positive
709255.0,"J&J Reports Velcade Sales $502M, Remicade Sales $1.504B, Prezista Sales $353M",2013-01-22 07:49:00-05:00,JNJ,neutral
709256.0,Johnson & Johnson Sees FY2013 EPS $5.35-5.45 vs $5.49 Est,2013-01-22 07:47:00-05:00,JNJ,neutral
709257.0,Johnson & Johnson Reports Q4 EPS of $1.19 vs $1.17 Est; Revenue of $17.60B vs $17.67B Est,2013-01-22 07:46:00-05:00,JNJ,neutral
709258.0,"Benzinga Market Primer: Tuesday, January 22",2013-01-22 06:30:00-05:00,JNJ,neutral
709259.0,"US Stock Futures Flat Ahead Of Economic Data, Earnings",2013-01-22 05:53:00-05:00,JNJ,neutral
709260.0,"Earnings Scheduled For January 22, 2013",2013-01-22 01:25:00-05:00,JNJ,neutral
709261.0,"Stocks To Watch For January 22, 2013",2013-01-22 01:05:00-05:00,JNJ,neutral
709262.0,Earnings Expectations for the Week of January 21,2013-01-20 13:14:00-05:00,JNJ,neutral
709263.0,The Week Ahead: Tech Earnings in Focus,2013-01-18 17:17:00-05:00,JNJ,neutral
709264.0,S&P Highlights 1 ETF For Lengthy Streaks of Dividend Increases,2013-01-18 15:37:00-05:00,JNJ,neutral
709265.0,J&J Said to Have Offered to Pay More Than $200K per Hip Case; May Total $2B -Bloomberg,2013-01-18 14:14:00-05:00,JNJ,negative
709266.0,"UPDATE: Jefferies & Company Reiterates Hold Rating, Raises PT on Johnson & Johnson",2013-01-16 09:31:00-05:00,JNJ,neutral
709267.0,"Jefferies Maintains Hold on Johnson & Johnson, Raises PT to $79.00",2013-01-16 08:52:00-05:00,JNJ,neutral
709268.0,J&J's Janssen-Cilag Drug Zytiga Approved in EU for Use in Treatment of Metastatic Cancer,2013-01-11 10:38:00-05:00,JNJ,negative
709269.0,"UBS Maintains Buy on Johnson & Johnson, Raises PT to $78.00",2013-01-11 10:34:00-05:00,JNJ,neutral
709270.0,FDA Panel Backs J&J's New Type of Diabetes Drug,2013-01-10 16:20:00-05:00,JNJ,negative
709271.0,FDA Panel Votes 8-7 J&J's Canagliflozin Has Heart Concerns,2013-01-10 15:59:00-05:00,JNJ,neutral
709272.0,FDA Posts Briefing Documents for J&J's Canagliflozin,2013-01-08 08:00:00-05:00,JNJ,neutral
709273.0,4 Health Care ETFs Your Broker Forgot to Mention,2013-01-07 15:52:00-05:00,JNJ,positive
709274.0,Sanofi Buys OTC Antacid Rolaids from J&J's McNeil-PPC,2013-01-07 08:08:00-05:00,JNJ,neutral
709275.0,A Look Ahead: This Week's ETFs to Watch,2013-01-07 07:17:00-05:00,JNJ,neutral
709276.0,UPDATE: Deutsche Bank Upgrades Johnson & Johnson to Buy on Improving Trends  ,2013-01-04 08:34:00-05:00,JNJ,positive
709277.0,A Peek Into The Market Before The Trading Starts,2013-01-04 07:23:00-05:00,JNJ,neutral
709278.0,Benzinga's Top Upgrades,2013-01-04 07:18:00-05:00,JNJ,positive
709279.0,"Deutsche Bank Upgrades Johnson & Johnson to Buy, Raises PT to $82.00",2013-01-04 07:04:00-05:00,JNJ,neutral
709280.0,"Merck, Pfizer, Abbott, J&J, Sanofi Said to Show Interest in Bausch & Lomb Bid - Bloomberg",2013-01-03 16:00:00-05:00,JNJ,positive
709281.0,J&J Declares $0.61/Share Q1 Dividend,2013-01-02 09:27:00-05:00,JNJ,neutral
709282.0,US Stock Futures Higher On Fiscal-Cliff Deal,2013-01-02 07:13:00-05:00,JNJ,neutral
709283.0,"Stocks To Watch For January 2, 2013",2013-01-02 01:44:00-05:00,JNJ,neutral
709284.0,"Short Interest Swings in Biotech Stocks (CELG, GILD, REGN)",2012-12-28 11:10:00-05:00,JNJ,positive
709285.0,A Growth ETF for 2013 ,2012-12-26 07:48:00-05:00,JNJ,positive
709286.0,J&J to Host Analyst Meeting at 8:30AM EST on Jan. 22nd,2012-12-21 08:11:00-05:00,JNJ,neutral
709287.0,How To Avoid the Worst Sector ETFs,2012-12-19 16:06:00-05:00,JNJ,negative
709288.0,S&P Sees Better 2013 For Health Insurance Providers,2012-12-19 07:19:00-05:00,JNJ,positive
709289.0,These 2 Dow Laggards Could Rebound in 2013,2012-12-16 13:41:00-05:00,JNJ,neutral
709290.0,Barron's Recap (12/15/12): Outlook for 2013,2012-12-15 13:47:00-05:00,JNJ,neutral
709291.0,"Short Interest Swings in Biotech Stocks (BIIB, CELG, VVUS)",2012-12-12 12:57:00-05:00,JNJ,positive
709292.0,J&J's Janssen R&D Submits NDA for Canagliflozin/Metformin Fixed-Dose Combo Therapy,2012-12-12 09:05:00-05:00,JNJ,neutral
709293.0,FDA Expands J&J's Zytiga's Use for Late-Stage Prostate Cancer,2012-12-10 13:16:00-05:00,JNJ,negative
709294.0,Davenport Upgrades Johnson & Johnson to Buy,2012-12-10 11:12:00-05:00,JNJ,neutral
709295.0,"A Look at Fortune's Health Care Picks for 2013 (ALGN, FMS, GILD)",2012-12-08 23:17:00-05:00,JNJ,positive
709296.0,J&J's EVARREST Fibrin Sealant Patch Approved by FDA,2012-12-07 08:17:00-05:00,JNJ,positive
709297.0,"J&J's Janssen Submits Applications Requesting Approval of STELARA in US, Europe",2012-12-06 08:08:00-05:00,JNJ,positive
709298.0,J&J Says New Long-Term Study Suggests Lower Morality in Alzheimer's Patients Treated with Galantamine vs Placebo,2012-12-05 17:32:00-05:00,JNJ,negative
709299.0,How To Find the Best Sector ETFs,2012-12-03 16:28:00-05:00,JNJ,positive
709300.0,"BioMarin, Prestige Brands and Other Top Performing Health Care Stocks in November",2012-12-02 20:29:00-05:00,JNJ,positive
709301.0,Mid-Cap Dividend Stocks For 2013,2012-12-02 20:23:00-05:00,JNJ,neutral
709302.0,J&J Wins Reversal of $1.1M Levaquin punitive Verdict,2012-11-30 11:58:00-05:00,JNJ,positive
709303.0,J&J's Bill Weldon to Retire as Chairman in Q1; Names CEO Alex Gorsky Chair,2012-11-30 08:55:00-05:00,JNJ,neutral
709304.0,J&J's Janssen Announces Intent Not to Enforce Patents for Darunavir,2012-11-29 09:03:00-05:00,JNJ,neutral
709305.0,J&J Says FDA Panel Recommends Accelerated Approval of Bedaquiuline,2012-11-28 17:46:00-05:00,JNJ,positive
709306.0,UPDATE: Stifel Nicolaus Initiates Johnson & Johnson at Hold; Fairly Valued  ,2012-11-20 12:23:00-05:00,JNJ,positive
709307.0,Stifel Nicolaus Initiates Coverage on Johnson & Johnson at Hold,2012-11-20 08:27:00-05:00,JNJ,neutral
709308.0,"J&J's Cordis Says INCRAFT AAA Stent-Graft System INNOVATION Study Shows Safety, Efficacy",2012-11-19 17:00:00-05:00,JNJ,positive
709309.0,J&J's Janssen-Cilag's ZYTIGA Receives Positive EU Recommendation,2012-11-19 07:45:00-05:00,JNJ,positive
709310.0,Mid-Cap Dividend Dynamos,2012-11-18 18:52:00-05:00,JNJ,positive
709311.0,S&P Reiterates Bullish View on Health Care ETFs,2012-11-16 12:56:00-05:00,JNJ,positive
709312.0,Berkshire Dumps Most of J&J and GE Stakes; Adds Deere & Co. ,2012-11-15 07:27:00-05:00,JNJ,negative
709313.0,"Buffett's Berkshire Hathaway Cuts Stakes in GE, Visa, J&J, Conoco",2012-11-14 16:45:00-05:00,JNJ,negative
709314.0,These ETFs Offer Solid Yield in Uncertain Times,2012-11-14 08:58:00-05:00,JNJ,negative
709315.0,New Phase 3 Findings Show STELARA® Significantly Reduced Signs and Symptoms of Active Psoriatic Arthritis,2012-11-12 08:10:00-05:00,JNJ,positive
709316.0,"UPDATE: Jefferies Downgrades Johnson & Johnson to Hold, Lowers PT",2012-11-12 07:33:00-05:00,JNJ,negative
709317.0,Benzinga's Top Downgrades,2012-11-12 07:25:00-05:00,JNJ,positive
709318.0,"Jefferies & Company Downgrades Johnson & Johnson from Buy to Hold, Lowers PT from $78 to $75",2012-11-12 06:10:00-05:00,JNJ,negative
709319.0,SMART Vascular Stent Systems Gets FDA Approval,2012-11-08 17:55:00-05:00,JNJ,positive
709320.0,Mylan Announces Settlement with Janssen Related to Ortho Tri-Cyclen Lo,2012-11-08 15:31:00-05:00,JNJ,neutral
709321.0,More Pain Awaits Medical Device ETFs,2012-11-07 13:55:00-05:00,JNJ,negative
709322.0,J&J Settles Suits Related to Levaquin and Tendon Injuries -Bloomberg,2012-11-01 13:34:00-04:00,JNJ,neutral
709323.0,"Vertex, JNJ's Janssen Enter Agreement for Phase 2 Hepatitis C Study",2012-11-01 07:39:00-04:00,JNJ,positive
709324.0,More Equal-Weight ETFs Your Broker Forgot to Mention ,2012-10-30 15:01:00-04:00,JNJ,neutral
709325.0,Johnson & Johnson Postpones November 1 Medical Devices & Diagnostics Review ,2012-10-30 10:46:00-04:00,JNJ,negative
709326.0,How To Find the Best ETFs,2012-10-25 13:46:00-04:00,JNJ,positive
709327.0,Sector Rankings For ETFs  &  Mutual Funds,2012-10-24 17:44:00-04:00,JNJ,neutral
709328.0,Rating Breakdown: Best & Worst ETFs & Mutual Funds by Sector,2012-10-24 17:44:00-04:00,JNJ,neutral
709329.0,"Top Performing Dividend Payers in Health Care with the Most Upside Potential (TRIB, STE, CMN)",2012-10-23 17:42:00-04:00,JNJ,positive
709330.0,"Barclays Maintains Johnson & Johnson at Overweight, Raises PT from $75 to $85",2012-10-17 12:15:00-04:00,JNJ,negative
709331.0,"UPDATE: Deutsche Bank Reiterates Hold Rating, Raises PT on Johnson & Johnson",2012-10-17 10:49:00-04:00,JNJ,neutral
709332.0,"Deutsche Bank Maintains Johnson & Johnson at Hold, Raises PT from $72 to $75",2012-10-17 06:54:00-04:00,JNJ,neutral
709333.0,Upbeat Earnings Reports Spark Triple Digit Gain in the Dow,2012-10-16 16:59:00-04:00,JNJ,positive
709334.0,"Johnson & Johnson Rises 1% After Topping Estimates, Raising Guidance",2012-10-16 15:01:00-04:00,JNJ,neutral
709335.0,"Johnson & Johnson Guides FY Revenue $67-67.6B, Had Seen $66.7-67.3B vs $67.22B Est",2012-10-16 09:09:00-04:00,JNJ,neutral
709336.0,"Johnson & Johnson Guides FY EPS $5.05-5.10, Had Seen $5.05-5.07 vs $5.08 Est",2012-10-16 07:47:00-04:00,JNJ,neutral
709337.0,Johnson & Johnson Reports Q3 EPS $1.25 vs $1.29 Est; Revenues $17.1B vs $16.70B Est,2012-10-16 07:46:00-04:00,JNJ,neutral
709338.0,"Benzinga Market Primer, Tuesday October 16",2012-10-16 06:12:00-04:00,JNJ,neutral
709339.0,"US Stock Futures Up Ahead Of Earnings, Economic Data",2012-10-16 05:53:00-04:00,JNJ,neutral
709340.0,"Earnings Scheduled For October 16, 2012 ",2012-10-16 02:26:00-04:00,JNJ,neutral
709341.0,"Stocks To Watch For October 16, 2012",2012-10-16 02:09:00-04:00,JNJ,neutral
709342.0,The Gores Group Extends Binding Offer to Acquire Therakos,2012-10-15 08:05:00-04:00,JNJ,positive
709343.0,"Short Interest Swings in Biotech Stocks (BIIB, CELG, GILD)",2012-10-15 06:59:00-04:00,JNJ,positive
709344.0,Earnings Expectations for the Week of October 15,2012-10-15 06:54:00-04:00,JNJ,neutral
709345.0,"Jefferies & Company Maintains Johnson & Johnson at Buy, Raises PT from $76 to $78",2012-10-12 06:59:00-04:00,JNJ,neutral
709346.0,Part I: Must Know ETFs For Q3 Earnings ,2012-10-09 14:37:00-04:00,JNJ,neutral
709347.0,Benzinga's Top Downgrades,2012-10-09 07:24:00-04:00,JNJ,positive
709348.0,S&P Index and Big 10 Weekly Outlook ,2012-10-02 12:23:00-04:00,JNJ,neutral
709349.0,From Earlier: J&J Says Phase 3 Trial for Canagliflozin Met Secondary Endpoints,2012-10-02 08:45:00-04:00,JNJ,neutral
709350.0,From Earlier: Janssen-Cilag Says Velcade Approved in EU,2012-09-28 07:52:00-04:00,JNJ,positive
709351.0,Amazon Could Relinquish Key Trademark to Apple,2012-09-27 08:51:00-04:00,JNJ,positive
709352.0,S&P Highlights Election ETFs,2012-09-25 16:24:00-04:00,JNJ,neutral
709353.0,Knee Replacements Have Doubled -Bloomberg,2012-09-25 16:00:00-04:00,JNJ,neutral
709354.0,Janssen Research & Development Says Will Present Latest Phase 3 Results  for Canagliflozin October 1-5,2012-09-25 09:13:00-04:00,JNJ,neutral
709355.0,Johnson & Johnson is Facing Trial Over Risperdal; Lawyer Says Company Hid Fact Caused Female Breasts in Boys,2012-09-24 12:58:00-04:00,JNJ,negative
709356.0,"S&P 500 Index and Big 10 Weekly Outlook-Week of September 24, 2012",2012-09-24 10:34:00-04:00,JNJ,neutral
709357.0,Johnson & Johnson Finding Support at $68,2012-09-18 14:07:00-04:00,JNJ,positive
709358.0,Defensive Stocks Maintain Gains in Mixed Market,2012-09-18 13:57:00-04:00,JNJ,positive
709359.0,Johnson & Johnson Establishing 4 Innovation Centers ,2012-09-18 08:32:00-04:00,JNJ,positive
709360.0,Sandra Peterson to Join Johnson & Johnson as Group Worldwide Chairman and Member of the Executive Committee,2012-09-13 08:44:00-04:00,JNJ,positive
709361.0,Johnson&Johnson Has Right to Buy Vascular After Phase 2,2012-09-12 08:39:00-04:00,JNJ,neutral
709362.0,"Credit Suisse Reinstates Coverage on Johnson & Johnson at Neutral, Announces PT of $70",2012-09-11 06:06:00-04:00,JNJ,positive
709363.0,These 4 Companies Have Been Increasing Their Dividends for Decades,2012-09-10 17:45:00-04:00,JNJ,neutral
709364.0,This Dividend ETF Isn't The Same Old Song,2012-09-06 14:27:00-04:00,JNJ,neutral
709365.0,U.S. FDA Grants Priority Review to Bedaquiline for Multi-Drug Resistant Tuberculosis Treatment ,2012-09-05 07:36:00-04:00,JNJ,positive
709366.0,Transvaginal Mesh Suit Filed Against Johnson & Johnson ,2012-09-04 09:43:00-04:00,JNJ,neutral
709367.0,Delaware Nets $4.2 Million Settlement from Johnson & Johnson Subsidiary,2012-08-31 08:12:00-04:00,JNJ,neutral
709368.0,U.S. FDA Grants Priority Review of Johnson & Johnson's ZYTIGA,2012-08-29 08:17:00-04:00,JNJ,positive
709369.0,FDA Approves Johnson and Johnson's NUCYNTA ER,2012-08-29 08:04:00-04:00,JNJ,positive
709370.0,Xarel Helped to Stemi Heart Attack Patients; Xarel Group Had Better Survival Rate Without Another Attack,2012-08-27 08:12:00-04:00,JNJ,negative
709371.0,     ORTHOCON Announces Uninterrupted Availability of HEMASORB Resorbable Hemostatic Bone Putty,2012-08-23 07:55:00-04:00,JNJ,neutral
709372.0,Five Practical Books &  5 Investment Lessons,2012-08-17 11:15:00-04:00,JNJ,neutral
709373.0,S&P Still Bullish on Health Care ETFs,2012-08-16 17:03:00-04:00,JNJ,positive
709374.0,Berkshire Hathaway Sells Intel; Buys National-Oilwell Varco,2012-08-14 16:47:00-04:00,JNJ,neutral
709375.0,"UPDATE: Berkshire Reduced Stake in Visa, UPS, J&J, P&G; Increased Stake in Lee Enterprises, IBM",2012-08-14 16:16:00-04:00,JNJ,positive
709376.0,Elan Shares Fall 11% After-Hours on Disappointing Pfizer Bapineuzumab Study,2012-08-06 17:08:00-04:00,JNJ,negative
709377.0,Teva Pharmaceutical Subpoenaed By SEC in Bribery Charge,2012-08-06 09:13:00-04:00,JNJ,neutral
709378.0,Johnson & Johnson Reaches Risperdal Lawsuit Agreement,2012-08-03 12:56:00-04:00,JNJ,positive
709379.0,"UBS Maintains Johnson & Johnson at Buy, Raises PT from $70 to $76",2012-08-01 11:14:00-04:00,JNJ,neutral
709380.0,Long Term Bull in Johnson & Johnson,2012-07-31 13:22:00-04:00,JNJ,neutral
709381.0,"Option Alert: Johnson & Johnson January 2014 77.5 Call; Block Trade: 16,000 Contracts; Currently $69.46",2012-07-31 11:15:00-04:00,JNJ,negative
709382.0,UPDATE: Dendreon on Call Says Provenge Should be Sequenced Upfront Before J&J's Zytiga,2012-07-30 17:36:00-04:00,JNJ,neutral
709383.0,J&J's Synthes Sued for Wrongful Death/Fraud -Bloomberg,2012-07-30 11:46:00-04:00,JNJ,neutral
709384.0,"S&P Likes Some ""Young"" ETFs",2012-07-25 15:16:00-04:00,JNJ,positive
709385.0,What You Need in Order to Retire Before Age 60,2012-07-24 16:09:00-04:00,JNJ,neutral
709386.0," J&J, DoJ Settlement for as Much as $2.2 Billion -WSJ, Sources",2012-07-19 15:40:00-04:00,JNJ,neutral
709387.0,"Kapito: 'We Like ATT, VZ, MRK, JNJ for Yields''",2012-07-18 12:23:00-04:00,JNJ,positive
709388.0,"UPDATE: Jefferies Reiterates Buy Rating, Raises PT on Johnson & Johnson",2012-07-18 11:26:00-04:00,JNJ,neutral
709389.0,"Piper Jaffray Maintains Johnson & Johnson at Neutral, Raises PT from $68 to $74",2012-07-18 10:11:00-04:00,JNJ,neutral
709390.0,Johnson and Johnson's Janssen Diagnostic's AVIGA™ Receives Complete ONC-ATCB Certification by Drummond Group,2012-07-18 08:49:00-04:00,JNJ,neutral
709391.0,"Jefferies & Company Maintains Johnson & Johnson at Buy, Raises PT from $75 to $76",2012-07-18 06:27:00-04:00,JNJ,neutral
709392.0,"Deutsche Bank Maintains Johnson & Johnson at Hold, Raises PT from $69 to $72",2012-07-18 06:16:00-04:00,JNJ,neutral
709393.0,Johnson & Johnson Beats on EPS but Fails to Impress,2012-07-17 10:19:00-04:00,JNJ,neutral
709394.0,J&J CEO Expects More Consolidation Among Hospitals      ,2012-07-17 09:45:00-04:00,JNJ,neutral
709395.0,UPDATE: J&J Sees Pretax Operating Margin Improving by 100-150 Basis Points,2012-07-17 09:27:00-04:00,JNJ,positive
709396.0,"J&J Sees Year Reported Sales $66.7-$67.3 Billion, Says Any 2012 Guidance Will Include Forex Impact, Sees Future Earnings Affected by Forex, Sees Net Interest Expense $500-$550 Million",2012-07-17 09:24:00-04:00,JNJ,positive
709397.0,  J&J Sees $600 Million in Restructuring Charges Ahes,2012-07-17 09:21:00-04:00,JNJ,negative
709398.0,UPDATE: J&J CEO Says Pharma Ops Will Continue to Be Strong Driver of Sales,2012-07-17 09:06:00-04:00,JNJ,positive
709399.0,UPDATE: Johnson and Johnson to Report Top-Line Results on Bapineuzumab This Quarter at Meeting in September,2012-07-17 08:50:00-04:00,JNJ,neutral
709400.0,Johnson and Johnson Plans to Resume Supply of Doxil in Q4,2012-07-17 08:47:00-04:00,JNJ,neutral
709401.0,Johnson & Johnson Falls On Weak Guidance,2012-07-17 08:43:00-04:00,JNJ,negative
709402.0,"UPDATE: Johnson & Johnson Posts Drop In Q2 Profit, Lowers Full-Year Forecast",2012-07-17 08:26:00-04:00,JNJ,positive
709403.0,Benzinga's Top Pre-Market Losers,2012-07-17 08:21:00-04:00,JNJ,negative
709404.0,Johnson & Johnson Guides FY EPS $5.00-5.07 vs $5.14 Est,2012-07-17 07:48:00-04:00,JNJ,neutral
709405.0,Popular Drug Manufacturing Stocks Among Hedge Funds,2012-07-17 07:47:00-04:00,JNJ,positive
709406.0,Johnson & Johnson Reports Q2 EPS $1.30 vs $1.29 Est; Revenues $16.5B vs $16.69B Est,2012-07-17 07:45:00-04:00,JNJ,neutral
709407.0,"Benzinga Market Primer, Tuesday July 17",2012-07-17 06:54:00-04:00,JNJ,neutral
709408.0,US Stock Futures Up; All Eyes On Bernanke,2012-07-17 06:37:00-04:00,JNJ,neutral
709409.0,Earnings Scheduled For July 17,2012-07-17 02:39:00-04:00,JNJ,neutral
709410.0,Stocks To Watch For July 17,2012-07-17 02:04:00-04:00,JNJ,neutral
709411.0,Earnings Expectations for the Week of July 16,2012-07-16 09:02:00-04:00,JNJ,neutral
709412.0,"Low Volume, High Returns for These ETFs (BIB, FHC, DRW)",2012-07-13 15:25:00-04:00,JNJ,negative
709413.0,"Jefferies & Company Maintains Johnson & Johnson at Buy, Raises PT from $72 to $75",2012-07-13 07:00:00-04:00,JNJ,neutral
709414.0,"J&J Agrees To Corporate Governance Changes, Drug Marketing Changes as Part of NJ Settlement - Bloomberg Headlines",2012-07-11 14:38:00-04:00,JNJ,positive
709415.0,Johnson & Johnson Receives Positive Mad Money/Jim Cramer Mention -CNBC,2012-07-09 18:04:00-04:00,JNJ,positive
709416.0,J&J Unit: Stent Thrombosis sNDA Contingent On ACS sNDA,2012-07-09 07:37:00-04:00,JNJ,neutral
709417.0,J&J: FDA Grants Priority Review For Xarelto Supplemental NDAs,2012-07-09 07:34:00-04:00,JNJ,positive
709418.0,"Benzinga's M&A Chatter for Tuesday July 3, 2012",2012-07-04 15:08:00-04:00,JNJ,neutral
709419.0,Elan Spokesperson Would Not Comment on Earlier Chatter of JNJ Offer,2012-07-03 10:32:00-04:00,JNJ,neutral
709420.0,"Hearing Unconfirmed Chatter of Johnson and Johnson Offer for Elan, $19/Share",2012-07-03 10:22:00-04:00,JNJ,negative
709421.0,ALPS Unveils Dogs of the Dow ETF,2012-06-29 12:51:00-04:00,JNJ,neutral
709422.0,Leveraged ETFs for the Obamacare Ruling,2012-06-26 18:07:00-04:00,JNJ,neutral
709423.0,The New High Frequency Trading Landscape: Man Versus Machine,2012-06-26 08:22:00-04:00,JNJ,neutral
709424.0,"Ahead of Obamacare Ruling, S&P Likes Health Care SPDR",2012-06-25 14:02:00-04:00,JNJ,positive
709425.0,Saving More Vs. Seeking Higher Returns for Retirement,2012-06-25 12:20:00-04:00,JNJ,neutral
709426.0,"Premarket Stock Talk: Sell the Market, Buy.. Facebook?",2012-06-22 09:00:00-04:00,JNJ,neutral
709427.0,Premarket Stock Talk: Beyond a Best Bed and Bath Buy,2012-06-21 08:48:00-04:00,JNJ,positive
709428.0,Study Says J&J Vaginal Sling Cuts Incontinence Risk in Half,2012-06-20 17:01:00-04:00,JNJ,negative
709429.0,Arkansas Judge Who Fined J&J $1.2 Billion Denies Request for New Trial in Risperdal Case -AP,2012-06-20 13:02:00-04:00,JNJ,negative
709430.0,"Goldman Sachs Raises PT on Johnson & Johnson from $65 to $67, Maintains Neutral",2012-06-15 16:16:00-04:00,JNJ,neutral
709431.0,Johnson & Johnson to Complete Synthes Acquisition ,2012-06-14 08:25:00-04:00,JNJ,neutral
709432.0,UPDATE: Jefferies Upgrades Johnson & Johnson,2012-06-13 10:24:00-04:00,JNJ,neutral
709433.0,UPDATE: JP Morgan Upgrades Johnson & Johnson to Overweight; Discounted Valuation Compared to Peers  ,2012-06-13 09:29:00-04:00,JNJ,positive
709434.0,"Financial Breakfast: Morning News Summary for June 13, 2012",2012-06-13 07:30:00-04:00,JNJ,neutral
709435.0,"Jefferies & Company Upgrades Johnson & Johnson from Hold to Buy, Raises PT from $68 to $72",2012-06-13 07:07:00-04:00,JNJ,neutral
709436.0,"JP Morgan Upgrades Johnson & Johnson from Neutral to Overweight, PT Raised from $74 to $69",2012-06-13 05:58:00-04:00,JNJ,neutral
709437.0,Johnson & Johnson Receives US Regulatory Clearance for Synthes Acquisition,2012-06-12 17:26:00-04:00,JNJ,neutral
709438.0,"Johnson and Johnson Receives US Regulatory Approval for Synthes Acquisition, Closing Date for Acquisition Set for June 14.",2012-06-12 17:22:00-04:00,JNJ,positive
709439.0,Johnson and Johnson Announces $12.9B Accelerated Buyback Plan,2012-06-12 17:20:00-04:00,JNJ,neutral
709440.0,5 Healthcare Stocks With The Highest Revenue,2012-06-12 07:45:00-04:00,JNJ,neutral
709441.0,Johnson&Johnson Reports Positive Results from First Human Clinical Trials of a First-Generation Artificial Pancreas System,2012-06-11 09:05:00-04:00,JNJ,positive
709442.0,Johnson & Johnson to Incur Special Charge in Q2 Due to Legal Matters -8K,2012-06-08 16:58:00-04:00,JNJ,positive
709443.0,Elan Spokesperson Says Company is Not Involved in Actual Data of Alzheimer Treatment. Says Data is Handled by Johnson & Johnson and Pfizer,2012-06-07 11:54:00-04:00,JNJ,neutral
709444.0,Three Keys to Finding Good Dividend Stocks,2012-06-06 12:37:00-04:00,JNJ,positive
709445.0,Dendreon Jumps 10% ,2012-06-05 13:37:00-04:00,JNJ,neutral
709446.0,The US Economy and the United Nations: Bold Strategies Needed - Tax Reform and Benefits Reform,2012-06-04 12:16:00-04:00,JNJ,positive
709447.0,"UPDATE: J&J's Zytiga Slows Cancer Growth In Men With Prostate Cancer; Negative for Dendreon, Positive for Medivation",2012-06-04 09:07:00-04:00,JNJ,negative
709448.0,ZYTIGA Plus Prednisone Show Improvements in Asymptomatic or Mildly Symptomatic Chemotherapy-Naive Patients with Metastatic Castration-Resistant Prostate Cancer,2012-06-02 20:13:00-04:00,JNJ,negative
709449.0,Johnson & Johnson Receives Positive Mad Money/Jim Cramer Mention -CNBC,2012-06-01 20:26:00-04:00,JNJ,positive
709450.0,"5 Risky Dividend Stocks (WIN, EXC, FTR, HAS, JNJ)",2012-05-31 16:55:00-04:00,JNJ,negative
709451.0,Goldman Sachs Comments on Breaking Up of Johnson & Johnson,2012-05-31 06:37:00-04:00,JNJ,neutral
709452.0,FDA Issues Complete Response Letter for 800mg PREZISTA,2012-05-29 09:02:00-04:00,JNJ,neutral
709453.0,5 Healthcare Stocks With The Highest Cash,2012-05-29 07:32:00-04:00,JNJ,neutral
709454.0,S&P 500 Undex And Big 10 Weekly Outlook-Week of May 28th,2012-05-28 14:48:00-04:00,JNJ,neutral
709455.0,"Three Stocks from Goldman's Hedge Fund Short List, Will They Pop or Flop?",2012-05-24 16:37:00-04:00,JNJ,negative
709456.0,FDA Advisory Panel Votes 6-4-1 Against the Approval of Johnson & Johnson's and Bayer's XARETO Pill,2012-05-23 16:19:00-04:00,JNJ,positive
709457.0,Health Care SPDR In Focus Ahead Of Obamacare Decision,2012-05-22 12:34:00-04:00,JNJ,positive
709458.0,Prostate Cancer Companies Suffer When They Ignore Urologists,2012-05-22 11:47:00-04:00,JNJ,negative
709459.0,S&P 500 Index and Big 10 Weekly Outlook-Week of May 14th,2012-05-14 11:23:00-04:00,JNJ,neutral
709460.0,ETFs on the Market that will Line Your Pockets 12 Times a Year,2012-05-09 15:01:00-04:00,JNJ,neutral
709461.0,"Option Alert: Johnson & Johnson July 67.5 Calls; Block Trade: 10,000 Contracts; Currently $64.41",2012-05-09 11:08:00-04:00,JNJ,negative
709462.0,Buffett's Holdings Beat the S&P 500 One Month After Meeting,2012-05-07 14:45:00-04:00,JNJ,neutral
709463.0,"S&P 500 Index and Big Ten Analysis - Week of May 7, 2012",2012-05-07 14:35:00-04:00,JNJ,neutral
709464.0,S&P 500 Index and Big Ten Weekly Outlook - April 30th,2012-04-30 11:38:00-04:00,JNJ,neutral
709465.0,Johnson & Johnson Announces Dividend Increase of 7.0% to $0.61,2012-04-26 10:48:00-04:00,JNJ,positive
709466.0,Fitch Removes Johnson & Johnson from Watch Negative,2012-04-25 17:37:00-04:00,JNJ,negative
709467.0,"Five Cheap Stocks Under $15 (BAC, NAK, SD, RIMM, ELN)",2012-04-25 14:37:00-04:00,JNJ,neutral
709468.0,"Colgate-Palmolive Earnings Preview: Q1 EPS, Sales Expected to Be Higher",2012-04-25 06:55:00-04:00,JNJ,neutral
709469.0,S&P Futures and Big 10 Weekly Analysis - Week of April 23,2012-04-23 12:09:00-04:00,JNJ,neutral
709470.0,Street Yearning For Better Earnings?,2012-04-19 17:41:00-04:00,JNJ,positive
709471.0,S&P: Bullish On Pharma ETFs Long-Term,2012-04-19 14:45:00-04:00,JNJ,neutral
709472.0,"UBS Maintains Johnson & Johnson at Buy, Lowers PT from $71 to $70",2012-04-18 11:42:00-04:00,JNJ,negative
709473.0,UPDATE: Goldman Sachs Lowers Johnson & Johnson's PT,2012-04-18 11:04:00-04:00,JNJ,negative
709474.0,"UPDATE: Citigroup Reiterates Buy Rating, Raises PT on Johnson & Johnson",2012-04-18 10:12:00-04:00,JNJ,neutral
709475.0,"Citigroup Maintains Johnson & Johnson at Buy, Raises PT from $76 to $77",2012-04-18 07:19:00-04:00,JNJ,neutral
709476.0,"Goldman Sachs Maintains Johnson & Johnson at Neutral, Lowers PT from $70 to $65",2012-04-18 06:54:00-04:00,JNJ,negative
709477.0,"Checking In: Turn Down The ""Vol"" (LVOL, SPLV)",2012-04-17 22:51:00-04:00,JNJ,neutral
709478.0,"Deutsche Bank: Johnson & Johnson Beat EPS, Misses Sales",2012-04-17 09:30:00-04:00,JNJ,negative
709479.0,J&J Says Will File Motion to Dismiss Risperdal Ruling; Will Appeal if Dismissal Fails,2012-04-17 09:24:00-04:00,JNJ,negative
709480.0,Earnings Roundup,2012-04-17 09:02:00-04:00,JNJ,neutral
709481.0,"UPDATE: Johnson & Johnson Posts 12% Rise In Q1 Earnings, Lifts Forecast",2012-04-17 08:29:00-04:00,JNJ,neutral
709482.0,Johnson & Johnson Reports Q1 EPS $1.37 vs $1.35 Est; Revenues $16.1B vs $16.26B Est,2012-04-17 07:46:00-04:00,JNJ,neutral
709483.0,Stocks To Watch For April 17,2012-04-17 06:47:00-04:00,JNJ,neutral
709484.0,Earnings Scheduled For April 17,2012-04-17 06:46:00-04:00,JNJ,neutral
709485.0,US Stock Futures Up Ahead Of Earnings,2012-04-17 06:44:00-04:00,JNJ,neutral
709486.0,US Stock Futures Up Ahead Of Earnings,2012-04-17 06:26:00-04:00,JNJ,neutral
709487.0,Earnings Scheduled For April 17,2012-04-17 04:31:00-04:00,JNJ,neutral
709488.0,Earnings Scheduled For April 17,2012-04-17 04:23:00-04:00,JNJ,neutral
709489.0,Stocks To Watch For April 17,2012-04-17 04:05:00-04:00,JNJ,neutral
709490.0,S&P Futures and Big 10 Weekly Analysis - Week of April 16,2012-04-16 08:45:00-04:00,JNJ,neutral
709491.0,UPDATE: Citi Raises Johnson & Johnson's PT,2012-04-16 08:14:00-04:00,JNJ,neutral
709492.0,"Citigroup Maintains Johnson & Johnson at Buy, Raises PT from $75 to $76",2012-04-16 06:27:00-04:00,JNJ,neutral
709493.0,"Earnings Expectations for the Week of April 16 (GS, MSFT, MCD)",2012-04-15 10:45:00-04:00,JNJ,neutral
709494.0,Volatility Is Not Risk,2012-04-12 11:32:00-04:00,JNJ,positive
709495.0,Judge Awards Arkansas $1.1B Over Johnson & Johnson's Risperdal Sales,2012-04-11 10:55:00-04:00,JNJ,positive
709496.0,We like these proven performers in this market,2012-04-10 21:35:00-04:00,JNJ,positive
709497.0,S&P 500 Index and Big Ten Analysis - Week of April 9th,2012-04-09 13:19:00-04:00,JNJ,neutral
709498.0,Avon's New CEO to Cleanse Brand Image as L'Oreal Sparks Upgrade Rumors,2012-04-09 12:32:00-04:00,JNJ,neutral
709499.0,Morgan Stanley Comments on Johnson & Johnson's First 100 Days in 2012,2012-04-09 08:50:00-04:00,JNJ,neutral
709500.0,Johnson & Johnson Announces Resignation of Sheri S. McCoy ,2012-04-09 07:02:00-04:00,JNJ,negative
709501.0,Biomet in Pact to Buy J&J's Depuy Trauma Business,2012-04-03 08:37:00-04:00,JNJ,negative
709502.0,Is 1400 The Top For Now?,2012-03-29 18:06:00-04:00,JNJ,positive
709503.0,Arkansas Seeking $1.25B in Penalties Over Marketing for J&J Antipsychotic Drug,2012-03-27 10:33:00-04:00,JNJ,neutral
709504.0,FDA Approves INTELENCE Tablets for Treatment-Experienced Pediatric Patients with HIV-1,2012-03-27 08:06:00-04:00,JNJ,positive
709505.0,Brean Murray Carret: Johnson & Johnson's EINSTEIN-PE Results Overshadowed,2012-03-27 07:56:00-04:00,JNJ,neutral
709506.0,S&P 500 Index and Big 10 Weekly Outlook - March 26th,2012-03-26 16:26:00-04:00,JNJ,neutral
709507.0,UPDATE: Bayer's Xarelto Comparable to Standard Therapy; Blood Thinner Treats Blood Clots with Less Bleeding,2012-03-26 09:04:00-04:00,JNJ,neutral
709508.0,Bayer's Xarelto Comparable to Standard Therapy; Blood Thinner Treats Blood Clots with Less Bleeding,2012-03-26 09:03:00-04:00,JNJ,neutral
709509.0,Three Effective Tools For Controlling Portfolio Risk Without Relying Purely on Fixed Income ,2012-03-23 11:24:00-04:00,JNJ,positive
709510.0,"Fast Money Picks For March 23rd (FCX, CHD, JNJ)",2012-03-22 21:43:00-04:00,JNJ,neutral
709511.0,"St. Jude, Novo Nordisk and Other Health Care Stocks Worth a Look Now",2012-03-21 07:20:00-04:00,JNJ,positive
709512.0,"S&P 500 and Big 10 Weekly Outlook - March 19, 2012",2012-03-19 10:32:00-04:00,JNJ,neutral
709513.0,"ETF Showdown: Dividend Dilemma (HDV, HDIV, JNJ)",2012-03-16 14:55:00-04:00,JNJ,negative
709514.0,"Accenture, Covidien, Seagate and Other St. Patrick's Stock Picks",2012-03-16 06:49:00-04:00,JNJ,neutral
709515.0,"A Look At The New Russell High Yield ETF (HDIV, ABT, KFT)",2012-03-15 14:55:00-04:00,JNJ,neutral
709516.0,Investor Alert: Xerox is a Cash Machine  ,2012-03-14 08:29:00-04:00,JNJ,positive
709517.0,"Painkillers Win FDA Panel Backing to Continue Development; Pfizer, JNJ, Regeneron Pain Drugs Should Resume Halted Studies -Bloomberg",2012-03-12 15:59:00-04:00,JNJ,positive
709518.0,"Option Alert: Johnson & Johnson July 70 Call; Block Trade, 10,000 Contracts",2012-03-12 14:07:00-04:00,JNJ,negative
709519.0,S&P 500 and Big 10 Weekly Outlook - March 12th,2012-03-12 11:18:00-04:00,JNJ,neutral
709520.0,Will Johnson & Johnson Cure Cancer?,2012-03-08 12:57:00-05:00,JNJ,negative
709521.0,Medivation Rises 17% on Positive J&J Zytiga,2012-03-08 11:02:00-05:00,JNJ,positive
709522.0,"Medivation Shares Rise 10% on J&J's Zytiga Data, Dendreon Falls 12%",2012-03-08 09:00:00-05:00,JNJ,positive
709523.0,"J&J's Zytiga Study to be Unblinded on Committee Recommendation; Interim Data Could Show Clinical Benefit; Could be Positive for Medivation, Negative for Dendreon",2012-03-08 08:44:00-05:00,JNJ,positive
709524.0,Pfizer Sues Johnson & Johnson Over Heat Patch Patent,2012-03-05 13:15:00-05:00,JNJ,neutral
709525.0,"S&P 500 And Big 10 Weekly Outlook - March 5, 2012",2012-03-04 19:41:00-05:00,JNJ,neutral
709526.0,U.S. FDA Grants Priority Review for XARELTO to Reduce Secondary Cardiovascular Events in Patients with Acute,2012-02-27 16:32:00-05:00,JNJ,positive
709527.0,S&P 500 & Big 10 Analysis - Week of February 27,2012-02-27 12:06:00-05:00,JNJ,neutral
709528.0,"Buffett On Johnson & Johnson: Still An Attractive Business At This Price, But Would Sell If He Needed Capital -CNBC",2012-02-27 08:46:00-05:00,JNJ,positive
709529.0,"Option Alert: Johnson & Johnson January 2013 50 Call; Block Trade, 2X 12,000; 2X 10,000 Contracts",2012-02-23 15:47:00-05:00,JNJ,negative
709530.0,"Financial Breakfast: Morning News Summary for February 22, 2012",2012-02-22 07:33:00-05:00,JNJ,neutral
709531.0,"Johnson & Johnson Says Bill Weldon Will Retire in April, Gorsky Will Succeed as CEO",2012-02-21 17:08:00-05:00,JNJ,positive
709532.0,Johnson & Johnson to Name Vice Chairman Gorsky CEO -WSJ,2012-02-21 16:33:00-05:00,JNJ,neutral
709533.0,US High Court Rejects J&J's Bid To Save Patent Case Against Abbott,2012-02-21 10:02:00-05:00,JNJ,neutral
709534.0,S&P Futures & Big 10 Analysis - Week of February 20,2012-02-20 12:01:00-05:00,JNJ,neutral
709535.0,Johnson & Johnson Wins First Personal Injury Trial Over Risperdal Risk,2012-02-16 11:43:00-05:00,JNJ,negative
709536.0,"Hedge Fund 13-F Updates: Berkshire, Greenlight, Paulson & Co., Appaloosa and More!",2012-02-14 17:44:00-05:00,JNJ,neutral
709537.0,Berkshire Filing Shows Reduced JNJ Stake,2012-02-14 16:36:00-05:00,JNJ,neutral
709538.0,S&P Futures & Big 10 Analysis - Week of February 13,2012-02-13 11:13:00-05:00,JNJ,neutral
709539.0,Healthcare Analyst: Contraceptive Costs Are Not Issue; Birth Statistics Can be Manipulated,2012-02-10 15:20:00-05:00,JNJ,negative
709540.0,Grandpa's 2012 ETF Portfolio,2012-02-10 13:48:00-05:00,JNJ,neutral
709541.0,"S&P Futures & Big 10 Analysis - Week of Feb 6, 2012",2012-02-06 11:19:00-05:00,JNJ,neutral
709542.0,"Benzinga's M&A Chatter for Thursday February 2, 2012",2012-02-02 19:57:00-05:00,JNJ,neutral
709543.0,UPDATE: First Global Downgrades Johnson & Johnson to Market Perform,2012-02-02 10:02:00-05:00,JNJ,neutral
709544.0,First Global Downgrades Johnson & Johnson to Market Perform,2012-02-02 09:21:00-05:00,JNJ,neutral
709545.0,"S&P Futures & Big 10 Analysis - Week of Jan 30th, 2012",2012-01-31 16:10:00-05:00,JNJ,neutral
709546.0,"Benzinga's M&A Chatter for Thursday January 26, 2012",2012-01-26 18:24:00-05:00,JNJ,neutral
709547.0,Johnson & Johnson Wins Jury Verdict Over Levaquin Warning Claim,2012-01-26 14:09:00-05:00,JNJ,positive
709548.0,Elan Spokesperson Will Not Comment on Rumor of Johnson & Johnson Offer,2012-01-26 07:44:00-05:00,JNJ,neutral
709549.0,Hearing Chatter Johnson & Johnson to Bid for Elan,2012-01-26 07:23:00-05:00,JNJ,neutral
709550.0,Johnson & Johnson Receives Positive Mad Money/Jim Cramer Mention -CNBC ,2012-01-25 18:27:00-05:00,JNJ,positive
709551.0,Piper Jaffray Lowers PT on Johnson & Johnson to $68,2012-01-25 08:34:00-05:00,JNJ,negative
709552.0,Morgan Stanley Concerned with Johnson & Johnson Sustaining a Path to Leverage,2012-01-25 08:10:00-05:00,JNJ,neutral
709553.0,Morgan Keegan Maintains Market Perform Rating on Johnson & Johnson,2012-01-25 08:01:00-05:00,JNJ,neutral
709554.0,Morgan Keegan Maintains Market Perform Rating on Johnson & Johnson,2012-01-25 08:01:00-05:00,JNJ,neutral
709555.0,"Benzinga's M&A Chatter for Tuesday January 24, 2012",2012-01-24 18:53:00-05:00,JNJ,neutral
709556.0,Hearing William Blair Making Negative Comments on Mako Surgical; Johnson  & Johnson Not Interested in Acquistion,2012-01-24 14:48:00-05:00,JNJ,negative
709557.0,JP Morgan Reiterates Neutral on Johnson & Johnson,2012-01-24 13:34:00-05:00,JNJ,positive
709558.0,Earnings Roundup,2012-01-24 10:01:00-05:00,JNJ,neutral
709559.0,Achillion Pharmaceuticals Spiking Higher on Renewed Takeover Chatter,2012-01-24 09:49:00-05:00,JNJ,neutral
709560.0,UPDATE: Johnson & Johnson Q4 Net Income Drops 89%,2012-01-24 08:01:00-05:00,JNJ,neutral
709561.0,Johnson & Johnson Guides FY2011 EPS $5.05-5.15 vs $5.20 Est,2012-01-24 07:48:00-05:00,JNJ,neutral
709562.0,Johnson & Johnson Reports Q4 EPS $1.13 vs $1.10 Est; Revenues $16.30B vs $16.28B Est	 		,2012-01-24 07:46:00-05:00,JNJ,neutral
709563.0,"US Stock Futures Down; McDonald's, Johnson & Johnson In Focus",2012-01-24 06:37:00-05:00,JNJ,neutral
709564.0,Earnings Scheduled For January 24,2012-01-24 06:03:00-05:00,JNJ,neutral
709565.0,Stocks To Watch For January 24,2012-01-24 05:46:00-05:00,JNJ,neutral
709566.0,Johnson & Johnson Earnings Preview,2012-01-24 03:40:00-05:00,JNJ,neutral
709567.0,Earnings Expectations for the Week of January 23,2012-01-22 14:13:00-05:00,JNJ,neutral
709568.0,"Democrats Seeks Hearing on Hazardous Medical Devices; Says Studies Show Risks wit J&J, Allergan Devices",2012-01-20 13:27:00-05:00,JNJ,negative
709569.0,"Benzinga's M&A Chatter for Wednesday January 18, 2012",2012-01-18 18:53:00-05:00,JNJ,neutral
709570.0,Positive Rumors Circulate About Vertex Pharmaceuticals,2012-01-18 09:43:00-05:00,JNJ,positive
709571.0,"Hearing Wedbush Says Idenix Pharmaceuticals Takeover Target of Merck, Johnson & Johnson, Abbott Labs; $24/Share",2012-01-18 08:07:00-05:00,JNJ,neutral
709572.0,Going Nuc-lear on Hepatitis C -- Is Idenix the Next Target?,2012-01-10 14:54:00-05:00,JNJ,neutral
709573.0,Dividend Champions a Rare Undervalued Opportunity,2012-01-06 13:41:00-05:00,JNJ,positive
709574.0,FDA Says Johnson & Johnson Doribax Trial Was Recently Stopped Early Because of Significant Safety Concerns -Reuters  ,2012-01-05 15:37:00-05:00,JNJ,positive
709575.0,J&J Said to Agree to $1B Accord in Risperdal Sales Probe,2012-01-05 14:50:00-05:00,JNJ,positive
709576.0,J&J and CR Bard Ordered to Study Injuries from Vaginal Implants,2012-01-04 15:00:00-05:00,JNJ,neutral
709577.0,Bark At The Dow's Dogs With These ETFs,2012-01-04 13:40:00-05:00,JNJ,neutral
709578.0,ETF Showdown: Fun With Pharma,2011-12-30 16:10:00-05:00,JNJ,positive
709579.0,Benzinga's Top Pre-Market Losers,2011-12-30 08:22:00-05:00,JNJ,negative
709580.0,Five ETFs For Fans Of Extreme Couponing,2011-12-28 13:12:00-05:00,JNJ,neutral
709581.0,"Fast Money Picks For December 28th (CP, TSM, SLB, SBUX, JNJ, ANF)",2011-12-27 21:03:00-05:00,JNJ,neutral
709582.0,Will This Company's Drug Cure Your Allergies?,2011-12-27 12:32:00-05:00,JNJ,neutral
709583.0,Best Biotech Stocks of 2011,2011-12-27 10:39:00-05:00,JNJ,positive
709584.0,FDA Advisers Vote That Current Label Adequately Reflects Risks and Benefits of Johnson & Johnson's Ortho Evra Contraceptive Patch  ,2011-12-09 15:38:00-05:00,JNJ,positive
709585.0,Mad Money Lightning Round: Cramer Likes Johnson & Johnson,2011-12-09 03:43:00-05:00,JNJ,negative
709586.0,Janssen Says Deal to Cut Johnson & Johnson 2011 EPS by $0.04-$0.05,2011-12-08 16:25:00-05:00,JNJ,negative
709587.0,Pharmacyclics Forms Pact to Develop and Commercialize PCI-32765 for Hematologic Cancers with Janssen Biotech ,2011-12-08 16:08:00-05:00,JNJ,neutral
709588.0,Affymax Wins FDA Panel Backing on Anemia Drug to Rival Amgen's,2011-12-07 16:53:00-05:00,JNJ,positive
709589.0,Biotech Stocks On the Move,2011-12-05 17:26:00-05:00,JNJ,neutral
709590.0,Are the Samsung M&A Rumors True?,2011-12-01 14:52:00-05:00,JNJ,positive
709591.0,Piper Jaffray Maintains Neutral Rating and $69 PT on Johnson & Johnson ,2011-12-01 07:26:00-05:00,JNJ,neutral
709592.0,These Stocks May Be Better Than Their Dow Equivalents,2011-12-01 04:03:00-05:00,JNJ,positive
709593.0,UPDATE: Citi Lowers PT to $70 on Johnson & Johnson ,2011-11-29 09:48:00-05:00,JNJ,negative
709594.0,Citigroup Lowers PT on Johnson & Johnson to $70,2011-11-29 07:23:00-05:00,JNJ,negative
709595.0,Stocks Going Ex Dividend the Fourth Week of November,2011-11-16 22:16:00-05:00,JNJ,neutral
709596.0,"Moving Away From The Materials Sector, Toward A Growth/Momentum Style",2011-11-16 02:41:00-05:00,JNJ,neutral
709597.0,Invest Like Buffett...With ETFs,2011-11-15 14:03:00-05:00,JNJ,positive
709598.0,"Brean Murray Carret & Co maintain Buy, $77 Target on Johnson & Johnson ",2011-11-14 11:06:00-05:00,JNJ,neutral
709599.0,Citi Has Buy on J&J,2011-11-14 07:38:00-05:00,JNJ,neutral
709600.0,Maintaining Stability in My Dividends and Yield Portfolio,2011-11-11 04:18:00-05:00,JNJ,neutral
709601.0,"Four Defensive ETFs You're Not Considering, But Should",2011-11-09 14:06:00-05:00,JNJ,neutral
709602.0,JNJ's Sterilmed Gets FDA Letter on Lack of Approval for Device,2011-11-08 09:28:00-05:00,JNJ,positive
709603.0,FDA Approves Bayer/J&J's Xarelto for Stroke Prevention,2011-11-04 20:21:00-04:00,JNJ,positive
709604.0,J&J-Synthes Deal Will Get Extend EU Antitrust Review,2011-11-03 18:22:00-04:00,JNJ,positive
709605.0,Mad Money Lightning Round: Cramer Advises Investors Not To Buy Microsoft,2011-11-01 03:32:00-04:00,JNJ,negative
709606.0,A Look at The New DRGS ETN,2011-10-31 13:34:00-04:00,JNJ,neutral
709607.0,How We Pick Stocks: The Case of Johnson & Johnson,2011-10-31 09:44:00-04:00,JNJ,neutral
709608.0,"Merck Earnings Preview: Analysts Expect Higher EPS, Revenue",2011-10-25 12:10:00-04:00,JNJ,neutral
709609.0,"Bristol-Myers Squibb Earnings Preview: Analysts Expect Rising Revenue, Falling EPS",2011-10-24 10:16:00-04:00,JNJ,negative
709610.0,The Donald Trump Bottom? 2 Months Later,2011-10-21 14:06:00-04:00,JNJ,neutral
709611.0,"Earnings Preview: Analysts Expect Boston Scientific's Revenue, Earnings to Dip",2011-10-19 16:13:00-04:00,JNJ,neutral
709612.0,JP Morgan Maintains Neutral on Johnson & Johnson's Mixed 3Q Results,2011-10-19 11:06:00-04:00,JNJ,positive
709613.0,Piper Jaffray Raises PT on Johnson & Johnson to $69,2011-10-19 08:21:00-04:00,JNJ,neutral
709614.0,Morgan Stanley Maintains Equal Weight Rating on Johnson & Johnson ,2011-10-19 07:56:00-04:00,JNJ,neutral
709615.0,Deutsche Bank Reiterates Hold Rating on Johnson & Johnson,2011-10-19 07:10:00-04:00,JNJ,neutral
709616.0,"End-of-Day Market Summary for October 18, 2011",2011-10-18 16:15:00-04:00,JNJ,neutral
709617.0,Earnings Roundup For October 18,2011-10-18 09:11:00-04:00,JNJ,neutral
709618.0,Johnson & Johnson Sees Net Income Climb,2011-10-18 08:22:00-04:00,JNJ,neutral
709619.0,UPDATE: Johnson & Johnson Reports Drop In Q3 Profit,2011-10-18 08:04:00-04:00,JNJ,positive
709620.0,Johnson & Johnson Guides FY2011 EPS $4.95-5.00 vs $4.96 Est,2011-10-18 07:46:00-04:00,JNJ,neutral
709621.0,Johnson & Johnson Guides FY2011 EPS $4.95-5.00 vs $4.96 Est,2011-10-18 07:46:00-04:00,JNJ,neutral
709622.0,Johnson & Johnson Reports Q3 EPS $1.24 vs $1.21 Est; Revenues $16.0B vs $16.02B Est		,2011-10-18 07:45:00-04:00,JNJ,neutral
709623.0,US Stock Futures Mixed Ahead Of Earnings Reports; IBM Shares Down In Pre-Market,2011-10-18 06:02:00-04:00,JNJ,positive
709624.0,Earnings Scheduled For October 18,2011-10-18 04:45:00-04:00,JNJ,neutral
709625.0,Brean Murray Carret & Co. Reiterates Buy Rating on J&J,2011-10-17 15:08:00-04:00,JNJ,neutral
709626.0,UBS Lowers PT on Johnson & Johnson to $72,2011-10-17 10:14:00-04:00,JNJ,negative
709627.0,Earnings Expectations for the Week of October 17,2011-10-16 09:36:00-04:00,JNJ,neutral
709628.0,"Abbott Laboratories Earnings Preview: Analysts Expect Higher EPS, Revenue",2011-10-14 17:54:00-04:00,JNJ,neutral
709629.0,"Johnson & Johnson Earnings Preview: Analysts Expect Rising Revenue, Falling EPS",2011-10-14 10:19:00-04:00,JNJ,negative
709630.0,Under The Hood: Emerging Markets Health Care,2011-10-13 13:01:00-04:00,JNJ,positive
709631.0,Piper Jaffray Neutral on Johnson & Johnson,2011-10-13 07:45:00-04:00,JNJ,neutral
709632.0,Boston Scientific Announces Favorable Appellate Court Ruling Affirming Non-Infringement of Johnson & Johnson Patent ,2011-09-29 06:49:00-04:00,JNJ,positive
709633.0,Remicade Receives FDA Approval as First Biologic Treatment for Pediatric Ulcerative Colitis,2011-09-24 10:37:00-04:00,JNJ,positive
709634.0,Charles Sizemore Quoted in Smart Money,2011-09-23 14:33:00-04:00,JNJ,positive
709635.0,"Johnson & Johnson Recalls 200,000 Syringes of Eprex Anemia Drug",2011-09-23 11:39:00-04:00,JNJ,neutral
709636.0,5 Exceptional Dividend Growth Stocks - Lower Volatility and Higher Total Return,2011-09-22 14:46:00-04:00,JNJ,positive
709637.0,UPDATE: Goldman Sachs Downgrades Johnson & Johnson to $63.13,2011-09-22 09:14:00-04:00,JNJ,neutral
709638.0,"Financial Breakfast: Morning News Summary for September 22, 2011",2011-09-22 07:54:00-04:00,JNJ,neutral
709639.0,"Goldman Sachs Downgrades Johnson & Johnson to Neutral, $74 PT",2011-09-22 07:28:00-04:00,JNJ,neutral
709640.0,Piper Jaffray Comments on Johnson & Johnson,2011-09-19 16:00:00-04:00,JNJ,neutral
709641.0,Johnson & Johnson CEO Weldon Says Too Early to Tell on US Economy,2011-09-16 11:46:00-04:00,JNJ,neutral
709642.0,Greece: The Questions Investors Should be Asking,2011-09-14 23:09:00-04:00,JNJ,neutral
709643.0,Johnson & Johnson to Face Arkansas Trial Over Risperdal -Bloomberg,2011-09-14 19:15:00-04:00,JNJ,neutral
709644.0,S&P Likes Three Health Care ETFs,2011-09-14 16:18:00-04:00,JNJ,positive
709645.0,"UPDATE: J&J Unit To Pay $85M Fine, Plead Guilty To Charge",2011-09-14 15:57:00-04:00,JNJ,negative
709646.0,"J&J Unit, US In Plea Pact For Natrecor Marketing Probe - Court Filing",2011-09-14 15:56:00-04:00,JNJ,neutral
709647.0,What If I'm Wrong?,2011-09-13 00:11:00-04:00,JNJ,negative
709648.0,Is Hansen Medical a Takeover Target?,2011-09-12 15:28:00-04:00,JNJ,neutral
709649.0,Citi Has Buy On Johnson & Johnson ,2011-09-09 07:51:00-04:00,JNJ,neutral
709650.0,Benzinga's Top Pre-Market Gainers,2011-09-09 07:46:00-04:00,JNJ,positive
709651.0,FDA Advisory Committee Recommends Approval of Johnson & Johnson Oral Anticoagulant,2011-09-08 17:39:00-04:00,JNJ,positive
709652.0,S&P Endorses Two Dividend ETFs,2011-09-07 12:01:00-04:00,JNJ,positive
709653.0,Johnson & Johnson's Zytiga Prostate-Cancer Drug Gets European Approval,2011-09-07 07:57:00-04:00,JNJ,positive
709654.0,Citi Maintains Buy on Johnson & Johnson,2011-08-30 09:21:00-04:00,JNJ,neutral
709655.0,"Groupon's Andrew Mason: ""I've Never Been More Confident and Excited about the Future of our Business""",2011-08-26 10:54:00-04:00,JNJ,neutral
709656.0,12 Most Popular Healthcare Stocks Among Hedge Funds,2011-08-25 17:10:00-04:00,JNJ,positive
709657.0,12 Most Popular Healthcare Stocks Among Hedge Funds,2011-08-25 11:36:00-04:00,JNJ,positive
709658.0,The Greatest Risk We Face: To Again Falling Into a Recession,2011-08-23 17:55:00-04:00,JNJ,negative
709659.0,The Global Meltdown of Confidence,2011-08-15 14:00:00-04:00,JNJ,positive
709660.0,Johnson & Johnson's McNeil Healthcare Division Recalling Tylenol Cold Nighttime Gelcaps,2011-08-15 13:11:00-04:00,JNJ,neutral
709661.0,Perrigo Earnings Preview,2011-08-15 09:55:00-04:00,JNJ,neutral
709662.0,The Donald Trump Bottom,2011-08-11 10:19:00-04:00,JNJ,neutral
709663.0,Warren Buffett Said Ignore Political and Economic Forecasts,2011-08-10 16:54:00-04:00,JNJ,negative
709664.0,Embrace Your Inner Spock: Three Questions Investors Should be Asking,2011-08-10 10:33:00-04:00,JNJ,positive
709665.0,"UPDATE: Goldman Sachs Reiterates Buy on Johnson & Johnson, Reduces PT to $74",2011-08-09 09:28:00-04:00,JNJ,neutral
709666.0,Goldman Sachs Lowers PT on Johnson & Johnson To $74,2011-08-09 08:46:00-04:00,JNJ,negative
709667.0,Where to Invest When the Market Crashes,2011-08-08 22:37:00-04:00,JNJ,neutral
709668.0,"S&P States that Recent US Downgrade Won't Affect Rating of these Six Top-Tier Companies: ADP, XOM, JNJ, MSFT, GE, GWW",2011-08-08 15:09:00-04:00,JNJ,neutral
709670.0,The New World Order of Global Sovereigns,2011-08-02 18:06:00-04:00,JNJ,neutral
709671.0,Hold These Funds Forever! Really? Forever?,2011-08-01 08:16:00-04:00,JNJ,neutral
709672.0,Benzinga's Top Pre-Market Losers,2011-08-01 07:58:00-04:00,JNJ,negative
709673.0,The Best 8 Stocks in the Dow,2011-07-29 17:06:00-04:00,JNJ,positive
709674.0,10 Wall Street All-Stars With Money-Making Potential,2011-07-29 17:02:00-04:00,JNJ,neutral
709675.0,Trading Weekly Options to Extract Profit from Amazon (AMZN),2011-07-29 17:00:00-04:00,JNJ,positive
709676.0,7 'Buy Rated' Stocks Trading Under $20,2011-07-29 16:57:00-04:00,JNJ,neutral
709677.0,15 Safe Dividend Kings for This Summer: Part 2,2011-07-29 16:53:00-04:00,JNJ,positive
709678.0,Central Bank of Colombia Raises Rate 25bps to 4.50%,2011-07-29 16:51:00-04:00,JNJ,neutral
709679.0,15 Safe Dividend Kings for This Summer: Part 1,2011-07-29 16:50:00-04:00,JNJ,positive
709680.0,7 Fortune 500 Companies That Are Hiring: Time to Jump in and Buy?,2011-07-29 16:45:00-04:00,JNJ,neutral
709681.0,What Investors Should Know About Apple but Often Don't,2011-07-29 16:40:00-04:00,JNJ,neutral
709682.0,High Yield Birth Control Stocks,2011-07-28 21:45:00-04:00,JNJ,neutral
709683.0,How to Profit from Exploding Government Healthcare Costs ,2011-07-28 09:37:00-04:00,JNJ,positive
709684.0,Top Yield Stocks of Warren Buffett,2011-07-28 01:19:00-04:00,JNJ,positive
709685.0,Hearing Supreme Court Asked to Overturn Obama's Health Care Reform,2011-07-27 15:19:00-04:00,JNJ,positive
709686.0,"Earnings Preview: Merck EPS, Revenue Expected to Rise from Previous Quarter",2011-07-26 13:00:00-04:00,JNJ,neutral
709687.0,Ratchet Back The Risk With These ETFs,2011-07-25 14:00:00-04:00,JNJ,negative
709688.0,"Boston Scientific Earnings Preview: Analysts Expect Rising Revenue, Falling EPS Over Previous Quarter",2011-07-25 13:49:00-04:00,JNJ,negative
709689.0,"Bristol-Myers Squibb Earnings Preview: Analysts Expect Rising Revenue, Falling EPS Over Previous Quarter",2011-07-25 12:45:00-04:00,JNJ,negative
709690.0,Nothing To Sneeze At Here,2011-07-25 08:35:00-04:00,JNJ,neutral
709691.0,No Respect: The Rodney Dangerfield of the Investment World,2011-07-22 18:11:00-04:00,JNJ,positive
709692.0,Johnson and Johnson: FDA Panel Backs Additional Use Of Remicade For Pediatric Patients,2011-07-21 15:25:00-04:00,JNJ,negative
709693.0,Fifteen Health Care ETFs Trading Near 52-Week Highs,2011-07-21 13:57:00-04:00,JNJ,positive
709694.0,"Earnings Preview: Gilead Sciences EPS, Revenue Expected to Rise from Previous Quarter",2011-07-21 13:12:00-04:00,JNJ,neutral
709695.0,Deutsche Bank Comments on Johnson & Johnson,2011-07-20 09:02:00-04:00,JNJ,neutral
709696.0,Gabelli Maintains Earnings Estimates On Johnson & Johnson ,2011-07-20 08:59:00-04:00,JNJ,neutral
709697.0,JP Morgan Reiterates JNJ Neutral Rating,2011-07-20 08:07:00-04:00,JNJ,positive
709698.0,UPDATE: Citi Raises PT on Johnson & Johnson to $73,2011-07-20 08:07:00-04:00,JNJ,neutral
709699.0,Morgan Stanley Comments on Johnson & Johnson,2011-07-20 07:35:00-04:00,JNJ,neutral
709700.0,Citigroup Raises PT On Johnson & Johnson To $73,2011-07-20 06:43:00-04:00,JNJ,neutral
709701.0,Is It Time To Buy Cisco?,2011-07-19 19:05:00-04:00,JNJ,neutral
709702.0,Malus domestica Produces  07-19-2011,2011-07-19 18:41:00-04:00,JNJ,neutral
709703.0,Will AAPL Succumb to Gravity?  07-19-2011,2011-07-19 15:21:00-04:00,JNJ,neutral
709704.0,Dow Jones Industrial Average Companies Increase Expected Dividend Distribution by 12.66% From a Year Ago,2011-07-19 10:14:00-04:00,JNJ,positive
709705.0,Earnings Roundup ,2011-07-19 09:01:00-04:00,JNJ,neutral
709706.0,UPDATE: Johnson & Johnson Reports Upbeat Q2 Profit,2011-07-19 08:35:00-04:00,JNJ,positive
709707.0,Benzinga's Top Pre-Market Losers,2011-07-19 08:22:00-04:00,JNJ,negative
709708.0,FDA Posts Staff Review of Study of J&J's Remicade in Children,2011-07-19 08:10:00-04:00,JNJ,neutral
709709.0,Johnson & Johnson Guides 2011 EPS $4.90-5.00 vs $4.96 Est.,2011-07-19 07:51:00-04:00,JNJ,neutral
709710.0,Johnson & Johnson Reports Q2 EPS of $1.28 vs. $1.23 Est; Revenues $16.6B vs. $16.22B Est,2011-07-19 07:49:00-04:00,JNJ,neutral
709711.0,US Stock Futures Up As Investors Await Earnings Reports,2011-07-19 06:26:00-04:00,JNJ,positive
709712.0,Earnings Scheduled For July 19,2011-07-19 03:20:00-04:00,JNJ,neutral
709713.0,Johnson & Johnson Announces Third-Quarter 2011 Quarterly Dividend of $0.57/Share,2011-07-18 14:56:00-04:00,JNJ,neutral
709714.0,Earnings Expectations for the Week of July 18,2011-07-17 09:18:00-04:00,JNJ,neutral
709715.0,"Boston Scientific Earnings Preview: Revenue, Earnings Expected to Fall from Previous Quarter",2011-07-15 11:00:00-04:00,JNJ,neutral
709716.0,Forest Laboratories Earnings Preview: Analysts Expect Rising Revenue,2011-07-15 10:55:00-04:00,JNJ,neutral
709717.0,"Earnings Preview: Johnson & Johnson EPS, Revenue Expected to Rise from Previous Quarter",2011-07-15 10:36:00-04:00,JNJ,neutral
709718.0,"Earnings Preview: Analysts Expect Abbott Laboratories Revenue, Earnings to Dip from Previous Quarter",2011-07-15 10:13:00-04:00,JNJ,neutral
709719.0,Benzinga's Top Pre-Market Losers,2011-07-15 08:19:00-04:00,JNJ,negative
709720.0,5 High Dividend Names For Sound Sleeping,2011-07-14 14:30:00-04:00,JNJ,neutral
709721.0,"Boston Scientific Earnings Preview: Revenue, Earnings Expected to Fall from Previous Quarter",2011-07-13 12:44:00-04:00,JNJ,neutral
709722.0,Twelve Health Care ETFs Trading Near 52-Week Highs,2011-07-13 07:38:00-04:00,JNJ,positive
709723.0,J.P. Morgan Previews 2Q Results For JNJ,2011-07-12 07:16:00-04:00,JNJ,neutral
709724.0,Twelve ETFs Trading Near 52-Week Highs,2011-07-12 06:56:00-04:00,JNJ,neutral
709725.0,UPDATE: Deutsche Bank Initiates Johnson & Johnson at Hold,2011-07-08 07:44:00-04:00,JNJ,neutral
709726.0,"Deutsche Bank Initiates Johnson & Johnson At Hold, $73 PT",2011-07-08 06:47:00-04:00,JNJ,neutral
709727.0,Stocks to Watch for 07/8/11: Fresh 52 Week Highs and Lows,2011-07-08 00:59:00-04:00,JNJ,positive
709728.0,Court of Appeals Affirms $16.56 Million Judgment Against Johnson & Johnson in Defective Fentanyl Patch Case ,2011-07-07 15:54:00-04:00,JNJ,negative
709729.0,Johnson & Johnson Announces Global Sponsorship of the 2014 FIFA World Cup Brazil ,2011-07-07 10:01:00-04:00,JNJ,neutral
709730.0,"""Can Stocks Be Safer than Bonds?""",2011-07-06 08:14:00-04:00,JNJ,positive
709731.0,Piper Jaffray Remains Neutral On Johnson & Johnson,2011-07-05 09:27:00-04:00,JNJ,neutral
709732.0,UPDATE: Johnson & Johnson: FDA Approves XARELTO,2011-07-01 15:14:00-04:00,JNJ,positive
709733.0,Time To Look At Boston Scientific?,2011-07-01 13:10:00-04:00,JNJ,neutral
709734.0,High Yield Big Pharmaceutical Stocks,2011-06-24 01:19:00-04:00,JNJ,neutral
709735.0,"Morgan Stanley Provides Color on Johnson & Johnson, Equal-Weight",2011-06-23 07:18:00-04:00,JNJ,neutral
709736.0,3 High Dividend Stocks The Smart Money Is Buying,2011-06-20 11:59:00-04:00,JNJ,positive
709737.0,Ortho-McNeil-Janssen Pharmaceuticals Voluntarily Recalls One Lot of RISPERDAL® Tablets and One Lot of Risperidone Tablets,2011-06-17 13:39:00-04:00,JNJ,neutral
709738.0,Goldman Sachs Maintains Buy on Johnson & Johnson,2011-06-16 08:00:00-04:00,JNJ,neutral
709739.0,Johnson & Johnson Announces Special Charge of $500-$600 Million Related to Restructuring Plans for Cordis Corporation Subsidiary ,2011-06-15 09:03:00-04:00,JNJ,positive
709740.0,The 8 Most Appropriate Strategies,2011-06-15 08:07:00-04:00,JNJ,neutral
709741.0,Hearing that J&J's Depuy has Won U.S. Approval for the First Ceramic-on-Metal Hip,2011-06-14 11:54:00-04:00,JNJ,positive
